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?
English?abstract??
Introduction:? Social? inequalities,? both? within? countries? and? between? countries,? influence? the?
occurrence?of?and?survival?from?cancer,? including?childhood?cancer.?This?dissertation?aimed?to?gain?
further?insight?into?social?inequalities?in?childhood?cancer?–?on?the?national?level?within?a?country?and?
also?between?countries?with?different? levels?of?socioeconomic?development.?The?first?objective?was?
to? obtain? a? better? understanding? of? the? reported? geographical? differences? in? childhood? cancer?
worldwide? by? studying? incidence? patterns? in? a? Sub?Saharan? African? country? (with? a? diverse?
racial/ethnic?population)?and?comparing? the? findings? to? the? incidence?patterns?of?a? representative?
high?income? country? (Germany).? The? second? objective?was? to? investigate? survival? from? childhood?
cancers?in?relation?to?social?and?family?factors?within?high?income?countries.?
Methods:? The? two? objectives?were? addressed? by? seven? conceptually? independent? but? topic?wise?
interrelated?studies.?Four?studies?provided?the?core?manuscripts? for?this?thesis:? i)?childhood?cancer?
incidence?patterns?by? race? in?South?Africa,?and? in? comparison? to?Germany;? ii)? survival? from?acute?
lymphoblastic?leukaemia?(ALL)?in?relation?to?socio?demographic?background?in?Germany;?iii)?survival?
from? ALL? in? relation? to? family? factors? in? Germany;? iv)? survival? from? childhood? haematological?
malignancies? in?relation?to?family?factors? in?Denmark.?Data?from?the?South?African?National?Cancer?
Registry,? the?German? Childhood? Cancer? Registry,? a? former?German? case?control? study,? as?well? as?
from?the?Danish?registries?served?as?the?basis?for?these?studies.?The?incidence?data?were?analysed?by?
applying? descriptive? epidemiological?methods.? Kaplan?Meier? curves? and? Cox? proportional? hazard?
models?were?used?for?the?survival?analyses.?
Results:?Substantial?differences? in?the?reported? incidence?rates?were?observed?within?South?African?
racial?groups,?with?lowest?rates?among?Black?children?and?highest?among?White?children.?There?were?
also? considerable? differences? between?White? children? in? South? Africa? and? in? Germany,? but? the?
differences?varied?markedly?by?cancer?type?and?by?age?at?diagnosis.?Social?and?family?characteristics?
were? found? to? be? associated? with? survival? from? childhood? cancers,? although? not? consistently?
between?Germany?and?Denmark?and?not?across?cancer?types.?An?impact?of?socioeconomic?factors?on?
survival?from?ALL?was?not?observed?for?either?Germany?or?Denmark,?however?a?beneficial?effect?of?
higher?maternal?education?among?children?with?non?CNS?solid? tumours? in?Denmark?was?observed.?
Higher? birth? order? and? having? siblings? was? associated? with? poorer? survival? among? childhood?
haematological? cancer? patients? in? Denmark,?with? associations? being? suggestive? for? ALL? and? non?
Hodgkin? lymphoma?but?stronger?and?statistically?significant? for?acute?myeloid? leukaemia.?Similarly,?
most? associations?with? family? factors?were? suggestive? for? survival? from? ALL? in? German? children.?
Highest? survival? in?Germany?was? seen? for? second?born? children.?Patterns?of?associations?between?
parental?age?and?survival?from?childhood?cancers?were?diverse?across?studies.?
Discussion:?Findings?of?this?dissertation?highlight?social?inequalities?in?childhood?cancer?with?respect?
to?reported?incidence?differences?between?racial?groups?in?South?Africa?and?compared?to?Germany.?
Furthermore,?survival?differences?between?social?groups? in?Germany?and?Denmark?were?observed,?
although? not? consistently? across? cancer? types.? To? reduce? those? observed? social? inequalities? in?
childhood?cancer,?a?thorough?understanding?of?the?underlying?mechanisms?and?pathways?is?needed.?
Observed? incidence? differences? in? South? Africa?might? be,? at? least? to? some? extent,? due? to? socio?
cultural?factors?related?to?access?and?utilization?of?health?care?services?rather?than?reflecting?actual?
differences? in?cancer?risks.?Under?ascertainment?of?cases?may?not?only?drive?the?findings?for?South?
Africa?but? the?global? reported?geographical?patterns?of?childhood?cancer? incidence.?Despite?highly?
specialized? and? standardised? treatment? and? free? health? services? for? all? children? in? Germany? and?
Denmark,?not?all?children?benefit?equally? from? improvements? in?childhood?cancer?survival.?Further?
studies?are?warranted? to?gain? knowledge?on? the? impact?of? social?and? family? factors?on? childhood?
cancer?survival?in?other?populations?and?to?identify?underlying?pathways.?
? ?
II?
?
German?abstract?
Hintergrund:? Soziale? Unterschiede? stehen? im? Zusammenhang? mit? der? Inzidenz? von?
Krebserkrankungen? sowie?mit?dem?Überleben?nach?Krebserkrankungen,?einschließlich?Kinderkrebs.?
In?Rahmen?dieser?Dissertation?sollten?vertiefende?Erkenntnisse?über?sozial?bedingte?Ungleichheiten?
bei?Kinderkrebs? gewonnen?werden?–? sowohl? auf?nationaler?Ebene? als? auch? zwischen? Ländern?mit?
unterschiedlichem? sozioökonomischem?Entwicklungsstand.?Die?erste?Zielsetzung?dieser?Arbeit?war,?
ein? besseres? Verständnis? über? die? berichteten? geographischen? Unterschiede? im? Auftreten? von?
Kinderkrebs?zu?gewinnen?und?hierzu?die?Kinderkrebsinzidenz?eines?Landes? in?Sub?Sahara?Afrika?(mit?
einer? ethnisch? vielfältigen? Bevölkerung)? zu? untersuchen? und? die? Ergebnisse? mit? der? Inzidenz?
Deutschlands? (als? Repräsentant? der? Inzidenz? von? Industrieländern)? zu? vergleichen.? Die? zweite?
Fragestellung? bezog? sich? auf? das? Überleben? von? Kinderkrebs? in? Bezug? auf? soziale? und? familiäre?
Merkmale?innerhalb?Bevölkerungen.?
Methoden:? Die? beiden? Fragestellungen? wurden? anhand? von? sieben? konzeptionell? unabhängigen,?
jedoch? thematisch?verknüpften?Studien?adressiert.?Vier?dieser?Studien?bilden?die?Kernmanuskripte?
dieser? Dissertation:? i)? Die? Inzidenz? von? Kinderkrebs? in? Südafrika? verglichen? zwischen? ethnischen?
Gruppen? und? im? Vergleich? zu? Deutschland;? ii)? Das? Überleben? von? Kindern? mit? akuter?
lymphoblastischer?Leukämie? (ALL)? in?Bezug?auf?soziodemographische?Merkmale? in?Deutschland;? iii)?
Das? Überleben? von? ALL? im? Zusammenhang? mit? familiären? Merkmalen? in? Deutschland;? iv)? Das?
Überleben? von? Kindern? mit? malignen? hämatologischen? Erkrankungen? im? Zusammenhang? mit?
familiären?Merkmalen?in?Dänemark.?Als?Datenquellen?dienten?das?südafrikanische?Krebsregister,?das?
deutsche? Kinderkrebsregister,? eine? deutsche? Fall?Kontroll?Studie? sowie? die? dänischen?
Bevölkerungsregister.? Die? südafrikanischen? Inzidenzdaten? wurden? mittels? deskriptiv?
epidemiologischer? Methoden? ausgewertet.? Für? die? Studien? zum? Überleben? nach? Krebs? wurden?
Überlebenskurven?nach?Kaplan?Meier?und?Cox?poportinal?hazard?Modelle?berechnet.?
Ergebnisse:? Die? beobachteten? Inzidenzraten? von? Kinderkrebs? in? Südafrika? unterschieden? sich?
erheblich?zwischen?ethnischen?Gruppen? innerhalb?Südafrikas.?Die?niedrigsten? Inzidenzraten?wurden?
bei?Kindern?der?schwarzen?Bevölkerung?und?die?höchsten?bei?weißen?Kindern?verzeichnet.?Auch? im?
Vergleich? zwischen? weißen? südafrikanischen? Kindern? und? deutschen? Kindern? zeigten? sich? große?
Inzidenzunterschiede,? wobei? sich? die? Abweichungen? deutlich? zwischen? Krebsformen? und?
Altersgruppen? unterschieden.? In? den? Studien? zum? Überleben? nach? Kinderkrebs? wurden?
Zusammenhänge? mit? sozialen? und? familiären? Merkmalen? und? dem? Überleben? von? Kinderkrebs?
beobachtet.? Allerdings? bestanden? diese? Zusammenhänge? nicht? einheitlich? für? Deutschland? und?
Dänemark? und? unterschieden? sich? auch? zwischen? den? untersuchten? Krebsformen.? Weder? für?
Deutschland? noch? für? Dänemark? zeigte? sich? ein? Zusammenhang? zwischen? sozioökonomischen?
Faktoren? und? dem? Überleben? nach? ALL,? wobei? hingegen? in? Dänemark? ein? positiver? Effekt? von?
höherer? mütterlicher? Bildung? für? Kinder? mit? solidem? Tumor? (andere? als? Tumore? des? zentralen?
Nervensystems)? beobachtet? wurde.? Zunehmende? Geburtenreihenfolge? sowie? die? Anzahl? an?
Geschwistern? war? mit? niedrigerem? Überleben? bei? Kindern? mit? malignen? hämatologischen?
Erkrankungen? in?Dänemark?assoziiert,?obwohl? sich?die?Zusammenhänge? für?ALL?und?Non?Hodgkin?
Lymphomen?überwiegend?als?nicht?statistisch?signifikant?erwiesen.?Statistisch?signifikant?und?stärker?
ausgeprägt?zeigten?sich?diese?Zusammenhänge?jedoch?bei?Kindern?mit?akuter?myeloischer?Leukämie.?
Auch? in? Deutschland? erreichte? die? Mehrheit? der? beobachteten? Zusammenhänge? zwischen? dem?
Überleben?nach?ALL?und? familiären?Merkmalen?keine? statistische?Signifikanz.?Das?beste?Überleben?
nach?ALL?wurde? in?Deutschland? für?Zweitgeborene?beobachtet.?Bezüglich?des?Alters?der?Eltern?und?
dem?Überleben?von?Kinderkrebs?zeigte?sich?kein?einheitliches?Bild.?
Diskussion:? Im? Rahmen? dieser? Dissertation? wurden? weitere? Erkenntnisse? zu? sozial? bedingter?
Ungleichheit? bei? Kinderkrebs? gewonnen.? Diese? Erkenntnisse? beinhalten? Inzidenzunterscheide?
zwischen?ethnischen?Gruppen? in?Südafrika?sowie? im?Vergleich?zu?Deutschland?und?Unterschiede? im?
Überleben? nach? Kinderkrebs? im? Zusammenhang? mit? sozialen? und? familiären? Merkmalen? in?
III?
?
Deutschland? und? Dänemark.? Um? Maßnahmen? zur? Verringerung? der? beobachteten? sozialen?
Unterschiede?zu?entwickeln,?ist?ein?genaues?Verständnis?der?zu?Grunde?liegenden?Wirkmechanismen?
und? Kausalzusammenhänge? wichtig.? Die? beobachteten? Unterschiede? in? der? Inzidenz? innerhalb?
Südafrikas? könnten? zumindest? zu? einem? gewissen? Teil? eher? auf? soziokulturelle? Unterschiede? im?
Zugang? und? in? der? Inanspruchnahme? von? Gesundheitsleistungen? zurückzuführen? sein? als? auf?
Unterschiede?im?Krebsrisiko.?Untererfassung?von?Kinderkrebsfällen?könnte?nicht?nur?in?Südafrika?eine?
Rolle? spielen,? sondern? auch? die? weltweiten? geographischen? Unterschiede? von? Kinderkrebs?
beeinflusst?haben.?Trotz?der?hoch? spezialisierten?und? standardisierten?Behandlung?und?dem? freien?
Zugang? zu?Gesundheitsleistungen? für? alle?Kinder? in?Deutschland?und?Dänemark? scheinen?dennoch?
nicht? alle? Kinder? gleichermassen? von? den? Fortschritten? bei? der? Diagnose? und? Therapie? von?
Kinderkrebs? profitiert? zu? haben.?Weitere? Studien? sollten? den? Einfluss? von? sozialen? und? familiären?
Hintergründen? im? Überleben? von? Kinderkrebs? in? weiteren? Bevölkerungen? untersuchen? sowie?
Erkenntnisse?über?deren?Kausalzusammenhänge?aufdecken.?
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?
Preamble?
Although? the? overall? incidence? is? low,? childhood? cancer? is? the? leading? cause? of? disease?
related?mortality?among? children? in?high?income? countries? [1].?Specific? types?of? childhood?
cancer? are? very?uncommon? [2?4],? collectively,?however,? they?present? an? important?public?
health?problem.??
Childhood? cancer? is? a? heterogeneous? group? of?malignancies,? each? representing? different?
epidemiological? characteristics,? biological? features,? treatment? approaches,? and? survival?
probabilities.?Little?is?known?about?their?aetiology,?although?it?is?likely?that?both?genetic?and?
environmental? factors?play?a? role? [5?8].?The?early?age?at?diagnosis?suggests? that?childhood?
cancer?might?originate? in?utero,?and?that? factors?prior?to?birth,? i.e.?preconception?or? foetal?
environmental? exposures,? as? well? as? those? in? early? childhood? may? be? important?
determinants? of? the? cancers? [9,? 10].?While? survival? from? childhood? cancer? has? improved?
considerably? over? the? last? decades? in? developed? countries,? with? five?year? survival? rates?
exceeding?now?77%?in?most?of?Europe?[11],?it?is?still?lower?for?some?diagnoses?such?as?certain?
types? of? leukaemia,? brain? cancers? or? sarcomas? [11]? and? is? presumably? much? lower? in?
developing? countries,? although? systematic? data? are? largely?missing? [1,? 12,? 13].? A? better?
understanding?of?risk?factors?influencing?incidence?and/or?survival?is?still?required.?
?
The?vast?majority?of?reported?data?in?the?literature?suggests?that?social?factors,?in?particular?
the? level?of?socioeconomic?development?of?a?country,?have?an? impact?on?childhood?cancer?
incidence?and?survival?rates?[1,?11,?14].?This?is?reflected?in?the?reported?higher?incidence?and?
survival? rates? in? high?income? countries? [3,? 4,? 11,? 15,? 16],? particularly? for? leukaemia,?
compared?to? low??and?middle?income?countries,?especially? in?Sub?Saharan?Africa?[2,?13,?17,?
18].?However,?the?geographical?incidence?patterns?are?increasingly?put?into?doubt?by?raising?
the? issue? that? under?diagnosis? and? under?reporting? may? at? least? partially? explain? those?
differences?[19,?20].?This?may?be?due?to?differences? in?access?and?utilization?of?health?care?
services,?high?prevalence?of?other?competing?diseases?(e.g.?malaria,?HIV/AIDS,?tuberculosis)?
with? sometimes? cancer?like? symptoms,? high? proportions? of? deaths? from? unknown? causes?
and?lack?of?systematic?disease?registration?[20].?
?
2?
?
Recent,? albeit? inconsistent? findings? suggest? that? social? and? family? factors? including?
socioeconomic?position?(SEP),?family?structure?and?family?size?as?well?as?place?of?residence?
and? accessibility? of? treatment? facilities? could? be? associated?with? survival? from? childhood?
cancer?not?only?in?developing?countries?but?also?in?high?income?countries?[21?29].??
?
The?overall?aim?of?this?dissertation?was?to?use?the?childhood?cancer?networks?established?at?
the? International? Agency? for? Research? on? Cancer? (IARC)? to? gain? further? insight? in? social?
inequalities? in?childhood?cancer?–?at? the?national? level?within?a?country,?but?also?between?
countries?with? different? socioeconomic? development.? The? cancer? registry? of? South? Africa?
was? used? for? the? first? time? to? systematically? quantify? the? registered? burden? of? childhood?
cancers? at? national? level? and? study? stratification? by? racial? groups.? Since? race? is? highly?
correlated?with?socio?cultural?factors?including?SEP?and?access?to?private?health?care?services?
in?South?Africa?[30],?differences?in?the?reported?incidence?by?racial?groups?might?be?at?least?
partly? explained? by? case? under?ascertainment.? No? systematic? follow?up? of? patients? is?
performed? in? the? South? African? cancer? registry,? so? that? the? quantification? of? childhood?
cancer?as?public?health?problem?also?aims?at?supporting?improved?monitoring?of?occurrence?
and?survival?in?the?future.?
?
The? role?of? social?and? family? factors? in? survival? from?childhood?cancer?was? investigated? in?
two?high?income?countries,?namely?Germany?and?Denmark,?countries?with?uniform?access?to?
health?care?and?standardised?treatment?for?childhood?cancers?[31?33].?From?a?public?health?
perspective? the? goal? was? to? potentially? identify? families? that? require? a? more? targeted?
approach?to?benefit?from?recent?survival?improvements.??
?
Family?characteristics?were?also?associated?with?risk?of?childhood?cancer?in?previous?studies,?
although?they?were?used?as?proxy?measures?of?specific?exposures.?For? instance,?birth?order?
was?used?as?a?proxy?for?child’s?exposure?to?infectious?agents?[34,?35].?If?these?exposures?are?
associated?with?the?risk?of?developing?cancer,?they?may?also?be?related?to?risk?of?relapse?and,?
consequently,? survival? [36].? Thus,? it? is? important? to?have? solid?evidence? for?both? risk? and?
survival,?but?also? for? the? former? the? literature? is?not?entirely?consistent? [37?41]?and? large?
scale?systematic?studies?are?still?needed.?For?that?reason,?investigating?the?role?of?birth?order?
concerning?childhood?cancer?risk?at?a?nationwide?level?in?Denmark?is?also?part?of?this?thesis.?
3?
?
The?overall?and?specific?objectives?of?this?dissertation?are?further?defined?in?Chapter?5?of?this?
thesis.?
? ?
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1 Health?in?children?
1.1?Morbidity?and?Mortality?in?children?
The?population?age?structure?differs?across?the?world.?About?17%?of?the?population?of?high?
income? countries? are? children? younger? than? 15? years,?with? slightly?more? boys? than? girls?
(estimates? from? the?United?Nations? Population?Division's?World? Population? Prospects? for?
2012)?[42].?Because?of?high?birth?rates?on?one?hand,?but?also?fairly?high?death?rates?and?low?
life? expectancy? on? the? other? hand,? the? population? age? structure? in? developing? countries?
differs?considerably? from? the?age? structure? in?developed?countries? [1]:?Almost?40%?of? the?
population? in? low?income? countries? are? younger? than? 15? years,?while? it? is? 32%? in? lower?
middle?income? countries? and? 22%? in? upper?middle?income? countries,? respectively? [42].?
Nearly?90%?of?the?world’s?children?live?in?low??and?middle?income?countries.?
?
As?well?as?differences? in?age?structure?between?developed?and?developing?countries,?there?
are?similarly?differences?in?the?burden?of?disease,?mortality?rates?and?causes?of?deaths.?
While?the?under?five?mortality?in?2012?in?high?income?countries?was?6.6?per?1,000?live?births,?
it?was?substantially?higher?in?low?income?countries,?with?a?rate?of?almost?80?per?1,000?and?as?
high? as? 95? per? 1,000? in? Sub?Saharan? Africa? [42].? The? causes? of? under?five?mortality? are?
predominately?neonatal? conditions? (including?preterm?birth? complications),? communicable?
diseases? and? nutritional? deficiencies,? but? vary? widely? between? regions? (with? substantial?
variation? across? regions?with? similar? level?of? socioeconomic?development)? and? for? infants?
younger?than?1?month?versus?children?aged?1?59?months?[43].?While?the?causes?of?neonatal?
mortality?are?similar?across?populations? (neonatal?disorders?and?preterm?birth),?the?causes?
of?post?neonatal?mortality?vary?by? region.?For? instance,? in?Sub?Saharan?Africa? for?children?
aged?1?–?59?months?diarrhoeal?diseases,?lower?respiratory?infections,?Malaria,?HIV/?AIDS?and?
nutritional?deficiencies?are?the?most?important?causes?of?deaths.?By?contrast,?in?high?income?
countries,?main?causes? include? injuries,? the?sudden? infant?death?syndrome?and?other?non?
communicable?disease?[43].??
According? to?WHO?mortality?data? for?2008,? in?children?aged?5?14?years? the?most?common?
cause?of?disease?related?death?in?children?was?cancer?in?high?income?countries?(32.4%),?with?
more?than?5?times?as?many?deaths?from?cancer?as?from?communicable?diseases?[1].?In?low??
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and?middle?income?countries?deaths? from?communicable?diseases?dominate?cancer?deaths?
in? all? age? groups,? although? due? to? improving? economic? development? the? ratio? between?
communicable?and?non?communicable?becomes?smaller.?In?children?aged?5?14?years?in?low?
income?countries,?about?18?times?more?deaths?result?from?infections?and?parasitic?diseases?
than? from? cancer,? compared? to?about?2?times? as?many? in?upper?middle?income? countries?
[1].? The? burden? of? communicable? disease? varies? considerably? between? and? within?
developing? regions.? In? Sub?Saharan? Africa,? similar? to? the?mortality? in? children? aged? 1?59?
months,?diarrhoeal?diseases,?lower?respiratory?infections,?Malaria?and?also?HIV/?AIDS?are?the?
major?causes?of?deaths?in?children?under?15?years?[43].?
?
Malnutrition? in?children? is?still?a?major?public?health? issue? in?most? low??and? lower?middle?
income? countries,?with? a?prevalence?of? about? 23? –? 26%? in? children?under? 5? [42].?On? the?
contrary,?with?an?estimated?prevalence?of?3.3%?for?children?under?5?years?in?upper?middle?
income?countries?and?of?1%?in?high?income?countries?(in?the?WHO?Global?Database?on?Child?
Growth?and?Malnutrition)?[42]?malnutrition?is?of?minor?relevance?for?those?countries.?There,?
however,?the?prevalence?of?overweight?and?obesity?has?substantially?increased?over?the?past?
decades.?According? to? the?Global?Burden?of?Disease?Study,?about?24%?of?boys?and?23%?of?
girls?aged?2?19?years?were?overweight?or?obese? in?2013? [44].?However,? the?prevalence?of?
overweight? and?obesity? is? also? rising? in? children? and? adolescents? in?developing? countries.?
With?a?prevalence?of?approximately?13?%?in?2013?[44]?overweight?and?obesity?has?become?a?
major?global?health?challenge,?as?chronic?diseases?including?diabetes,?cardiovascular?disease,?
cancer?and?osteoarthritis? in? later? life?may?be?a?consequence?of?overweight?and?obesity? in?
early?life?[44].?
?
1.2?Cancer?in?children?
The?term?childhood?cancer?is?most?commonly?used?to?describe?cancers?that?occur?in?patients?
younger?than?15?years?of?age?[2],?although?this? is?an?arbitrary?cut?off?and? in?practice?based?
on?convenience?as?many?childhood?cancer?registries?collect?case? information?of?children?up?
to?the?age?of?15?(or?are?sufficiently?complete?in?their?collection?of?case?information?up?to?this?
age).?An?alternative?definition?for?childhood?cancer,?frequently?used?in?the?US,?is?cancers?that?
occur?in?patients?younger?than?20?years?[4,?45].?
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The? spectrum?of? cancers? in? children? compared? to? adults? is? very?different.?Haematological?
malignancies?represent?40?–?60%?of?all?cancers? in?the? first?15?years?of? life? [2,?3,?15],?while?
they? make? up? less? than? 10%? in? adults? in? developed? countries.? Structure? of? childhood?
leukaemia? by? types? also? differs? from? a? structure? of? adult? leukaemia.? Several? histological?
types? of? solid? tumours? almost? exclusively? occur? in? childhood,? especially?Wilms? tumour,?
neuroblastoma?and? rhabdomyosarcoma.?Tumours?of? the?central?nervous?system? (CNS)?are?
the?most?common?solid?tumours?in?children;?pilocytic?astrocytoma?and?medulloblastoma?are?
the?most? frequent? types?of?brain? tumours? that?almost?exclusively?occur? in?childhood? [46].?
There? are? also? differences? between? childhood? and? adulthood? cancers? in? terms? of? cancer?
origin? and? various? clinical? characteristics.? The? biological? nature? of? cancers? in? childhood? is?
clinically,?histopathologically,?and?biologically?distinct?from?that?of?adult?onset?malignancies.?
Childhood? cancers? tend? to? have? short? latency? periods,? are? often? rapidly? growing? and?
aggressively? invasive,? are? rarely? associated? with? exposures? to? carcinogens? which? are?
associated? with? adult? onset? cancers,? and? are? generally? more? responsive? to? standard?
modalities? of? treatment,? in? particular,? chemotherapy? [47].?Unlike? cancer? in? adults,?many?
childhood? cancers? develop? as? a? result? of? abnormal? cell?maturation.? The? tissue? of? tumour?
origin,?rather?than?tumour? location? in?the?body,? is?the?best?predictor?of?tumour?behaviour,?
and?following?prognosis?and?treatment?[47].??
For?this?reason?a?separate?classification?system? for?childhood?cancers?has?been?developed,?
based?on?the?morphology?and?topography?axes?of?the?International?Classification?of?Diseases?
for?Oncology?(ICD?O)?[48]?which?is?the?main?coding?system?for?adult?cancers.?However,?while?
most?cancers?in?adults?are?classified?according?to?topography,?the?internationally?recognised?
childhood?cancer?classification?is?based?mainly?on?morphology?[49,?50].?The?current?standard?
for? childhood? cancer? is? the? third? edition? of? the? International? Classification? of? Childhood?
Cancers? (ICCC?3),?which? classifies? tumours? coded? according? to? the? ICD?O?3? nomenclature?
into?the?12?major?diagnostic?groups? [49]?shown? in?Table?1.?Although?tumours?of?benign?or?
uncertain? behaviour? are? generally? not? reported? in? cancer? statistics? for? adults,? the? ICCC?
includes?non?malignant? intracranial?and? intraspinal?tumours? in?categories? III?and?X?[49]?due?
to?similarities?with?malignant?tumours?in?their?clinical?symptoms?and?prognosis.?
?
? ?
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Table?1:?The?12?major?diagnostic?groups?as?well?as?subgroups?of?leukaemia?and?lymphoma?of?the?
International?Classification?of?Childhood?Cancer,?third?edition?[49].?
?
ICCC?3?diagnostic?group? Term/Abbreviation? used? in? this?
report?
I? Leukaemias,?myeloproliferative?disease?and?
myelodisplastic?diseases?
Leukaemias?
I?a? Lymphoid?leukaemias? ALL
I?b? Acute?myeloid?leukaemias? AML
I?c? Chronic?myeloproliferative?diseases
I?d? Myelodysplastic?syndrome?and?other?myeloproliferative?
diseases?
I?e? Unspecified?and?other?specified?leukaemias
II? Lymphomas?and?reticuloendothelial?neoplasms Lymphomas??
II?a? Hodgkin?lymphomas? HL
II?b? Non?Hodgkin?lymphomas?(except?Burkitt?lymphoma) NHL
II?c? Burkitt?lymphoma?
II?d? Miscellaneous?lymphoreticular?neoplasms
II?e? Unspecified?lymphomas?
III? CNS?and?miscellaneous?intracranial?and?
intraspinal?neoplasms?
CNS?tumours??
IV? Neuroblastoma?and?other?peripheral?nervous?
cell?tumours?
Sympathetic?nervous?system?
tumours??
V? Retinoblastoma?? Retinoblastomas?
VI? Renal?tumours?? Renal?tumours?
VII? Hepatic?tumours?? Hepatic?tumours?
VIII? Malignant?bone?tumours? Malignant?bone?tumours
IX? Soft?tissue?and?other?extraosseous?sarcomas? Soft?tissue?sarcomas?
X? Germ?cell?tumours,?trophoblastic?tumours,?and?
neoplasm?of?gonads?
Germ?cell?tumours??
XI? Other?malignant?epithelial?neoplasm?and?
melanomas?
Malignant?epithelial?neoplasms?
XII? Other?and?unspecified?malignant?neoplasm? Other?&?unspecified?malignant?
tumours?
?
Leukaemia??
Leukaemias?are?cancers?of?the?blood?causing?the?bone?marrow?to?produce?abnormal?white?
blood? cells.? Leukaemia? is? classified?according? to? the? type?of?white?blood? cells? it?affects?as?
either? lymphoblastic? leukaemia? or? myeloid? leukaemia? and? according? to? how? quickly? it?
develops?as?acute?or?chronic;?acute?lymphoblastic?leukaemia?(ALL)?is?the?most?common?type?
in?children.?Symptoms?especially?of?ALL?are? relatively?unspecific?and? include? fatigue,? fever?
and? infections,?weight? loss,?pallor,?bruises,? a? fine? rash?of?dark? red? sports,?breathlessness,?
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swelling?of?the?abdomen?and?swollen? lymph?glands.?Some?children?may?experience?pain? in?
the? bones? as? result? of? increased? bone? marrow? activities.? Blood? tests,? bone? morrow?
aspiration? and? biopsy? and? lumbar? puncture? are? the?most? important? diagnostic? tests? for?
leukaemia?[51].??
Treatment?and?prognosis?depend,?among?other?factors,?on?the?type?of?leukaemia.?Treatment?
for? ALL? typically? spans? 2? –? 2.5? years? and? includes? three? phases:? induction? of? remission,?
intensification?(or?consolidation),?and?maintenance?(or?continuation)?[51,?52].?
?
Lymphoma?
Lymphomas? are? cancers? that? originate? in? the? body’s? lymphatic? tissues.? Lymphomas? are?
divided?into?two?broad?types,?depending?on?the?appearance?of?their?malignant?cells,?Hodgkin?
and? non?Hodgkin? lymphomas? including? the? subgroup? of?Burkitt? lymphoma.? Each? of? these?
types? also? has? several? subtypes.? Children? with? Hodgkin? lymphoma? (HL)? typically? have?
abnormal?cells?called?Reed?Sternberg?cells?(a?cancerous?B?lymphocyte)?in?the?cancer?affected?
lymph?nodes.?In?non?Hodgkin?lymphoma?(NHL),?there?is?a?malignant?growth?of?specific?types?
of?lymphocytes?which?is?also?seen?in?ALL.?In?general,?people?with?lymphoma?have?no?or?only?
minimal? bone?marrow? involvement,?whereas? those?with? leukaemia? have? extensive? bone?
marrow? involvement? [53].? The? commonest? places? for? lymphoma? to? be? found? are? lymph?
nodes? in?the?neck,? liver,?or?spleen.?Most?common?symptoms?of? lymphoma? include?painless?
swellings? in?the?neck,?armpit?or?groin;?and?more?general?symptoms?are?fever,?night?sweats,?
difficulty?in?breathing?and?weight?loss?[53].?Hodgkin?lymphomas?tend?to?be?relatively?slowly?
growing,?whereas? the?majority? of?non?Hodgkin? lymphomas? are? highly? aggressive? and? fast?
growing.?The?most?important?diagnostic?test?is?a?lymph?node?biopsy?[53].?Type?of?lymphoma?
determines?treatment?and?prognosis;?Hodgkin? lymphoma? is?one?of?the?most?curable?forms?
of?childhood?cancer?[54].?
?
Central?nervous?system?(CNS)?tumours?
Together,? the?brain?and? spinal?cord?make?up? the?central?nervous? system.?There?are?many?
types?of?CNS?tumours?in?children?with?most?of?them?occurring?in?the?brain.?CNS?tumours?are?
classified?by?the?affected?cell?type?and?in?children?astrocytomas?(originating?from?astrocytes),?
medulloblastomas?(originating?from?cells? left?from?the?earliest?development?of?the?body? in?
the?womb)?and?ependymomas?(ependymal?cells)?are?the?most?common?ones.?CNS?tumours?
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are?formed?by?the?abnormal?growth?of?cells?and?may?be?begin?or?malignant.?Both?benign?and?
malignant? brain? tumours? can? cause? severe? symptoms? and? need? treatment.? Presenting?
features?are?mainly?dependent?on?the?location?within?the?brain?or?spinal?cord,?the?size?of?the?
tumour? and?how? fast? the? tumour? grows.? Tumours? in? any?part?of? the?brain?may? raise? the?
pressure? inside?the?skull,?causing?headache,?nausea,?vomiting,?seizures,?strabismus?and? loss?
of? vision,? coordination? and? balance? [55].?Diagnostic? imaging? such? as?magnetic? resonance?
imaging?and?computer?tomography?are?used?for?diagnosis.?Treatment?is?based?among?others?
on?the?type?of?tumour,?position,?tumour?size?and?age?of?the?child?[55].?
?
Sympathetic?nervous?system?tumours/?Neuroblastoma?
Neuroblastoma?develops?from?nerve?cells?called?neuroblasts?and?most?commonly?originates?
from? the? tissue? of? the? adrenal? glands,? the? triangular? glands? on? top? of? the? kidneys.?
Neuroblastoma?has?a?diverse?pattern?of?clinical?presentation?and?prognosis?that?ranges?from?
spontaneous?regression?to?metastatic?tumours.? It? is?the?most?common?cancer?diagnosed? in?
infancy?[56].?In?a?few?cases,?the?tendency?to?get?this?type?of?cancer?can?be?passed?down?from?
a?parent?to?a?child?(familial?type),?but?most?cases?of?neuroblastoma?(98%)?are?not?inherited?
(sporadic?type)?[56].?The?first?symptoms?are?often?vague?and?may?include?irritability,?fatigue,?
loss? of? appetite,? and? fever? [56].? Symptoms? depend? on? primary? tumour? locations? and?
metastases?if?present.?Treatment?of?neuroblastoma?depends?on?the?stage?of?the?cancer,?the?
age?and?other?prognostic?markers.?
?
Retinoblastoma??
Retinoblastoma? is? the?most? common? neoplasm? of? the? eye? in? children? and? grows? in? the?
retina,? a? layer? of? nerve? tissue? in? the? back? of? the? eye.? Retinoblastoma? affect? very? young?
children? [57].?Two?clinical? forms?of? retinoblastoma?are? identified:?75%?of?all?cases?present?
with? unilateral? retinoblastoma? (only? one? eye? affected)? and? 25%?with? the? bilateral? form.?
Children?with?bilateral?retinoblastoma?carry?a?specific?germline?mutation?(of?the?RB1?gene).?
The?mutation?is?in?25%?of?all?cases?inherited?from?an?affected?parent?and?in?75%?of?all?cases?
results? from?a?de?novo?mutation? in?utero? [57].?Visible?symptoms? include?odd?looking?pupil?
(looking?white? and? reflecting? light)? and? swelling? of? the? eye.? Treatment? is? risk?adapted? by?
intraocular?and?extraocular?stage,?laterality?and?potential?for?vision?[57].??
? ?
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Renal?tumours?
The? most? common? form? of? kidney? tumours? in? children? is? Wilms? tumour.? Most? Wilms?
tumours?are?unilateral,?but?about?5%?of?children?with?Wilms?tumors?have?bilateral?disease?
[53].?The?most? common? signs?are?a? lump?often? larger? than? the?kidney? itself? in? the? child’s?
abdomen? and? abdominal? pain,? blood? in? urine? and,?more? general,? hypertension,? nausea,?
constipation?and? fever? [53].?Common? tests? to?diagnose?kidney? tumours? include?blood?and?
urine? tests? as?well? as? diagnostic? imaging.? The? primary? treatment? of? all? renal? tumours? in?
children?is?surgical?removal?[53].?
?
Hepatic?tumours??
There?are?two?main?types?of?malignant?hepatic?tumours?in?children:?Hepatoblastoma?usually?
occurs? in? children? under? the? age? of? three? years,? and? hepatocellular? carcinoma? in? older?
children.?The?most?common?sign?is?a?lump?or?swelling?in?the?abdomen,?which?can?be?painful.?
Other?possible?symptoms? include?weight? loss,?a? loss?of?appetite,?nausea?and?vomiting?[53].?
Diagnostic? procedures? include? diagnostic? imaging,? blood? tests? and? biopsy.? Treatment? of?
malignant?liver?tumours?depends?on?staging?[53].?
?
Malignant?bone?tumours??
Malignant?bone? tumours?occur?most?often? in? teenagers.?The? two?most? common? types?of?
bone? cancer? in? children? are? osteosarcoma? and? Ewing? sarcoma.? About? 80%? of? childhood?
osteosarcomas?develop?at? the?ends?of? the? long?bones? that? form? the? knee? [53].?However,?
osteosarcoma?can?develop?in?any?bone?of?the?body.?Ewing?sarcomas?are?more?likely?occur?in?
pelvis,?ribs?or?spine?[53].?The?most?common?symptoms?are? localised?bone?pain.?This?can?be?
accompanied?by? tenderness,? swelling?and? fever.?The?grading? largely?determines?prognosis?
and?treatment?strategy?[53].?
?
Soft?tissue?sarcomas??
Soft? tissue? sarcomas? are? a? diverse? group? of? cancers? that? develop? in? soft? tissue? around?
muscles,? fat,? blood? vessels,? lymphatic? vessels,? nerves,? ligaments? and? tendons,? which?
connects,? supports,?or? surrounds?bones? and?organs? [53].?Rhabdomyosarcoma? is? the?most?
common? type? of? soft? tissue? sarcoma? in? children?which? usually? affects? infants? and? young?
children.?It?tends?to?occur?in?the?head?and?neck?area,?bladder,?vagina,?and,?in?or?around?the?
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prostate?and?testes.? In?comparison?to?other?cancers,?sarcomas?tend?to?occur? in?extremities?
of? the?body? [53].?Symptoms?are? specific? to? the?affected?area.?Some? children?may?present?
with? lump?on?specific?sites,?nasal,?vaginal?or?rectal?bleeding,?headache,?sinusitis,?persistent?
ear,?nasal?discharge?or?bulging?eyes.?The?primary?treatment?is?surgical?removal.?
?
Germ?cell?tumours??
Germ? cell? tumours? are? made? of? varied? group? of? cancers? that? originate? from? cells? that?
normally?develop?into?gonads?(testes?in?boys,?and?ovaries?in?girls)?usually?then?affecting?the?
gonads,?but? they?can?also?occur? in?other?parts?of? the?body?such?as?pelvis,?brain?and?chest?
[53].?Treatment?usually?includes?either?surgery?or?chemotherapy,?or?often?a?combination?of?
the?two.?
?
Epithelial?tumours?and?melanoma??
Epithelial?cells?form?outer?layer?of?skin?and?line?internal?cavities?in?the?body.?Most?glands?are?
usually?composed?of?epithelial?cells.?Melanoma,?although?very?rare,?is?the?most?common?skin?
cancer? in? children,? followed? by? basal? cell? carcinomas? and? squamous? cell? carcinomas.?
Melanoma?typically?occurs?as?skin?cancer.?It?originates?from?the?cells?which?produce?pigment?
defining?colour?of?skin?hair?and?eye?(melanocytes).?The?cancer?does?not?present?symptoms?
[53].?Exposure?to?ultraviolet?radiation?and?a?light?skin?type?have?been?shown?to?be?the?main?
causes? of? skin? cancer? [58].?Diagnosis? usually? follows? discovery? of? suspicious? lesion?which?
changes?size,?colour,?itching?or?bleeding?[53].?Treatment?depends?on?the?stage?of?melanoma?
and? includes? typically? surgery? to? remove? the? lesion?which?might?be? sufficient? for? children?
with?localized?melanoma?or?non?melanoma?skin?cancer.?
? ?
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2 Incidence,? aetiology? and? risk? factors? of?
childhood?cancer?
2.1?Incidence?and?geographical?patterns?of?childhood?cancer?
Population?based? cancer? registries? around? the? world? report? overall? incidence? rates? of?
childhood?cancer? in?under?15?years?olds?that?vary?between?50?and?200?per?million?children?
per?year?[59].??
The? incidence? is?well?described?for?economically?developed?countries?[60?62].?For? instance,?
recent?age?standardised?incidence?rates?of?164,?178,?and?157?per?million?children?have?been?
reported? in?Germany? [3],?US?Whites? [4],?and?Australia? [15],? respectively.?According? to? the?
Automated?Childhood?Cancer?Information?System?(ACCIS)?database?the? incidence?of?cancer?
in? children?under?15?years?of?age?during?1988?1997?was?139? cases?per?million? for?Europe?
overall,?ranging?from?131.1?in?the?British?Isles?to?160.1?in?Northern?Europe.?When?looking?at?
individual? countries,? the? highest? incidence? was? reported? for? Finland? (173? per? million?
children)? [61].?The? incidence?rates?vary?between?age?groups?and?sex,?with?highest?rates? in?
infants?(<?1?year)?but?just?slightly?lower?at?age?1?–?4?years;?incidence?rates?at?ages?5?–?9?years?
and?10?–?14?years?are?similar?to?each?other?but?substantially?lower?in?the?first?5?years?of?life.?
Boys?of?any?age?have?a?higher?risk?of?cancer?than?girls?(sex?ratio?boys?to?girls:?1.2)?[3,?61].??
In?contrast,?high?quality?data? in? less?economically?developed?countries?and,? in?particular,? in?
Sub?Saharan?Africa?are?limited?[1].?From?Sub?Saharan?Africa?childhood?cancer?incidence?rates?
of?35,?120,?and?174?per?million?were?reported?from?Gambia?[17],?Zimbabwe?(Harare?city)?[18]?
and?Kyadono? (including?the?city?of?Kampala)? in?Uganda? [17].? It? is?noteworthy?that?data? for?
Zimbabwe? and? Uganda? are? from? restricted? geographical? regions? including? major? urban?
centres?of?their?countries.??
?
The?spectrum?of?tumour?types?in?children?differs?across?populations?[3,?4,?15,?17,?63,?64].?In?
high?income?countries?patterns?are?quite?consistent?across?regions:?leukaemias?are?the?most?
frequent? childhood? cancer? (with? 32%? of? all? childhood? cancer? for? Europe? and? 34%? for?
Germany)?with? ALL? accounting? for? up? to? 25%? of? all? childhood? cancers,? followed? by? CNS?
tumours?(22???24%),?lymphomas?(11%)?and,?lastly,?other?solid?tumours?than?CNS?tumours?[3,?
15,? 16,? 65].? In? contrast,? in? Sub?Saharan? Africa,? NHL? (Burkitt’s? lymphomas)? and? Kaposi?
sarcoma
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White/Black? ancestry,? cancer? rates? were? approximately? 28%? lower? than? that? of?Whites,?
whereas?estimates? for?White/Asian?as?well?as?White/Hispanic? children?did?not?differ? from?
those? for?Whites? [69].?Authors? speculated? that?different? racial/ethnic? groups?may? vary? in?
terms? of? their? environmental? exposures? and? that? there?might? be? important? interactions?
between?selected?exposures?and?underlying?genetic?susceptibility?[69].?
?
According?to?the?data?from?population?based?cancer?registries,?the?overall?incidence?rate?of?
childhood?cancer?has?been? increasing?by?about?1%?per?year?over?the? last?three?decades? in?
Europe,?North?America,?Australia? [3,?15].?The? rate?of? increase? is?observed? to?have? slowed?
down? since? the? turn? of? the?millennium.? However,? these? temporal? trends?might? be? also?
related?to? improved?diagnosis?and?more?complete?reporting?of?childhood?cancer,?although?
effects? of? changes? in? exposure? and? lifestyle? cannot? be? excluded? and? remain? a? plausible?
explanation.??
?
There? is?evidence?that?social?factors,? in?particular? level?of?socioeconomic?development?of?a?
population,? are? related? to? the? reported? incidence? of? childhood? cancer? in? the? respective?
country? [1,?14].?This? is?consistent?with? the?higher? reported? incidence? rates? in?high?income?
countries? [3,?4,?15,?16]?compared? to? low??and?middle?income?countries? [1,?17,?63,?64,?70],?
especially?Sub?Saharan?Africa,?and? is?particularly?pronounced? for? leukaemia? [17].?Observed?
geographical?differences?in?incidence?rates?have?been?used?to?support?several?hypotheses?of?
the? association? between? exposures? related? to?modern? lifestyle? and? the? risk? of? childhood?
cancer,?particularly?childhood?leukaemia?[34].?These?include?factors?related?to?social?contacts?
and? patterns? of? infection? or? infectious? contacts? in? early? life? [34],? but? also?maternal? diet?
during? pregnancy? [71],? parental? occupational? exposures? prior? to? conception? or? during?
pregnancy?[6,?72],?and?exposures?to?electromagnetic?fields?[73]?(see?Chapter?2.2).??
However,?comparing?international?childhood?cancer?rates?is?challenging?because?of?different?
diagnostic? and? reporting? standards? across? countries.?Recent? studies? from?Brazil? and? India?
suggest?that?under?reporting?of?ALL?may?be?sufficiently?large?to?account?for?most,?if?not?all,?
of? the? observed? differences? between? these? countries? compared? with? Europe? and? North?
America?[74,?75].?Less?though?is?known?on?potential?under?diagnosis?and?under?reporting?in?
most?of?African?or?Asian? countries? [1],?where? registries?are? facing?various? challenges?with?
respect? to?capturing? information?on?cases.? In? these? regions,?many? (young)?cancer?patients?
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may? not? even? reach? a? physician/? a? clinic,? hence? no? treatment? or?misdiagnosis? are?major?
issues,?and? linkage?between?cancer?registries?(if?they?exist)?and?hospitals?are?not?always? in?
place? [1,?14,?20,?76].?Geographical?differences? in? incidence? rates?may?also? suggest?unique?
genetic?or?environmental?exposures?that?affect?the?risk?of?childhood?cancer?(or?certain?types?
of?childhood?cancer).?However,?for?most?of?African?or?Asian?countries?the?extent?of?under?
diagnosis? under?reporting? remains? unclear? at? present.? The? degree? of? incomplete?
ascertainment? may? vary? by? cancer? type,? race/ethnicity,? sex? or? age? [77],? depending? for?
instance?on?the?fatality?of?the?cancer,?whether?ethnicities/?racial?groups?have?similar?access?
to?health?care,?gender?based?differences?in?some?cultures,?or?competing?risks?in?certain?ages?
(e.g.,?infant?mortality?due?to?infections?[78]).?
?
2.2?Risk?factors?of?childhood?cancer?
As? previously? stated,? childhood? cancer? is? a? heterogeneous? group? of? malignancies? with?
different?aetiologies.?Given?the?challenges?related?to?childhood?cancer?epidemiology?due?to?
this?great?heterogeneity,?coupled?with?low?incidence?rates,?evidence?regarding?causal?factors?
has? accumulated? slowly.? Little? is? still? known? about? the? aetiology? of? these? cancers,? but? it?
appears? that?genetic,? intrinsic?as?well?as?environmental? factors?play?a? role? [6?8].?The?early?
age?at?diagnosis? indicates? that?childhood?cancer?might?originate? in?utero,?and? that? factors?
prior? to? birth,? including? preconception? and/or? foetal? environmental? exposures,? as?well? as?
those? in?early?childhood?may?be? important?determinants? [7,?10,?34].?For?example? for?ALL,?
some?genetic?aberrations?have?been?detected? in?neonatal?blood? spots?of?healthy?children?
that? later?developed? the?disease? [79],?providing?evidence?of? the? initiation?of?at? least?some?
types?of?ALL?prior?to?birth.?
?
A? few? chromosomal? and? genetic? conditions,? exposure? to?high?dose? ionizing? radiation? and?
prior? chemotherapy,? and?birth?weight? are? confirmed? risk? factors? [7,?8]?but?explain?only? a?
small?percentage?(<10%)?of?all?cases.?Children?with?Down?syndrome?(trisomy?21)?are?at?10?
20?fold?higher?risk?to?develop?leukaemia?in?comparison?to?general?children?[80].?In?nearly?all?
patients?with?retinoblastoma?germ? line?mutations? in?the?RB?gene?cause?the?disease.?These?
patients? are? also? at? increased? risk? of? other? cancers? [57].? There? are? numerous? other?
syndromes? which? are? related? to? an? extremely? high? cancer? risk,? such? as? Li?Fraumeni?
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syndrome,?Gorlin? syndrome? and? other? [81,? 82].?However,? these? syndromes? are? rare? and?
explain?only?a?small?minority?of?all?childhood?cancers?[7].?
?
Exposure? to? infections? has? been? one? of? the? most? extensively? studied? environmental?
exposures? in? relation? to?ALL? risk,?with? two?major?hypotheses? regarding? the?nature?of? this?
relationship.? Kinlen? [83]? initially? hypothesized? that? previously? isolated,? and? thus?
immunologically? naïve,? rural? populations? are? susceptible? when? exposed? to? unfamiliar?
infections? because? of? population?mixing.? Later? this? was? expanded? to? include? in? general?
children?with?more?social?contacts?and?thereby?potential? for?exposure?to? infections.?Meta?
analyses? give? some? support? to? the? hypothesis,?with?most? evidence? coming? from? specific?
settings? in? the? UK? [84],? for? example? around? nuclear? power? plants? or? other? major?
construction?sites.?Greaves’?“delayed?infection”?hypothesis?suggests?that?ALL?(or,?to?be?more?
precise,?its?most?common?subtype?called?common?ALL)?results?from?an?unregulated?immune?
response?from?an?immature?and?unchallenged?immune?system?caused?by?delayed?exposure?
to? common? infections? in? infancy? [34,? 85],? i.e.? lack? of? exposure? to? infections? in? infancy?
coupled?with?higher?burden?to? infections? later? in? life.?Direct?measurements?of?exposure?to?
infections? and? the? resulting? immune? response? are? not? feasible.?However,? several? proxies?
have?been?used?including?birth?order,?assuming?lower?potential?of?infections?among?firstborn?
children?[10,?40],?day?care?attendance,?assuming? lower?potential?of? infections?among?those?
not?attending?day?care?[86],?breast?feeding,?assuming?better?immunological?training?by?those?
breast?fed?[87],?as?well?as?directly?assessing? infectious? illness?history?and?vaccinations?[88].?
Protective?effects?were?found?for?breastfeeding?and?day?care?attendance?[89,?90],?although?
it? is?unclear?whether?exposure? to? infections?or?other? factors?drove? these?associations.?For?
birth? order,? according? to? the? “delayed? infection? hypothesis”? it? would? be? expected? that?
firstborn? children?would?have? less? contact?with? infectious?agents? than? children?with?older?
siblings?and,?as?such,?have?an?increased?risk?of?ALL.?However,?findings?from?epidemiological?
studies?on?ALL?are?inconclusive?[37,?38,?40,?41,?91],?as?they?are?for?other?childhood?cancers?
[10,?37,?39,?40,?92].?
?
Recent?pooled?and?meta?analyses?provide?some?support?of?an? increased? leukaemia?risk?for?
both? residential? [72,?93]?and?maternal?occupational? [94,?95]?exposure? to?pesticides.?Many?
other?promising?hypotheses? related? to?environmental? factors?have?been? studied? including?
19?
?
history? of? maternal? infections? and? medication? use? around? the? time? of? pregnancy? [96],?
maternal? [97]? and? paternal? [10,? 98]? smoking,? maternal? alcohol? consumption? [10,? 99],?
maternal? coffee? consumption? [100]? and? vitamin? use? [101]? and? parental? exposure? to?
chemicals?such?as?solvents?and?metals?[7],?but?without?conclusive?evidence.?Epidemiological?
studies?have?consistently?shown?a?positive?association?of?extremely?low?frequency?magnetic?
fields? with? an? approximately? two?fold? higher? childhood? leukaemia? risk? at? average? 24?h?
exposure? levels? exceeding? 0.3?0.4? μT? [73].? A? causal? relationship,? however,? has? not? been?
established?due? to? the?potential? for?bias?and?confounding? in? those?studies?and? the? lack?of?
supporting?evidence?from?experimental?studies?and?mechanistic?data?[102].?
Few?studies?were?published?on?gene?environment? interactions,?with? inconsistent?results?to?
date,?but?this?is?a?relatively?recent?approach?and?many?more?studies?are?in?progress.?
?
With? respect? to? intrinsic? factors? of? the? children? or? their? parents,? birth? weight? was?
consistently? found? to? be? associated?with? several? childhood? cancers,? albeit?with? differing?
patterns.?Risk?of?ALL? [103,?104],?neuroblastoma? [105]?and?Wilms? tumour? [106]? is?elevated?
with?high?birth?weight?with?a? linear? rising? risk?with? increasing?birth?weight,?although? to?a?
varying?degree.?For?acute?myeloid?leukaemia?(AML)?and?CNS?tumours?[107,?108]?the?risk?may?
be? elevated? at? both? high? and? low? birth?weight? [103].? Very? high? risk? in? low? birth?weight?
children?of?hepatoblastoma?was?also?observed?[109].?The?reasons?behind?the?association?of?
higher? birth? weight? with? childhood? cancers? are? not? fully? understood? but? might? include?
prenatal? grow? hormone? exposure? (insulin?like? growth? factor?1)? [110],? the? underlying?
genetics?of?birth?weight? [111]?or?simply? the?higher?number?of?cells?at?risk? for?carcinogenic?
transformation?[8].?
Advanced?parental?age?has?also?been?associated?with?most?childhood?cancers,?but?findings?
are?not? fully? consistent? across? studies? [10,? 40,? 112?115].?A? large?population?based? cohort?
study? from?Sweden?noticed?no?significant? results? for?parental?age? in?children?5?–?14?years?
age,?but?in?children?younger?than?5?years,?maternal?age?was?associated?with?an?elevated?risk?
of? retinoblastoma? and? leukaemia? and?paternal? age?with? an? increased? leukaemia? and?CNS?
tumour? risk? [114].? In? another? Swedish? investigation? parental? age? was? not? found? to? be?
associated?with?ALL? [115].?However,?a? recent? large?pooled?analysis? from? the?US?observed?
significantly?increasing?risks?of?leukaemia,?lymphoma,?brain?tumours,?neuroblastoma,?Wilms?
tumour,?bone?tumours?and?soft?tissue?sarcoma?with?6%?to?15%? increase? in?risk?per?5?years?
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advancing?maternal? age,?while? advancing? paternal? age?was? not? independently? associated?
with? these? cancers? after? adjustment? for?maternal? age? [113].? The? reasons? behind? those?
observed? associations? are? not? clear,? but? may? include? genetic? and? epigenetic? mutations?
related?to?advanced?parental?age.?
?
Similar? to?most? factors? studied,? findings? for? the? association? between? SEP? and? childhood?
cancer?risk?are?conflicting?[40,?68,?115?119],?with?associations?varying?by?study?design,?time?
period,?cancer?type?and?SEP? indicator?used?and?whether?the? indicator?was?at?the? individual?
or? family? level? versus? ecological? grouping.? The? relationship? with? SEP? has? been? most?
exhaustively?studied?for? leukaemia?risk,?with?heterogeneous?results?[40,?68,?115?119].?Little?
is?known?on?SEP?patterns?of?risk? for?other?types?of?childhood?cancer.?A? large?pooled?study?
from?the?US?found?an? indication?of?a?positive?association?with? lower?parental?education?for?
both? Hodgkin? and? Burkitt? lymphomas? and? for?Wilms? tumour? and? in? contrast? a? possibly?
protective? effect? of? lower? parental? education? for? astrocytoma? (a? common? type? of? CNS?
tumour)? and? hepatoblastoma? [68].? Finally,? however,? and? irrespective? of? the? SEP?markers?
used,?the?observed?associations?between?SEP?and?some?childhood?cancer?types?may?reflect?
differences? in? exposure? to? certain? risk? factors? of? the? respective? cancer? type? that? vary? by?
socioeconomic?groups.?
? ?
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3 Mortality,? survival? and? prognostic?
factors?of?childhood?cancer?
3.1?Clinical?trials?and?standardised?treatment??
Childhood?cancer?histologically?embodies?very?diverse? types?of?cancers,?which?are? treated?
differently? and?with? dissimilar? survival? [11].? Over? the? past? decades,? advances? in? tumour?
biology,?risk?grouping,?and?pharmacology?have?led?to?substantial?improvements?in?treatment?
of?childhood?cancers?which,?alongside?with?advances?in?diagnostic?procedures,?have?resulted?
in?substantial?survival?improvements?and?declining?mortality?rates.??
The?longstanding?integration?of?clinical?research?with?front?line?care?in?paediatric?oncology?is?
considered? the? most? important? reason? for? this? substantial? progress.? First? collaborative?
clinical?research?to?identify?effective?treatment?for?children?with?cancer?started?in?the?US?and?
dates?back? to? the?1950s,?when?children?with?ALL?were?some?of? the?earliest?participants? in?
clinical?trials?of?new?drugs?for?cancer?treatment?[12].?While?the?initial?clinical?trials?primarily?
focused?on?new?treatment?protocols?for?leukaemia,?the?scientific?agenda?was?soon?expanded?
to?common?solid? tumours,?namely?neuroblastoma?and?brain? tumours.?By? the?1970s,?every?
common?childhood?cancer?was?being?studied?as?part?of?various?collaborative?clinical?study?
groups?from?the?US?or?Europe?[12].?
Diagnostic? procedures? and? treatment? protocols? are? nowadays? largely? standardised?within?
developed? countries? [31?33,? 120?122].? Almost? all? childhood? cancer? patients? are? treated?
according? to? the? treatment? schemes?developed?by? collaborative? study?groups? such?as? the?
Nordic?Society?of?Paediatric?Haematology?and?Oncology?[31,?32,?120],?the?Berlin?Frankfurt?
Münster? study? group? (BFM)? [33],? the? cooperative? study? group? for? childhood? acute?
lymphoblastic? leukaemia? (COALL)? [123],? the? United? Kingdom? Medical? Research? Council?
Childhood?Leukaemia?Working?Party?[122],?the?Children’s?Oncology?Group?(COG)?[124]?or?the?
International?Society?of?Paediatric?Oncology? (SIOP)? [125],?with?specific?treatment?protocols?
depending?on?type,?prognostic?risk?group?and?stage?of?cancer.?For?each?cancer?type?several?
specific?protocols?exist?for?subtypes?based?on?staging,?histology,?genetics?and?early?response?
to? treatment? [12].The? ongoing? challenge? is? to? maximise? the? chance? of? survival? from?
childhood?cancers?while?minimising?the?short?term?and? long?term?side?effects?of?treatment?
[12].?Notably,? however,? survival? remains? poor? for? some? childhood? cancer? types? [11]? and?
develop
(see?Ch
diagnos
countrie
protoco
them.?
chemot
?
3.2?Mo
Nowada
better?
leukaem
The?5?y
nowada
?
Figure?3
groups?
countrie
(EUROC
ing? countr
apter?3.2).?
ed?annually
s,? paediat
ls?as?best?a
The? main?
herapeutic?
rtality?an
ys,? in?high
than? for? a
ia?and? lym
ear?surviva
ys?in?the?de
:?Country?
for? childre
s? diagnos
ARE?5?data
ies?have?no
It? is?estima
?in?the?EU?
ric? oncolog
s?possible?
relevant?
agents?and
d?surviva
?income?co
dult? canc
phoma,? im
l?rate?from?
veloped?w
weighted?5
n? (under? 1
ed? with? c
).?Figure?is?
t?benefitte
ted?that?m
[59]?enter?
ists? try? to
but?depend
factors? in
?their?relate
l?from?ch
untries,?su
er.? Surviva
proved?sub
childhood?
orld?[11,?12
?year? survi
5? years? of?
ancer? bet
based?on?d
?
d? from? the
ore?than?9
standardise
? adapt? th
ing?on?the?
clude? the
d?costs.?
ildhood?c
rvival? from
l? rates? fo
stantially?o
cancer?has?
,?62,?126?1
val?by? ICCC
age)? from?
ween? 200
ata?from?re
?progress?
0%?of?the?1
d?treatme
e? internati
local?circum
availabilit
ancer?an
?childhood
r? most? ch
ver?the?pa
increased?f
29].??
?3?diagnos
29? Europe
0? and? 20
ference?[11
made? in?de
5,000?child
nt?program
onally? esta
stances?th
y? of? radi
d?geogra
cancer? is?g
ildhood? ca
st?decades?
rom?30%?in
?
tic?
an?
07?
].?
veloped? c
hood?canc
mes.?In?dev
blished? tre
ey?need?to
ation? facil
phical?pa
enerally?g
ncers,? par
[11,?62,?12
?the?1960s
22?
ountries?
er?cases?
eloping?
atment?
?modify?
ities? or?
tterns?
ood?and?
ticularly?
6,?127].?
?to?80%?
23?
?
Figure?3?shows?the?5?year?survival?for?children?from?29?European?countries?diagnosed?with?
cancer?between?2000?and?2007,?presenting?the?most?recent?EUROCARE?results?(a?European?
wide? project? on? population?based? cancer? survival).? For? all? childhood? cancer? combined?
survival?after?5?years?was?78%,?however,?there?was?considerable?variation?between?cancer?
types? [11].? Most? haematological? cancers? carried? favourable? prognosis,? with? the? 5?year?
survival?ranging?from?84%?to?95%?(86%?for?ALL),?except?for?AML?with?less?than?63%?survival.?
The? 5?year? survival? for? CNS? tumours?was?modest? at? 58%? [11].? For?most? cancers,? survival?
dropped?considerably?after? the? first?year? from?diagnosis.?Survival?did?not?differ?noticeably?
between?boys?and?girls,?but?the?5?year?survival?of?girls?with?ALL?was?slightly?higher?compared?
to?boys.?For?all?childhood?cancer?combined?as?well?as? just? for?ALL? the?5?year? survival?was?
highest? for? children? aged? 1?4? years.? Children? aged? younger? than? 1? year? showed? lowest?
survival? for? several? cancers,? including? ALL,? AML,? non?Hodgkin? lymphoma? and?most? CNS?
tumours.?In?contrast,?infants?with?neuroblastoma?have?good?survival?[11].?
?
Despite? these? improvements? in? survival,?disparities?exist?even?between?European? regions.?
Table?2?presents?the?5?year?survival?from?childhood?leukaemia?diagnosed?from?1999?to?2007?
in? Europe? by? regions.? Survival? differs? obviously? between? European? regions? with? lowest?
survival? in? Eastern? Europe? –? a? rather? less? privileged? region? compared? to? other? European?
regions.?Dissimilarities? in?survival?persisted?over?the?entire?time?period?and?were?particular?
pronounced?for?AML?[11].?Gatta?and?colleagues?discussed?that?a?lack?of?resources?as?well?as?
differences? in?paediatric?oncology? services?might?explain? these? intra?European?differences?
[11].? In?recent?decades,? improvements? in?childhood?cancer?survival?were?most?pronounced?
in?Eastern?Europe?[11].?
?
? ?
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Table? 2:? 5?year? age?standardised? survival? from? leukaemia? in? European? children? (under? 15?
years?of?age)?by?region?from?1999?to?2007.?The?table?is?based?on?data?from?reference?[11].?
? N?(1995?–?2007)? %?Survival?
1999?–?2001? 2002?–?2004? 2005?–?2007?
ICCC?3?Ia:?Acute?lymphoblastic?leukaemia?
Northern?Europe? 2,305? 84.8? 87.9? 86.7?
UK?and?Ireland? 5,022? 81.5? 87.0? 89.4?
Central?Europe? 8,565? 86.1? 90.0? 90.1?
Southern?Europe? 1,202? 83.6? 86.0? 87.2?
Eastern?Europe? 2,003? 69.7? 75.8? 80.3?
All?Europe? 19,097? 82.2? 86.3? 87.6?
? ? ?
ICCC?3?Ib:?Acute?myeloid?leukaemia? ? ?
Northern?Europe? 445? 66.9? 71.4? 67.3?
UK?and?Ireland? 1,005? 65.6? 61.1? 66.5?
Central?Europe? 1,525? 60.8? 62.8? 67.3?
Southern?Europe? 218? 79.1? 58.8? 67.4?
Eastern?Europe? 398? 42.9? 45.4? 49.0?
All?Europe? 3,591? 63.3? 59.5? 64.4?
?
The?survival? improvements?are?reflected? in?the?decline? in?childhood?cancer?mortality?rates.?
According? to?data? from? the?US? the? childhood? cancer?mortality? rate? (in? children?under? 20?
years?of?age)?has?decreased?by?more?than?50%?between?1975?and?2006.?The?decrease?was?
mainly?due?to?the?declining?mortality?for? leukaemia?(64%?reduction),?gonadal?cancer?(85%),?
Non?Hodgkin?lymphoma?and?Hodgkin?lymphoma?(75%),?and?neuroblastoma?and?bone?cancer?
(35?40%).?The? leading?causes?of?cancer?death? in?children?are? leukaemias?and?CNS? tumours?
[62].?Similar?decreases?in?mortality?were?also?noticed?in?Europe?[65].?The?rate?of?decrease?in?
mortality,?however,?has?slowed?down?since?the?early?2000s?[2]?with?an?estimated?mortality?
rate?of?29?per?million?children?in?Europe?in?2012?[59].?
?
The? substantial? improvement? in? survival? is? mainly? limited? to? high?income? countries.?
Information?on?childhood?cancers? in?middle?? income?countries? is?scarce?and? indicates?that,?
despite?of?the?different?reporting?periods,?the?proportion?of?5?year?survivors? is?much? lower?
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3.3?Clinical?prognostic?factors?
Important?prognostic?factors?for?childhood?cancers?are?patient?sex?and?age?at?diagnosis,?as?
well?as?clinical?parameter?including?disease?subtype,?histology,?stage,?grade,?white?blood?cell?
count? or? site? [51,? 54,? 55,? 57,? 62,? 131].? However,? patterns? of? prognostic? factors? vary?
considerably?by?type?of?cancer.??
For?ALL,? clinical? prognostic? factors? are? age,? sex,? presenting? leucocyte? count,? racial? group,?
immunophenotype,?recurrent?chromosomal?abnormalities,?spread?to?certain?organs?(such?as?
cerebrospinal?fluid?or?testicles?(boys))?and?response?to? initial?therapy?[51,?52,?132].?Clinical?
prognostic?factors?for?AML?include?age,?cytogenetic?and?molecular?markers,?leukocyte?count,?
and? response? to? induction? therapy? [133].?For? lymphoma?age,? sex,? clinical? stage,?histology,?
site,? chromosomal? abnormalities,? tumour? burden? and? response? to? initial? therapy? are?
important? clinical? factors? for? prognosis? [54,? 134].? With? respect? to? solid? tumours,?
predominantly? stage,? histology,? tumour? site,? tumour? size? and? age? are? the? most? robust?
prognostic?factors?[55?57,?135].?Prognostic?factors?are?used?for?the?stratification?of?therapy?
as?patients?with?high?risk? features?receive?more? intensive?or?specific?treatment? [51,?54?57,?
133].?
?
3.4?Social?and?family?factors?and?survival?from?childhood?cancer?
For?adult?cancers,?it?is?well?established?that?socioeconomic?characteristics?influence?survival.?
More?socially?deprived?patients?have?consistently?inferior?survival?than?those?who?are?better?
off?[136?138].?By?contrast,?little?is?known?about?the?potential?role?of?social?and?family?factors?
in? childhood? cancer? survival. Evidence? from? low?? and?middle?income? countries? is? largely?
regional?within? individual?countries?and? typically? focused?on? leukaemia?and?socioeconomic?
factors? [139?143].?Observed? associations?between? inferior? survival? and? low? SEP? [139?143]?
have? been? attributed? to? a? range? of? factors? including? malnourishment? [140,? 144],? and?
treatment?abandonment?[143,?145].??
For?developed?countries,?only?few?studies?have?investigated?the?relationship?between?social?
and? family? factors?and? survival? from? childhood? cancer,?mainly? studying? leukaemia? survival?
and?with?diverse?findings,?even?within?Europe?[21,?22,?24?26,?146?148].?The?sparse?evidence?
includes? findings? on? SEP? (with? different? markers? used,? varying? considerably? between?
studies),?ethnicity/? race,?number?of? siblings,?maternal?age?at?child’s?birth,?parent’s?marital?
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status,?attendance?to?day?care?and?place?of?residence.?An?overview?of?the?current?state?of?
evidence?is?given?below:? 
?
Socioeconomic?factors?
Socioeconomic? differences? in? childhood? cancer? survival? have? been? observed? in? some?
developed?populations?including?United?Kingdom,?Norway,?Greece,?and?South?Korea?[21,?22,?
26,?148,?149],?but?the?evidence?is?inconsistent?and?sometimes?conflicting.?
Markedly? higher? ALL? survival?was? observed? among?more? affluent? socioeconomic? groups,?
measured? by? both? area?based? deprivation? scores? and? father’s? occupational? status,? in?
England,?Scotland?and?Wales? [21,?148],?while?a?similar?study? from?Northern?England? [127]?
that?used?solely?area?measures?of?SEP?did?not?find?significant?differences? in?survival?for?any?
type? of? childhood? cancer.? An? exception?was? CNS? tumours?with? survival? being? higher? for?
children?living?in?more?deprived?areas?compared?with?those?from?more?affluent?areas?[127].?
For?earlier?time?periods?(before?1990)?little?evidence?of?a?socioeconomic?gradient?in?survival?
from?ALL?was?reported? for?England?and?Wales? [150],?although?small?differences? in?survival?
between? socioeconomic? groups? (3?6%)? were? noticed.? Also? a? recent? study? from? Ireland?
observed? only?weak? trends? in? survival? disparity? from?ALL? in? relation? to? SEP,? but? no? clear?
evidence?was?found?of?a?deprivation?related?impact?for?other?childhood?cancers?[25].?
For? Greece,? findings? from? a? recent? nationwide? study? indicate? an? association? between?
parental?socio?professional?level?and?ALL?survival.?Children?diagnosed?with?ALL?of?lower?SEP?
status?experienced?40%?worse?survival? than?more?privileged?children? [26].?The?association?
between?maternal?education?and?ALL?survival?observed?in?previous?Greek?studies?[146,?147]?
appeared? to? persist? no? longer? [26].? On? the? contrary,? a? very? comprehensive? study? from?
Norway?on?social? inequalities? in?childhood?cancer?survival?observed?an?about?15%?reduced?
mortality?rate?for?children?with?highly?educated?mothers?[22].?Findings?from?the?Netherlands?
on? parental? education? have? been? less? convincing? and? correspond? to? leukaemia? cases?
diagnosed?already?in?the?70ies?[24].??
Recent?investigations?from?Ontario,?Canada?did?not?find?evidence?for?a?relationship?between?
SEP,?measured? by? neighbourhood? income? quintile? and?material? deprivation? quintile,? and?
survival? from? childhood? lymphoma? [29]? nor? for? an? impact? of? SEP,? defined? by? only?
neighbourhood?income,?on?ALL?survival?[28].?Also?in?California,?a?US?state?with?no?universal?
access? to? health? care,? the? SEP? neighbourhood? status? appeared? not? be? related? to? survival?
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from? childhood? leukaemia;? however,? lack? of? health? insurance? or? an? unknown? status? of?
insurance?coverage?was?associated?with?inferior?survival?from?leukaemia?[27].?
?
Race/?ethnicity??
The? impact? of? race/? ethnicity? on? disease? outcome? has? been? studied? in? several? childhood?
cancers? [151?158],? although? the? evidence? has? been? more? extensively? described? for?
haematological?malignancies?than?for?solid?tumours?[159].?Poorer?outcome?was?reported?for?
Black?children?compared?to?White?children?by?the?majority?of?the?studies.?
For? instance,? large?studies?based?on?population?based?data?and?cooperative?group?trials? in?
the? US? noticed? significant? racial? and? ethnic? differences? in? survival? from? ALL,? with? poor?
survival? for? Black? children? compared? to?White? children? but? similarly? inferior? outcome? for?
Hispanics? [153,? 160,? 161].? Bhatia? and? colleagues? reported? superior? outcome? for? Asians?
compared?to?White?children?[160],?while?a?recent?comprehensive?investigation?based?on?the?
SEER?data?did?not?confirm?a?generally?better?survival?for?Asians?but?dissimilarities?in?outcome?
by?Asian?subgroups?[153].?However,?the?evidence?is?very?limited.?
These?racial/?ethnic?differences? in?childhood?cancer?survival?may?be?attributable?to?disease?
biology? and? host? pharmacogenetics? but? are? probably? also? linked? to? socioeconomic? and?
cultural? factors,? including? differences? in? access? to? health? care,? inadequate? education,?
advanced? disease? stage? at? presentation,? adherence? to? therapy? and? disbelief? in? modern?
medicine? [159].? However,? some? studies? identified? race/? ethnicity? as? an? independent?
predicting?factor?[140,?152].?
?
Family?factors?
Literature?addressing?a?potential?impact?of?family?factors?on?childhood?cancer?survival?is?very?
rare.?The?large?Norwegian?survival?study?on?children?with?cancer?did?not?only?point?towards?
the?relationship?with?maternal?education?but?reported?that?having?no?siblings?was?associated?
with?mortality?reductions?of?almost?20%?[22].? In?contrast,?a?study?from?Greece?on?children?
diagnosed?with?ALL?in?the?late?1990s?early?2000s?observed?better?prognosis?for?children?with?
increasing?number?of?siblings?[146].?However,?this?finding?was?not?confirmed?by?the?recent?
follow?up?study.?Likewise?no?relationship?between?survival?from?AML?and?number?of?siblings?
was?observed?[26].??
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No? studies?were? identified? that?had? addressed? the?possible? importance?of?birth?order?on?
childhood?cancer?survival,?neither?of?parental?age?at?the?child’s?cancer?diagnosis.?A?study?of?
mother’s? age? at? child’s? birth? from?Norway? did? not? indicate? a? relationship?with? childhood?
cancer?survival,?whereas?the?most?recent?observations?from?Greece?indicated?better?survival?
from?AML?with?older?maternal?age?[22,?26].?Findings?from?Greece,?although?not?statistically?
significant,? suggest? a? possible? positive? effect? for? child’s? attendance? to? day? care? (before?
diagnosis)?for?ALL?survival?[146].?Furthermore,?marital?status?of?the?child’s?parents?might?be?
associated?with?survival?from?childhood?cancer.?Greek?children?of?unmarried?parents?had?a?
2?fold? increased? risk? of? death? from? ALL? and? a? 20%? increased? risk? of? AML? death? [26].?
However,? on? the? contrary,? no? effect? of? marital? status? of? the? parents? was? observed? in?
Norwegian?children?[22].?
?
Similarly,? the? evidence? on? place? of? residence,? used? as? an? indicator? for? the? degree? of?
urbanization? or? distance? from? the? child’s? residence? to? the? next? treatment? centre,? is? very?
limited.?A? study? from?Australia,?a? country?with? vast?areas?of? very? low?density?population,?
reported? better? survival? rates? for? all? childhood? cancers? and? specifically? leukaemia? for?
children?living? in?major?cities?compared?to?those? living?elsewhere.?However,?no?evidence?of?
geographical? variation? in? survival? was? observed? when? solely? looking? at? children? with?
lymphoma? [23].?Living? in? rural?areas?was?also?associated?with? less? favourable?prognosis? in?
recent?multi?national?findings?from?Bulgaria,?Turkey?and?Russia?for?survival?from? leukaemia?
as? well? as? from? lymphoma? [162].? In? contrast? in? Greece,? where? an? earlier? study? found?
indications?of?a?trend?of?poorer?survival?with?increasing?distance?to?treatment?centre?[146],?
this? was? not? confirmed? in? more? recent? years,? which? was? suggested? to? be? linked? to?
considerable? improvements? in? the?motorway? infrastructures? [26].?Likewise,?no?evidence?of?
an? association?between? living? in? a? rural? area?or?distance? to? the? closest?paediatric? tertiary?
centre?and?ALL?survival?was?found?for?children?diagnosed? in?Ontario?[28].?A?study?from?the?
US? investigating? neuroblastoma? survival? based? on? the? SEER? database? observed? higher?
survival?in?children?living?in?metropolitan?areas?versus?children?from?nonmetropolitan?areas?
[163].?
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4 Theoretical?framework:?Social? inequality?
and?cancer?in?children?
Pervious? chapters? cite? important?evidence?on? social? inequalities? in? cancer? and? specifically?
childhood?cancer.?This?chapter?gives?an?overview?on?the?current?empirical?evidence?around?
social? inequalities? in? cancer? and? discuses? theoretical? explanatory? frameworks? of? social?
inequalities?in?health?and?specifically?in?cancer.?
?
4.1?Empirical?evidence?of?social?inequalities??
Numerous?studies?have?revealed?strong?evidence?for?social?inequalities?in?health?within?and?
between?countries.?For? instance,? life?expectancy?at?birth? in?2012,? ranged? from?45?years? in?
Sierra? Leone? to? 83? years? in? several? high?income? countries? including? Switzerland,? Japan,?
Iceland?and?France? [42].? Likewise,? large?differences?persist?within? countries?–? for?example?
there? is?a?20?year?gap? in? life?expectancy?between?the?most?and?the? least?advantaged?social?
groups?in?the?US?[164].?Another?striking?example?is?the?probability?of?death?in?men?between?
age?15?and?60?years,?with?a?probability?of?about?8%?in?Sweden,?80%?in?Zimbabwe?and?90%?in?
Lesotho.?Clear? socioeconomic?gradients? in?adult?mortality? rates?also?exist?within?countries?
[164].??
?
A?large?body?of?evidence?has?been?published?on?inequalities?in?cancer,?indicating?that?social?
inequalities? similarly?exist? in? cancer? incidence,?mortality?and? survival?across? countries? [59,?
165]?as?well?as?within?countries,? including?high?income?countries? [136,?138,?166?168].?Not?
only? do? incidence,? mortality? and? survival? rates? differ? across? populations? by? levels? of?
socioeconomic? development,? with? substantially? lower? survival? rates? in? less?developed?
countries? [169],?but?also? the? cancer? spectrum?differs.? In?high?income? countries? cancers?of?
the? lung,? breast,? prostate? and? colorectum? are? by? far? the? most? frequent? cancer? types.?
Although? colorectal,? breast,? and? lung? cancers? have? also? become?more? frequent? in? less?
developed?regions,?poverty?and?infection?related?cancer,?such?as?cancers?of?the?liver,?cervix,?
stomach? and? oesophagus? still? contribute? considerably? to? the? cancer? burden? in? low?? and?
middle?income? countries? [165].? Irrespective? of? level? of? socioeconomic? development,? the?
major?cause?of?cancer?deaths?is?lung?cancer.?In?high?income?countries?colorectal?cancer?ranks?
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clearly?second,?while,?as?a?result?of?high? incidence?and?very?poor?prognosis,? liver,?stomach?
and?oesophagus? cancer? remain?major? causes?of? cancer?deaths? in? low??and?middle?income?
countries?[165].?
?
The? evidence? for? social? inequalities? within? countries? derives? predominately? from? high?
income? countries.? Associations? between? socioeconomic? factors? and? the? incidence? of?
different? cancers? are? heterogeneous.? Low? socioeconomic? position? for? instance? has? been?
associated?with? increased?risks?for?cancers?of?the?cervix,? lung,?head?and?neck,?and?stomach?
and?reduced?risks?for?cancers?of?the?breast,?colon,?prostate?and?malignant?melanoma?[136,?
168].?Social? inequalities? in?adult?cancer? incidence?can?be?partially?explained?by?known? risk?
factors? related? to? lifestyle,? occupational? exposure,? reproductive? behaviours? and? biological?
agents?[66,?136,?168,?170].?It?appears?that?social?circumstances?at?different?times?across?the?
life? course? are? associated?with? risks? of? different? cancer? types? [170].?Moreover,? different?
socioeconomic?factors?may?point?towards?different?mechanisms?of?social?inequalities?[170].??
Evidence?for?social?inequalities?in?survival?has?been?consistently?found?in?many?populations,?
for?many?cancers?and?for?various?socioeconomic? indicators?[136,?138,?167,?168,?170].?More?
socially? disadvantaged? patients? have? poorer? survival? compared? to?more? affluent? patients.?
Underlying? causes? may? be? related? to? the? time? of? diagnosis,? to? tumour? characteristics?
including? most? importantly? stage? at? diagnosis? which? has? been? widely? recognised? as?
differently? distributed? across? socioeconomic? groups,? to? the? treatments? received? and? to?
patient?specific?factors?such?as?life?style?and?co?morbidities?[138,?170,?171].?
?
4.2?Theoretical?frameworks?of?social?inequalities?
There?are?many?frameworks?dedicated?to?elucidate?the?social?determinants?of?health?and?of?
health? inequalities,? how? those? determinants? operate? and? how? they? can? be? improved? to?
reduce? social? inequalities? in? health.? Besides? rather? general? frameworks? such? as? those?
designed?and?used?by?the?Word?Health?Organization?(WHO)?and?their?Commission?for?Social?
Determinants?of?Health?[172]?or?others?for?example?adopted?for?use?in?Germany?[173,?174],?
some?specifically?focus?on?social?determinants?of?cancer?inequalities?[175,?176].?
?
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The?WHO?model?is?a?conceptual?framework?for?action?on?the?social?determinants?of?health,?
taking?note?of?the?specific?theories?of?the?social?construct?of?health?and?based?on?previous?
frameworks,? including? significantly? the?Diderichsen’s?model?of? “the?mechanisms?of?health?
inequality”? [172].? The? WHO? model? intended? to? provide? a? comprehensive? conceptual?
framework? to? i)? identify? the? social?determinants?of?health? and? the? social?determinants?of?
health? inequalities;? ii)?point?out?how?major?determinants?relate?to?each?other;? iii)? illustrate?
the? mechanisms? by? which? social? determinants? create? health? inequalities;? iv)? provide? a?
framework?for?evaluating?which?are?the?most? important?determinants?to?address?and?v)?to?
map? specific? levels? of? intervention? and? policy? entry? points? for? interventions? on? social?
determinants?of?health?[172].?Figure?5?shows?the?comprehensive?WHO?model.? It? illustrates?
how? social,?economic?and?political?mechanisms?have?an?effect?on? socioeconomic?position,?
whereby?populations?are?stratified?by?income,?education,?occupation,?ethnicity/race,?gender?
and? other? factors? (“structural? determinants”).? Socioeconomic? positions? in? turn? constitute?
specific? determinants? of? health? reflective? of? people’s? rank? in? social? hierarchies.? These?
“intermediary? determinants”? include? material? circumstances,? behaviours? and? biological?
factors,?psychosocial?factors?as?well?as?the?health?system?and?impact?directly?on?health?and?
well?being.? Poor? health? in? turn,? can? also? feed? back? on? a? given? individual? socioeconomic?
position?[172]?to?negatively?impact?and?lower?a?person’s?position.??
The?WHO?model?differentiates?clearly?between?the?social?cause?of?health?and?well?being?and?
the? factors? assigning? the? distribution? of? theses? causes? between? different? socioeconomic?
positions.? Together,? socioeconomic? and? political? context,? socioeconomic? position? of?
individuals? and? the? structural? mechanisms? between? these? two? are? the? “structural?
determinants”.?These?are?the?determinants?of?health?inequalities?and?they?operate?through?
a?set?of?the?intermediary?determinants?of?health?(social?determinants?of?health)?to?ultimately?
impact?health?and?well?being?[172].?By?understanding?the?health?care?system?itself?as?a?social?
determinant?of?health,?the?WHO?model?departs?from?many?previous?models?[172].?
?
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Insertion:?Definition?of?socioeconomic?position?(SEP)?
SEP? is? an? established? concept? in? health? research.? According? to? Krieger? et? al.? [177],? the?
concept?of?“socioeconomic?position”?refers?to?both?material?and?social?resources?and?assets?
as?well?as?individual’s?rank?or?status?within?a?social?hierarchy?of?a?society.?SEP?is?measured?in?
numerous?ways?which?indicates?the?complexity?of?the?multidimensional?construct?[177,?178].?
SEP? can?be?measured?on?different? levels:? at? the? individual? level? (such? as?by?education?or?
occupation),?at?the?household?level?(such?as?by?the?household/family?income?or?savings)?and?
the?area?or?neighbourhood? level? (such?as?by?area?deprivation? index?or?available? facilities).?
There? are? strengths? and? limitations? of? all?measures? of? SEP,?which?may? vary? by? age,? sex,?
race/ethnicity?and?country? [177?179].?Different?socioeconomic? factors?might? impact?health?
at?different?phases?across?the?life?course?and?through?different?causal?pathways?[178].??
Besides?SEP,?various?other?terms,?such?as?social?or?socioeconomic?status?or?social?class,?are?
often?interchangeably?used?in?health?research?[177].?In?line?with?the?definition?by?Krieger?et?
al.?[177]?for?this?report?SEP?rather?than?socioeconomic?status?is?used.?
?
4.3?Social?inequalities?in?childhood?cancer?
The? empirical? evidence? that? social? inequalities? also? exist? in? childhood? cancer? is?
comprehensively?described?in?previous?chapters.?In?brief,?Chapter?2.1?describes?geographical?
differences? in? the? reported? incidence? of? childhood? cancers? by? level? of? socioeconomic?
development? of? a? country? [1,? 14],? with? higher? reported? incidence? rates? in? high?income?
countries? [3,?4,?15,?16]?compared? to? low??and?middle?income?countries? [1,?17,?63,?64,?70],?
especially? Sub?Saharan? Africa,? and? particularly? pronounced? in? leukaemia? [17].? Recent?
evidence? suggests? that? under?diagnosis? and? under?reporting?might? account? for? some? of?
these? observed? geographical? differences? in? incidence? rates? [19].? Similarly,? substantial?
childhood?cancer?survival? inequalities?exist?between?countries.?These? inequalities?are?seen?
within? both? well?resourced? regions? such? as? Europe? with? roughly? 10%? poorer? survival? in?
Eastern?Europe? compared?with? the? rest?of?Europe? [11],?and? to?a?presumed?much?greater?
extent?for?less?developed?regions?[2,?12]?(see?Chapter?3.2).?With?respect?to?social?inequalities?
within?countries,?Chapter?2.2?describes?the?conflicting?and?limited?evidence?of?an?association?
between?SEP?and?childhood?cancer?risk.?The?current?evidence?on?childhood?cancer?survival?
inequalities?and?social?and?family?factors?is?extensively?described?in?Chapter?3.4.?Findings?for?
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high?income?countries? including?Europe?are? inconsistent.?Different?social?and?family?factors?
are?likely?to?have?different?impact?and?importance,?varying?noticeably?by?country.?However,?
dissimilarities? in?welfare?systems,? including?access?to?health?care?and?public?family?support,?
geographic?coverage?and?distance?to?treatment?facilities,?lifestyle?and?socio?cultural?aspects,?
treatment? protocols? as? well? as? methodological? differences? between? studies? make? an?
international?comparison?difficult.??
?
While?social?inequalities?in?cancer?have?been?extensively?studied?in?adults,?there?appears?to?
be? a? gap? in? the? childhood? cancer? epidemiologists’? literature? particularly? with? regard? to?
empirical? evidence? on? underlying? mechanisms? and? pathways? of? social? inequalities? in?
childhood? cancer,? as?well? as? the? theoretical? frameworks? needed? to? direct? investigations.?
Neither?the?WHO?framework?nor?the?framework?proposed?by?Hiatt?and?Breen?are?suited?to?
point?out? causal?pathways? for? childhood? cancer? inequalities.? The? framework?proposed?by?
Hiatt?and?Breen?might?be?more?suited?to?investigate?social?determinants?of?cancer?in?adults?
than?in?children.?The?framework?addresses?interventions?such?as?early?detection?or?primary?
prevention?which? are?of?high? importance? for? adult? cancer?but? less? relevant? for? childhood?
cancer.?The?model?could?be?used?as?a?basis?to?develop?a?tailored?model?specifically?focusing?
on?pathways?of?social?inequalities?in?childhood?cancer.??
The? concept? of? structural? and? intermediary? determinants? emphasised? in? the?WHO?model?
applies? equally? to? cancer? in? adults? and? cancer? in? children.? However,?whereas? the? social?
determinants? of? health? inequalities? are? universal,? the? social? determinants? of? childhood?
cancer?are? likely? to?differ? from? those?of?adult?cancer.?For? instance? in?contrast? to?cancer? in?
adults,?differences? in? survival? from? childhood? cancer?would?be?expected? to?be? (at? least? in?
high?income?countries)?less?related?to?co?morbidities?and?lifestyle?[136,?138,?170],?but?more?
related? to? reasons? such? as? adherence? to? treatment? recommendations? [180]? and? psycho?
social?aspects.?
? ?
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5 Objectives,?material?and?methods?
This?chapter?describes? the?specific?objectives?and?hypotheses?of? the?dissertation?and?gives?
an?overview?of?the?data?sources?utilized,?the?study?populations?and?the?statistical?methods?
applied.?Table?3?summarizes?the?objectives,?material?and?methods?of?all?seven?articles.?
?
5.1?Objectives?and?hypotheses?
The?overall?aim?of? this?dissertation?was? to?gain?a?better?understanding?of? the? relationship?
between?social?and?family?factors?and?incidence?of?and?survival?from?childhood?cancer,?using?
the?international?childhood?cancer?research?networks?established?at?IARC.??
?
5.1.1?Objective?I?
Reported? incidence? rates? for? childhood? cancer? vary? considerably? by? socioeconomic?
development?of?a?country,?with?particularly?low?rates?in?Sub?Saharan?Africa,?particularly?for?
leukaemia? (see?Chapter?2.1).?As?observed?geographical?differences? in? incidence? rates?have?
been?used? to?put? forward? several?hypotheses? related? to? risk? factors?of? childhood? cancers?
(see?Chapter?2.2),?one?of?the?two?main?objective?of?the?dissertation?was?to?study?childhood?
cancer? incidence?data?from?a?Sub?Saharan?African?country.?South?Africa?was?chosen?due?to?
availability?of?not?yet?analysed?or?published?data,?its?large?childhood?population,?and?having?
a? diverse? racial/ethnic? population? [181]? that? would? also? allow? insight? into? socio?cultural?
structures?within? the? country.?Among? the?14.5?million? children?under? the?age?of?15?years?
living? in? the? country? in? 2006,? 83.7%? were? Black? African,? 8.8%? mixed? ancestry,? 1.9%?
Indian/Asian?and?5.6%?White?[181].??
The?terms?“race”?or?“racial?group”,?focusing?on?both?biological?and?cultural?differences,?are?
frequently?used?in?South?Africa.?Although?different?approaches?and?terminologies?for?issues?
around? race? and? ethnicity? are? discussed? in? epidemiology? [182],? “race”? or? “racial? group”?
rather?than?“ethnicity”?are?used?from?hereafter?in?this?thesis.?
Since?race? is?correlated?with?socio?cultural?circumstances? including?access?to?private?health?
care? services? in? South? Africa? [30],? particular? emphasis? was? given? to? investigation? of?
differences?between? racial? groups? and? to?discussing?potential?under?diagnosis? and?under?
reporting? of? childhood? cancer? in? the? country.? Results? were? compared? with? data? from?
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Germany,? as? a? representative? high?income? country? [183]? that? has? a? long?established?
population?based?childhood?cancer?registry?and?a? large?childhood?population.?The?German?
Childhood?Cancer?Registry?(GCCR)?was?willing?to?provide?me?with?incidence?data?tailored?to?
the?inclusion?criteria?of?the?available?South?African?cancer?registry?data?for?direct?comparison?
(article? I).?An? independent?analysis?on?haematological?malignancies?among?adults? in?South?
Africa?adds?to?the?knowledge?on?incidence?patterns?by?race?in?South?Africa?(article?II).?
Hypotheses?I:?
o The?reported?incidence?of?childhood?cancer?is?higher?in?Germany?in?comparison?to?South?
Africa.?
o The?distribution?of?reported?childhood?cancer?by?diagnostic?group?and?age?group,?differs?
between?Germany?and?South?Africa.?
o The?reported?incidence?of?childhood?cancer?in?South?Africa?differs?between?racial?groups.?
?
5.1.2?Objective?II?
Diagnostic?procedures?and? treatment?protocols? are? largely? standardised?within?developed?
countries? [31?33,?120?122]?and,?particularly? in?Europe,?welfare? systems?ensure? free?health?
care? services? for? children.? Therefore? it? would? be? expected? that? survival? from? childhood?
cancer? in?populations?with? free?health? services? should?be? fairly?equal?across? social?groups?
and? independent?of? family?circumstances.?On? the?other?hand? treatment?periods?are?often?
long? with? emphasis? on? compliance.? Besides? physician’s? compliance? to? the? treatment?
protocols,? parents’? and? child’s? adherence? to? the? treatment? and? supportive? care,? the?
interaction?between?families?and?physicians?may?affect?survival.?Associations?between?social?
and? family? factors? and? survival? have? indeed? been? noticed? in? some? studies.?However,? the?
evidence?is?sparse?and?conflicting,?even?within?Europe?[21,?22,?24?26,?146,?147]?(see?Chapter?
3.4).?
Therefore,?the?second?objective?of?the?dissertation?was?to?investigate?the?role?of?social?and?
family?factors?on?survival?from?childhood?cancer?or?certain?types?of?childhood?cancer.?Hereby?
knowledge?for?further?improvement?of?survival?and?reduction?of?social?inequalities?in?cancer?
care?should?be?gained.?Data?from?Germany?and?Denmark?were?utilized,?which?had?not?been?
studied?for?this?purpose?before?(articles?III?VI).?In?both?countries,?all?children?and?adolescents?
are?presumed? to?have?equal? and? free? access? to?health? care? services,? irrespective?of? their?
social?circumstances?[184,?185].?
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Hypotheses?II:?
o Children?with?higher?socioeconomic?position?have?better?survival?from?childhood?cancer/?
certain? types?of? childhood? cancer? in? comparison? to? children?with? lower? socioeconomic?
position.?
? Children? from? families? with? higher? parental? education? have? better? survival? in?
comparison?to?children?from?families?with?lower?parental?education.??
? Children? from? families? with? higher? monthly? income? have? better? survival? in?
comparison?to?children?from?families?with?lower?monthly?income.??
o Family? circumstances? affect? survival? from? childhood? cancer/? certain? types?of? childhood?
cancer.?
? First?born?children?have?better?survival?in?comparison?to?later?born?children.?
? Only?children?have?better?survival?in?comparison?to?children?with?siblings.?
? Children? with? cohabiting? parents? have? better? survival? than? children? with? single?
parents.?
? Children?with?young?parents?at?date?of?diagnosis?have?worse?survival?than?children?
with?older?parents.?
? Children?living?in?more?rural?areas?have?worse?survival?than?children?living?in?urban?
areas.?
?
Supplementary?objective?II?
Some?family?characteristics?have?been?shown?to?be?related?to?the?risk?of?childhood?cancer;?
they?are?hypothesized?to?be?proxies?for?specific?exposures,?for?example?birth?order?as?proxy?
for?the?child’s?exposure?to?infectious?agents.?If?these?exposures?are?associated?with?the?risk?
of? developing? cancer,? they?may? also? be? related? to? the? risk? of? relapse? and,? consequently,?
influence?survival.?Therefore?it?is?important?to?have?clear?evidence,?if?there?is?an?association?
for? risk? and/or? survival.? Thus? studying? the? role? of? birth? order?with? respect? to? childhood?
cancer?risk?at?a?nationwide?level?in?Denmark?was?a?supplementary?objective?of?this?thesis.?
Supplementary?hypothesis?II:?
o Children?of?higher?birth?order?have?a?higher?childhood?cancer?risk?compared?to?children?of?
lower?birth?order.?
?
Table?3?provides?a?comprehensive?overview?of?objectives?and?associated?scientific?articles.?
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5.2?Data?sources?
Different?data?sources?served?as?a?basis?for?conducting?the?seven?independent?studies;?some?
studies?were?based?on?several?data?sources.?The?South?African?Cancer?Registry?provided?data?
for?articles?I?and?II.?Data?from?the?German?Childhood?Cancer?Registry?(GCCR)?were?analysed?
for?articles?I,?III?and?IV.?Cases?from?a?former?German?case?control?study?on?childhood?cancer?
aetiology?served?as?another?data?source?for?articles?III?and?IV.?Danish?registry?data?were?the?
basis?for?articles?V,?VI?and?VII.?The?various?data?sources?are?described?below.?
?
5.2.1?The?South?African?Cancer?Registry?
The?South?African?National?Cancer?Registry? (NCR)?was?established? in?1986?as?a?pathology?
based? surveillance? system? of? the? National? Health? Laboratory? Service? (NHLS)? (pathology?
services?of? the?public?sector)? [186].?The?NCR?collects?all?malignant?diseases? including?non?
melanoma? skin? cancer?but?does?not? receive? information? about?benign? tumours? (including?
benign? CNS? tumours).? Copies? of? pathology? reports? confirming? a? cancer? diagnosis? are?
submitted? to? the?NCR?on?a?voluntary?basis? (until?2011),?by? laboratories? in?both?public?and?
private? sector? histology.? Although? reporting?was? on? a? voluntary? basis,? laboratories?were?
actively?followed?up.?Concerns?regarding?voluntary?sharing?of?patient?data?led?some?private?
laboratories?to?withhold?cancer?pathology?reports,?beginning? in?2005?[186].?New? legislation?
introduced? in? April? 2011? makes? the? reporting? of? diagnosed? cancer? cases? to? the? NRC?
compulsory.? The? legislation? requires? health? professionals? and? laboratories? to? report?
confirmed?cancers?within?3?months?of?diagnosis?to?the?NCR?[187].?
?
The? information? provided? by? the? pathology? reports? constitutes? the? basis? of? the? cancer?
registry.?Data? reported? for?each?patient? include:?patient’s?name?and? surname,? sex,?age?at?
diagnosis,?race?group,?diagnosis?and?tumour?information?(topography,?morphology),?date?of?
diagnosis?and?whether?the?report?was?received?from?a?private?or?public? (NHLS)? laboratory.?
Diagnosis?is?coded?by?trained?NCR?coders,?by?organ?site?and?morphological?type?according?to?
ICD?O?3? [48]? [188].? Only? primary? incident? cases?with? histology,? cytology? or? haematology?
confirmation?are?recorded.?Each?multiple?primary?cancer? is?recorded?as?an?additional?case.?
Doubtful,? in?situ?or?borderline?cancers?are?excluded.?For?multiple?notifications?of?the?same?
cancer,? only? one? record? is? kept.? All? cases? not? resident? in? South? Africa? (e.g.? results? of?
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specimens?sent?to?South?African?laboratories?by?other?countries)?are?excluded.?No?follow?up?
information?for?instance?on?vital?status?is?collected.?
?
Since? the? beginning? of? the? 1990s? an? increasing? number? of? reports? are? received?without?
information? on? racial? group,?with? 54%? of? childhood? cancer? cases? having?missing? data? on?
racial? group? between? 2000? and? 2006.? An? imputation? method? is? used? to? allocate? cases?
missing? this? information? to? a? racial? group? [186].? The?method?makes? use? of? a? reference?
database?of?approximately?1.4?million?surnames?with?known?race?(surname?algorithm)?[189].?
Sensitivity? analyses? using? data? collected? prior? to? the?mid?1990s?when? race?was? routinely?
reported?have?shown?that?this?method?is?highly?accurate.?Surnames?which?do?not?appear?in?
the?database?are?classified?as?unknown?race.?The?database?is?continuously?updated?with?the?
addition? of? each? new? patient?whose? racial? group? is? known,? and? information? from? other?
sources?is?also?used?to?improve?quality?and?completeness.??
?
The?two?studies?analysing?data?from?the?South?African?Cancer?Registry?(article?I?and?II)?were?
restricted?to?cases?diagnosed?between?2000?and?2006,?a?time?period?under?which?the?cancer?
registry?worked?under?stable?and?defined?conditions.?
?
5.2.2?The?German?Childhood?Cancer?Registry?
The?GCCR?at?the?University?of?Mainz?was?established?in?1980?and?is?a?nationwide?population?
based?childhood?cancer?registry,?collecting?data?on?all?malignancies?and?benign?CNS?tumours?
diagnosed?before? the?age?of?15?with?annually?about?1,800?new?cases.?Since?2009? the?age?
range? has? been? expanded? to? include? all? cases? younger? than? 18? years.? Physicians? report?
patients’?diagnosis?on?a?voluntary?basis?and?patients?or?their?guardians?are?required?to?give?
their?consent? for? registration.?As?most?patients?are?enrolled? in?clinical? trials,?a?network?of?
paediatric? oncology? centres? guarantees? the? coverage? of? all? childhood? cancer? cases.?Only?
about?1%?of?families?do?not?give?their?consent?and?further?1%? is?missing?for?other?reasons.?
The?completeness?of?registration?is?higher?than?95%?since?1987?[3,?190,?191].??
Active? vital? status? follow?up? is? conducted? routinely? by? the? GCCR? using? information? from?
clinical? studies,? treating?hospitals,? families?and?communities.?A? set?of?minimal? information?
for?each?patient?including?date?of?birth,?diagnosis,?date?of?diagnosis,?date?of?first?recurrence?
or? relapse,?date?and? type?of? secondary?neoplasm,? vital? status,?date?of?death,?date?of? last?
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contact?and?current?address?are?stored?and?regularly?updated.?Information?on?racial?group?is?
not? collected? by? the? GCCR,? but? racial? diversity? is? low? in? Germany.? German? children? are?
usually?Caucasian?and? larger?migrant?groups? living? in?Germany?originate? from?elsewhere? in?
Europe?or?in?Turkey?[192]?and?are?therefore?also?Caucasian.??
In?the?first?years?after?diagnosis?the?GCCR?receives?follow?up?information?from?the?respective?
clinical? trial? or? hospital.?At? the? end? of? the? regular? clinical? follow?up? the?GCCR? takes? over?
surveillance?and?contacts? the?patients?or?parents?directly,? if? the? last? follow?up? information?
dates?back?5?years?or?longer?[190,?191].?
?
5.2.3?The?German?case?control?study?
A? population?based? case?control? study? on? potential? risk? factors? of? childhood? cancer?was?
conducted?in?the?1990s?in?West?Germany.?Particular?emphasis?was?given?to?maternal?factors?
and?factors?related?to?pregnancy?and?birth,?factors?related?to?the?immune?system,?exposure?
to?ionising?radiation?as?well?as?parental?occupations?and?environmental?factors?[193].?Cases?
were? identified?by?using?the?nationwide?GCCR.?Besides?children?with? leukaemia,?cases?with?
non?Hodgkin? lymphomas,? with? tumours? of? the? central? nervous? system,? neuroblastomas,?
nephroblastomas,?malignant?bone? tumours,?and?soft? tissue?sarcomas?were? included? in? the?
study.?Cases?were?eligible,?if?diagnosed?between?October?1992?and?September?1994,?before?
the?age?of?15?years?and?if?the?child?was?living?anywhere?in?former?West?Germany?(excluding?
West? Berlin).? Controls?were? randomly? selected? via? files? of? local? offices? for? registration? of?
residents.? Controls? were? matched? on? age,? sex? and? place? of? residence? at? diagnosis?
(community).?The?families?of?2,286?children?with?cancer?and?2,998?controls?were?asked?for?
their? consent? to? participate? in? the? study.? Information? on? potential? risk? factors? as?well? as?
information? on? socio?demographic? characteristics? including? parental? education,? parental?
occupational? training? and? net?monthly? family? income?was? collected? by? self?administered?
questionnaire? and? a? subsequent? telephone? interview? with? both? parents.? Of? the? 2,286?
contacted?case?families,?1,938?(84.8%)?completed?the?questionnaire.?An?additional?criterion?
was?that?cases?and?controls?must?have?lived?in?their?respective?community?for?at?least?half?a?
year?before?diagnosis? (which? could?only?be?assessed?after? recruitment).?3.4%?of? recruited?
families? did? not?meet? this? criterion? and?were? excluded.? This? left? a? total? of? 1,867? eligible?
childhood? cancer? cases? of? which? 1,772? participated? in? the? telephone? interview.? Among?
families?of?healthy?control?children,?2,126?(70.9%)?families?returned?the?questionnaire,?2,057?
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fulfilled? the?additional?eligibility? criteria?and?1,957?participated? in? the? telephone? interview?
[193,?194].?
?
5.2.4?The?Danish?Registries?
In?Denmark? information?on?many? issues?are?stored? in?national?population?based?registries,?
ranging? from? information? on? birth,? deaths,? immigration? and? emigration? over? disease?
incidence?to?social?and?economic?issues?[195].?The?Danish?Civil?Registration?System?registers?
all?persons?who?have?a?permanent?residence?in?Denmark?including?every?live?born?baby?and?
new? inhabitant.? It? stores? information? on? name,? gender,? date? of? birth,? place? of? birth,?
citizenship,?identity?of?parents?and?continuously?updated?information?on?vital?status,?place?of?
residence?and?spouses?[196].?Since?1968,?all?residents?of?Denmark?are?assigned?a?unique?civil?
personal?registration?number?(CPR?number)?by?the?Danish?Civil?Registration?System,?which?is?
used? in? all? national? registries? (including? health? and? social? registries),? enabling? accurate?
linkage?of?information?between?registries?[196].?The?CPR?number?includes?date?of?birth?and?
sex?and?allows,?via?the?Danish?Civil?Registration?System,?linkage?to?first?degree?relatives.?This?
linkage? is?considered? to?be?100%?correct.?CPR?was?established? for?administrative?purposes?
independently?of?health?and?social?factors.?Although?no?studies?exist?that?explore?the?quality?
of?the?information?recorded?by?the?CRS,?a?very?high?quality?is?assumed?[196].??
The?social?registers?of?Denmark,?such?as?The?Population’s?Education?Register?(established?in?
1981)? or? The? Income? Statistics? Register? (established? in? 1970)? are? exclusively? handled? by?
Statistics? Denmark.? To? guarantee? confidentiality? and? fully? preserve? anonymity,? individual?
data?from?Statistics?Denmark? is?not?delivered?to?any?external? institution?or?person.?Instead,?
researchers? from? specific? authorized? environments? can? establish? remote? online? access? to?
data?from?Statistics?Denmark?or?link?datasets?containing?data?from?Statistics?Denmark?[195].?
The? Danish?Medical? Birth? Register? was? established? in? 1973? and? collects? information? on?
pregnancy? and? child’s? birth.? The? Danish? Cancer? Registry? contains? records? of? all? incident?
malignancies? and? certain? precancerous? and? benign? lesions? in? the?Danish? population? from?
1943?onwards.?Besides?tumour?characteristics?some?personal?characteristics? including?date?
of?diagnosis,?date?of?birth,?sex,? the?municipality?and?county/? region?as?well?as? the?date?of?
death? or? emigration.? These? variables,? however,? are? derived? from? the? Civil? Registration?
System?and?updated?once?a?year?[196].?
?
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5.3?Social?and?family?factors?
A?broad,?but?still? limited?range?of?social?and?family?factors?were?considered?for? inclusion? in?
this? dissertation.? The? selection? of? characteristics? was? driven? by? the? a? priori? defined?
hypotheses?(see?Chapter?5.1)?but?was?restricted?by?the?availability?of?certain?characteristics?
in?the?data?sources?of?the?dissertation.?Race,?SEP,?place?of?residence,?birth?order,?number?of?
siblings,? parental? age? and? cohabitation? status? of? the? parents? were? studied? within? the?
different?articles.?As?a?proxy?for?children’s?SEP?several?makers?of?parental?SEP?were?used.??
?
From? the? South? African? Cancer? Registry? data? racial? group? was? the? only? available? social?
characteristic.? Since? racial? group? is? highly? correlated? with? socioeconomic? circumstances?
including?access?to?private?health?care?services?in?South?Africa?[30],?race?in?these?analyses?is?
primarily?understood?as?a?social?characteristic?rather?than?a?genetic?factor?(article?I?&?II).??
For?the?German?survival?studies?information?on?socioeconomic?factors?(article?III?)?and?family?
factors? (article? IV)?were?derived? from? the? former?German? case?control? study? collected?via?
standardised? telephone? interview? and? were? therefore? predefined.? The? socioeconomic?
factors? disposable? family? income,? parental? education? and? parental? occupational? training?
were?available?and? the? family? characteristics?birth?order,?number?of? siblings,?parental?age?
and?degree?of?urbanization?of?the?place?of?residence.?
The?Danish?registries?enabled?the?investigation?of?a?broad?variety?of?social?and?family?factors?
including?maternal?income,?parental?education,?number?of?full?and?half?siblings,?cohabitation?
status? of? the? parents,? parental? age,? birth? order? and? degree? of? urbanization? of? place? of?
residence?(article?V?&?VI).?However,?as?the?analyses?for?article?VI?were?conducted?at?IARC?in?
France?and? the?social? registries?of?Denmark?do?not?allow?analyses?of? their?data?outside?of?
Denmark?socioeconomic?factors?could?not?be?included?in?that?study?but?were?covered?by?the?
other?Danish?article?(article?V).?
?
More? detailed? information? on? the? definition? and? data? collection? of? the? social? and? family?
factors? used? for? the? various? investigations? can? be? found? in? the? respective? articles? (s.?
Appendix).?
?
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5.4?Study?populations?
An?overview?of? the?different?study?populations?analysed? in? the?context?of? this?dissertation?
and? their? special? features? is? given? below.? The? term? childhood? cancer?was? defined? in? two?
ways?depending?on?the?data?source.?Childhood?cancer?was?defined?as?any?cancer?diagnosed?
before?the?age?of?15?for?the?articles?I,?III?and?IV?(German?and?South?African?data).?Articles?V,?
VI?and?VII,?based?on? the?Danish? registry?data,?used? the?alternative?definition?of?childhood?
cancer:?any?cancer?occurring?in?patients?below?the?age?of?20.?
?
Article? I? ??Childhood? cancer? incidence?patterns?by? race,? sex?and?age? for? 2000? –? 2006:?A?
report?from?the?South?African?National?Cancer?Registry:?
4,601?newly?diagnosed?childhood?cancer?cases?were?reported?to?the?South?African?National?
Cancer?Registry?during?the?period?2000?to?2006;?with?a?greater?number?of?cases?among?boys?
than?girls?(55%?vs.?45%).?67.9%?of?the?reported?childhood?cancer?cases?were?Black?Africans,?
8.7%?had?a?mixed?ancestry,?3.2%?were?of? Indian/Asian?ancestry,?15%?were?Whites?and? for?
5.2%? information? on? racial? group?was?missing.? The? percentage? of? cases? reported? by? the?
public? laboratories? of? the?NHLS? ranged? from? 92%? among? Black? children? to? 66.5%? among?
Whites.?The?most?commonly?reported?childhood?cancer?was?leukaemia?(19%).?
?
Article?II???Haematological?malignancies?in?South?Africa:?2000?2006:?
Between?2000?and?2006,?there?were?a?total?of?14,662?haematological?malignancies?in?adults?
(defined?as?over? the?age?of?14? years?at?diagnosis)? reported? to? the? South?African?National?
Cancer?Registry.?Almost?50%?of?the?cases?were?reported?among?the?Black?population,?one?
third? among?Whites,?10%? among? individuals?of?mixed? ancestry,?4%? among? Indians/Asians?
and? for? just?below?5%? information?on? racial? group?was?missing.? The?distribution?of? racial?
groups? differed? considerably? on? whether? cases? where? notified? by? public? or? private?
laboratories.? 84%? of? the? cases? reported? among? Blacks? were? reported? by? the? public?
laboratories?compared?to?50%?of?the?reported?cases?among?Whites.?Regardless?of?gender?or?
race,?NHL?was? the?most?commonly?reported?haematological?malignancy,?accounting? for?at?
least? 50%? of? cases? in?most? gender? and? racial? groups.? In? all? groups,? this?was? followed? by?
leukaemia,?contributing?15?25%?of?cases?in?the?various?subgroups.?
?
? ?
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Article? III? ?? Survival? from? childhood? acute? lymphoblastic? leukaemia? in? Germany? –? Does?
socio?demographic?background?matter??:?
The?study?population?consisted?of?all?childhood?ALL?cases?diagnosed?between?October?1992?
and? September? 1994? in?West?Germany? and? identified? by? the?GCCR? in? the? context? of? the?
former? German? case?control? study.? Children?were? followed? for? 10? years? after? diagnosis,?
using?survival?data?from?the?GCCR.?Of?the?788?cases? identified,?58.4%?were?boys?and?more?
than?60%?were?1???5?years?of?age?at?diagnosis.?Information?on?socioeconomic?characteristics?
was?available? for?647?cases.? Information?was?missing? for?a? further?6.5%?on? income,?5%?on?
maternal?education?and?10%?on?paternal?school?education.?Most?commonly,?families?ranked?
in? the? second? lowest?categories?–?a?monthly? family? income?between?2,000?and?4,000?DM?
(53%)? and? education? with? “low? degree”? (“Hauptschulabschluss”)? (paternal:? 43%? and?
maternal:?38%).?Over? the? follow?up?period?of?10?years?137?children?had?died.?The?10?year?
overall?survival?of?all?cases?was?82.5%.??
?
Article? IV? ?? Family? circumstances? and? survival? from? childhood? acute? lymphoblastic?
leukaemia?in?West?Germany:?
The?article?studied? the?same? study?population?as?analysed? in?article? III?but? solely? included?
cases? for?which? family? characteristics?were? available.? Of? the? 647? cases,? 334? (52%)?were?
firstborns?and?159? (25%)?were?the?only?child;?almost?half?of?the? families?had?two?children.?
With? respect? to? place? of? residence,?most? families?were? living? in? urban? areas,? and?most?
parents?were?aged???30?years?at?diagnosis.?Numbers?of?missing?values?were?very?low?for?the?
key?variables,? ranging?between?0.5%? for?maternal?age?and?1.6%? for?paternal?age.?Children?
were?followed?for?10?years?with?10?year?overall?survival?being?84.7%,?based?on?98?deaths.?
?
Article?V???Effect?of?socioeconomic?position?on?survival?after?childhood?cancer?in?Denmark:?
The? nationwide? survival? study? was? conducted? by? linking? data? from? the? Danish? public?
administrative? registries? with? the? Cancer? Registry.? 3,797? children? diagnosed? with? cancer?
below?the?age?of?20?between?1?January?1990?and?31?December?2009?were?identified.?Most?
of? the?children?were?diagnosed? in? the?age? range?of?0?4?years? (29%)?or?15?19?years? (33%),?
with?slightly?more?boys?diagnosed?with?cancer? than?girls.?The?most?common?cancers?were?
CNS?tumours?(26%)?followed?by?leukaemia?(24%).?About?half?of?the?parents?had?a?vocational?
education,?and?about?80%?were?cohabiting.?62%?of?the?childhood?cancer?patients?had?one?or?
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more? full? siblings.?Follow?up? time?was?not?censored? for? this? study.?Median? follow?up? time?
was?9.0?years?(range?0?22?years)?with?841?deaths?and?an?overall?survival?of?78%.?
?
Article?VI???Family?characteristics?and?survival?from?childhood?haematological?malignancies?
in?Denmark,?1973?2006:?
Similar? to? article? V? this? survival? study? analysed? data? from? the? Danish? administrative?
registries.? The? study? population? comprised? all? children? born? and? diagnosed? with? any?
haematological?malignancy?in?Denmark?between?1?January?1973?and?31?December?2006.?Of?
the? 1,819? children? diagnosed?with? haematological?malignancies? in? this? time? period,? 59%?
were?boys?and?40%?of?the?cases?occurred?in?children?ages?1?to?4.?More?than?half?of?the?cases?
were?diagnosed?with?ALL?(56%),?followed?by?HL?(compromising?13%?of?all?cases),?AML?(12%)?
and?NHL? (9%).?Among?all?cohort?members,?834? (46%)?were? firstborns?and?664? (37%)?were?
second?born.?285?(16%)?were?the?only?child?at?date?of?diagnosis.?Most?families?were?living?in?
provincial?cities?(53%).?Mothers?and?fathers?were?most?frequently?aged?31?35?years?at?their?
child’s?diagnosis.?Children?were? followed? for?10?years.?Overall?10?years?survival?was?72.1%?
based?on?504?deaths.?
?
Article?VII???Birth?order?and?the?risk?of?childhood?cancer?in?the?Danish?birth?cohort?of?1973?
2010:?
This? cohort? study? was? also? based? on? data? from? the? Danish? registries.? The? birth? cohort?
comprised?2,461,283?children?born?between?1973?and?2010? inclusively,?of?which?1,262,979?
(51.3%)? were? boys.? Among? the? total? cohort,? 1,099,058? children? were? firstborn? (44.7%),?
906,852? (36.8%)? second?born,?336,017? (13.7%)? third?born,?and?119,356? (4.8%)?had?a?birth?
order? of? four? or? higher.? 227,913? (9.3%? of? total? and? 20.7%? of? firstborn)? remained? only?
children.? In?the?study?population?accruing?a?total?of?38.6?million?person?years?of?follow?up;?
5,699? childhood? cancers? were? observed,? with? leukaemias? and? CNS? tumours? each?
representing? approximately? one? quarter? of? cases.? 45.6%? of? cancer? cases?were? firstborn,?
similar?to?the?proportion?in?the?overall?cohort.?
?
More?detailed? information?on?the?study?populations?can?be?found? in?the?respective?articles?
(s.?Appendix).?
?
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5.5?Statistical?methods?
The?statistical?methods?used?for?this?dissertation?depended?on?the?respective?article.?Articles?
I?and?II?analysed?incidence?data?from?the?South?African?Cancer?Registry?applying?descriptive?
epidemiological?methods.?Article?III?to?VI?analysed?survival?data?from?Germany?and?Denmark?
using? Kaplan?Meier? curves? and? Cox? proportional? hazard?models.? Article? VII? analysed? the?
childhood? cancer? risk? in? a? birth? cohort? using? Poisson? regression?models.?A?more? detailed?
description?is?given?below?and?in?the?respective?articles?(s.?Appendix).??
Generally,?childhood?cancer?cases?were?grouped?according?to?the?International?Classification?
of?Childhood?Cancer,?depending?on?the?time?period?of?the?data?either?ICCC??1?or?ICCC?3?(see?
Chapter?1.2).?
?
Analyses?of?childhood?cancer?and?adult?haematological?malignancies? incidence?data?from?
the?South?African?National?Cancer?Registry?(articles?I?and?II)?
Descriptive?epidemiological?methods,? in?particular?calculation?of? (relative)? frequencies,?sex?
ratios,? age?specific? and? age?standardised? incidence? rates? stratified? by? racial? group? and/or?
certain? diagnostic? subgroups? were? used? to? analyse? the? reported? incidence? of? childhood?
cancer?and?adult?haematological?malignancies? in?South?Africa? (article? I?and? II).?The?directly?
age?standardised? incidence?rates?(ASR)?were?calculated?using?the?weights?of?the?Segi?world?
standard?population?[197].?Consistent?with?the?approach?used? in?the?annual?reports?of?the?
South?African?National?Cancer?Registry,? the?Alternative?South?African?mid?year?population?
estimates?from?the?Centre?for?Actuarial?Research,?University?of?Cape?Town?were?used?as?the?
denominator?[181,?198]?for?calculating?incidence?rates.?These?mid?year?population?estimates?
are?similar? in?magnitude?to?the?official?mid?year?estimates?but?maintain?an?age?distribution?
that? is?consistent?with? that?of? the?most? recent?Census? in?2011? [181].?Therefore? they?were?
considered? as? the?more? appropriate? population? estimates? for? the? purposes? of? studying?
differences?by?age?group.?
?
For? article? I,? the? incidence? rate? proportions? in? South? Africa? compared? to? the? reference?
incidence?rates?of?Germany?were?calculated?to?investigate?differences?for?specific?subgroups?
of?childhood?cancer.?For?this?purpose,?the?ASRs?in?Germany?in?the?respective?sub?categories?
(by?cancer?type?and?by?sex),?as?well?as?age?specific?rates,?were?set?to?100%?and?these?were?
compared?to?the?reported?incidence?rates?among?White?and?Black?South?Africans?separately.?
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The? German? childhood? cancer? incidence? rates?were? provided? by? the? GCCR? according? to?
specifications? defined? by?me? to? exactly?match? the? eligibility? criteria? of? the? South? African?
Cancer?Registry?in?terms?of?included?diagnoses?and?diagnostic?time?period.?
?
For?article?II,?Incidence?rate?ratios?(IRRs)?and?95%?confidence?intervals?(CIs)?were?estimated?
using? Poisson? regression? models? with? the? number? of? cases? for? a? given? category? of?
haematological?malignancy?as?the?outcome,?the?population?size?as?the? log?offset?and?a? log?
link?function,?overall?and?stratified?by?racial?group,?comparing?rates?of?adult?haematological?
malignancies? among? females? to? that? of?males.? Similar?models,? stratified? by? gender,?were?
used?to?compare?incidence?rates?across?the?racial?groups,?using?the?Black?population?as?the?
reference?group.??
?
Survival?analyses?(articles?III?–?VI)?
Two?primary?outcomes?were?defined?for?the?two?German?survival?studies?(articles?III?&?IV):?
overall?survival,?with?death?from?any?cause?as?the?endpoint,?and?event?free?survival,?with?the?
first? (if? any)? relapse? (defined? as? >5%? lymphoblasts? in? bone? marrow),? second? malignant?
neoplasm?or?death? as?events.? Since? information?on? relapse? is?not? recorded? in? the?Danish?
Cancer?Registry?only?overall?survival?was?defined?as?outcome?for?the?Danish?studies?(article?V?
&?VI).?Children?were?observed?from?the?date?of?diagnosis?until?the?date?of?event?(previous?
defined?event,?e.g.?death?from?any?cause,?relapse?or?secondary?malignancy),?emigration?or?
lost? to? follow?up,?or?date?of?10?years?of? follow?up,?whichever?came? first.?Follow?up?period?
was?censored?at?10?years?as?very?few?disease?related?events?occur?afterwards,?whereas?the?
incidence? of? competing? risks? rises.? An? exception? is? the?Danish? survival? study? on? SEP? and?
survival?from?childhood?cancer?(article?V)?for?which?the?follow?up?period?was?not?censored.?
?
For?graphical? illustration?(unadjusted)?survival?probabilities?stratified?by?selected?social?and?
family? characteristics? were? calculated,? using? Kaplan?Meier? curves.? Statistical? significance?
(defined?as?p?0.05)?of?differences?in?survival?probabilities?was?assessed?by?the?log?rank?test?
[199].?Cox?proportional?hazards?models?were?used? to?assess? the? impact?of? selected? social?
and?family?characteristics?on?survival?with?time?since?diagnosis?as?the?underlying?time?scale.?
It?is?the?most?commonly?used?multiple?regression?model?for?analysing?survival?data?in?health?
research?and?illustrates?the?relationship?between?the?event?incidence?and?a?set?of?mutually?
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adjusted? covariates? using? hazard? ratios? [200,? 201].?Models? were? adjusted? for? the? well–
established?prognostic?factors?child’s?age?at?diagnosis?[31?33,?120]?and?sex?[120,?132]?as?well?
as? for? the? possible?mediating? effect? of? other? social? variables? (adjustment? varied? between?
articles? and? models).? Results? were? expressed? as? adjusted? hazard? ratios? (HRs)? with?
corresponding?95%?confidence?intervals.?
?
Analyses?of?Danish?birth?cohort?data?and?childhood?cancer?risk?(article?VII)?
All?children?were?followed?up?from?date?of?birth?until?20?years?of?age,?date?of?death,?date?of?
first?cancer?diagnosis,?or?end?of?study?period?(October,?31,?2013),?whichever?occurred?first.?
Poisson? regression?models? were? used? to? evaluate? associations? between? birth? order? and?
different?types?of?childhood?cancer,?estimating?the?rate?ratios?(RRs)?and?corresponding?95%?
confidence?intervals,?with?and?without?controlling?for?maternal?age,?paternal?age,?and?birth?
weight.?The?firstborn?children?served?as?the?reference?group?for?the?comparisons.?
? ?
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6 Key?results?
This? chapter? provides? a? summary? of? the?main? results? observed? in? the? conducted? studies,?
organised?according?to?the?two?objectives?of?this?dissertation.?More?detailed?descriptions?of?
the?study?results?can?be?found?in?the?respective?articles?(s.?Appendix).?
?
6.1?Objective? I?–?Reported? childhood? cancer? incidence?patterns?by? race? in?
South?Africa?
With?a?reported?ASR?of?45.7?childhood?cancer?cases?per?million? in?South?Africa? the?ASR? in?
Germany?was?more? than? 3?times? higher? (144.4? per?million).? Key? results?with? respect? to?
childhood? cancer? in? South?Africa? (article? I)? include? substantial?differences? in? the? reported?
incidence? rates? and? the? distribution? of? childhood? cancer? types? both?within? South?African?
racial? groups? as? well? as? between? South? African? and? German? children.? Moreover,? a?
particularly? low? incidence? rate? in? South?African? infants? compared? to?German? infants?was?
observed.??
Overall,? as?well? as? for? the?major? diagnostic? groups? including? leukaemias? and? lymphomas,?
White? South? African? children? had? approximately? 3?fold? higher? ASRs? than? Black? South?
Africans,?with?mixed?ancestry?and?Indian/Asian?children?falling?in?between?these?two?groups.?
ASRs? were? 4?5?times? higher? among?Whites? than? Blacks? for?malignant? CNS? tumours? and?
malignant?bone?tumours?whereas?rates?were?relatively?similar?for?retinoblastomas?and?soft?
tissue?sarcomas.??
Comparing?German?children?with?White?South?African?children,?the?overall?childhood?cancer?
ASR? in? Germany?was? 1.25?fold? higher,? but? there?were? large? variations? across? diagnostic?
groups.?While? the?difference?was? striking? for? leukaemias? (primarily?driven?by? the? low?ALL?
rates?among?South?African? children),?being?more? than?2?fold?higher? in?Germany,?and?also?
markedly?higher?for?sympathetic?nervous?system?tumours,?germ?cell?tumours?and?malignant?
CNS? tumours,? ASRs? were? similar? for? some? other? types? such? as? soft? tissue? sarcomas,?
lymphomas? and? hepatic? tumours.? Notably,? they? were? even? somewhat? higher? in? South?
African?Whites?for?renal?tumours?and?malignant?bone?tumours.?An?8?fold?higher?incidence?in?
South?African?Whites?was?seen?in?malignant?epithelial?neoplasms?driven?by?high?numbers?of?
skin?cancers.??
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German? infants?had?a?2?fold?higher? incidence?rate?when?compared? to? infant?South?African?
Whites?and?almost?10?fold?higher?compared?to?infant?Blacks,?whereas?in?10?14?year?olds?the?
incidence?rates?of?Germans?and?South?African?Whites?were?almost?identical.?
Patterns? across? the? South? African? racial? groups? and? in? comparison? with? Germany? were?
generally?similar?for?boys?and?girls.?
?
Similar?to?the?pattern?observed?for?the?reported?childhood?cancer?incidence,?incidence?rates?
of?adult?haematological?malignancies?in?South?Africa?varied?markedly?by?race?(article?II),?with?
generally?higher?rates?among?White,?mixed?ancestry?and?Indian/Asian?populations?compared?
to? the? Black? population.? Differences? were? most? pronounced? between?White? and? Black?
populations,?incidence?rate?ratios?for?males?and?females?combined?ranged?from?1.56?(95%?CI?
1.38?1.76)? for? myeloma? to? 3.77? (95%? CI? 3.38?4.21)? for? HL.? For? all? four? major? types? of?
haematological?malignancies? investigated,? incidence? rates?were? consistently? higher? in? the?
White? population? compared? with? the? Blacks,? irrespective? of? age,? but? these? differences?
tended?to?increase?with?age.?
?
6.2? Objective? II? ?? The? role? of? social? and? family? factors? in? survival? from?
childhood?cancer??
Results? of? the? analyses? on? ALL? survival? in?German? children? confirm? the?well?known? non?
linear?relationship?between?age?at?diagnosis?and?survival?(p?<?0.001)?(article?III);?infants?had?
an? approximate? 6? to? 7?fold? (depending? on? the?model)? increased? risk? of? dying? and? 4?fold?
increased?risk?of?any?event,?compared?to?1?5?year?old?children,?while?older?children?had?an?
about?2.5?fold? increased?risk?of?death.?Boys?showed?worse?survival?compared?to?girls?(HRadj?
1.52;?95%?CI?0.96;?2.40?for?overall?survival).??
With? respect? to? socioeconomic? factors? (article? III),? neither? parental? education? nor? family?
income? showed? a? trend? or? significant? impact? on? survival? from? childhood? ALL? in? West?
Germany.? For? income,? all? HRs? were? close? to? 1.? For? maternal? education,? the? HR? was?
somewhat? elevated,? although? not? statistically? significantly,? in? the? small? group? of?mothers?
having?no?school?degree?in?the?event?free?analysis?(HRadj?1.80;?CI?0.47;?2.56).?The?results?for?
family?characteristics?(article?IV)?indicate?that?family?factors?may?have?an?impact?on?survival?
from? childhood?ALL? in?Germany,? although?most? associations?were? suggestive? rather? than?
statistically? significant.? The? group? of? second?born? children? had? a? statistically? significant?
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better?survival?compared?to?first??or?later?born?children,?with?HRs?ranging?between?0.54?and?
0.64? compared? to? firstborns,? depending? on? the?model.? Poorer? survival?was? observed? for?
children?having?3?or?more?siblings?(HRadj?1.58;?95%?CI?0.73;?3.44? in?the?fully?adjusted?model?
for?overall? survival).?Mutually?adjusting? for?birth?order?and?number?of? siblings? resulted? in?
even?higher?HRs?for?the?relationship?between?number?of?siblings?and?ALL?survival.??
A?non?linear?relationship?in?the?West?German?data?was?found?for?parental?age?at?diagnosis,?
with?poorer? survival? for? children?with?younger? fathers?and?mothers,?and?most?distinct? for?
children? with? older? fathers? (paternal? age? ?? 41? years? HRadj? 2.09;? 95%? CI? 1.04;? 4.20).? A?
sensitivity?analysis?distinguishing?between?having?either?a?young?mother?or?a?young? father?
and?having? two?young?parents? (both? ??25?years)? indicated? that?particularly? the? latter?was?
related?to?poorer?survival;?elevated?HRs?of?up?to?1.76?were?found.?Whether?children?lived?in?
urban?or?rural?areas?of?West?Germany?had?no?impact?on?survival.?
?
The?population?based?and?comprehensive?Danish?studies?indicated?that?having?parents?with?
a? higher? SEP?was? associated?with? better? survival? of? children?with? cancer? (article? V).? The?
effects? of? the? different? indicators? of? SEP? differed,? however,? by? cancer? type.? A? beneficial?
effect?of?maternal?higher?education?compared?to?children?of?mothers?with?a?basic?education?
was? only? observed? among? children?with? non?CNS? solid? tumours? (HRadj? 0.66;? 95%? CI? 0.44;?
0.99).?A?positive?effect?of?cohabitating?parents?on?survival?found?in?the?overall?analysis?of?all?
childhood?cancers?combined,?was?mainly?observed?in?children?with?CNS?tumours?(HRadj?0.70;?
95%?CI?0.51;?0.97)?and?non?significantly?so?in?children?with?non?CNS?solid?tumours.?Number?
of?full?siblings?was?most?strongly?and?statistically?significantly?associated?with?the?survival?of?
children?with?non?CNS?solid?tumours,?who?had?a?45%?increase?in?the?risk?for?dying?if?they?had?
one?sibling?(95%?CI?1?11;?1?89)?and?a?29%?increase?if?they?had?two?or?more?full?siblings?(95%?
CI?0.93;?1?79).?Associations?with?maternal?age?at?child’s?birth?were?inconsistent?across?cancer?
types.?
In?separate?analyses?for?ALL,?the?risk?estimates?were?closer?to?null?than?those?for?all?cancers.?
Similarly,? in? separate? analyses? of? subgroups? of? non?CNS? solid? tumours? that? require? early?
surgery? or?more? complex? treatment,? no? difference? was? found? from? the? results? for? the?
combined?group?of?non?CNS?solid?tumours.?
?
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The? second? Danish? study? (article? VI),? solely? focusing? on? survival? from? haematological?
malignancies,?observed?worse? survival? from?ALL? and?AML?with? increasing?birth?order? and?
among? children?with? siblings? compared? to? children?without? any? siblings.? The? associations?
with?AML?were?stronger?and?reached?statistical?significance?in?contrast?to?rather?suggestive?
results?for?ALL.?A?HRadj?of?1.62?(95%?CI?0.85;?3.09)?was?observed?for?4th?or?later?born?children?
with?ALL,?while? the?HRadj?was? 5.76? (95%? CI? 2.01;? 16.51)? for? children?with?AML.?Mutually?
adjusting? for? birth? order? and? number? of? siblings? in? one?model? abolished? the? association?
between?number?of?siblings?and?survival?from?ALL?and?AML,?but?did?not?substantially?alter?
the?HRs? for? the?effect?of?birth?order?on?ALL? survival?and? showed?even?higher?HRs? for? the?
association? with? birth? order? and? AML? survival.? Children? with? older? parents? showed? a?
tendency?of?inferior?survival?from?ALL,?while?for?survival?from?AML?young?maternal?age?was?
related? to? poorer? prognosis.? An? effect? of? better? AML? survival? among? children?with? older?
mothers?was?attributed?to?the?high?survival?of?children?having?both?an?older?mother?and?an?
older? father.?The?HRadj?was?0.55? in? the? fully?adjusted?model? (95%?CI?0.17;?1.80).?Sensitivity?
analysis?distinguishing?between?having?either?an?older?mother?or?an?older?father?and?having?
two?older?parents?(both???46?years)?showed?that?particularly?the?latter?was?related?to?poorer?
survival?from?ALL.?Restricting?the?analyses?to?children?diagnosed?from?1990?onwards?showed?
similar?results?to?those?for?the?full?period?1973?2006.??
Wide? confidence? intervals? reflected? the? small? numbers? available? for? the? analyses? of?NHL?
survival.?Poorer? survival?was?observed? for? children?with? full?and?half? siblings? compared? to?
only?children.?Although?for?most?of?the?categories?not?statistically?significant,?the?trend?test?
reached? statistical? significance.?No?clear? relationship?was? found? for?number?of? full? siblings?
only.?Young?parental?age?might?be?related?to?poorer?survival,?but?numbers?were?small.??
?
Supplementary?objective?II?–?Birth?order?and?the?risk?of?childhood?cancer??
The?results?did?not?show?associations?between?birth?order?and?risk?of?any?childhood?cancer?
subtype,? including?ALL? for?which? the?a?priori? evidence?was? strongest.? For? the?majority?of?
cancer? types,?RRs?were? all? around?one.?Considering? stillbirths? and/or? controlling? for?birth?
weight? or? parental? age? in? the? analyses? had? no? effect? on? the? results,? indicating? that? both?
number?of?subsequent?siblings?or?pregnancy?order?did?not?matter.??
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7 Discussion?
Findings?from?this?thesis?highlight?the?social?inequalities?in?childhood?cancer?that?have?been?
observed?with?respect?to?reported?differences? in? incidence?between?racial?groups? in?South?
Africa?and?between?South?African?and?German?children.? In?addition,?differences? in?survival?
between?social?groups? in?Germany?and?Denmark?have?been? found? further?highlighting? the?
impact?of? social? inequalities?even?within?high?income? countries.? The?present?discussion? is?
organised? according? to? the? two? objectives? of? this? dissertation,? followed? by?more? general?
considerations?of?potential?underlying?pathways?of?social?inequalities?in?childhood?cancer.?
?
7.1?Reported?childhood?cancer?incidence?patterns?by?race?in?South?Africa?
The?first?objective?was?to?study?the? incidence?of?childhood?cancer? in?a?Sub?Saharan?African?
country,?namely?South?Africa,?focusing?on?differences?between?racial?groups?and?discussing?
the?potential?for?under?diagnosis?and?under?reporting?of?childhood?cancer?in?this?country.?
?
Interpretation?of?key?findings?
Key? findings? include? substantial? differences? in? the? reported? incidence? rates? and? the?
distribution? of? childhood? cancers?within? South? African? racial? groups? and? between? South?
African? and? German? children,? who? represent? the? incidence? patterns? of? high?income?
countries.?Furthermore,?a?particularly? low? incidence?rate? in?South?African? infants?compared?
to?German? infants?was? observed.? Patterns? across? the? South? African? racial? groups? and? in?
comparison?with?Germany?were?generally?similar?for?boys?and?girls.?
The? key? results? (see? Chapter? 6.1)? provide? support? for? all? hypotheses? defined? a? priori? in?
Chapter?5.1.1:?
o The? reported? incidence? of? childhood? cancer?was? higher? in?Germany? in? comparison? to?
South?Africa.?
o The?distribution?of?reported?childhood?cancer?by?diagnostic?group?and?age?group?differed?
between?Germany?and?South?Africa.?
o The? reported? incidence? of? childhood? cancer? in? South? Africa? differed? between? racial?
groups,?being?much?higher? in?White? children? compared? to?Black? children,?with? Indian/?
Asian?and?children?with?mixed?ancestry?falling?in?between.?
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Similar? to? childhood? cancer,? higher? incidence? rates? of? adult? haematological?malignancies?
among?White? and? Indian/Asian? populations? compared? to? the? Black? population? are? also?
observed,?which? adds? to? the? evidence? of? reported? cancer? incidence? differences? by? racial?
group? in?South?Africa.?Although?direct?quantitative?comparison? is?not?useful?as?the?types?of?
haematological? malignancies? in? adults? are? very? different? compared? to? children? (with?
particular? regard? to? leukaemias?and? the? lack?of? chronic? leukaemias? in? children),? there? is?a?
general?trend?of?lower?reported?incidence?in?Blacks?that?can?be?seen.?
?
Racial? differences? in? childhood? cancer? in? South? Africa? and? the? potential? for? under?
ascertainment??
Incidence? differences? by? racial? group? in? South? African? children? have? also? been? observed?
previously?in?regional?studies?[202?204]?as?well?as?in?the?annual?NCR?reports?[205].?In?a?study?
from? 1974?1983? in? Johannesburg,? significant? differences? in? the? incidence? of? leukaemia?
between? Black? and?White? children?were? found,?with?much? lower? rates? in? Black? children?
[203].?A?more?recent?study?from?the?Western?Cape?observed?a?lower?incidence?of?ALL?among?
children?with?mixed?ancestry?compared?to?White?children?[204].?
Significant?variations?in?incidence?rates?according?to?race?have?also?been?noted?in?the?US?(see?
Chapter?2.1).?White?children?showed?an?overall?1.5?fold?higher?childhood?cancer? incidence?
than? Black? children,? which? was? slightly? higher? for? leukaemia? (1.8?fold)? and? lower? for?
lymphoma?(1.3?fold)?[45].?However,?differences? in? incidence?rates?between?racial?groups? in?
the?US?were?much? smaller? than? those? observed? in? South?Africa.? Even? assuming? that? the?
differences? in? incidence? rates? between? racial? groups? in? the?US? are? entirely? explained? by?
differences?in?genetic?susceptibility?and?variability?in?environmental?exposures,?for?the?South?
African? setting? it? can? implied? that? the? further? excess? differences? found? are? likely? due? to?
additional?factors.??
?
The? observed? incidence? differences? may? instead? be? partly? explained? by? socioeconomic?
and/or?cultural?factors?related?to?access?or?utilization?of?health?care?services?and?health?care?
seeking? behaviour.? In? South? Africa,? race? is? strongly? correlated? with? socio?cultural?
circumstances?(such?as?education,?income,?medical?aid?and?cultural?beliefs),?and?having?a?low?
socioeconomic? position? is? considerably? more? common? among? Blacks? [30].? Higher?
unemployment?in?Blacks?[30]?may?result?in?a?lack?of?financial?resources?available?for?seeking?
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medical? help.? Only? 7%? of? the? Black? population? and? 16%? of? the? population? with? mixed?
ancestry?in?2006?were?covered?by?medical?aid?(which?provides?access?to?private?health?care?
services)? compared? to? 29%? of? Indian/Asians? and? 63%? of? the?White? population.? The? post?
apartheid?bill?of?rights?grants?everyone?the?right?to?basic?education,?but?as?a?consequence?of?
the?previous?regime?21.5%?of?the?Black?population?still?had?no?schooling,?compared?to?7.4%?
of?Whites? [30].?A? lack?of?parental?education? and? low? awareness?of? cancer,?particularly? in?
children? [1],? might? delay? or? inhibit? health? care? seeking? behaviour.? Furthermore,? some?
parents?might?not?know?that?cancer?is?treatable?and?therefore?do?not?seek?medical?care.??
The?non?specific?nature?of?many?early?symptoms? (e.g.? for? leukaemia?which?often?presents?
with? symptoms? similar? to? those? of? infections)? (see? Chapter? 1.2)? may? result? in? delayed?
diagnosis?or?failure?to?detect?the?disease?[20].?This?may?explain?why?differences?in?incidence?
for?cancer? types?with?clearly?visible?symptoms? (such?as? retinoblastoma?or?hepatoblastoma?
with?the?tumour?itself?being?large)?are?smaller?than?for?cancer?types?with?rather?non?specific?
symptoms?or?less?visible?tumours.?A?greater?proportion?of?Black?South?African?families?live?in?
rural/remote?areas? [30],?and?may?not?access? the?medical?centre?due? to? inadequate?public?
transportation?infrastructure?or?the?inability?to?pay?for?transport?and?accommodation?when?
their? child? is? ill? [1].?Therefore,? cancer?diagnosis?may?be?delayed?or? the? child?may?possibly?
never? get?diagnosed.? In? addition,?primary?healthcare? facilities? and? local/regional?hospitals?
may? lack? awareness? of? and? experience? in? diagnosing? paediatric? cancer? [1,? 14,? 75].? For?
instance,?the?observation?from?the?Western?Cape?that?the?lower?incidence?of?ALL?in?children?
with?mixed?ancestry? compared? to?White? children?was?particularly?pronounced? in? children?
from?rural?areas?[204]?would?support?this?explanation.?
Traditional?medicine? and? cultural?beliefs? continue? to?play?an? important? role? in?healthcare?
delivery?in?South?Africa,?particular?among?the?Black?population?[206].?Some?parents?may?rely?
on? traditional?healers?using?herbs?or?witchcraft?rather? than?attending?a?medical?centre? for?
diagnosis? and? treatment.? Some? families?might? first? seek? advice? from? traditional? healers?
before?seeking?Western?medical?treatment,?which?may?cause?a?delay?in?diagnosis?and?clinical?
treatment?[1].??
?
Although? the? potential? for? under?diagnosis? is?much? higher? for? the? Black? population,? the?
lower? incidence? rates? for? some? cancers? in? South?African?Whites? compared? to? rates? from?
Germany?may? be? due? in? part? to? under?ascertainment? rather? than? necessarily? reflecting? a?
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lower?cancer?risk.?Under?diagnosis,?due?to?parents?not?being?aware?of?the?warning?signs?of?
cancer?or? clinicians?being? less?experienced?at?detecting? childhood? cancer? (particular? types?
with?non?specific? symptoms)?may?be?a?general? issue? [1],? irrespective?of? racial?groups.?The?
pathology?based?reporting?process?of?the?NCR? itself?may?cause?some?under?ascertainment,?
as?cancers?without?a?pathology?based?diagnosis?are?not?recorded?[186]?(see?Chapter?5.2.1).?
This?might?be?of?particular?concern?for?some?brain?tumour?cases?diagnosed?solely?by?medical?
imaging,?but?could?also?apply?more?generally?to?the?situation?of?cancer?patients?who?present?
at?a? late?stage?and?for?whom?the?cancer?was?too?advanced?to?benefit?from?a?more?precise?
diagnosis.? It? is? also? possible? that? some? leukaemia? cases?might? have? been? diagnosed? only?
from?peripheral?blood?tests?performed?outside?the?tertiary?laboratory?structures.?This?would?
be?expected?to?occur?primarily?among?children?who?die?before?being?referred?to?a?tertiary?
hospital?where? bone?marrow? biopsies?would? have? been? analysed,? and? could? explain?why?
rates? of? leukaemia?were? particularly? low.? Therefore,? even? if?malignancies? are? accurately?
diagnosed?they?may?not?be?captured?by?the?NCR,?resulting? in?under?reporting?of?the?actual?
diagnosed?incidence?of?cancer.??
Notably,?however,?there?were?also?some?cancers?that?were?more?common? in?South?African?
Whites.?While?higher?exposure?to?ultraviolet?radiation?may?explain?the?excess?of?skin?cancer?
in?the?White?population?[58],?the?higher?rates?of?hepatic,?renal?and?malignant?bone?tumours?
were? unexpected? and?may? suggest? that? the? excess? in? South? Africa? is? even? higher? than?
observed.?
?
Incidence?rates?were?particular? low?among? infants,?with? the?rates? in?Germans?being?2?fold?
higher?when?compared?to?South?African?White?infants?and?almost?10?fold?higher?compared?
to? Blacks.? However,? among? 10?14? year? olds? the? incidence? rates? of? Germans? and? South?
Africans?were?almost?identical.?This?suggests?that?under?diagnosis?may?be?a?particular?issue?
among?both?Black?and?White? South?African? infants.?Diagnosis?during? infancy? is?difficult? in?
general.?Moreover,?in?South?Africa,?with?its?overwhelming?burden?of?infectious?disease?[78],?
cancer?may?not?be?among?the?first?diagnoses?suspected?and?thus?even?children?cared?for?in?
the?private?sector?may?not?be?diagnosed?before?they?die.?In?contrast?to?age,? incidence?rate?
proportions?were?similar?for?boys?and?girls?and?differences? in?diagnosis?or?reporting?by?sex?
appeared? to?not?play?a?great? role? in? South?Africa.?This? finding?was?unexpected,?as? recent?
evidence?points?out?that?rates?of?cancer?registrations?in?girls?remain?lower?than?expected?in?
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low??and?middle?income?countries?[77].?Nonetheless,?my?findings?indicate?this?is?not?the?case?
in?South?Africa.?
?
International?context?
The?observed?distribution?of? childhood? cancer? types? in? South?Africa? is?unique? and?differs?
from?those?observed?in?other?Sub?Saharan?African?[2,?18]?and?middle?income?countries?[63,?
64,?207],?as?well?as?high?income?countries?[4,?15,?16].?In?high?income?countries,? leukaemias?
are?the?most?frequent?childhood?cancer,?followed?by?brain?tumours,? lymphomas?and?other?
solid?tumours?[3,?4,?15,?16]?(see?Chapter?2.1).?Particularly?in?Sub?Saharan?Africa,?children?are?
more? prone? to? develop? NHL? (Burkitt’s? lymphomas)? and? Kaposi? sarcoma? due? to? higher?
exposure?to?infections?(namely?Epstein?Barr?virus,?HIV?and?human?herpes?virus?8)?[1,?66,?67].??
South?Africa?is?an?upper?middle?income?country?[183]?with?a?relatively?high?level?of?wealth?in?
some?regions,?and?is?therefore?distinct?from?the?Sub?Saharan?region?[14].?This?study?reveals?
that? leukaemias? in? South? Africa,? as? in? high?income? countries,? are? the? most? frequently?
reported? cancer? type,? although? rates? are? substantially? lower,? particularly? for? ALL.? These?
differences?might?be?again?the?result?of?the?cumulative?effect?of?genetic?predisposition,?the?
added?burden?of?various?infectious?diseases,?environmental?exposures?and?chronic?immune?
stimulation,?but?in?addition?due?to?incomplete?diagnosis?and?registration.?
?
Differences?between? the? reported?and?actual? incidence?of? childhood?malignancies? in? low?
income? countries? is? generally? assumed? to? be? most? striking? for? leukaemia? due? to? the?
unspecific? symptoms? resembling? those? of? infectious? diseases,? thereby? resulting? in? death?
before?cancer?is?suspected?or?diagnosed?[17,?20].?Many?Sub?Saharan?African?countries?report?
fewer?brain?tumours,?and?substantial?under?estimation?is?assumed?[17].?In?South?Africa?this?
seemed? to?be?more?pronounced? in? the?Black?population?as? the?observed? incidence?rate? in?
White?children?was?more?than?70%?of?that?reported?for?Germany.?For?lymphomas?and?some?
solid?tumours,?visible?symptoms?(see?Chapter?1.2)?might?encourage?parents?to?seek?medical?
help?and?early?death?is?less?common.??
? ?
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Strengths,?limitations?and?methodological?considerations?
This?study?presents,?for?the?first?time,?the?incidence?of?childhood?cancers?in?South?Africa?on?a?
national? level?and? is?one?of?very?few?studies?on?childhood?cancer?from?Sub?Saharan?Africa.?
The? strengths?of? conducting? this? analysis? in? South?Africa? include? the?availability?of? cancer?
registry?data,?the?large?population?of?children,?and?the?racially?diverse?population.?The?latter?
strength? allowed? us? to? investigate? differences? by? racial? group,? which? is? an? important?
determinant?of?socioeconomic?circumstances?and?access?to?high?quality?health?care?in?South?
Africa?(via?the?private?health?care?sector).?
The?second?major?strength?of?this?study?was?the?availability?of?directly?comparable?data?from?
Germany.? Incidence? rates?of?German? children? represent? typical? rates?of? childhood? cancer?
occurrence?in?a?high?income?country.?The?GCCR?has?a?very?high?estimated?level?of?childhood?
cancer?ascertainment? (>95%?since?1987? [3])? in?a? large?population?of?children?which?has?an?
assumedly?high?similarity?in?genetic?make?up?with?White?South?African?children.?The?registry?
was?able? to?provide?data? in?a? structure?comparable? to? that?of? the?South?African?database?
with? respect? to? the? time? period? (2000? –? 2006)? and? included? diagnoses? (e.g.? exclusion? of?
benign?brain? tumours?not?recorded? in? the?National?Cancer?Registry?of?South?Africa? (NCR)),?
making?the?comparison?very?meaningful.?
?
The? South? African? cancer? registry? captures? data? from? all? public?sector? pathologically?
confirmed?cancers?across?the?country?as?well?as?a? large?proportion?of?cancers?diagnosed? in?
the?private?sector.?However,?as?some?private?laboratories?discontinued?reporting?to?the?NCR?
in?2005?because?of?concerns?about?patient?privacy?[186]?(see?Chapter?5.2.1),?marginal?under?
reporting?of?childhood?cancer?cases?diagnosed? in? the?private?healthcare?sector? is? likely? for?
the?years?2005?–?2006.??
A?major? limitation?of?the?study? is?the?pathology?based?reporting?process?of?the?NCR.?Since?
cancers?without?a?pathology?based?diagnosis?are?not?captured,?the?reporting?process? itself?
might? result? in? under?reporting? (see? above? &? Chapter? 5.2.1).? Since? the? early? 1990s? an?
increasing?number?of?pathology?reports?have?been?received?without?information?on?race.?An?
imputation?method? (using? a? surname? algorithm)?was?used? to? assign? racial? group? to? cases?
missing? this? information? (see? Chapter? 5.2.1).? Thus,?misclassification? of? some? cases? with?
regard? to? race? cannot? be? excluded,? but? previously?conducted? validation? analyses? of? the?
imputation? method? have? shown? this? method? to? be? reasonably? accurate,? so? that? this?
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limitation?is?considered?to?be?of?minor?importance.?Another?limitation?of?this?study?was?the?
lack?of?data?on? stage? at?diagnosis,?which? could?provide? further? insight? into?differences? in?
stage?at?diagnosis?and?diagnostic?delay?by? race?and?age?groups? [202].?Moreover,?no?other?
socio?cultural? characteristics? such? as? socioeconomic? factors? (education,? income),? place? of?
residence? or? cultural? beliefs? (e.g.? belief? in? traditional? healer)? were? available.? Those?
characteristics?are?most?likely?related?to?access?and?utilization?of?health?care?service?as?well?
as? certain? environmental? exposures,? and? would? have? been? very? interesting? to? study.?
Nevertheless,? this? is? a? limitation? that? can? be? considered? to? be? a? characteristic? of? all?
population?based?cancer?registry?data.??
Finally,?the?analysed?data?were?from?the?time?period?2000?2006,?a?period?when?the?cancer?
registry? operated? under? defined? and? stable? conditions.?However,? these? results?might? not?
reflect? the? current? situation.? Studies? based? on?more? recent? data?will? be? important? once?
available? for? analysis,? especially? considering? the? introduction? of? new? legislation? in? 2011?
which?made?reporting?of?all?confirmed?cancers?to?the?NCR?mandatory?(see?Chapter?5.2.1).?
?
Considering? the? overall? objective? of? this? dissertation,? a?major? limitation? is? that? childhood?
cancer? incidence?patterns?were?studied? in?only?one?Sub?Saharan?country?and?not? in?one?of?
the? low?income?countries? in?the?region?[183].?It? is?questionable?to?what?extent?the?findings?
from?South?Africa?are?generalizable? to?other?Sub?Sahara?African?countries.?With? regard? to?
differences?in?the?burden?of?infections?[66],?environmental?exposures,?genetic?susceptibility?
and?access?to?as?well?as?utilization?and?quality?of?health?care? [1,?14],?patterns?might?differ?
considerably? in? other? populations.? Analysing? data? from? other? developing? countries,? for?
instance? from?Central?Africa,?might?provide? further? insight? into?geographical?differences? in?
childhood? cancer? and?under?ascertainment.?Unfortunately,? there? are? still? too? few? reliable?
data?sources,?particularly? in?Sub?Saharan?Africa,?and?additional?data?were?not?available? for?
this?dissertation.?
?
Conclusion?
Taken? together,? the? reported? lower? incidence? rates? for? some? childhood? cancers? in? South?
Africa?compared? to?developed?countries,?most?pronounced? for?Black?children,?might?be?at?
least? to? some? extent? related? to? under?diagnosis? and? under?reporting.? Since? the? actual?
incidence? of? childhood? cancer? in? South? Africa? and? other? Sub?Sahara? African? countries? is?
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unknown,? the? extent? of? under?ascertainment? is? difficult? to? quantify? at? present.? It? is? very?
likely? that? the?extent?of?under?ascertainment? varies?between? i)? cancer? types?with? greater?
under?diagnosis? likely? occurring? in? cancer? types? with? unspecific? symptoms? such? as?
leukaemia,?ii)?age?groups?with?greater?under?diagnosis?likely?occurring?in?infants,?and?iii)?race?
with?the?greatest?likely?under?diagnosis?in?South?African?Blacks.??
Observed? geographical? differences? in? incidence? rates? have? been? used? to? put? forward?
aetiological?hypotheses?to?explain?the?apparent?cancer?excess? in?high?income?countries,?for?
instance?related?to?lack?of?immunological?training?due?to?“over?hygiene”?resulting?in?delayed?
exposure?to? infections?or?related?to?modern?technology?such?as?those?producing?EMFs?(see?
Chapter? 2.1? &? 2.2).? The? South? African? findings? suggest? the? need? to? be? cautious? in?
interpreting? geographical? differences? in?many? childhood? cancers.? Further? research? on? the?
geographical?variation?of?childhood?cancer? incidence?rates? is?needed?to?quantify?the?extent?
of? under?reporting? and? under?diagnosis? compared? to? true? differences? in? incidence? rates?
between?more?developed?and?less?developed?countries.?
?
7.2?The?role?of?social?and?family?factors?in?survival?from?childhood?cancer??
The?second?objective?was?to?investigate?the?role?of?social?and?family?factors?on?survival?from?
childhood? cancer? or? certain? types? of? childhood? cancer? in? two? countries? with? presumed?
uniform?and?free?access?to?health?care?services,?namely?Germany?and?Denmark.?
?
Interpretation?of?key?findings?
Table? 4? presents? an? overview? of? the? key? findings? observed? from? the? four? independently?
conducted? studies? on? social? and? family? factors? and? survival? from? childhood? cancers? in?
Denmark?and?Germany.?Despite?the?highly?specialized?treatment?of?children?with?cancer?and?
universal? healthcare? coverage? in?Denmark? and?Germany,? social? and? family? characteristics?
were?found?to?be?associated?with?survival?from?childhood?cancers,?although?not?consistently?
so?between?Germany?and?Denmark?and?across?cancer?types.?
No? strong? impact? of? socioeconomic? factors? on? survival? from?ALL?was? observed? for? either?
Germany?or?Denmark.?The?beneficial?effect?of?maternal?higher?education? in?Denmark?was?
only? observed? among? children?with? non?CNS? solid? tumours.? The? superior? survival? among?
children?with?having?cohabitating?parents?was? seen?mainly? for?children?with?CNS? tumours?
and? less? so? for? children? with? non?CNS? solid? tumours.? Increasing? birth? order? and? having?
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siblings? was? associated? with? inferior? survival? among? childhood? haematological? cancer?
patients? in? Denmark,?with? the? associations? being? rather? suggestive? for? ALL? and? NHL? but?
stronger?and?statistically?significant?for?AML.?Similarly,?associations?with?family?factors?were?
rather? suggestive? for? survival? from? ALL? in? German? children.? Poorer? survival? was? only?
observed? for?children?having?3?or?more?siblings.? In?contrast?to?the? findings? from?Denmark,?
highest? survival? in?Germany?was? seen? for? second?born? children.?A? non?linear? relationship?
was? found? for?parental?age?at?child’s?diagnosis,?with?poorer?ALL? survival? for? children?with?
young?parents? and?particular?with?older? fathers.? In?Denmark,? children?with?older?parents?
showed? a? tendency? towards? lower? survival? from?ALL,?while? for? survival? from?AML? young?
maternal?age?was?related?to?a?poorer?prognosis.?
?
With? respect? to? the? a? priori? defined? hypotheses? regarding? the? relationship? between?
socioeconomic? position? and? survival? from? childhood? cancer? (see? Chapter? 5.1.2),? the?
hypothesis? that?children? from? families?with?higher?parental?education?have?better? survival?
compared?to?children?from?families?with?lower?parental?education?is?supported?for?children?
with?non?CNS? solid? tumours? in?Denmark.? The?hypothesis? that? children? from? families?with?
higher?monthly? income? have? better? survival? finds? no? support? based? on? the? analyses? of?
survival? from? ALL? in? Germany,? and? very? weak? support? for? survival? from? haematological?
malignancies?or?CNS?tumours?in?Denmark.??
My? findings?with? respect? to? family? factors? confirm? several? of? the? hypotheses? outlined? in?
Chapter?5.1.? Firstborn? children?have?better? survival? from?ALL? and?AML? compared? to? later?
born?children?in?Denmark.?Findings?from?Germany?and?Denmark?support?the?hypothesis?that?
only? children?have?better? survival?compared? to? children?with? siblings.?The?hypothesis? that?
children?with? cohabiting? parents? have? better? survival? than? children?with? single? parents? is?
support?by?the?Danish?study?among?children?with?a?CNS?or?non?CNS?solid?tumour.??
On?the?contrary,?the?hypothesis?that?children? living?in?more?rural?areas?have?worse?survival?
than? children? living? in? urban? areas? finds? no? support? both? from? either? the? findings? from?
Denmark? or?Germany.? Findings? for? parental? age? and? survival? from? childhood? cancers? are?
inconclusive.?Finally,?the?supplementary?hypothesis?that?children?of?higher?birth?order?have?a?
higher? childhood? cancer? risk? compared? to? children?of? lower?birth?order? finds?no? support,?
since?the?results?from?the?Danish?cohort?study?did?not?indicate?an?association?between?birth?
order?and?risk?of?any?childhood?cancer.?
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The?role?of?social?and?family?factors?in?survival?from?childhood?cancer?
Out?of?the?broad?range?of?social?and? family? factors?under?study,?the?observed?associations?
between? family? factors? and? survival? from? childhood? cancers? are? particularly? interesting,?
especially? in? that? associations? with? socioeconomic? factors? were? not? very? pronounced.?
Whereas?parental?education?and? income?did?not?appear?to? impact?survival? from?childhood?
haematological?malignancies? in?Denmark?and?ALL? in?Germany,?strains?on?families?and?their?
social?resources?(as?measured?by?birth?order,?number?of?siblings?and?parental?age?at?child’s?
diagnosis? in? this? dissertation)? appeared? to? be? more? relevant? than? the? socioeconomic?
situation?of? the? family,?at? least? for?survival? from?haematological?malignancies.?For?survival?
from?non?CNS?solid?tumours,?both?maternal?education?and?number?of?siblings?appeared?to?
be? relevant.? Little? is?known?about? the? role?of? family? factors?on? survival? (see?Chapter?3.4),?
particularly?their?interaction?with?socioeconomic?circumstances.?
?
The?well?documented?impact?of?social?factors?on?cancer?outcome?in?adults?[136,?138,?167]?is?
associated?with?differences? in? the? time?of?diagnosis,? in? the?biological?characteristics?of? the?
tumour,? treatments? given? and? individual? factors,? such? as? lifestyle? or? the? presence? of?
comorbidities? [138,? 166,? 171].? However,? for? childhood? cancers? dissimilarities? in? survival?
would? be? expected? to? be? less? likely? related? to? co?morbidities? and? children’s? lifestyle,? but?
more? likely? related? to? delayed? diagnosis? for? some? social? groups? [208],? adherence? to?
treatment? recommendations? [180],? communication? barriers? with? health? professionals? as?
well?as?psycho?social?effects?[209].??
Treatment?of?lymphoblastic?malignancies?(ALL?and?NHL)?usually?lasts?several?years,?and?poor?
adherence?to?oral?maintenance?therapy?may?have?a?negative?impact?on?cure?rates?[210].?As?
soon?as? the? child? is?discharged? from?hospital? (typically?after?about?8?9?months? [33,?122]),?
parents?are?responsible?for?complying?with?the?recommendations?for?the?continuation?of?a?
highly? demanding? therapy,? including? daily? drug? administration? and? frequent? medical?
outpatient? appointments.? Accordingly,? findings? from? the? UK? indicated? that? ALL? survival?
dissimilarities? by? socioeconomic? position? emerge? about? the? time? when? treatment?
management?requires?parental/child’s?adherence,?i.e.?from?the?time?of?oral?treatment?in?the?
outpatient? setting.? Investigators? hypothesized? that? this? dissimilarity? may? be? due? to?
treatment? adherence? [21].? In?Germany,? children?with? 3? or?more? siblings? showed? inferior?
survival?and?these?dissimilarities?emerged?about?1.5?years?after?diagnosis,?a?time?by?which?
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treatment?management? had? usually?moved? from? hospital? to? home? [33,? 123].? Similarly? in?
Denmark,? children?with? siblings? as?well? as? children? of? higher? birth? order? showed?worse?
survival.?The?pattern?of?diverging?survival?curves?after?the?beginning?of?home?administered?
therapy?seen?in?the?UK?was,?however,?not?reflected?in?the?survival?curves?for?Danish?children.?
Moreover,? I? observed? an? even? stronger? relationship? between? the? number? of? siblings? and?
AML?survival?and?AML? is?entirely?treated? in?hospital.?Thus,?family?resources?might?not?only?
be?of?relevance?for?the?period?of?the?home?administered?maintenance?therapy?for?ALL,?but?
for? the? entire? treatment? period? of?AML? and?ALL.? Smaller? families?may? be? able? to? devote?
more?time?to?assisting?the?sick?child?and?may?thus?be?better?at?coping?with?and?managing?the?
cancer?experience?[180,?211].?
?
However,? and? in? contrast? to? the? findings? from? Germany,? the? associations? seen? between?
number? of? siblings? and? leukaemia? survival? in? Denmark? (both? ALL? and? AML)?were?mainly?
attributed? to? the? effect? of? birth? order.?According? to? the? adrenal? hypothesis? [212],? higher?
birth? order? [38]? and? more? social? contacts? [213]? could? suggest? that? the? lymphoblastic?
malignancies? emerged? in? spite? of? high? glucocorticosteroid? exposure? and? thus?were?more?
glucocorticosteroid?resistant? when? diagnosed,? a? feature? associated? with? poor? prognosis?
[214].? Nevertheless,? this? explanation? would? only? apply? for? the? observed? relationship?
between?birth?order?and?survival?from?ALL.?However,?the?relationship?between?survival?and?
birth?order?noticed? for?children?with?AML? in?Denmark?was?even?stronger?than? for?ALL?and?
more?pronounced?for?cases?diagnosed?since?1990?characterised?by?a?standardised?treatment?
approach? [31,? 32,? 120].?Perhaps? firstborns? and? children?with? fewer? siblings?might? receive?
more? attention? from? their? parents,? possibly? positively? affecting? abilities? to? cope?with? the?
cancer? experience? [211],? the? demanding? therapy? and? associated? uncertainties,? but? this? is?
speculation.?
?
The?observed?relationship?between?parental?cohabitation?status?and?survival?from?CNS?and?
non?CNS?solid?tumours?in?Denmark?implies?that?living?with?a?partner?might?facilitate?sharing?
of?the?prolonged?attention?and?practical?work?required?in?caring?for?a?child?with?cancer?and?
also? for?coping?with? the?associated?mental?challenges?and?anxiety? [22,?211].?Furthermore,?
cohabitation?might? enable? one? parent? to? reduce? his? or? her?working? hours? to? be? at? the?
hospital?[211].?
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The?poorer?survival?from?AML?and?NHL?reported?in?the?Danish?study?for?children?with?young?
mothers? (for? the? latter?also? for? children?with?young? fathers)?and? from?ALL? in? the?German?
study?for?children?with?young?fathers?may?possibly?also?reflect?the?capacity?to?cope?with?the?
cancer?diagnosis?and?related?circumstances,?which?may?be?particularly?challenging?for?young?
parents? [211].? In? an? investigation? from? Brazil? younger? parents? of? children? with? cancer?
reported?higher?levels?of?stress?and?anxiety?[215].?This?might?also?explain?the?better?survival?
from? AML? and? NHL? among? children?with? older?mothers.? However,? as? the? parental? age?
survival?relationship?appeared?to?be?reversed?for?ALL?among?Danish?children,?interpretation?
of?these?findings?remains?unclear?at?present.?
 
While?the?financial?situation?of?a?family?does?not?appear?to?be?strongly?relevant?to?survival,?
parental? educational?might? have? a? potential? effect? on? survival? –? as? seen? among? Danish?
children?with?non?CNS? solid? tumours.? Families?depend?on? information? and? guidance? from?
health?personnel,?but?general?health?literacy,?communication?and?cognitive?skills?may?differ?
by?level?of?education,?resulting?in?different?understanding?by?parents?who?receive?the?same?
information?[180].?The?problem?might?be?exacerbated?for?children?with?cancers?that?require?
multidisciplinary?treatment,?like?non?CNS?solid?tumours.?
 
Whether?children?lived?in?urban?or?more?rural?areas?in?Germany?or?Denmark?was?not?found?
to?be?of?relevance?for?their?survival.?This?is?plausible?as?a?dense?network?of?paediatric?clinics?
cover?both?countries,?with?relatively?short?distances?to?the?treating?centre?from?most?places.?
Further,?treatment?is?highly?standardised?[31?33,?120,?123]?(see?Chapter?3.1),?irrespective?of?
the?treating?hospital.??
?
As?described? in?Chapter?5.1.2,? family? factors? such?as?birth?order,?parental?age?or?place?of?
residence?have?been?proposed?as?risk?factors?for?some?childhood?cancers,?especially?for?ALL,?
either?operating?directly?(parental?age)?or?indirectly?as?proxy?of?other?exposures?(birth?order?
as?proxy?of?infectious?contacts)?(see?Chapter?2.2).?It?could?therefore?be?hypothesized?that?if?
such? factors? increase? the? risk? of? developing? ALL? they? may? also? increase? the? risk? of?
subsequent?relapse?and?consequently? impact?survival? through?similar?mechanisms,?namely?
promoting? the? aberrant? leukaemic? clone.?The?only? factor? for?which? this?has?been? already?
investigated? is?magnetic?fields,?where?studies?on?risk?show?a?weak?positive?association,?but?
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no? association?was?observed?with? survival? [36].? Similarly? I?did?not?observe? an? association?
between?birth?order?and?risk?of?ALL? in?the?same?Danish?population? in?which?I?observed?the?
association?with? survival.?Moreover,? advanced? parental? age? has? been? associated?with? an?
increased?risk?of?most?childhood?cancers,?although?findings?are?not?fully?consistent?[10,?40,?
112?115]?(see?Chapter?2.2).?However,?these?increased?cancer?risks?reported?in?the?literature?
do? not? correspond? to? the? diverse? patterns? observed? for? survival? and? parental? age? in?my?
studies.?
?
International?context?
The? findings? indicate?that?some?social?and? family?circumstances?are?associated?with?better?
survival.? However,? the? impact? of? the? different? indicators? differed? by? cancer? type? and?
between? countries,?even?between?neighbouring?Germany?and?Denmark?as? investigated? in?
the? present? analysis.? This? illustrates? why? findings? from? previous? studies? only? including?
leukaemia? [24,? 26,? 148],? lymphomas? [29]? or?ALL? [21,? 28,? 146]? cancer? cases? are?markedly?
limited?by?patient?selection?(only?certain?cancer?types)?or?sample?size,?with?limited?power.??
?
While?survival?from?non?CNS?solid?tumours?was?superior?among?Danish?children?of?mothers?
with? higher? educational? attainment,? parental? education? and? income? did? not? appear? to?
strongly? impact? survival? from? childhood?haematological?malignancies?and?CNS? tumours? in?
Denmark? and? ALL? in? Germany.? On? the? contrary,? among? studies? from? other? European?
countries,? mainly? investigating? leukaemia? or? ALL? alone,? parental? education,? income? or?
occupation?did?matter?[21,?22,?24,?26,?146]?(see?Chapter?3.4).?
?
Family? characteristics? such?as?number?of? siblings,?birth?order?and?parental?age?have?been?
postulated?to?be?related?to?the?occurrence?of?childhood?cancer?[10,?37?39,?92,?112,?113,?216]?
(see? Chapter? 2.2),? but? evidence? of? their? role? as? prognostic? factors? for? leukaemia? and? in?
particular? lymphoma?and? solid? tumours? is? sparse?and?with?conflicting? findings? [22,?23,?26,?
146,?147,?162]?(see?Chapter?3.4).?In?line?with?the?findings?of?this?dissertation?research,?a?large?
Norwegian? study?on? children?with? cancer? reported? that?having?no? siblings?was?associated?
with?mortality?reductions?of?almost?20%?[22].? In?contrast,?a?study?from?Greece?on?children?
diagnosed?with?ALL?in?the?late?1990s?early?2000s?observed?better?prognosis?for?children?with?
increasing? number? of? siblings? [146].?However,? this? finding?was? not? confirmed? in? a? recent?
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follow?up? study? [26]? (see?Chapter?3.4).? Likewise?and? in? significant? contrast? to? the? findings?
from? Denmark,? no? relationship? between? survival? from? AML? and? number? of? siblings?was?
observed?there?[26].?
To?my?knowledge,?so?far?no?earlier? investigation?had?addressed?the?possible? importance?of?
parental? age? at? the? child’s? cancer? diagnosis? for? childhood? cancer? survival.? Although? only?
somewhat? comparable,? analyses? of? mother’s? age? at? child’s? birth? from? Norway? did? not?
indicate? a? relationship?with? childhood? cancer? survival,?whereas? the?most? recent? findings?
from? Greece? indicated? better? survival? from? AML? with? older?maternal? age? [22,? 26]? (see?
Chapter? 3.4).? This? trend? is? similar? to?what?was?observed? for?maternal? age? at? child’s?AML?
diagnosis?in?Denmark.?As?for?ALL?survival,?however,?old?parental?age?was?related?to?inferior?
prognosis.?
?
The? large?Norwegian?study?did?not?find?an?association?between?parental?marital?status?and?
survival? [22],?whereas? in?Denmark? I?observed?an?association? in?children?with?CNS? tumours?
but? also? noticed? indications? of? an? association? in? children? with? non?CNS? solid? tumours.?
Notably?however,? the?definition?of?marital? status? in? the?Norwegian? study?did?not? include?
cohabiting? unmarried? parents,? which? in? the? Danish? study? constituted? some? 19%.? Single?
parenthood? was? also? reported? as? a? critical? factor? for? childhood? leukaemia? prognosis? in?
Greece? [26].?Apart? from?methodological?differences?between?studies,?socio?cultural?aspect?
of?the?respective?countries?might?also?affect?these?associations.?
?
With?respect?to?place?of?residence,?a?study?from?Australia?reported?better?leukaemia?survival?
for?children?living?in?major?cities?compared?to?those?living?elsewhere.?However,?no?evidence?
of?geographical?variation?in?survival?was?observed?for?children?with?lymphoma?[23].?Living?in?
rural? areas? was? also? associated? with? less? favourable? prognosis? in? recent? multi?national?
findings?from?Bulgaria,?Turkey?and?Russia?[162].?This?may? likely?contrast?the?smaller?size?of?
Germany? and?Denmark,? the?excellent? infrastructure? and? the? lack?of? real? remote?areas.? In?
Greece,? an? earlier? study? found? indications? of? a? trend? of? poorer? survival? with? increasing?
remoteness?[146].?This?was?not?confirmed?in?more?recent?years,?which?was?suggested?to?be?
linked?to?improvements?in?motorway?infrastructure?[26]?(see?Chapter?3.4).?
?
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However,?dissimilarities?in?welfare?systems,?including?access?to?health?care?and?public?family?
support,? coverage?and?distance? to? treatment? facilities,? lifestyle?and? socio?cultural?aspects,?
treatment? protocols? as? well? as? methodological? differences? between? studies? make? an?
international?comparison?challenging.?An?essential?question? is?to?what?extent?the?observed?
differences? across? studies? are? real? (reflecting? different? impact? of? social? and? family?
characteristic?due? to?differences? in?health?care?and?social?stratification,? true?overall?health?
inequity)?or?to?what?extent?differences?can?be?explained?by?features?of?the?studies,?including?
differences?in?data?sources,?data?collection,?cancer?type,?and?diagnostic?period.?
?
Strengths,?limitations?and?methodological?considerations??
These? are? the? first? studies? in? Germany? and? Denmark? on? this? topic? among? very? few?
investigations? from?Europe.?The?population??and?register?based?Danish?cohort?studies?with?
minimal? risk?of?bias?were?an?excellent?data?source? for? the? investigation.?With? the?national?
and? register?based? approach? these? studies? covered? virtually? all? Danish? childhood? cancer?
cases?with?a? complete? follow?up?and? thus?provided?a? factual? reflection?of? the? situation? in?
Denmark.? Through? the? unique? registries? in? Denmark? a? broad? range? of? social? and? family?
factors?were? available?with?high? validity?excluding? any? kind?of? information?bias?and? again?
with? virtually? no? missing? information.? For? the? analysis? part? taking? place? in? Denmark,?
individual? level?SEP?markers?were?available?and?both?married?and?cohabiting?parents?could?
be? identified.? Thus,? this? is? one? out? of? few? studies? that? could? take? into? account? the? joint?
influence?of?family?and?social?factors,?acknowledging?that?these?factors?operate?together.?
?
An? inherent? limitation? is?the? low?power?of?epidemiologic?studies?for?rare?outcomes,? in?this?
case? the? fortunately? low? incidence? of? childhood? cancers? (see? Chapter? 2.1).? The? cohorts?
studied? reflect? the? population? size? of?Denmark? and?West?Germany? and? thus? include? the?
maximum?population?available?at?national?level.??
Several?estimates?failed?to?reach?statistical?significance?despite?clear?patterns?of?risk?by?social?
factors.? Since?diagnostic?periods?and? respective? treatment?protocols?as?well?as? the?model?
adjustments?differ?notably?between?studies,?risk?estimates?and?therefore?the?magnitudes?of?
associations? are? not? directly? comparable? across? studies,? but? give? indications? about?
differences?or?similarity?of?patterns?between?Denmark?and?Germany.?
?
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Further?major? limitations?apply?to?specific?studies.?One? is?the?diagnostic?time?period?of?the?
German? study.? Data? of? survival? studies? are? by? default? historical? by? the? time? they? are?
analysed,?but?the?cases? in?the?German?studies?were?diagnosed?between?October?1992?and?
September?1994.?Since?then?treatment?protocols?have?improved?considerably?[33,?123]?and?
the?German?health?care?system?went? through?a?series?of?reforms? [185],?although? financial?
compensation?for?diagnosis?and?treatment?of?childhood?cancers? is?not?known?to?have?been?
changed? by? these? reforms.? Nevertheless,? it? cannot? be? excluded? that? the? most? recent?
improvements?of?treatment?may?have?offset?or?attenuated?the?relationship?between?family?
characteristics? and? ALL? survival? found? here.? Unfortunately,? no?more? recent? dataset? was?
available?for?Germany?as?no?new?analytical?studies?have?been?carried?out?since?the?conduct?
of?the?nationwide?studies?in?the?1990s?and?restricted?epidemiological?studies?(such?as?in?the?
vicinity?of?nuclear?installations)?were?not?useful?for?my?research?questions.?
The?German? study? focusing? on? socioeconomic? factors? had? 18%?missing? data? due? to? non?
participation? in?the?original?case?control?study;?a?further?6.5?%?of?the?participating?families?
did? not? specify? their? monthly? family? income? and? 5.3%? did? not? provide? information? on?
maternal?education.?Poorer?survival?was?noticed?in?non?participants?suggesting?that?families?
where? the? child? had? died? where? less? likely? to? participate? and? potentially? not? invited? to?
participate? by? their? treating? physician.? As? non?participation? in? epidemiological? studies? is?
possibly? associated?with? lower? socioeconomic? position,? the? results?might? theoretically? be?
biased.? However,? sensitivity? analyses? assuming? the? worst? case? scenario? that? every? non?
participant?had? lowest?maternal?education? level?and? lowest? family? income?also?yielded?no?
association?between?socioeconomic?factors?and?ALL?survival.?
?
No?sex?and/?or?age?group?specific?analyses?were?undertaken? in?any?of? the?survival?studies?
due?to?very?small?numbers?in?subgroups?and?subcategories.?Age?was?found?to?be?a?predictor?
of? treatment? compliance?with? exceptionally? poor? compliance? in? adolescents? [180].? Thus,?
patterns?for?the?relationship?between?social?and?family?factors?and?childhood?cancer?survival?
might?vary?by?age?group.?Similarly,?although?there?is?little?evidence?for?paediatric?patient?sex?
being?related?to?compliance?with?a?possible?exception?for?adolescent?girls?[180],?the?role?of?
family?and?social? factors? in?childhood?cancer?survival?might?be?different? for?girls?and?boys.?
Nevertheless,?comparing?crude?and?adjusted?results?in?my?analyses?does?not?provide?strong?
evidence?that?patterns?differ?by?sex?or?age.?
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None? of? the? investigations? accounted? for? clinical? and? immunophenotypic? features? of? the?
diseases,? leaving? open? the? possibility? that? factors? predictive? of? the? occurrence? and? the?
characteristics? of? the? disease?may? confound? the? prognostic? results.? For? instance,? any? risk?
factor? associated?with? leukaemia? cases? diagnosed?with? high?white? blood? cell? count? could?
appear?as?prognostic?of?the?outcome? if? it?was?not?adjusted? for?number?of?white?blood?cell?
count?at?diagnosis.?However,?the?respective?data?were?not?available.?
?
Conclusion?
Social? and? family? factors? have? the? potential? to? impact? survival? from? childhood? cancer,?
although? findings?vary?by? cancer? type?and?across? countries.?Despite? the?highly? specialized?
and? centralized? treatment? and? free? access? for? all? children? to? all? health? services,? not? all?
children?benefit?equally?from?improvements?in?survival?[11].?My?findings?suggest?that?cancer?
biology?and? treatment?are?not? the?only? factors? influencing?survival?and? that?some? families?
may?need?extra?supportive?care?during?the?demanding?treatment?and?recovery?of?their?child.?
Further?studies?are?warranted?to?gain?further?knowledge?on?the?impact?of?social?and?family?
factors?on?childhood?cancer?survival?in?other?populations?and?to?identify?potential?underlying?
mechanisms,?particularly?with? regard? to? social?differences? in? coping? strategies,?differential?
adherence? to? therapy? and? related? interactions? of? families? with? paediatric? oncologists? in?
Germany,? Denmark? and? elsewhere.? Understanding? the? pathways? leading? to? such?
associations?is?necessary?in?order?to?reduce?health?inequalities.?
?
7.3?Social?inequalities?in?childhood?cancer?and?potential?pathways??
In? the? context? of? this? dissertation? I? observed? social? inequalities? in? childhood? cancer?with?
respect? to? reported? incidence? differences? between? racial? groups? in? South? Africa? and?
compared? to?Germany,?and?with?respect? to?survival?differences? in?Germany?and?Denmark.?
This? work? adds? to? the? existing? evidence? on? geographical? differences? in? the? reported?
incidence?of?childhood?cancers?(see?Chapter?2.1)?and?on?survival?differences?between?social?
groups?within?European?populations?(see?Chapter?3.4).?Explanations?or?underlying?pathways?
of? these? social? inequalities? cannot? be? derived? from? my? research,? however,? as? these?
investigations?were?not?designed?for?this?purpose.??
Differences? in? the? genetic? make?up,? environmental? exposures? and? exposure? to? certain?
infectious?diseases?(see?Chapter?2.1)?as?well?as?under?ascertainment?of?cases?are?discussed?
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as?explanations?for?the?observed?geographical?differences?of?childhood?cancers?[1,?19,?20].?In?
the?context?of?social? inequalities? in?survival,?primarily?adherence? to?and? refusal?of? therapy?
[139,? 145,? 152,? 180]? are? discussed? in? the? literature.? For? developing? countries,? also?
malnutrition,? variability? in? drug?metabolism? and? access? and? utilization? of? health? care? and?
treatment?are?cited?[1,?14,?140,?152].?Although?there?are?some?investigations?on?the?impact?
of?childhood?cancer?on?the?family?life?with?respect?to?stress?levels?of?parents?of?children?with?
cancer,? mental? health? of? parents,? important? stressors? and? resources? as? well? as? coping?
strategies?and?behaviour?[209,?211,?215,?217,?218],?there? is? little?evidence?available?on?the?
role?of?those?psychosocial?aspects?in?pathways?of?survival?inequalities.?
?
A?better?understanding?of?the?underlying?pathways?of?those?survival?differences?would?help?
to? develop? strategies? to? diminish? social? inequalities? in? childhood? cancer.? The? well?
documented?impact?of?social?factors?on?cancer?outcome?in?adults?(see?Chapter?4.1)?[136]?is?
associated?with?differences? in? the? time?of?diagnosis,? in? the? tumour? characteristics,? in? the?
treatments?given?and?in?individual?factors,?such?as?lifestyle?or?the?presence?of?comorbidities?
[138,? 170,? 171].? However,? in? European? countries? differences? in? survival? from? childhood?
cancer?would?be?expected?to?be? less? likely?related?to?co?morbidities?and?children’s? lifestyle?
or? early? detection? (as? children? are? usually? subjected? to? close? parental? and? medical?
surveillance),?but?might? include?reasons?such?as?adherence?to?treatment?recommendations?
[180].? In? low?? and? middle?income? countries? time? of? diagnosis? and? co?morbidities? might?
indeed? be? important? determinants? [1].? Possibly? a? complex? interplay? of? disease? biology,?
pharmacogenetics,?economic,?social,?psychosocial,? family?and?cultural? factors?contribute?to?
the?observed?inequalities?in?childhood?cancer.??
?
Based? on? the? proposed? theoretical? framework? by? Hiatt? and? Breen? (see? Chapter? 4.2)? I?
developed? a? conceptual? model? specifically? focusing? on? social? inequalities? in? childhood?
cancer,? illustrating? potential? pathways? by?which? social? and? family? factors?might? have? an?
impact?on? the?childhood?cancer?continuum? (see?Figure?7).? In? the?model? family? factors?are?
defined?in?a?broader?sense?than?in?my?investigations,?to?also?encompass?cultural?factors?and?
race.? Potential? key? pathways? of? social? inequalities?may? travel? from? social? and/or? family?
factors?through?individual?risk?factors?to?affect?points?along?the?childhood?cancer?continuum;?
moreover? important? routes?might? travel? through? factors? related? to? health? care? including?
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psychosocial?aspects?at?the?time?of?diagnosis?and?treatment.?The?pathways?related?to?health?
care?are?probably?solely?affecting?inequalities?in?morbidity,?survival?and?survivorship.?As?the?
drivers? that? influence? social? inequalities? in? childhood? cancer? incidence? are? likely? to? differ?
from?those?of?inequalities?in?survival?and?survivorship,?so?are?the?pathways?they?take?likely?to?
differ.?Social? inequalities? in?the? incidence?of?childhood?cancers?are?most? likely?explained?by?
differences?in?exposures?to?biological,?genetic?and/or?environmental?risk?factors?of?childhood?
cancers.??
Underlying? mechanisms? of? social? inequalities? in? survival? are? rather? complex? and? might?
involve?several?pathways.?Family?factors?are?likely?to?have?a?particularly?important?role?since?
children? rely?on? their?parents?help?and? support.?Possible?mediating?pathways?may? include?
different? tumour? biology,? clinical? prognostic? factors,? age,? sex,?malnutrition? and? comorbid?
conditions,?and?particularly?affect?the?pathways?related?to?treatment.??
The?impact?of?different?pathways?may?vary?between?settings?(such?as?between?low?,?middle??
and? high?income? countries)? and? cancer? types.? The? hypothesised? pathways? on? survival?
differences? related? to? access? and? utilization? of? health? care,? treatment? and? treatment?
adherence,?abandonment?or?refusal?of?treatment?might?be?of?more?relevance?for?developing?
countries?or?populations?without?universal?access?to?health?care?[175].?Compliance?will?have?
greater? potential? effect? upon? outcome? in? malignancies? for? which? outpatient? oral?
chemotherapy? plays? a?major? role? such? as? ALL? [21,? 51]? than? for? those? involving? mainly?
inpatient? therapy.? However,? again? little? is? known? about? the? mechanisms? involved? in?
compliance?of?children?and?adolescents?in?general?and,?in?particular,?in?oncology?[180].??
?
Finally,?social?and?family?factors?might?similarly?have?an?impact?on?health?and?life?quality?of?
childhood? cancer? survivors? and? their? families.? In? turn,? social? inequalities? might? also? be?
created? or? increased? among? children? who? survive? after? a? cancer? diagnosis.? The? cancer?
experience,?its?treatment?and?related?psycho?social?factors?especially?during?childhood?might?
have?long?term?consequences?that?disrupt?educational?attainment?and?social?functioning?of?
children/?adolescents?and?thus? influence? later?socioeconomic?position?[170,?172].?However,?
inequalities?in?survivorship?were?not?the?focus?of?this?dissertation.?
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8 Overall?conclusions?and?perspectives?
Social? inequalities? affect? the?health?of? children,? for?whom? childhood? cancer? is?one?of? the?
most?dreaded?diseases?and? the? leading?cause?of?disease?related?deaths?among?children? in?
high?income?countries?[1].?The?Commission?of?Social?Determinants?of?Health?calls?for?global?
action? on? the? social? determinants? of? health? to? advance? health? equity? and? stresses? the?
importance?to?promote?health?equity?from?the?start?of?life?[219].?
?
Findings? from?this?dissertation? indicate?substantial?differences? in?the?reported? incidence?of?
childhood? cancers? between? South? Africa? and? Germany? as?well? as? between? racial? groups?
within? South?Africa,?with? lowest? rates?observed?among?Black? children?and?highest?among?
White?children.?At? least?to?some?extent,?these?observed?differences?are?most? likely?due?to?
social? inequalities? in? access? and? utilization? of? health? care? services? rather? than? reflecting?
actual? differences? in? cancer? risks.?More? research? is? needed? to? understand? the? extent? to?
which?under?reporting?and?under?diagnosis?drive?not?only?the?findings?for?South?Africa?but?
the? global? reported? geographical?patterns?of? childhood? cancer.?A?better?understanding?of?
the?actual?incidence?in?low??and?middle?income?countries?and?the?extent?of?under?diagnosis?
and?under?reporting?might?bring?more? insight? into?the?aetiology?of?childhood?cancers.?This,?
in?turn,?might?also?reveal?specific?pathways?for?under?diagnosis,?identify?social?groups?which?
are? particularly? affected,? and? uncover?weaknesses? in? the? respective? health? care? systems.?
Since? survival? for?many? childhood? cancers,?when?diagnosed?at?an?early? stage?and? treated?
according?to?high?standard?treatment?protocols,?is?generally?very?good?[11]?it?is?essential?to?
facilitate?access?to?medical?services?for?disadvantaged?families,?raise?awareness?on?childhood?
cancers?and?its?treatment?options?in?the?general?population,?train?health?care?providers,?and?
enhance?diagnostic?capacities.?
?
Moreover,?findings?of?this?dissertation?highlight?social?inequalities?in?survival?from?childhood?
cancer? in?Germany?and?Denmark,?although?not?consistently?across?cancer? types.?Similarly,?
the? evidence? is? rather? inconsistent? for? entire? Europe,? with? existing? studies? being? also?
methodologically?very?heterogeneous? (see?Chapter?3.4).?Different?social?and? family? factors?
may?have?different?impact?and?importance,?varying?noticeably?by?country.?A?crucial?question?
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is? to? what? extent? the? observed? differences? across? studies? are? real? or? to? what? extent?
differences? can? be? explained? by? features? of? the? studies.? Therefore,? first? of? all,? further?
knowledge?on?a?national?level?on?various?social?and?family?factors?by?cancer?type?is?required.?
Secondly,?reduction?of?social?inequality?in?disease?and?survival?from?diseases?is?an?important?
public?matter.?Understanding?the?pathways?and?underlying?mechanisms?by?which?social?and?
family?factors?may?influence?prognosis?of?childhood?cancers?would?help?to?develop?targeted?
strategies?to?diminish?those?social? inequalities.?However,?this?knowledge? is?very?sparse.?We?
need?to?distinguish?which?factors?are? involved? in?the?development?of? inequalities?and?what?
the?relative?contribution?of?each?of? these? factors? is;?we?also?need?to? identify?where? in?the?
childhood?cancer?continuum?the?social?differences?are?most?pronounced.?
?
In? future? studies,? investigators? should?propose? specific?mechanisms?and?pathways?a?priori?
and? identify?measures? of? social? factors? and? outcomes? consistent? with? their? hypotheses.?
Mixed?methods? approaches? could? be? used?with? qualitative?methods? such? as? focus? group?
discussions? or? expert? interviews? complementing? a? quantitative? study? design? [211,? 220].?
Focus?groups?with? for? instance?parents?concerned,?children?with?cancer? (of?a?certain?age),?
childhood? cancer? survivors,? and? health? professionals? including? paediatric? oncologists?may?
reveal?specific?pathways?for?survival?inequalities.?The?information?learned?from?a?qualitative?
study? could? be? used? for? development? of? a? structured? questionnaire? for? a? quantitative?
investigation? [220],? studying? the? importance? of? certain? pathways? and? possible? variability?
between?populations.??
Although?my?research?findings?on?survival?inequalities?only?concern?Germany?and?Denmark,?
this?is?equally?of?relevance?for?less?developed?countries.?Since?with?high?standard?treatments?
80%?of?all?childhood?cancer?are?potentially?curable? [11],?yet?about?91,000?deaths?per?year?
occur? in? low??and?middle?income?countries?(which? is?94%?of?the?global?mortality)?[12],?and?
survival? inequalities?are?even?more?pronounced? in? less?developed?countries? [13,?139,?142,?
143],? improvement?of?health?care?and? reduction?of?social? inequalities?are?similarly?of?high?
priority?for?low??and?middle?income?countries.?
?
Lastly,?as?a?result?of?the?improvements?in?survival?the?number?of?childhood?cancer?survivors?
continues?to?substantially? increase?[12].?Thus?health?and?quality?of? life?of?childhood?cancer?
survivors?and? the? relationship?with?social?and? family? factors?are?also? likely? to?substantially?
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increase? in?terms?of?public?health?relevance.? In?the?first? instance?this?will?be?particularly?so?
among? high?income? countries? but? will? subsequently? also? affect? low?? and?middle?income?
countries.??
? ?
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for 2000–2006: A report from the South African National
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Higher childhood cancer incidence rates are generally reported for high income countries although high quality information on
descriptive patterns of childhood cancer incidence for low or middle income countries is limited, particularly in Sub-Saharan
Africa. There is a need to quantify global differences by cancer types, and to investigate whether they reflect true incidence
differences or can be attributed to under-diagnosis or under-reporting. For the first time, we describe childhood cancer data
reported to the pathology report-based National Cancer Registry of South Africa in 2000–2006 and compare our results to
incidence data from Germany, a high income country. The overall age-standardized incidence rate (ASR) for South Africa in
2000–2006 was 45.7 per million children. We observed substantial differences by cancer types within South Africa by racial
group; ASRs tended to be 3–4-fold higher in South African Whites compared to Blacks. ASRs among both Black and White
South Africans were generally lower than those from Germany with the greatest differences observed between the Black popu-
lation in South Africa and Germany, although there was marked variation between cancer types. Age-specific rates were partic-
ularly low comparing South African Whites and Blacks with German infants. Overall, patterns across South African population
groups and in comparison to Germans were similar for boys and girls. Genetic and environmental reasons may probably
explain rather a small proportion of the observed differences. More research is needed to understand the extent to which
under-ascertainment and under-diagnosis of childhood cancers drives differences in observed rates.
Worldwide, country-specific estimates of the annual inci-
dence rates of childhood cancer in 0–14 year olds range from
about 50 to 200 new cases per million children for 2012.1
The incidence is well described for economically developed
countries,2,3 with recent incidence rates of 164, 178 and 157
per million children reported in Germany,4 US Whites5 and
Australia,6 respectively. In contrast, high quality data from
low or middle income countries and, in particular, from Sub-
Saharan Africa are limited.7 Childhood cancer incidence rates
of 35, 120 and 174 per million were reported from The Gam-
bia,8 Harare in Zimbabwe9 and Kyadono in Uganda,8 with
substantial variation in the spectrum of cancer types.10 Par-
ticularly for leukemia, the most common childhood cancer
type in developed countries, reported rates were considerably
lower in Sub-Saharan Africa.10
Childhood cancer is a heterogeneous group of malignan-
cies. Little is known about the aetiology of these cancers, but
it appears that both genetic and environmental factors play a
role.11,12 The early age at diagnosis indicates that childhood
cancer might originate in utero, and that factors prior to
birth, including preconception and/or fetal environmental
exposures, as well as those in early childhood may be impor-
tant determinants.11,13,14 Observed geographical differences in
incidence rates have been used to support several hypotheses
for the association between exposures related to modern life-
style and the risk of childhood cancer.14 These include factors
related to social contacts and opportunities for infection in
Key words: childhood cancer, incidence, South Africa, race,
ethnicity
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early life,14 but also maternal diet during pregnancy,15 paren-
tal occupational exposures prior to conception or during
pregnancy,12,16 and exposures to electromagnetic fields.17
While the risk factors for childhood cancer are not well
understood, there is evidence that social factors, in particular
wealth, are related to the reported incidence of childhood
cancer.7,18 This is consistent with the higher reported inci-
dence in high income countries compared to low and middle
income countries, especially Sub-Saharan Africa, and is par-
ticularly strong for leukemia.7,8
Recent studies from Brazil and India suggest, however,
that under-reporting of acute lymphoblastic leukemia (ALL)
may be sufficiently large to account for most, if not all, of
the observed differences between these countries compared
with Europe and North America.19,20 The extent to which
under-reporting may explain lower rates reported in Sub-
Saharan Africa is not known.7 Thus, there is a need to
understand the contribution of true differences versus under-
diagnosis or under-reporting in reported childhood cancer
incidence rates in Sub-Saharan Africa.21,22
This study describes for the first time childhood cancer data
reported to the pathology-based South African National Cancer
Registry (NCR) for the time period 2000–2006, a period during
which the cancer registry operated under stable and defined con-
ditions. As race is correlated with wealth and socioeconomic cir-
cumstances in South Africa,23 particular emphasis was given to
investigating differences by racial groups. We focused on South
African Black and White populations as they represent the
extremes of the socioeconomically disadvantaged and advantaged
groups respectively. In addition, these groups have sufficiently
large numbers of cancer to conduct robust analyses, whereas num-
bers are much more limited among the Indian/Asian and mixed
ancestry populations. Furthermore, we compared our results to
data from Germany, as a representative of a high income coun-
try3,24 and that has a long-established population-based childhood
cancer registry. Comparisons of reported incidence rates in South
Africa and Germany provide a basis for considering the potential
impact of differences in diagnosis, reporting and risk factor distri-
butions by sex, age, race and diagnostic groups.
Material and Methods
Population structure and access to health care in South
Africa
National statistics in South Africa classify the population
using broad population groups, largely reflecting pre- 1994
legislative groupings: “Black African,” “White,” “Colored” (a
heterogeneous mixed ancestry population with Khoisan,
Black African, European and Asian ethnic origins), “Indian/
Asian” (the majority of whom are of Indian origin) and
“Other.” Thus, from hereafter this report uses the terminol-
ogy of “population group” rather than “race.” Among the
14.5 million children under the age of 15 years living in the
country in 2006, 83.7% were Black African, 8.8% mixed
ancestry, 1.9% Indian/Asian and 5.6% White25 (Supporting
Information Table 1). South Africa is an upper-middle
income country24 with healthcare provided by both public
and private facilities. According to the household survey of
2006,23 14.7% of the population was covered by a medical
aid scheme giving access to private health care services. Med-
ical aid coverage differs by population group and is generally
affordable for the more affluent section of the South African
population. In 2006, 63.1% of Whites had medical aid com-
pared to 7.2% of Blacks.23 Public sector health services are
available at the primary, secondary, and tertiary levels at a
nominal fee calculated on income and thus at little or no
cost to those who cannot afford it.26 Pathology services are
provided by the National Health Laboratory Service (NHLS)
in public sector hospitals and a number of private laborato-
ries provide pathology services to private healthcare
institutions.
The South African National Cancer Registry
The South African NCR was established in 1986 as a
pathology-based surveillance system under the then South
African Institute for Medical Research, located in Johannes-
burg. The NCR, currently a division of the NHLS, collates all
cases of malignancies including nonmelanoma skin cancers
but not benign tumors. Copies of pathology reports confirm-
ing a cancer diagnosis (based on histology, cytology and
hematology) were submitted to the NCR on a voluntary basis
until 2011, by laboratories serving both the public and private
sectors. Although reporting was voluntary, laboratories were
actively followed up. Over time, and mainly from 2006
onwards, many private laboratories discontinued their volun-
tary contribution because of concerns about disclosure of
confidential patient information to the NCR. For this reason,
our analysis is restricted to the years 2000–2006. New legisla-
tion introduced in April 2011 makes the reporting of diag-
nosed cancer cases to the NCR by health professionals and
laboratories mandatory.27
What’s new?
Reported geographical and racial differences in childhood cancer incidence contribute to hypotheses regarding the possible
risk factors for the disease. Analysis of data from the National Cancer Registry of South Africa uncovered marked differences
in childhood cancer incidence within South African populations, with significantly higher rates in Whites compared to Blacks.
Compared to data from Germany (representing childhood cancer incidence in Western countries) lower rates were even found
in South African Whites, with the greatest differences being noted for the Black population. Under-diagnosis and under-report-
ing may drive in part the observed patterns. These findings are highly informative for future policy making and improving
access to health care services in South Africa.
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Data reported to the NCR include: patient’s name and
surname, sex, age at diagnosis, population group, diagnosis
and tumor information (topography, morphology), date of
diagnosis and name of the reporting laboratory. Diagnosis is
coded by trained coders based on primary organ site and
morphological type according to the International Classifica-
tion of Diseases for Oncology, third edition (ICD-O-3).28
Only primary incident cases with histological, cytological or
hematological confirmation are recorded. Each multiple pri-
mary cancer is recorded as an additional case. Doubtful, in
situ or borderline cancers are excluded. For multiple notifica-
tions of the same cancer, only one record is kept.
Since the beginning of the 1990s an increasing number of
reports were received without information on population
group, with 54% of childhood cancer cases missing data in
2000–2006. The NCR used a hot-deck imputation method to
determine population group for those with this information
missing. The algorithm makes use of a reference database of
approximately 1.4 million surnames with known population
group. Surnames which do not appear in the database are
classified as unknown. The database is continually updated
with the addition of each new patient whose population
group is known, and information from other sources is also
used to improve quality and completeness. In a former vali-
dation study (unpublished and herewith reported for the first
time), cases reported to the cancer registry from 1990–1995
(N5 277,130) with known information on population group,
were also used for the hot desk imputation method, and the
proportions by population group were very similar; the origi-
nal distribution was 53% Whites, 40% Blacks, 2% Indian/
Asian and 5% with mixed ancestry, compared to the imputed
distribution of 50% Whites, 41% Blacks, 2% Indian/Asian,
7% with mixed ancestry and 0.01% unknown (Chi-square
test p-value5 0.94 for distribution differences).
The German Childhood Cancer Registry
Our reference registry for comparison with high income
country incidence, the nationwide German Childhood Cancer
Registry (GCCR), was established in 1980 and collects all
malignancies and benign brain tumors diagnosed before age
15 (approximately 1,800 new cases each year in a population
of about 11.5 million children). As most childhood cancer
patients are enrolled in clinical trials in Germany, a network
of pediatric oncology centers guarantees the coverage of vir-
tually all cases. The GCCR was chosen as a reference registry
because of (in order of importance) the very high estimated
level of completeness of nationwide registration (>95% since
19874), the assumed high comparability of genetic make-up
between German and White South African children, and the
ability of the registry to provide data in a structure compara-
ble to that of the South African database with respect to the
time period (2000–2006) and included diagnoses (e.g., exclu-
sion of benign brain tumors which are not recorded in the
NCR). Information on racial group is not collected by the
Table 1. Childhood cancer cases reported to the South African NCR in 2000–2006 according to population group, sex, age group and
reporting laboratory (public vs. private)
All Black
Mixed
ancestry Indian/Asian White
Race
missing
Childhood cancer N 4,601 3,125 399 148 689 240
Sex (120 missing) Boys N 2,474 1,659 231 84 384 116
% 55.2 54.7 58.9 57.5 56.6 50.2
Girls N 2,007 1,374 161 62 295 115
% 44.8 45.3 41.1 42.5 43.5 49.8
Age groups <1 year N 289 186 36 13 43 11
% 6.3 6.0 9.0 8.8 6.2 4.6
1–4 years N 1,569 1,063 132 63 235 76
% 34.1 34.0 33.1 42.6 34.1 31.7
5–9 years N 1,306 901 115 37 170 83
% 28.4 28.8 28.8 25 24.7 34.6
10–14 years N 1,437 975 116 35 241 70
% 31.2 31.2 29.1 23.7 35.9 29.2
Reported laboratory NHLS1 N 3,995 2,878 356 116 458 187
% 86.8 92.1 89.2 78.4 66.5 77.9
Private laboratory N 606 247 43 32 231 53
% 13.2 7.9 10.8 21.6 33.5 22.1
1The NHLS is a national network of public laboratories and the largest diagnostic pathology service in South Africa.
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GCCR, but racial diversity is very low in Germany, with Ger-
man children usually being Caucasian and with larger
migrant groups living in Germany originating elsewhere in
Europe or in Turkey.29
Case definition
Childhood cancer was defined as a cancer diagnosed at ages
younger than 15 years. Data on pediatric cancer cases for
2000 to 2006 was obtained from the NCR and recoded using
the International Classification of Childhood Cancer, third
edition (ICCC-3)30 which classifies tumors coded according
to the IDC-O-3 nomenclature into 12 major diagnostic
groups: I. Leukemias, myeloproliferative disease and myelo-
displastic diseases (leukemias), II. Lymphomas and reticulo-
endothelial neoplasms (Lymphomas), III.CNS and
miscellaneous intracranial and intraspinal neoplasms (malig-
nant CNS tumors), IV. Neuroblastoma and other peripheral
nervous cell tumors (Sympathetic nervous system tumors), V.
Retinoblastomas (Retinoblastomas), VI. Renal tumors (Renal
tumors), VII. Hepatic tumors (Hepatic tumors), VIII. Malig-
nant bone tumors (Malignant bone tumors), IX. Soft tissue
and other extraosseous sarcomas (Soft tissue sarcomas), X.
Germ cell tumors, trophoblastic tumors, and neoplasm of
gonads (Germ cell tumors), XI. Other malignant epithelial
neoplasms and melanomas (Malignant epithelial neoplasms),
and XII. Other and unspecified malignant neoplasms (Other
and unspecified malignant tumors). All cancer cases among
children who were clearly not South Africa residents (e.g.,
specimens sent to South African laboratories from other
countries) were excluded.
Statistical methods
Frequencies, sex ratios, and age specific and age-standardized
rates (ASRs; per 1,000,000 children) were used to analyze the
incidence data of childhood cancer in South Africa. Subgroup
analyses were performed by major ICCC-3 group30 as well as
by subtypes of leukemia, lymphoma and soft tissue sarcoma,
by age group (grouped into <1, 1–5, 6–9 and 10–14 years),
sex and population group (Black, White, mixed ancestry and
Indian/Asian). Because of small case numbers, comparisons
by population group were largely restricted to Blacks and
Whites, while results for the mixed ancestry and Indian/
Asian populations are shown in supplemental material. The
directly age-standardized incidence rates (ASR) per 1,000,000
were estimated using the weights (by age groups 0, 1–4, 5–9,
10–14 years) of the Segi world standard population.31 The
Alternative South African mid-year population estimates
were used as the denominator25,32 for calculating incidence
rates. These mid-year population estimates are similar in
magnitude to the official mid-year estimates but maintain an
age distribution that is consistent with that of the most
recent Census in 2011.25 We therefore considered them as
the more appropriate population estimates for the purposes
of studying differences by age group. The incidence rate pro-
portion in South Africa compared to the reference registry of
Germany was calculated to investigate differences for specific
subgroups of childhood cancer. For this purpose, the ASRs in
Germany in the respective subcategories (by cancer type and
by sex) as well as age-specific rates were set to 100% and
these were compared to the reported rates among South Afri-
can Whites and Blacks separately. The German childhood
cancer incidence rates presented here were calculated by the
GCCR.
All statistical analyses were performed using Stata 1333
and Microsoft Excel 2010.
Results
Characteristics of reported childhood cancer cases
Newly diagnosed cancer cases (4601) under the age of 15
years were reported to the NCR during the period 2000 to
Table 2. Childhood cancer reported to the South African NCR and to the GCCR in 2000–2006 by population group, sex ratio and age specific,
crude and age-standardized incidence rates1
SA2 all SA2 Black
SA2 Mixed
ancestry
SA2 Indian/
Asian SA2 White Germany
N 4,601 3,125 399 148 689 11,669
M/F3 1.2 1.2 1.4 1.4 1.3 1.3
Age specific incidence4 < 1 year 41.39 31.51 59.54 112.11 119.77 249.8
1–4 years 59.81 48.50 56.37 134.68 155.71 191.3
5–9 years 38.48 31.92 38.43 57.48 81.99 106.9
10–14 years 39.81 32.44 37.92 48.34 106.84 106.6
Crude incidence5 44.56 36.29 44.34 75.84 111.17 138.8
ASR6 45.70 37.17 45.47 82.97 114.96 144.4
1Sex ratio is based on cases with known sex. Total number (N) and rates include cases with sex missing.
2SA: South Africa
3M/F: sex ratio—male cases/female cases
4Age specific incidence: age group specific incidence rates per 1,000,000 population aged 0–14 years.
5Crude incidence: crude incidence rate per 1,000,000 population aged 0–14 years.
6ASR: age-standardized incidence rate (using the world standard population) per 1,000,000 population aged 0–14 years.
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2006; with a greater number of cases among males than
females (55% vs. 45%; sex ratio: 2:1). The percentage of cases
reported by the public laboratories of the NHLS ranged from
92% among Black children to 66.5% among Whites (Table
1). The overall ASR was 45.7 per million children, 37.2/mil-
lion among Black, 45.5/million among mixed ancestry, 83/
million among Indian/Asian and 115/million among White
South African children (Table 2). The highest age-specific
incidence rate was observed for children aged 1–4 years
(59.8/million), with considerable differences by population
group (highest in Whites and lowest in Blacks). In compari-
son, the ASR in Germany during 2000 and 2006 was 144.4/
million with the highest age-specific incidence rate of 250/
million children observed in infants less than one year of age
(Table 2).
Reported childhood cancer for South African Blacks and
Whites and Germans
Figure 1 presents the percentage distribution of the major
diagnostic groups of pediatric cancers for South African
Blacks and Whites and Germans. The distribution of cancer
types varied substantially between these population groups,
with the distribution among South African Whites being only
slightly closer to the distribution reported from Germany
than to Black South Africans. Among Black South Africans,
the most commonly reported cancer types were leukemias,
soft tissue sarcomas, and lymphomas, while among White
South Africans the most common cancer types were leuke-
mias, lymphomas, and malignant epithelial neoplasms. The
high proportion of malignant epithelial neoplasm among
South African Whites is primarily explained by their higher
incidence of skin cancers (data not shown).
As shown in Table 3, incidence rates differed considerably
by age and diagnostic group. The highest rates were reported
for leukemia with an ASR of 8.5/million in South Africa and
54.5/million in Germany. Among South Africans, the inci-
dence rate patterns varied substantially between Blacks and
Whites. With few exceptions, reported rates were lower
among Blacks than Whites across the diagnostic groups.
ASRs tended to be 3 to 4-fold higher in South African
Whites compared to Blacks. Table 4 shows a more detailed
presentation of the reported leukemia, lymphoma and soft
tissue sarcoma incidence. The observed low incidence of leu-
kemia in South African Whites compared to German chil-
dren is more pronounced in ALL than in acute myeloid
leukemia. Also the age patterns varied substantially in ALL
between Black and White South African children. Unlike
most other cancer types, the ASR for Kaposi sarcoma was
higher among Blacks than Whites (1.8 vs. 0.3/million).
Figures 2a–c show the childhood cancer incidence rates in
South Africa (by (i) major diagnostic group, (ii) age group
and (iii) sex) stratified by Blacks and Whites as a proportion
of the corresponding incidence rate in Germany (incidence
rate proportions). The observed incidence rates of lympho-
mas, hepatic, renal and malignant bone tumors, and malig-
nant epithelial neoplasm among South African Whites exceed
the corresponding ASRs of German children. In contrast,
ASRs for leukemias, tumors of the sympathetic nervous
Figure 1. Distribution of childhood cancer (2000–2006) by major diagnostic group (in %) based on cases reported to the South African
NCR among Blacks and Whites vs. childhood cancer reported to the GCCR.
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Table 3. Childhood cancer reported to the South African NCR compared to the GCCR in 2000–2006 by major diagnostic group, population
group (all, Blacks vs. Whites), sex ratio, and age specific, crude and age-standardized rates1
Age specific incidence4
ICCC-3 diagnostic group2 Race N M/F3 <1 year 1–4 years 5–9 years 10–14 years
Crude
incidence5 ASR6
Germany
ASR6
Germany
M/F3
Leukemias
All 875 1.3 7.2 9.6 8.1 8.3 8.5 8.5 54.5 1.2
Black 598 1.2 5.9 6.4 6.6 7.9 6.9 6.9
White 134 1.3 22.3 37.8 20.7 11.5 21.6 23.5
Lymphomas
All 725 2.1 1.3 6.3 8.4 7.3 7.0 6.9 15.7 2
Black 458 1.9 0.8 5.3 6.2 5.4 5.3 5.3
White 106 2.7 5.6 11.9 16.4 23.1 17.1 16.1
Malignant CNS tumors
All 431 1.2 2.3 5.3 4.5 3.4 4.2 4.3 21.5 1.3
Black 240 1.3 1.2 3.5 3.3 2.1 2.8 2.9
White 93 1.2 8.4 21.9 11.6 14.6 15.0 15.4
Sympathetic nervous
system tumors
All 209 1.3 6.0 4.5 1.1 0.4 2.0 2.3 14.0 1.2
Black 121 1.1 3.9 2.7 1.0 0.3 1.4 1.6
White 39 1.8 22.3 18.6 1.0 0.4 6.3 7.9
Retinoblastomas
All 278 1.3 4.6 7.9 1.0 0.2 2.7 3.2 4.3 1.2
Black 225 1.4 4.4 7.7 0.9 0.2 2.6 3.1
White 18 1.6 5.6 8.6 1.4 0.0 2.9 3.6
Renal tumors
All 542 1.1 6.2 12.6 3.9 1.0 5.2 5.9 9.8 0.9
Black 410 1.1 4.4 11.4 3.6 1.0 4.8 5.3
White 60 1.1 11.1 25.8 6.3 1.8 9.7 11.4
Hepatic tumors
All 87 1.6 2.3 1.3 0.4 0.6 0.8 0.9 2.1 1.6
Black 57 1.6 1.7 0.8 0.4 0.6 0.7 0.7
White 11 1.8 8.4 4.0 0.5 0.4 1.8 2.2
Malignant bone tumors
All 260 0.9 0.6 0.4 1.4 5.5 2.5 2.2 5.9 1.1
Black 167 0.9 0.3 0.2 0.9 4.5 1.9 1.7
White 50 1.0 0.0 2.0 6.3 15.1 8.1 7.0
Soft tissue sarcomas
All 630 1.3 4.7 7.4 5.7 5.8 6.1 6.2 9.5 1.2
Black 499 1.3 4.4 6.9 5.8 5.2 5.8 5.9
White 53 1.0 11.1 12.6 3.9 9.8 8.6 8.8
Germ cell tumors
All 118 0.3 1.1 1.1 0.9 1.4 1.1 1.1 4.7 0.8
Black 82 0.2 0.8 0.8 0.8 1.2 1.0 0.9
White 19 0.3 2.8 2.0 2.9 4.0 3.1 2.9
Malignant epithelial
neoplasms
All 350 0.9 3.7 2.0 2.3 5.3 3.4 3.2 2.1 0.8
Black 187 0.8 2.2 1.2 1.7 3.4 2.2 2.1
White 101 1.1 22.3 10.6 9.6 25.3 16.3 15.5
Other & unspecified
malignant tumors
All 96 1.0 1.4 1.5 0.7 0.6 0.9 1.0 0.1 1.2
Black 81 1.0 1.4 1.6 0.7 0.6 0.9 1.0
White 5 1.0 0.0 0.0 1.4 0.9 0.8 0.7
1Sex ratio is based on cases with known sex. Total number (N) and rates include cases with sex missing.
2Diagnostic groups defined using the International Classification of Childhood Cancer Third Edition (ICCC-3)
3M/F: sex ratio—male cases/female cases
4Age specific incidence: age group specific incidence rates per 1,000,000 population aged 0–14 years.
5Crude incidence: crude incidence rate per 1,000,000 population aged 0–14 years.
6ASR: age-standardized incidence rate (using the world standard population) per 1,000,000 population aged 0–14 years.
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system and germ cell tumors were markedly lower than
among German children. Among Black South African chil-
dren, the observed rates were noticeably lower across all diag-
nostic groups (except for malignant epithelial neoplasms; Fig.
2a). Looking at incidence rates by age group, the incidence
among South African children (both Black and White) under
the age of 1 was particularly low when compared to German
infants (Fig. 2b). Incidence rate proportions were similar for
boys and girls (Fig. 2c).
Reported childhood cancer for South African Indian/Asian
and children with mixed ancestry
This study focused primarily on Black and White South Afri-
can children as the numbers of cases were highest for these
Table 4. leukemias, Lymphomas and soft tissue sarcomas reported to the South African NCR compared to the GCCR in 2000–2006
by diagnostic subgroup, population group (all, Blacks vs. Whites), sex ratio, and age specific, crude and age-standardized incidence rate1
Age specific incidence4
ICCC-3
diagnostic
group2 Race N M/F3 <1 year 1–4 years 5–9 years 10–14 years
Crude
incidence5 ASR6
Germany
ASR6
Germany
M/F3
Leukemias
Lymphoid
leukemia
All 498 1.5 2.4 5.9 5.0 4.4 4.8 4.9 43.4 1.2
Black 324 1.5 1.9 3.5 4.0 4.2 3.8 3.7
White 81 1.8 13.9 24.5 12.5 5.8 13.1 14.4
Acute myeloid
leukemia
All 226 0.9 3.2 2.1 1.9 2.3 2.2 2.2 7.2 1.1
Black 175 0.9 2.2 1.9 1.8 2.3 2.0 2.0
White 21 0.8 8.4 4.6 2.4 2.7 3.4 3.6
Other &
unspecified
All 151 1.1 1.6 1.6 1.2 1.6 1.5 1.5 3.9 1.3
Black 99 1.1 1.9 1.0 0.8 1.5 1.1 1.1
White 32 1.0 – 8.6 5.8 3.1 5.2 5.4
Lymphomas
Hodgkin
Lymphoma
All 241 2.2 0.4 1.0 3.1 3.0 2.3 2.2 6.2 1.4
Black 171 2.1 0.3 1.1 2.7 2.3 2.0 1.9
White 27 4.4 – 0.7 3.9 8.0 4.4 3.8
Non-Hodgkin
Lymphoma
All 227 1.8 0.3 2.1 2.0 2.8 2.2 2.1 6.3 2.2
Black 150 1.7 0.3 1.9 1.6 2.1 1.7 1.7
White 34 2.4 – 2.7 4.3 9.3 5.5 4.9
Burkitt
Lymphoma
All 182 2.7 0.3 2.3 2.6 0.9 1.8 1.8 3.0 4.7
Black 91 2.8 – 1.8 1.3 0.4 1.1 1.1
White 31 1.7 5.6 4.6 6.3 4.0 5.0 5.0
Other &
unspecified
All 75 1.4 0.3 0.9 0.7 0.7 0.7 0.7 0.1 1.0
Black 46 1.1 0.2 0.5 0.6 0.5 0.5 0.5
White 14 5.0 – 4.0 1.9 1.8 2.3 2.4
Soft tissue
sarcomas
Rhabdomyo
sarcomas
All 281 1.2 1.0 4.0 2.7 2.1 2.7 2.8 5.4 1.4
Black 212 1.1 0.7 3.6 2.6 1.9 2.5 2.5
White 30 1.0 2.8 11.3 2.9 2.7 4.8 5.4
Kaposi
sarcoma
All 166 2.1 0.7 2.2 1.9 1.0 1.6 1.7 0.0 0.0
Black 152 2.0 0.8 2.5 2.3 1.0 1.8 1.8
White 2 – – – 0.9 0.3 0.3
Other &
unspecified
All 183 1.0 3.0 1.2 1.1 2.6 1.8 1.7 1.1 4.0
Black 135 1.0 2.9 0.9 1.0 2.3 1.6 1.5
White 21 0.9 8.4 1.3 1.0 6.2 3.4 3.2
1Sex ratio is based on cases with known sex. Total number (N) and rates include cases with sex missing.
2Diagnostic groups defined using the International Classification of Childhood Cancer Third Edition (ICCC-3)
3M/F: sex ratio—male cases/female cases
4Age specific incidence: age group specific incidence rates per 1,000,000 population aged 0–14 years.
5Crude incidence: crude incidence rate per 1,000,000 population aged 0–14 years.
6ASR: age-standardized incidence rate (using the world standard population) per 1,000,000 population aged 0–14 years.
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Figure 2. (a) Proportion of age-standardized childhood cancer incidence rates (2000–2006) by major diagnostic group based on cases reported
to the South African National Cancer Registry stratified by Black and White children in relation to the age-standardized childhood cancer inci-
dence rates of Germany, sorted from lowest to highest proportion of White South African childhood incidence with German children as a refer-
ence. 1Ref: age-standardised incidence rates (using the world standard population) of Germany were set to 100% as reference points.
*Truncated, the proportion of age standardized incidence rate of malignant epithelial neoplasm among White children in South Africa in relation
to the incidence rate for Germany is 736%. (b) Proportion of age-standardized childhood cancer incidence rates (2000–2006) by age group
based on cases reported to the South African National Cancer Registry stratified by Black and White children in relation to the age-standardized
childhood cancer incidence rates of Germany, sorted from lowest to highest proportion of White South African childhood incidence with German
children as a reference. 1Ref: age-standardised incidence rates (using the world standard population) of Germany were set to 100% as reference
points. (c) Proportion of age-standardized childhood cancer incidence rates (2000–2006) by sex based on cases reported to the South African
National Cancer Registry stratified by Black and White children in relation to the age-standardized childhood cancer incidence rates of Germany.
1Ref: age-standardised incidence rates (using the world standard population) of Germany were set to 100% as reference points.
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8 Childhood cancer incidence patterns in South Africa
population groups. The reported childhood cancer incidence in
the Indian/Asian and in mixed ancestry groups by diagnostic
group, age and sex are shown in Supporting Information Table
2. Considering all four population groups, the second highest
rates (following the White population) were generally observed
among the Indian/Asian population followed by those among
children of mixed ancestry and lowest rates in Black children.
Discussion
Key findings
This study describes for the first time the reported childhood
cancer incidence in South Africa on a national level, based on
data from the South African National Cancer Registry,
addressing variation in incidence overall, and by age, sex and
population group. Key findings include substantial differences
in the reported incidence rates and the distribution of pediatric
cancer types within South African population groups, and
between South African and German children, as well as a par-
ticularly low incidence rate in South African infants compared
to German infants. Rates among South African Whites were
much closer overall to the reported rates from Germany than
among Black South Africans, but with marked variation across
cancer types. Some cancer types were slightly more common
in South African Whites than in German children. Patterns
across the South African population groups and in comparison
with Germany were generally similar for boys and girls.
Observed differences between Black and White South
Africans
Overall, as well as for the major diagnostic groups including
leukemias and lymphomas, White South Africans had
approximately threefold higher ASRs than Black South Afri-
cans, with mixed ancestry and Indian/Asian children falling
in between. ASRs were 4–5-times greater among Whites than
Blacks for malignant CNS tumors and malignant bone
tumors whereas rates were relatively close for retinoblastomas
and soft tissue sarcomas.
Differences by population group in South African children
have been also observed in previous regional studies34–36 as well
as in the annual reports of NCR.37 In a study from 1974 to 1983
in Johannesburg, significant differences in the incidence of child-
hood leukemia between Black and White children were found
with much lower rates in Black children.35 A more recent study
from the Western Cape observed that children with mixed ances-
try showed a lower incidence of ALL than White children.36
Observed differences in incidence likely reflect a combina-
tion of variation in access to and utilization of health care
services, in environmental exposures as well as in genetic sus-
ceptibility. Significant variations in incidence rates according
to race were also reported in the United States. US White
children had an approximately 1.5-fold higher rate of child-
hood cancer than Blacks, particularly pronounced for leuke-
mia (1.8-fold higher) but less so for lymphomas (1.3-fold
higher).38 A large population based case-control study of
more than 13,000 cases confirmed that compared to Whites,
Black children have a decreased risk of childhood cancer in
the United States. Among both the Black population and
children of mixed White/Black ancestry, cancer rates were
approximately 28% lower than that of Whites, whereas esti-
mates for White/Asian as well as White/Hispanic children
did not differ from those for Whites.39 Authors speculated
that different racial/ethnic groups may vary in terms of their
environmental exposures, and that there might be important
interactions between selected exposures and underlying
genetic susceptibility.39 However, incidence rate differences
between racial groups in the United States were much smaller
than the ones we observed in South Africa. Thus, genetic sus-
ceptibility and variability in environmental exposures can
probably account for a smaller proportion of the large
observed differences in South Africa than other factors.
Observed differences across the South African populations
may be explained by socioeconomic and/or cultural factors
related to access or utilization of health care services and
health care seeking behavior. In South Africa, population
group is strongly correlated with socioeconomic circumstan-
ces (such as education, income and medical aid), with low
socioeconomic status most frequent among Blacks.23 Higher
unemployment in Blacks23 may be related to a lack of finan-
cial resources available for seeking medical help. Only 7% of
the Black population and 16% of the population with mixed
ancestry were covered by medical aid compared to 29% of
the Indian/Asians and 63% of Whites. The postapartheid bill
of rights grants everyone the right to basic education, but as
a consequence of the previous regime, in 2006 21.5% of the
Black population had no schooling, compared to 7.4% of
Whites.28 Lack of parental education and low awareness of
cancer, particularly in children, might delay or inhibit seeking
of medical help. Furthermore, some parents may believe can-
cer is incurable and, therefore, not seek medical care.
The nonspecific nature of many early symptoms (e.g., for
leukemia which often presents as infection) may result in
delayed diagnosis or failure to detect the disease.21 This could
explain the smaller population differences for cancer types
with clearly visible symptoms than for cancer types with
more nonspecific symptoms.
A greater proportion of Black South African families live in
rural/remote areas23 and may not access to a medical centre due
to inadequate public transport infrastructure or inability to pay
for transport and accommodation when their child is ill. There-
fore, cancer diagnosis may be delayed. Moreover, primary
healthcare facilities and local/regional hospitals may lack aware-
ness of and experience in diagnosing pediatric cancer.20 For
instance, the observed lower incidence of ALL in children with
mixed ancestry compared to White children in Western Cape
was particularly pronounced in children from rural areas.36
In addition, as traditional medicine and cultural beliefs
continue to play an important role in healthcare delivery in
South Africa.40 Therefore, parents may rely on traditional
healers using herbs or witchcraft rather than attending a
medical centre for diagnosis.
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Observed much lower survival rates among Black children
compared to Whites, recently estimated to be 48.5% in Black and
62.8% in White children,41 adds to the evidence that the lower
incidence rates among Black children may be, at least in part, due
to under-ascertainment than necessarily reflect a lower cancer risk.
Observed differences between South Africa and Germany
Comparing Germans with South African Whites, the overall
childhood cancer ASR in Germany was 1.25-fold higher, but
variation across diagnostic groups was large. While the differ-
ence was striking for leukemias, being more than twofold
higher in Germany and also markedly higher for sympathetic
nervous system tumors, germ cell tumors and malignant
CNS tumors, ASRs were similar for some other types such as
soft tissue sarcomas, lymphomas and hepatic tumors, and
even somewhat higher in South African Whites for renal
tumors and malignant bone tumors. An eightfold higher inci-
dence in South African Whites was seen in malignant epithe-
lial neoplasms driven by high numbers of skin cancers.
Incidence rate comparisons between South Africa and Ger-
many also differed by age. German infants had a twofold
higher incidence rate when compared to infant South African
Whites and almost 10-fold compared to infant Blacks, whereas
in 10–14 year olds the incidence rates of Germans and South
Africans were almost identical. This suggests under-diagnosis
among both Black and White South African children below the
age of 1 may be a particular issue. Diagnosis in infants is diffi-
cult in general, however, in South Africa, with its overwhelm-
ing burden of infectious disease,42 cancer may not be among
the first diagnoses suspected and thus children, even in the pri-
vate sector may not be diagnosed before they die.
In contrast to age, incidence rate proportions were similar
for boys and girls and differences in diagnosis or reporting by
sex appeared to not to play a great role in South Africa. This
finding was unexpected, as recent evidence points out that
rates of cancer registrations in girls remain lower than expected
in low and middle income countries.43 Explanations include
that sick girls tend not to be taken for health care services as
often or as early as boys. It is possible that when resources are
limited, culture and economics favour boys.43 Nonetheless, our
data suggest this is not the case in South Africa.
International comparison
The observed distribution of childhood cancer types in South
Africa is unique and differs from those observed in other
Sub-Saharan African9,10 and middle income countries,44–46 as
well as high income countries5,6,47 including Germany (Sup-
porting Information Table 3). In high-income countries, leu-
kemias are the most frequent childhood cancer with ALL
accounting for up to 25% of all pediatric cancers, followed by
brain tumors and other solid tumors.4–6,47 However, particu-
larly in equatorial Africa, children are more susceptible to
developing non-Hodgkin Lymphomas (Burkitt’s lymphomas)
and Kaposi sarcoma due to higher exposure to infectious dis-
eases (namely Epstein-Barr virus, HIV and human herpes
virus 8)7,48,49 (Supporting Information Table 3). Such differ-
ences might be again the result of the cumulative effect of
variable genetic predisposition, diverse burden of infectious
diseases, environmental exposures and chronic immune stim-
ulation, as well as incomplete diagnosis and registration. The
difference between the reported and actual incidence of child-
hood malignancies in low-income countries is assumed to be
most striking for leukemia, a disease with symptoms resem-
bling those of infectious diseases including malaria and tuber-
culosis, and so children could die before their cancer is
suspected or diagnosed.8,21 For lymphomas and some solid
tumors, visible symptoms might encourage parents to seek
medical help and early death is less common.
South Africa is an upper middle income country,24 with a
relatively high level of wealth, and is therefore distinct for the
Sub-Saharan region. Our study reveals that leukemias in
South Africa, as in high income countries, are the most fre-
quent reported cancers although rates are substantially lower,
in particular for ALL. Under-diagnosis, due to clinicians
being less experienced at recognizing leukemias in children
may partly explain this finding. Findings from the Tygerberg
and Bloemfontein hospitals highlight the need to increase
parental awareness of childhood cancer on the one hand but
also to increase the sensitivity of medical doctors and health
professionals to the warning signs of childhood cancers.36,41
Many Sub-Saharan African countries report few brain tumors
and substantial underestimation is assumed.8 In South Africa
this seemed to be more pronounced in the Black population
as the observed incidence rate in White children was more
than 70% of that reported for Germany.
Strengths and weaknesses
This study presents, for the first time, the incidence of pedi-
atric cancers in South Africa on a national level and is one of
very few studies from Sub-Saharan Africa. The strengths of
conducting this analysis in South Africa include the availabil-
ity of cancer registry data, the large childhood population,
and the diverse racial population, allowing us to investigate
differences by population group which is an important deter-
minant of socioeconomic circumstances in South Africa. The
NCR captures data from all public sector pathologically con-
firmed cancers across the country and a large proportion of
cancers diagnosed in the private sector. However, as many
private laboratories discontinued reporting to the NCR in
2006 because of concerns about patient privacy, marginal
under-reporting of pediatric cancer cases diagnosed in the
private healthcare sector is likely during the study period.
There were only 120 cases in our study with information
missing on sex and 240 cases for which population group
could not be assigned. Although we cannot entirely exclude
some bias, we do not envisage any systematic reason for the
missing data. A major limitation of our study is the pathology-
based reporting process of the NCR, as cancers without a
pathology-based diagnosis are missed. This might be of partic-
ular concern for some brain tumor cases diagnosed solely by
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medical imaging, but could also apply more generally to the
situation of cancer patients who present at a late stage and for
whom the cancer was too advanced to benefit from a more
precise diagnosis. Possibly also some leukemia cases might
have been diagnosed only on peripheral blood tests performed
outside the tertiary laboratory structures. This would be
expected to primarily concern children who died before referral
to a tertiary hospital where bone marrow biopsies would have
been analyzed and could explain why rates of leukemia were
particularly low. Therefore, even if malignancies are accurately
diagnosed, they may not be captured by the NCR resulting in
under-reporting of the actual incidence of cancer.
As there have been an increasing number of pathology
reports received without information on population group
since the early the 1990s, an imputation method (surname
algorithm) was used to assign population group to cases
missing this information. Thus, misclassification of some
cases with regard to population group cannot be excluded.
However, previously conducted validation analyses of the
imputation method have shown this method to be reasonably
accurate. Another limitation of this study was the lack of
data on stage at diagnosis which could provide further insight
into differences in stage at diagnosis by population and age
groups.34
Conclusions
Our study provides an overview of childhood cancer inci-
dence in South Africa as reported to the NCR between 2000
and 2006. Studies based on more recent data will be impor-
tant to see whether the observed differences by population
group, and between South Africa and high income countries,
persist. Considering that the differences by population group
were much greater than those observed in other settings, as
well as the marked differences between South African Whites
and the German population, genetic and environmental rea-
sons would seem likely to explain only a small proportion of
the substantial observed differences in incidence rates within
South Africa by population group, and between White South
Africans and Germans. More research is needed to under-
stand the extent to which under-reporting and under-
diagnosis may drive the observed patterns. Survival for many
childhood cancers, when diagnosed at an early stage, is gen-
erally very good, with recent survival probabilities for chil-
dren with cancer exceeding 80% in several European
countries.50 In contrast, survival from childhood cancer is
much lower in South Africa, with reported survival rates of
less than 50% among African Blacks.41 This underlines the
importance of raising awareness, training healthcare pro-
viders, enhancing diagnostic capacities, and facilitating access
to medical services for poor families, as most pediatric can-
cers are potentially curable.50
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Supplementary Information Table 2: Childhood cancer reported to the South African National Cancer Registry 
compared to the German Childhood Cancer Registry in 2000-2006 by diagnostic group, population group (all, Mixed 
ancestry vs. Indian/Asian), sex ratio, and age specific, crude, and age-standardized incidence rates.1 
ICCC-3 
diagnostic 
group2 
Race N M/F3 
Age specific incidence4 
Crude 
incidence5 ASR
6 Germany ASR6 
Germany 
M/F3 < 1 year 1 - 4 years 
5 – 9 
 years 
10 - 14 
years 
Leukaemias 
All 875 1.3 7.2 9.6 8.1 8.3 8.5 8.5 54.5 1.2 
Mixed 
ancestry 66 1.4 8.3 9.4 7.0 5.9 7.3 7.5   
Indian/Asian 47 1.5 8.6 51.3 18.6 13.8 24.1 26.6  
Lymphomas 
All 725 2.1 1.3 6.3 8.4 7.3 7.0 6.9 15.7 2 
Mixed 
ancestry 84 2.1 0.0 5.6 13.0 10.5 9.3 9.0   
Indian/Asian 15 1.5 0.0 10.7 9.3 5.5 7.7 7.9  
Malignant 
CNS tumours 
All 431 1.2 2.3 5.3 4.5 3.4 4.2 4.3 21.5 1.3 
Mixed 
ancestry 55 1.7 6.6 5.6 6.7 5.9 6.1 6.1   
Indian/Asian 18 0.5 0.0 15.0 12.4 4.1 9.2 9.8  
Sympathetic 
nervous 
system 
tumours 
All 209 1.3 6.0 4.5 1.1 0.4 2.0 2.3 14.0 1.2 
Mixed 
ancestry 29 1.4 9.9 7.3 1.0 1.0 3.2 3.6   
Indian/Asian 10 9.0 34.5 10.7 1.6 0.0 5.1 6.5  
Retino-
blastomas 
All 278 1.3 4.6 7.9 1.0 0.2 2.7 3.2 4.3 1.2 
Mixed 
ancestry 16 0.7 1.7 5.6 0.7 0.0 1.8 2.1   
Indian/Asian 7 0.8 25.9 8.6 0.0 0.0 3.6 4.7  
Renal 
tumours 
All 542 1.1 6.2 12.6 3.9 1.0 5.2 5.9 9.8 0.9 
Mixed 
ancestry 41 1.4 14.9 9.8 3.0 0.0 4.6 5.2   
Indian/Asian 9 1.3 8.6 15.0 1.6 0.0 4.6 5.8  
Hepatic 
tumours 
All 87 1.6 2.3 1.3 0.4 0.6 0.8 0.9 2.1 1.6 
Mixed 
ancestry 13 1.2 3.3 3.4 1.0 0.0 1.4 1.6   
Indian/Asian 2 1.0 8.6 2.1 0.0 0.0 1.0 1.3  
Malignant 
bone 
tumours 
All 260 0.9 0.6 0.4 1.4 5.5 2.5 2.2 5.9 1.1 
Mixed 
ancestry 19 0.6 1.7 0.4 1.3 4.2 2.1 1.9   
Indian/Asian 10 1.5 0.0 4.3 1.6 9.7 5.1 4.6  
Soft tissue  
sarcomas 
All 630 1.3 4.7 7.4 5.7 5.8 6.1 6.2 9.5 1.2 
Mixed 
ancestry 38 2.2 3.3 5.1 2.7 5.2 4.2 4.2   
Indian/Asian 11 1.5 8.6 6.4 4.7 5.5 5.6 5.8  
Germ cell 
tumours 
All 118 0.3 1.1 1.1 0.9 1.4 1.1 1.1 4.7 0.8 
Mixed 
ancestry 7 0.4 1.7 1.7 0.3 0.3 0.8 0.9   
Indian/Asian 6 2.0 8.6 6.4 1.6 1.4 3.1 3.6  
Malignant 
epithelial 
neoplasms 
All 350 0.9 3.7 2.0 2.3 5.3 3.4 3.2 2.1 0.8 
Mixed 
ancestry 27 1.2 6.6 2.1 1.0 4.9 3.0 2.9   
Indian/Asian 10 1.0 0.0 2.1 6.2 6.9 5.1 4.7  
Other & 
unspecified 
malignant 
tumours 
All 96 1.0 1.4 1.5 0.7 0.6 0.9 1.0 0.1 1.2 
Mixed 
ancestry 4 0.3 1.7 0.4 0.7 0.0 0.4 0.5   
Indian/Asian 3 2.0 8.6 2.1 0.0 1.4 1.5 1.7  
1Sex ratio is based on cases with known sex. Total number (N) and rates include cases with sex missing. 
2Diagnostic groups defined using the International Classification of Childhood Cancer Third Edition (ICCC-3) 
3M/F: sex ratio – male cases/female cases 
4Age specific incidence: age group specific incidence rates per 1,000,000 population aged 0 – 14 years. 
5Crude incidence: crude incidence rate per 1,000,000 population aged 0 – 14 years.  
6ASR: age-standardized incidence rate (using the world standard population) per 1,000,000 population aged 0 – 14 
years. 
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BACKGROUND 
Worldwide, leukemia, multiple myeloma, Hodgkin lymphoma (HL), and non-Hodgkin 
lymphoma (NHL) collectively accounted for an estimated 6.5% of new cancer cases in 2012 
with the majority of these cases coming from NHL followed by leukemia [1]. While global 
estimates suggest 2- and 3-fold higher incidence rates of NHL and leukemia, respectively, in 
high income countries compared to Sub-Saharan Africa (1), there is little known about the 
incidence patterns of hematologic malignancies in this region, including South Africa. Similar 
to worldwide figures, hematologic malignancies contributed an estimated 6% of new cancer 
cases in South Africa in 2012 (1).  
 
To date, the literature of hematologic malignancies in South Africa is largely based on 
hospital-based studies which report on patient and disease characteristics of leukemias and 
lymphomas (2-6), with a particular focus on the prevalence of HIV and the differences in 
cancer characteristics between HIV positive and negative patients. There is a well-established 
association between HIV and several types of hematologic malignancies, including but not 
restricted to the AIDS-defining subtypes of NHL (7-9). While hospital-based studies benefit 
from detailed patient information, there is also a need to estimate incidence and mortality 
rates, particularly at the national-level. Such data provide important information about the 
overall burden of disease which in turn inform cancer control strategies, and provide a basis 
for investigating underlying determinants of disease (REF). 
 
Studies from the United Kingdom and United States show considerable variability in the 
incidence of hematologic malignancies by gender and age (10-12) as well as by race 
(10,11,13). It is unknown whether the incidence of these malignancies in South Africa follows 
similar patterns to those reported in higher income areas. Recently, it was reported that the 
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incidence of pediatric hematologic malignancies was approximately 3-times higher among 
White compared with Black African children within South Africa (14). As race is highly 
correlated with socioeconomic position and access to private health care services in South 
Africa (15), the authors hypothesized that differences in access and utilization of health care 
services likely explain at least some of the observed incidence differences (14). To our 
knowledge, these patterns have not been investigated among adults in South Africa.   
 
In this report, we describe the incidence of adult cases of leukemia, multiple myeloma, HL, 
and NHL reported to the National Cancer Registry of South Africa (NCR-SA) between 2000 
and 2006, by age, gender and race in South Africa.  
 
METHODS 
National Cancer Registry 
A detailed description of the NCR-SA is provided in (16). Briefly, the NCR-SA 
(www.ncr.ac.za) is a pathology-based registry, receiving pathology reports from public and 
private laboratories throughout the country. The registry includes only incident, primary 
invasive cancers based on histologic, cytologic or hematologic confirmation. Trained coders 
at the registry code the diagnoses from pathology reports based on primary organ site and 
morphological type according to the International Classification of Diseases for Oncology, 
third edition (ICD-O-3) (17). Until 2011, reporting to the registry was done on a voluntary 
basis although all of the National Health Laboratory Services (NHLS) laboratories (i.e., public 
laboratories), have regularly reported to the registry over time. Reporting has been less 
complete from the private sector, particularly from 2005 onwards. In addition to basic 
demographic information about the patient (name, age and/or date of birth, gender) and tumor 
diagnosis information (topography, morphology, date of diagnosis), the registry extracts 
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information by race (Black African, White, Colored (i.e., mixed ancestry), and Asian/Indian) 
where available from the pathology reports. In the absence of race, they apply an algorithm, a 
hot deck imputation, which estimates this variable using a database of approximately 1.4 
million surnames with known race (16). In 2000-2001 approximately 67% of case reports had 
missing race and thus a large proportion is imputed. If race cannot be estimated (i.e., surname 
with no match in the database), it is left as missing. A comparison of the distribution of race 
based on actual versus imputed data for a subset of 277130 cancer cases (contributing to the 
database) reported to the registry between 1990 and 1995 showed very good agreement 
between actual and imputed values. The distribution of original (imputed) data was as 
follows: 53% (50%) Whites, 40% (41%) Black Africans, 2% (2%) Indian/Asian and 5% (7%) 
mixed ancestry (chi-square test p-value=0.94 for distribution differences).   
 
Hematologic malignancy cases 
For the present report, we included all incident cases of leukemia, myeloma, HL and NHL 
reported to the NCR-SA that were diagnosed at ages ?15 years between 2000 and 2006, a 
time period under which the cancer registry worked under stable and defined conditions. 
From all invasive cancers diagnosed, the initial selection was made of all cases with ICD-0-3 
morphology codes of 9590 to 9999 (17). Using the Surveillance, Epidemiology and End 
Results (SEER) Program site recode 
(http://seer.cancer.gov/siterecode/icdo3_dwhoheme/index.html) which is based on the ICD-O-
3 and the 2008 WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 
(18), hematologic malignancies were classified into broad groups of leukemia, myeloma, 
Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL). Leukemia cases could be further 
broken down into: acute lymphocytic leukemia, chronic lymphocytic leukemia, other 
lymphocytic leukemia, acute myeloid leukemia, acute monocytic leukemia, chronic myeloid 
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leukemia, other myeloid/monocytic, other acute leukemia, aleukemia, subleukemia, and NOS. 
As the registry does not routinely collect information of tumor grade, it was not possible to 
fully implement the more detailed classification of lymphoid neoplasms which is grade 
dependent for some categories (http://seer.cancer.gov/lymphomarecode/). Our analysis did not 
include myelodysplastic syndromes. 
 
Population data  
Consistent with the approach used in the annual reports of the NCR-SA for the years included 
in the present study , we used the Alternative South African mid-year population estimates 
(19) from the Centre for Actuarial Research, University of Cape Town, stratified by age, 
gender and population group for calculation of incidence rates. These mid-year population 
estimates are similar in magnitude to the official mid-year estimates but maintain an age 
distribution that is consistent with that of the most recent Census in 2011 and, as with the 
NCR for this time period, we considered them as the more appropriate population estimates 
for the purposes of studying differences by age group. 
 
Statistical methods  
Gender-specific crude incidence rates overall and stratified by race were estimated for the 
different classifications of hematologic malignancies described above. Most analyses were 
based on the first-level, broad classification of leukemia, myeloma, HL and NHL. Reflecting 
limited case numbers in individual age groups, age-specific rates were not estimated 
separately for males and females. Gender-specific age-standardized rates, overall and 
stratified by race, were calculated using the SEGI world standard (20) truncated for ages ?15 
(ASR 15+). The ASR 15+ is a weighted average of age-specific rates based with the 
following weights for each age group: 15-19 (0.13), 20-24 (0.12), 25-29 (0.12), 30-34 (0.09), 
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35-39 (0.09), 40-44 (0.09), 45-49 (0.09), 50-54 (0.07), 55-59 (0.06), 60-64 (0.06), 65-69 
(0.04), 70-74 (0.03), 75-79 (0.01), 80+ (0.01).   
 
Incidence rate ratios (IRRs) and 95% confidence intervals (CI) were estimated using Poisson 
regression models with the number of cases for a given category of hematologic malignancy 
as the outcome, the population size as the log offset and a log link function, overall and 
stratified by race, comparing rates among females to males. Similar models, stratified by 
gender, were used to compare incidence rates by race, using Black Africans as the reference 
group. All models were adjusted for age group (5-year categories) and calendar year (single 
year treated as a categorical variable). Models including all races and/or both males and 
females were further adjusted for race and gender. Hematologic patients with unknown race 
and/or gender (4.7%) were excluded from Poisson models as there were no corresponding 
population estimates for such groups. As under-ascertainment of cancers at older ages is a 
concern in many cancer studies (not specific to South Africa), sensitivity analyses were 
repeated by restricting the dataset to ages less than 75 years.  
 
RESULTS 
Between 2000 and 2006, there were a total of 14662 hematologic malignancies reported to the 
registry. There were 46 cases (0.3%) with unknown gender. Table 1 presents the distribution 
by race for the 14616 hematologic malignancy cases with known gender, by calendar year of 
diagnosis, reporting source (private vs. public), and year of diagnosis, separately for males 
and females. In all calendar years, approximately half of the cases were reported among Black 
Africans, one-third among Whites, 10% among individuals of mixed ancestry and 5% or less 
among Asians/Indians. The distribution of race differed substantially between public and 
private laboratories, with the White population accounting for approximately half of all cases 
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reported by private laboratories. With increasing age at diagnosis, the proportion of cases 
coming from the Black African population declined while that from the White population 
increased steadily. Similar patterns were observed for males and females with respect to 
calendar year, reporting source and age. 
 
The distribution of cases, by the four major categories of hematologic malignancies is 
presented in Figure 1. Regardless of gender or race, NHL was the most commonly reported 
hematologic malignancy, accounting for approximately 50% or more of cases in most groups. 
In all groups, this was followed by leukemia, contributing 15-25% of cases in the various 
subgroups.  
 
Crude and age-standardized incidence rates are presented for leukemia, myeloma, HL and 
NHL by race and gender in Table 2. Incidence rates varied markedly by race. In general, the 
lowest rates were observed among Black Africans and the highest among Whites. An 
exception was myeloma, for which rates were lowest among the Asian/Indian population 
among both males and females. Among males, the ASR of myeloma was similar for the 
White and Mixed ancestry groups. A more detailed breakdown of leukemia subtypes is 
presented in Supplemental Table 1. Among females, acute myeloid leukemia was the most 
common form of leukemia whereas the highest ASR for males was observed for chronic 
lymphocytic leukemia. As with the main groups, ASRs tended to be lowest among Black 
Africans and highest among Whites. For several subtypes of leukemia ASRs were similar in 
the White and Asian/Indian populations.  
 
Figure 2 presents the incidence rate ratio comparing males vs. females. For the whole 
population combined, the reported incidence rate of hematologic malignancies was 1.2 to 1.5-
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fold higher among males than females (Figure 2a). Similar patterns were observed across the 
four race groups (Figure 2b).  
 
The incidence rate ratios for race are presented in Figure 3. For males and females combined, 
reported incidence rates of hematologic malignancies tended to be higher among White, 
Mixed ancestry and Asian/Indian populations than among the Black population (Figure 3a). 
The exception was for myeloma, for which no statistically significant difference was observed 
between the Asian/Indian and Black populations, in either males or females. The largest rate 
ratios were observed comparing the White and Black populations, ranging from 1.56 (95% CI 
1.38-1.76) for myeloma to 3.77 (95% CI 3.38-4.21) for HL. Gender-specific patterns were 
similar to those observed for males and females combined (Figures 3b, 3c).  
 
Age-specific rates of leukemia, myeloma, HL and NHL are presented in Figure 4(a-d) by 
race. With the exception of HL, incidence rates tended to increase with age until 
approximately age 75, followed by a decline at the oldest ages. For HL (Figure 4c), the 
patterns appeared quite different between races, most notably comparing the White and Black 
populations. Among Whites, there was an early peak in HL incidence rates at ages 20-29 and 
a later peak around age 70-75 with rates somewhat lower and generally stable in between. 
Among Black South Africans, there was an increase with HL with age until approximately 
age 30, at which point the rate plateaued followed by a subsequent decline beginning around 
age 60. For all four major types of hematologic malignancies investigated, incidence rates 
were consistently higher among Whites than Black Africans, irrespective of age, but these 
differences tended to increase with age (Figures 4a-d).  
In sensitivity analyses restricted to ages less than 75, there were no marked changes in the 
results presented in Tables 1-2 or the Figures 1-3. Incidence rate ratios by racial group were 
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slightly attenuated at ages less than 75 compared with the full adult population, but the 
reduction was very minor and the interpretation unchanged. This observation is consistent 
with the patterns observed in age-specific rates whereby differences between the White and 
Black populations were most apparent at oldest ages. 
 
DISCUSSION  
Summary of key results 
We estimated the incidence of adult hematologic malignancies (diagnosed at ages 15 years or 
older) reported to the National Cancer Registry of South Africa (NCR-SA) between 2000 and 
2006, describing overall rates as well as those by age, gender and race. NHL was the most 
common hematologic malignancy reported to the NCR-SA during this time period, 
irrespective of gender and race. Incidence rates of reported hematologic malignancies were 
generally 20 to 50% higher among males than females. Our analyses suggested higher rates of 
reported hematologic malignancies among the White, mixed ancestry and Asian/Indian 
populations than among Black Africans, with differences most pronounced when comparing 
the White and Black African populations (IRRs ranging from 1.6 for myeloma to 3.8 for HL 
for males and females combined). These differences tended to become more marked with 
increasing age. With respect to age-specific rates, incidence rates increased with age for 
hematologic malignancies other than HL. For HL, among Whites, a bimodal peak was 
observed at ages 20-29 and 70-75. A different pattern was observed among Black South 
Africans; reported HL rates increased with age until approximately age 30, at which point the 
rate plateaued followed by a subsequent decline beginning around age 60.  
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Interpretation of key results 
The observation that NHL, followed by leukemia, was the most common of these four broad 
categories of hematologic malignancies is consistent with worldwide patterns (1). The higher 
incidence rates among males than females are also consistent with gender patterns reported 
elsewhere (12,21).  
 
With respect to race, age-adjusted incidence rates from the SEER-18 registries in the US for 
the period of 2000-2011 show a predominance among the White vs. Black populations with 
annual White to Black ratios (estimated using (22)) of 1.3-1.5 for total NHL, 1.2-1.4 for total 
leukemia and 1.1-1.3 for HL. These overall estimates are somewhat lower than those 
estimated in the NCR-SA data. Of note, previous analyses of the SEER data have shown that 
the magnitude and direction of these race rate ratios varies by subtype (10,11). The available 
data from the NCR-SA do not permit a full classification of NHLs as grade is not available 
but we were able to classify leukemia subtypes. Unlike SEER (10), there were no leukemia 
subtypes for which ASRs were higher among Black Africans than the White population 
(Supplemental Table 1). The apparently distinct age-specific patterns observed for HL 
between the White and Black populations in the NCR data is also reported in the SEER data 
where a clear bimodal pattern, classically associated with HL, is much more pronounced in 
the White than Black populations (23). Globally, the classic bimodal age pattern appears to be 
more a characteristic of more economically developed areas (24). In contrast to what is 
observed for NHL, HL and leukemia rates, the incidence of myeloma in the SEER data is 
approximately 2-fold greater among Blacks than Whites (13). This was not seen in the South 
African data; while the estimated IRR in the NCR-SA comparing the White and Black 
African populations was lower for myeloma (1.56) than for leukemia, HL or NHL, it 
remained above 1. 
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For any cancer site, differences in the underlying distribution of genetic and environmental 
risk factors as well as factors related to completeness of reporting and diagnosis drive 
demographic variations in the incidence patterns. The etiology of hematologic malignancies is 
largely unexplained, with few known determinants(24-26). Established environmental risk 
factors for leukemia include ionizing radiation and certain chemical exposures such as 
benzene (26). For NHL, there is clear evidence for an association with infectious diseases 
(HIV, Epstein Barr virus (EBV), Hepatitis C Virus (HCV), and Human T-Lymphotrophic 
Virus (HTLV-1)) (25) and increasing data to support a role for lifestyle, occupational and 
environmental factors (27). HL also has an infectious etiology -- EBV is one of few known 
risk factors (24). While we cannot exclude the possibility that differences in the distribution of 
or susceptibility to etiologic factors could explain the marked differences by race observed in 
the NCR-SA data, the known infectious and environmental risk factors would not seem likely 
explanations. In order for these factors to drive truly higher rates of disease within South 
African Whites versus Black Africans, they would need to be more prevalent in the White 
population.  
 
Disparities in the completeness of diagnosis and reporting between race groups may have 
contributed to the observed incidence rate patterns. The NCR is a pathology-based registry 
and thus only hematologic malignancies with a histologic, cytologic or hematologic (bone 
marrow aspirate or trephine biopsy) confirmation are captured. Consequently, there is an 
inherent risk of under-estimating rates based on the registry data as cases diagnosed by other 
means (i.e., peripheral blood smear) are not reported. Problems of under-reporting may be 
compounded, however, by other factors that disproportionately affect Black Africans 
compared with Whites and contribute not only to under-reporting but also under-diagnosis of 
these cancers. First, a smaller proportion of Black Africans have access to a private medical 
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aid fund (7.2% vs 63.1% among Whites according to 2006 data) (28). Public medical services 
are chronically under-resourced and understaffed (29,30). As such, patients in the public 
sector may be less likely than those in the private sector to receive a comprehensive 
diagnostic work-up. Further, the system operates under a tiered structure by which patients are 
referred from primary health clinics to tertiary hospitals via other tiers and many patients are 
thought to be lost from the system before presenting at referral centers (31). Second, the 
burden of HIV is markedly higher among Blacks than Whites in South Africa (in 2012, it was 
estimated that 22.7% of the Black South African population ages 15-49 was infected with 
HIV compared with 0.6% among Whites) (32). While HIV is associated with increased risk of 
lymphomas, particularly subtypes of NHL (9), atypical presentation and histology of HIV-
associated lymphomas may lead to misdiagnosis or delayed diagnosis (33). Competing 
mortality (9,34) and late-stage presentation of disease (3,35) may further reduce opportunity 
for lymphomas to develop and/or be diagnosed in populations with high HIV rates.  
 
Strengths/limitations 
This is the first country-wide study on hematologic malignancies in South Africa and one of 
very few studies from Sub-Saharan Africa. The study benefits from the large number of cases 
permitting detailed examination of rates and patterns by age, sex and race. The diverse racial 
population of South Africa enabled us to investigate differences by race which is an important 
determinant of socioeconomic circumstances and access to private health care in South Africa 
(15). Nonetheless, analyses of the Asian/Indian and mixed ancestry populations were less 
robust owing to smaller case numbers than in the Black and White populations, particularly 
when further examining age-specific patterns. Limitations include that, by definition, the 
cancer registry is limited to pathology-confirmed cancer cases and thus it is understood that it 
does not fully capture incident hematologic malignancies. Further, there was a decline in 
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reporting to the NCR by some private sector laboratories (beginning in 2005) (16) – this 
would be expected to have the greatest impact on the White population which could attenuate 
the observed rate ratios by race. In the absence of tumor grade, we were unable to fully 
classify lymphoid neoplasms following the WHO criteria. Previous studies of lymphoma and 
leukemia in the US suggest that racial differences may vary considerably by subtype (10,11). 
Race group had to be imputed for a substantial proportion of the dataset. The method however 
has been previously validated in the NCR and the limitation appears to be of minor 
importance, although some misclassification cannot be ruled out. While it is important to 
consider our results in the context of these limitations, the NCR provides the most 
comprehensive overview of these cancers in the country at this time.  
 
Conclusions 
The hematologic malignancies investigated here collectively account for an estimated 6% of 
new cancer cases and 8% of cancer deaths in South Africa (1). The consistency of patterns by 
age and gender with those reported in other populations (1,10,12,13,21,23) suggest that 
underlying risk factors for these cancers are unlikely to modify the age distribution or gender 
ratio. Differences between races, however, would appear to be more pronounced than those 
observed in some other settings. We hypothesize that challenges related to diagnosis and 
reporting of cancers play a role in the patterns by race while the set-up of the NCR 
(pathology-based) could lead to some degree of under-ascertainment, irrespective of race, 
gender or age. Despite challenges, it is important to analyze and report available national 
cancer incidence data to raise awareness of the cancer burden and to characterize patterns by 
demographic characteristics so as ultimately to improve the situation. 
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Figure 1: Distribution of confirmed cases ages 15+ reported to NCR by type of hematologic 
malignancy, by gender (a) and by gender and racial group (b) 
 
1a 
 
 
1b 
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Figure 2: Male to female incidence rate ratios (IRR) of histologically confirmed cases 
reported to the NCR-SA, overall (a) and by racial group (b) 
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2b 
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Figure 3: Incidence rate ratios compared with Black population of confirmed hematologic 
malignancy cases reported to NCR-SA, overall (3a) and by gender (3b females, 3c males) 
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3b 
 
(continued) 
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3c 
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Figure 4: Age-specific rates (per 100,000) of confirmed hematologic malignancies reported 
to the SA-NCR by population group, ages 15+, males and females combined 
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Abstract Background: Sex, age, immunophenotype and white blood cell count at diagnosis
are well accepted predictors of survival from acute lymphoblastic leukaemia (ALL) in
children. Less is known about the relationship between socio-economic determinants and
survival from paediatric ALL, studied here for the first time in German children.
Methods: ALL cases were diagnosed between 1992 and 1994 and their parents interviewed
during a previous nationwide case-control study. Children were followed-up for 10 years after
diagnosis by the German Childhood Cancer Registry. Cox proportional hazards models esti-
mating hazard ratios (HRs) were calculated to assess the impact of selected socio-demographic
characteristics on overall and event-free survival.
Results: Overall survival was 82.5%, with a higher proportion of girls than boys surviving
(85% versus 81%). We found a non-linear relationship between age at diagnosis and survival,
with poorer survival in infants and children aged >5 years. There was no association between
socio-economic factors and survival or risk of relapse. For five levels of increasing family
income, all HRs were close to one. No relationship was seen with parental educational level.
Conclusion: Socio-economic determinants did not affect ALL survival in West German
children, in contrast to studies from some other countries. Dissimilarities in social welfare
http://dx.doi.org/10.1016/j.ejca.2014.01.028
0959-8049/ 2014 Elsevier Ltd. All rights reserved.
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systems, including access to health care, lifestyle and differences in treatment may contribute
to these differences in findings. Our observation of no social inequalities in paediatric ALL
survival is reassuring, but needs continued monitoring to assess the potential impact of evolve-
ment of treatment options and changes in paediatric health service.
 2014 Elsevier Ltd. All rights reserved.
1. Introduction
With an annual incidence of 43 per million, acute
lymphoblastic leukaemia (ALL) is the most common
single malignancy in children (0–14 years) in Germany,
accounting for almost a third of all paediatric cancers
[1]. Over the last 30 years, advances in treatment have
led to considerable improvements in outcome [2–5], with
the 5-year survival now exceeding 80% in Germany and
other developed countries [1,2,4–7]. The improvement in
survival is – besides advances in diagnostic procedures
and treatment protocols [8,9] – to a certain extent
achieved by identifying determinants predicting poorer
survival and high risk groups [9,10]. Sex and age as well
as white blood cell count at diagnosis, diagnostic group
and response to initial therapy are important predictors
for survival [10–13].
As diagnostic procedures and treatment protocols for
ALL are generally standardised within developed coun-
tries [14,15], the survival rate should be fairly equal across
socio-demographic groups in countries where children
have equal and free access to health care services. None-
theless, differences by socio-economic factors have not
only been reported for developing regions [16,17], but
also for some developed countries [2,14,18–20].
Our aim was to investigate ALL survival in
Germany; hence in a country with presumably equal
and free access to high quality care for all children
and a dense network of specialised paediatric clinics.
2. Materials and methods
2.1. Study population
The study population consists of cases from a former
German case-control study, covering all of West
Germany [21]. Cases were identified in the nationwide
population-based German Childhood Cancer Registry
(GCCR). ALL cases were eligible, if diagnosed between
October 1992 and September 1994 before the age of
15 years and if the child was living in former West
Germany. In total, 788 children were identified. In total,
82% (N = 647) participated in the original case-control
study. Reasons for non-participation were parents’ refu-
sal to participate in the case-control study (74%), physi-
cian’s preference not to invite the parents to participate
(15%), no contact with parents could be made (5%) and
late detected violation of eligibility criteria (6%; mainly
insufficient language skills). Information on potential
risk factors was collected by self-administered question-
naire and a subsequent telephone interview with both
parents.
2.2. SES and demographic characteristics
While sex and age are available for all eligible cases,
information on socio-economic status (SES) of the fam-
ily was only available for participants of the former
case-control study. During the telephone interview con-
ducted within 2 years after diagnosis, information on
parental education, parental occupational training and
average monthly family disposable income was col-
lected. Information on monthly family income was com-
piled in five categories. Levels based on the
(internationally unique) German school and educational
system can be interpreted hierarchically with ‘high
degree’ as highest achievable level. The education levels
are broadly related to years of school education; a ‘low
degree’ is associated with at least 9 years mandatory
education, an ‘intermediate degree’ with at least 10 years
and a ‘high degree’ implies 12–13 years mandatory edu-
cation, with only the latter allowing later admittance to
University or technical college.
2.3. Follow-up
Active vital status follow-up is conducted routinely by
the GCCR using information from clinical studies, treat-
ing hospitals, families and communities. A set of minimal
information for each patient including date of first recur-
rence or relapse, date and type of secondary neoplasm,
vital status, date of death and date of last contact is reg-
ularly updated. In the first years after diagnosis (as long
as the patient is in contact with the hospital for treat-
ment/follow-up care) the GCCR receives follow-up
information from the respective clinical trial or hospital.
Almost all ALL patients are entered into clinical trials.
At the end of the regular clinical follow-up the GCCR
takes over surveillance and contacts the patients or par-
ents directly, if the last follow-up information dates back
5 years or longer [22,23]. Due to this procedure follow-up
for 10 years after diagnosis was available for our survival
analysis; we censored at 10 years as very few disease-
related events occur afterwards.
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2.4. Statistical analyses
We defined two primary outcomes for these analyses:
overall survival, with death from any cause as the end-
point, and event-free survival, with the first (if any)
relapse (defined as >5% lymphoblasts in bone marrow),
second malignant neoplasm or death as events. Children
were observed for a calendar period of 10 years from the
date of diagnosis until the date of event, last date known
to be alive or date of 10 years of follow-up, whichever
came first.
Initially, for graphical presentation we calculated
(unadjusted) survival probabilities stratified by age
(grouped into <1, 1–5, 6–9 and 10–14 years), sex, paren-
tal school education and monthly family disposable
income, using Kaplan–Meier curves. Statistical signifi-
cance (P 6 0.05) of differences in survival probabilities
was assessed by log-rank tests [24].
Cox proportional hazards models were used to assess
the impact of selected characteristics on overall (Models
I and III) and event-free survival (Models II and IV)
[25,26]. Results were expressed as adjusted hazard ratios
(HRs) along with corresponding 95% confidence inter-
vals (CI). Models including all cases (Models I and II)
analyse the association with sex and age at diagnosis,
with participation status as a covariate to account for
suspected different survival probabilities between study
participants and non-participants. Models III and IV
were fitted with selected SES indicators but restricted
to study participants since SES was only available among
respondents to the questionnaire. Two SES proxies were
included simultaneously in the main analyses, namely
maternal education and monthly family net income.
The variables were only weakly correlated (Spearman
correlation = 0.27) and reflected both financial resources
and educational achievement (Supplement Table S1).
Degree of urbanisation was considered as potential con-
founder and thus also included in these models.
When testing the proportional hazards assumption
for the Cox models using the Schoenfeld residuals test
[26] it failed for age at diagnosis with the category
‘<1 year’ in one of the models. To test the impact on
the hazard ratios, we excluded all cases of this age group
(N = 30) from the study population and performed sep-
arate analyses. However, as the hazard ratios changed
only marginally, results in this paper relate to all sub-
jects combined.
Sensitivity analyses were performed: (a) including
parental occupational training as SES indicator in vari-
ous combinations with other SES factors in the Cox
models; (b) restricting analysis to B-lineage ALL cases;
(c) modelling Cox models assuming that every non-par-
ticipant as well as item non-responder to the questions
on SES indicators had lowest maternal education level
(no degree) as well as lowest monthly family income
(<2000 DM) and that the distribution of residential area
(urban, mixed and rural) in the non-participants is equal
to the distribution in the participants.
All statistical analyses were performed using Stata 11
[27].
3. Results
Of the 788 cases, 58.4% were boys and more than
60% were 1–5 years of age at diagnosis (Table 1). Over
the follow-up period of 10 years 137 children died, with
a higher proportion (28%) in non-participants than par-
ticipants (15%). In terms of monthly family income and
parental education, most of the interviewed parents
ranked in the second lowest categories. Missing values
were 6.5% for income and 5% for maternal and 10%
for paternal school education (Table 1).
The 10-year overall survival of all cases was 82.5%.
Twenty-one deaths (18% of all deaths) occurred later
than 5 years after diagnosis. Within the first 5 years,
only 11 (1.4%) of the 788 ALL-cases were lost to fol-
low-up (Supplement Table S2).
Survival was generally better in girls (85% versus
81%), with differences emerging about 1 year after diag-
nosis; the sex difference however was statistically signif-
icant only in the event-free analyses (Figs. 1a and b).
Survival curves by age group and sex show the lowest
survival among infant boys, most pronounced in the
first 2 years after diagnosis, while among girls survival
was also lowest in infants but better compared to boys
(Figs. 2a and b).
The multivariate analyses confirm diverse survival
probabilities by sex and age (Table 2). We found a
non-linear relationship between age at diagnosis and
survival (p < 0.001); infants had almost a sixfold
increased risk of dying and fourfold increased risk of
any event, compared to 1–5 year old children. Older
children also had an increased HR (both 6–9 year-olds
and 10–14 year-olds) compared to the reference group,
the magnitude varying around 2.5-fold (overall sur-
vival). The greater sex disparity seen in event-free sur-
vival was caused by a higher proportion of relapse in
boys than in girls (23% versus 15%; data not shown).
Non-participants had an almost twofold increased HR
in overall survival compared to participants (Table 2).
No relationship between socio-economic factors and
survival was observed, in both in the univariate as well
as the multivariate analyses (Figs. 3a–c and Table 3).
Both maternal education and family income did not
show any trend or significant impact on survival from
ALL (Table 3). For income, all HRs were close to 1.
For maternal education, the HR was somewhat ele-
vated, although not significantly, in the small group of
mothers having no school degree in the event-free anal-
ysis (HR 1.80; CI 0.47; 2.56). Associations seen with sex
and age were confirmed in this subset of participants
compared to the full dataset.
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Sensitivity analyses using other SES indicators as well
as restricting the analyses only to B-lineage leukaemia
did not alter the overall results (Supplements Tables
S3 and S4). Calculating models assuming that every
non-participant had lowest maternal education level
and lowest family income did not show any trend
between SES and ALL survival either (data not shown).
4. Discussion
4.1. Main findings
We have studied the effect of sex, age and socio-
economics on long-term survival in paediatric ALL
cases diagnosed in the early 1990s in Germany. No trend
Table 1
Characteristics of the acute lymphoblastic leukaemia (ALL) cases by diagnosis, deaths and observed person-years.
ALL-cases Deaths % Deaths Person-years
Total 788 137 17.4 6732
Participants 647 (82.1%) 98 (71.5%) 15.2 5663
Non-participants 141 (17.9%) 39 (28.5%) 27.7 1069
Sex
Boys 460 (58.4%) 88 (64.2%) 19.1 3854
Girls 328 (41.6%) 49 (35.8%) 14.9 2878
Age at diagnosis (years)
<1 30 (3.8%) 13 (9.5%) 43.3 175
1–5 491 (62.3%) 54 (39.4%) 11.0 4477
6–9 155 (19.7%) 39 (28.5%) 25.2 1241
10–14 112 (14.2%) 31 (22.6%) 27.7 840
The following characteristics are just available for those who participated in the case-control study
ALL subtype
B-cella 571 (88.3%) 75 (76.5%) 13.1 5108
T-cell 58 (9.0%) 19 (19.4%) 32.8 423
Unknown subtype 18 (2.8%) 4 (4.1%) 22.2 132
Family incomeb
<2000 DM 51 (7.9%) 10 (10.2%) 19.6 429
2000–4000 DM 341 (52.7%) 52 (53.1%) 15.3 3000
4000–6000 DM 162 (25.0%) 19 (19.4%) 11.7 1429
6000–8000 DM 29 (4.5%) 6 (6.1%) 20.7 238
>8000 DM 22 (3.4%) 4 (4.1%) 18.2 193
Missing 42 (6.5%) 7 (7.1%) 16.7 364
Parental educationc
Mother
No degree 22 (3.4%) 4 (4.1%) 18.2 190
Low degree 248 (38.3%) 40 (40.8%) 16.1 2144
Intermediate degree 203 (31.4%) 23 (23.5%) 11.3 1857
High degree 134 (20.7%) 23 (23.5%) 17.2 1137
Others 6 (0.9%) 0 (0%) 0 60
Missing 34 (5.3%) 8 (8.2%) 23.5 276
Father
No degree 18 (2.8%) 2 (2.0%) 11.1 170
Low degree 277 (42.8%) 36 (36.7%) 13.0 2469
Intermediate degree 118 (18.2%) 19 (19.4%) 16.1 1022
High degree 162 (25.0%) 26 (26.5%) 16.1 1394
Others 6 (0.9%) 1 (1.0%) 16.7 55
Missing 66 (10.2%) 14 (14.3%) 21.2 552
Residential area
Urban 276 (42.7%) 44 (44.9%) 15.9 2377
Mixed 201 (31.1%) 34 (34.7%) 16.9 1734
Rural 170 (26.3%) 20 (20.4%) 11.8 1552
a Common ALL, mature-B ALL, pre-B ALL and pro-B ALL combined.
b Average monthly family disposable income stated in Deutsche Mark – Currency in Germany before implementation of the Euro in 2002 with an
exchange value of 1 DM = 0.51 €.
c The education categories should be interpreted hierarchically with ‘high degree’ as highest achievable degree. The education levels are related to
years of school education; a ‘low degree’ is associated with at least 9 years mandatory education, an ‘intermediate degree’ with at least 10 years and a
‘high degree’ comes along with 12–13 years mandatory education (only the latter allows admittance to university or technical college). The original
categories used in the German questionnaire are ‘kein Schulabschluss’ (no degree), ‘Hauptschulabschluss’ (low degree), ‘Mittlere Reife’ (intermediate
degree) and ‘Fachhochschulreife/Abitur’ (high degree).
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or statistically significant associations between socio-
economic factors and survival probability or risk of
relapse were found. With respect to age and sex, our
results are consistent with those described elsewhere
[2,13,28]. Boys – known to have a higher ALL incidence
than girls – showed also worse survival [1,29], noting
that boys and girls with ALL were treated identically,
both with respect to the intensity and to the length of
treatment during the time period 1992–94 [30,31].
Our main finding that socio-economic factors were
not related to ALL survival in German children appears
plausible in light of the fact that irrespective of coverage
by private or statutory health insurance (Germany has a
universal multi-payer health care system with two main
types of health insurance: private insurance and statu-
tory health insurance (SHI) called sickness funds) and
of social background, all German children and adoles-
cents have free access to health care [32].
4.2. Treatment of ALL-cases
The German Health care system allows for a direct
consultation of sick children and adolescents with a pae-
diatrician without having to pass through a General
Practitioner before. This access is not specific to social
groups and may contribute to an explanation of our
main finding. Importantly, more than 90% of all paedi-
atric oncology patients are included in clinical trials of
therapy optimisation studies in Germany [22]. Almost
all paediatric ALL cases are treated according to the
treatment schemes developed by the two collaborative
study groups ALL-BFM (Berlin–Frankfurt–Mu¨nster)
and COALL (cooperative study group for childhood
acute lymphoblastic leukaemia). Cases included in our
study were treated according to the protocol of the
ALL-BFM 90 [30] or COALL 92 trial [33]: in these tri-
als, 10-year overall survival as well as event-free survival
was reported to be generally better in patients treated by
the BFM-90 protocol compared to the COALL-92 pro-
tocol (overall survival: 85% versus 81%; event-free sur-
vival: 76% versus 73%), whereas the COALL-92 shows
better survival considering only T-lineage patients
[15,33]. However, we have no reason to assume that
treatment by a certain protocol was related to families’
Fig. 1a. Kaplan–Meier estimates of overall survival for all acute
lymphoblastic leukaemia (ALL)-cases by sex. Log-rank test of
heterogeneity: v2 = 2.34, p = 0.13.
Fig. 1b. Kaplan–Meier estimates of event-free survival for all ALL-
cases by sex. Log-rank test of heterogeneity: v2 = 7.35, p = 0.0067.
Fig. 2a. Kaplan–Meier estimates of overall survival for boys diag-
nosed with acute lymphoblastic leukaemia (ALL) by age group. Log-
rank test of heterogeneity: v2 = 32.46, p = 0.00.
Fig. 2b. Kaplan–Meier estimates of overall survival for girls diagnosed
with ALL by age group. Log-rank test of heterogeneity: v2 = 22.75,
p = 0.00.
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social circumstances and it is therefore very unlikely that
treatment introduced any bias in our study.
4.3. International comparison
Our finding is consistent with another German study
indicating that Turkish and non-Turkish children in
Germany do not differ with regard to childhood leukae-
mia survival [34]. As Turkish migration background is
frequently linked with a lower socio-economic status
in Germany [35], this study also suggests no differences
by socio-economic background.
Nonetheless, in contrast to our findings and besides
for developing countries [16,17], a socio-economic
impact on childhood leukaemia survival was reported
for some economically developed European populations
including The Netherlands [20], United Kingdom (UK)
Fig. 3b. Kaplan–Meier estimates of overall survival for all ALL-cases
by paternal school education. Log-rank test of heterogeneity:
v2 = 1.37, p = 0.71.
Table 2
Prognostic factors of overall and event-free survival for all cases of acute lymphoblastic leukaemia followed-up for 10 years from date of diagnosis.
Overall survival (Model I)a,b Event-free survival (Model II)b,c
Hazard ratio [95% CI]d Hazard ratio [95% CI]d
Sex
Boys 1.30 [0.91; 1.85] 1.50 [1.10; 2.05]
Girls 1.0 Reference 1.0 Reference
Age at diagnosis (year)
<1 5.80 [3.16; 10.63] 4.12 [2.34; 7.26]
1–5 1.0 Reference 1.0 Reference
6–9 2.35 [1.56; 3.55] 1.79 [1.25; 2.56]
10–14 2.62 [1.67; 4.09] 2.17 [1.49; 3.17]
Participation
Yes 1.0 Reference 1.0 Reference
No 1.95 [1.34; 2.83] 1.53 [1.08; 2.15]
a End-point of overall survival was defined as death from all causes or date of 10 years observation. 788 subjects (137 deaths) are included in the
Cox regression model.
b Mutually adjusted for each other.
c Event of event-free survival was determined as relapse, second malignant neoplasm and death from all causes. 788 subjects (186 events) are
included in the Cox regression model.
d Corresponding 95% confidence interval.
Fig. 3c. Kaplan–Meier estimates of overall survival for all ALL-cases
by average monthly family net income. Log-rank test of heterogeneity:
v2 = 3.11, p = 0.54.
Fig. 3a. Kaplan–Meier estimates of overall survival for all acute
lymphoblastic leukaemia (ALL)-cases by maternal school education.
Log-rank test of heterogeneity: v2 = 3.33, p = 0.34.
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[2,36], Greece [18] and Norway [14]. Hence, social disad-
vantage might influence survival from ALL in other
ways than just being an indicator for social inequality
in quality of medical treatment and follow-up care.
Reasons may include differences in ‘host factors’, i.e. a
poorer health status, health behaviour at the time of
diagnosis among socially deprived, as well as socio-
economic differences in treatment refusal, abandonment
and compliance with the prescribed treatment plan. The
most likely reason may be socio-economic variations in
the abilities of families to comply with the recommenda-
tions for follow-up assessment and treatment. Findings
from the UK support this idea, as divergence by SES
became more remarkable when treatment management
moved from hospital to home [2]. Potentially, also the
impact of maternal education on survival found in
Norway [14] might be related to follow-up care. Thus,
diverse findings for a social impact on leukaemia sur-
vival even within European countries may rather result
from varying procedure in terms of out-patient care
(e.g. frequency of contact to clinical care team) than dif-
ferences in treatment protocols.
Findings from Australia show that survival was gen-
erally poorer for children living in more isolated parts of
the countries [37]. Living in more rural, and thus possi-
bly poorer areas was also associated with less favourable
prognosis in a recent multi-national study (including
Greece, Bulgaria, Izmir, Antalya and Moscow) [38].
However, looking just at Greece, whereas an earlier
study found indications for a trend of poorer survival
with increasing remoteness, this was not confirmed in
more recent years, which was suggested to be linked to
improvements in motorway infrastructure [18].
All in all, dissimilarities in social welfare systems,
including access to health care, distance to treatment
facilities, lifestyle, as well as differences in socio-
economic status definitions make international
comparisons challenging.
4.4. Strengths and weaknesses
This is the first study in Germany on this topic, and
one of few from Europe. Among the strengths are the
nationwide coverage of cases of former West Germany
and the long and complete follow-up period of 10 years.
Multiple indicators of socio-economic status of the fam-
ily were available on an individual level. Confirmation
of known associations by sex and age underline the
Table 3
Prognostic factors of overall and event-free survival for children with acute lymphoblastic leukaemia followed-up for 10 years from date of
diagnosis, in those with data on SES indicators.
Overall survival (Model III)a,b Event-free survival (Model IV)b,c
Hazard ratio [95% CI]d Hazard ratio [95% CI]d
Sex
Boys 1.52 [0.96; 2.40] 1.55 [1.06; 2.26]
Girls 1.0 Reference 1.0 Reference
Age at diagnosis (years)
<1 7.66 [3.87; 15.18] 4.35 [2.28; 8.28]
1–5 1.0 Reference 1.0 Reference
6–9 2.35 [1.40; 3.95] 1.78 [1.15; 2.77]
10–14 2.24 [1.24; 4.05] 2.06 [1.28; 3.33]
Family income
<2000 DM 1.21 [0.60; 2.44] 1.15 [0.64; 2.06]
2000–4000 DM 1.0 Reference 1.0 Reference
4000–6000 DM 0.80 [0.47; 1.38] 0.79 [0.51; 1.24]
6000–8000 DM 1.27 [0.52; 3.06] 1.24 [0.59; 2.65]
>8000 DM 1.11 [0.37; 3.29] 0.84 [0.32; 2.19]
Maternal education
No degree 1.07 [0.38; 3.04] 1.80 [0.47; 2.56]
Low degree 1.0 Reference 1.0 Reference
Intermediate degree 0.69 [0.41; 1.17] 0.65 [0.41; 1.01]
High degree 0.92 [0.52; 1.62] 1.05 [0.66; 1.67]
Residential area
Urban 1.0 Reference 1.0 Reference
Mixed 1.16 [0.71; 1.91] 0.97 [0.64; 1.48]
Rural 0.88 [0.50; 1.55] 0.92 [0.59; 1.43]
a End-point of overall survival was defined as death from all causes or date of 10 years observation. 595 subjects (90 deaths) are included in the
Cox regression model.
b Mutually adjusted for each other.
c Event of event-free survival was determined as relapse, second malignant neoplasm and death from all causes. 595 subjects (130 events) are
included in the Cox regression model.
d Corresponding 95% confidence interval.
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validity of our findings as well as poorer survival of
T-cell compared with B-cell types [13,39,40] (data not
shown).
Our study has also limitations. With respect to
socio-economic status, we had 18% missing data due
to non-participation in the original case-control study,
6.5% of the participating families did not specify their
monthly family income and 5.3% did not provide infor-
mation on maternal education. We observed poorer
survival in non-participants. As refusing participation
in epidemiological studies is possibly associated with
lower socio-economic status, our results might theoreti-
cally be biased. However, sensitivity analyses assuming
the worst case scenario that every non-participant had
lowest maternal education level and lowest family
income also yielded no association between socio-
economic factors and ALL survival. Information about
socio-economic status was collected by an interviewer-
administered questionnaire via phone. Therefore,
reporting bias cannot entirely be excluded, especially
for income that is not very openly discussed in German
culture. Bias should be minor for education with easy-
to-recall and straightforward categories, assuming that
maternal education sufficiently reflects the socio-eco-
nomic status of a family in Germany in the beginning
of the 1990s.
Another limitation is that survival studies are by
default historical by the time they are published.
Survival probabilities observed in this study have
improved in the meantime [1]. As a consequence of the
demographic change in Germany and associated finan-
cial pressure, the German health care system went
through a series of reforms since the cases of our study
were treated. However, reimbursement for diagnosis
and treatment of paediatric cancer is not known to have
been changed by these reforms. Nevertheless, the rela-
tionship between SES and ALL survival might have
changed since then.
5. Conclusions
In conclusion, socio-economic background did not
influence ALL survival in Germany. This contrasts
somewhat to some other national studies, but dissimilar-
ities in social welfare systems, including access to health
care, remoteness to medical facilities as well as differ-
ences in lifestyle may explain diverse findings. Our
observation of no social inequalities in paediatric ALL
survival in Germany is reassuring. Nevertheless, further
research with high completeness as well as high validity
of SES indicators is needed. This study may be particu-
larly valuable in longitudinal national comparisons.
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 Supplementary Table S1: Collinearity of available SES indicators a 
 
Paternal 
occupational 
training 
Maternal 
occupational 
training 
Family 
income 
Paternal 
education 
Maternal 
education 
Paternal 
occupational 
training 
1.00     
Maternal 
occupational 
training 
0.48 1.00    
Family 
income 0.41 0.31 1.00   
Paternal 
education 0.66 0.42 0.41 1.00  
Maternal 
education 0.45 0.52 0.27 0.53 1.00 
a Spearman correlation 
 
 
 
 
 
a Corresponding 95% confidence interval. 
 
Supplementary Table S2: Deaths, losses to follow-up and survival 
by year of observation and sex 
Year of 
follow-up Total Deaths Losses Survival 
[95%-Confidence 
Interval]a 
Boys       
1. 460 25 0 0.95 [0.92 0.96] 
2. 435 19 0 0.90 [0.87 0.93] 
3. 416 16 1 0.87 [0.84 0.90] 
4. 399 10 2 0.85 [0.81 0.88] 
5. 387 7 3 0.83 [0.80 0.86] 
6. 377 3 3 0.83 [0.79 0.86] 
7. 371 5 3 0.82 [0.78 0.85] 
8. 363 0 3 0.82 [0.78 0.85] 
9. 360 2 8 0.81 [0.77 0.84] 
10. 350 1 10 0.81 [0.77 0.84] 
       
Girls       
1. 328 13 1 0.96 [0.93 0.98] 
2. 314 12 1 0.92 [0.89 0.95] 
3. 301 7 0 0.90 [0.86 0.93] 
4. 294 4 1 0.89 [0.85 0.92] 
5. 289 3 2 0.88 [0.84 0.91] 
6. 284 3 0 0.87 [0.83 0.90] 
7. 281 3 0 0.86 [0.82 0.90] 
8. 278 3 1 0.85 [0.81 0.89] 
9. 274 1 3 0.85 [0.81 0.88] 
10. 270 0 3 0.85 [0.81 0.88] 
       
Supplementary Table S3: Sensitivity analysis: overall and event-free survival 
restricted to children with B-lineage acute lymphoblastic leukaemia 
 
OVERALL SURVIVALab EVENT-FREE SURVIVAL bc 
 HAZARD 
RATIO  [95% CI]
d HAZARD RATIO  [95% CI]
d 
Sex     
Boys 1.48 [0.89; 2.48] 1.48 [0.98; 2.24] 
Girls 1.0 Reference 1.0 Reference 
     
Age at diagnosis 
(years)     
< 1 6.97 [3.40; 14.28] 4.02 [2.05; 7.88] 
1 – 5  1.0 Reference 1.0 Reference 
6 – 9  1.39 [0.72; 2.70] 1.27 [0.75; 2.18] 
10 – 14 1.73 [0.84; 3.59] 1.84 [1.04; 3.26] 
     
Family income     
< 2,000 DM 1.22 [0.55; 2.67] 1.20 [0.63; 2.27] 
2,000 – 4,000 DM 1.0 Reference 1.0 Reference 
4,000 – 6,000 DM 0.76 [0.40; 1.45] 0.81 [0.50; 1.34] 
6,000 – 8,000 DM 1.26 [0.48; 3.32] 1.20 [0.54; 2.70] 
> 8,000 DM 1.51 [0.50; 4.58] 0.87 [0.30; 2.50] 
     
Maternal education     
No degree 1.05 [0.32; 3.50] 1.14 [0.45; 2.90] 
Low degree 1.0 Reference 1.0 Reference 
Intermediate degree 0.67 [0.36; 1.25] 0.67 [0.40; 1.10] 
High degree 1.11 [0.59; 2.10] 1.25 [0.76; 2.08] 
     
Residential area     
Urban 1.0 Reference 1.0 Reference 
Mixed 1.39 [0.78; 2.45] 1.13 [0.70; 1.80] 
Rural 1.04 [0.54; 2.00] 1.07 [0.65; 1.77] 
a Endpoint of overall survival was defined as death from all causes or date of 10 years 
observation. 523 subjects (68 deaths) are included in the Cox regression model. 
b Mutually adjusted for each other. 
c Event of event-free survival was determined as relapse, second malignant neoplasm and 
death from all causes. 523 subjects (104 events) are included in the Cox regression model. 
d Corresponding 95% confidence interval. 
Supplementary Table S4: Sensitivity analysis: overall and event-free survival for 
children with acute lymphoblastic leukaemia analysing the impact of paternal 
occupational training and maternal school education 
 
OVERALL SURVIVALab EVENT-FREE SURVIVAL bc 
 HAZARD 
RATIO  [95% CI]
d HAZARD RATIO  [95% CI]
d 
Sex     
Boys 1.54 [0.95; 2.49] 1.66 [1.11; 2.48] 
Girls 1.0 Reference 1.0 Reference 
     
Age at diagnosis 
(years)     
< 1 8.07 [3.95; 16.48] 4.92 [2.51; 9.62] 
1 – 5  1.0 Reference 1.0 Reference 
6 – 9  2.51 [1.44; 4.37] 1.98 [1.25; 3.14] 
10 – 14 2.54 [1.40; 4.60] 2.14 [1.32; 3.49] 
     
Paternal 
occupational 
training 
    
No occupational 
training 0.38 [0.14; 1.08] 0.84 [0.44; 1.64] 
Vocational training 1.0 Reference 1.0 Reference 
Higher vocational 
training (school) 0.95 [0.37; 2.42] 0.94 [0.40; 2.20] 
Technical college/ 
University 1.08 [0.53; 1.98] 1.36 [0.82; 2.27] 
     
Maternal education     
No degree 1.51 [0.53; 4.30] 1.48 [0.63; 3.49] 
Low degree 1.0 Reference 1.0 Reference 
Intermediate degree 0.67 [0.38; 1.15] 0.66 [0.41; 1.05] 
High degree 0.77 [0.39; 1.50] 0.84 [0.48; 1.47] 
     
Residential area     
Urban 1.0 Reference 1.0 Reference 
Mixed 1.10 [0.65; 1.85] 0.93 [0.60; 1.45] 
Rural 0.72 [0.40; 1.32] 0.79 [0.49; 1.28] 
a Endpoint of overall survival was defined as death from all causes or date of 10 years 
observation. 563 subjects (82 deaths) are included in the Cox regression model. 
b Mutually adjusted for each other. 
c Event of event-free survival was determined as relapse, second malignant neoplasm and 
death from all causes. 563 subjects (118 events) are included in the Cox regression model. 
d Corresponding 95% confidence interval. 
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1. Introduction
With an annual incidence of 44 per million children, acute
lymphoblastic leukaemia (ALL) is the most common malignancy in
German children, accounting for over a quarter of all paediatric
cancers in Germany [1]. Over the last decades, advances in
diagnosis and treatment led to considerable improvements in
outcome [2,3], with the five-year survival now exceeding 85%
in Germany [1] and most of Europe [4].
Diagnostic procedures and treatment protocols are largely
standardized within developed countries [2,3,5–8] including
Germany [3,9]. Germany has a dense network of specialized
paediatric clinics and health care is free of charge for all children
irrespective of the family’s social circumstances [10]. Therefore we
would expect fairly equal survival rates across social groups and
independent of family circumstances and, indeed, a recent study
did not observe a relationship between socio-economic back-
ground and ALL survival in Germany [11]. However, besides
physician’s compliance to the treatment protocols, parents’ and
child’s adherence to the treatment and supportive care as well as
the interaction between families and physicians may indeed affect
survival. Treatment of ALL lasts over several years [3,9], and poor
adherence to oral maintenance therapy may have negative impact
on cure rates [12]. As soon as the child is discharged from hospital,
parents are responsible to comply with the recommendations for
continuation of a highly demanding therapy.
From an international perspective, only few studies have
investigated the relationship between family and social circum-
stances and survival from leukaemia, with very diverse observa-
tions even within Europe [11,13–20]. As an extension to the study
on survival from ALL and the impact of socio-economic
background [11] we investigated here for the first time the
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Background: Little is known about the relationship between family characteristics and survival from
childhood acute lymphoblastic leukaemia (ALL), which we studied for the first time in German children.
Methods: ALL cases were diagnosed between 1992 and 1994 and information on family characteristics
was collected during a previously conducted nationwide case–control study. Children were followed for
10 years after diagnosis, as few disease-related events occur afterwards. Cox proportional hazards
models estimating hazard ratios (HR) were calculated using overall as well as event-free survival
methods.
Results: Second born children showed statistically significant better survival compared to first or later
born children, with HRs ranging between 0.54 and 0.64 compared to firstborns. Somewhat poorer
survival was observed for children having 3 or more siblings. A relationship was found for parental age at
child’s diagnosis, with poorer survival for children with younger parents (25 years of age at child’s
diagnosis), or with older fathers. The HR was statistically significant for fathers being 41years of age
(HR of 2.1). No relationship between degree of urbanization of the place of residence at diagnosis and ALL
survival was observed.
Conclusion: Family circumstances may have an impact on survival from childhood ALL in Germany.
Further research is warranted to elaborate the relationship of specific family characteristics and ALL
survival and to investigate possible differential adherence to therapy and interactions with physicians.
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impact of family circumstances on survival from paediatric ALL in
Germany.
2. Material and methods
2.1. Study population and follow-up
Paediatric ALL was defined as diagnosed at ages younger than
15 years. The study population consists of cases from a former
German case–control study, covering all of former West Germany
(details published elsewhere [21]). Briefly, cases were identified in
the nationwide German Childhood Cancer Registry (GCCR), and
eligible if diagnosed between October 1992 and September
1994 and if the child was living anywhere in former West
Germany. 82% of the invited case families (N = 647) participated in
the former case–control [11] study which served as the study
population of this follow-up investigation. Information on all
family characteristics used in this study was collected by self-
administered questionnaire during the original case–control study.
Children with ALL were treated according to the treatment
protocol of the ALL-BFM 90 [3] or COALL 92 trial [9] during this
diagnostic period.
We defined family circumstances by a range of features
including parental age, birth order, number of siblings, as well
as degree of urbanization of the place of residence, using the
official governmental categorization. All characteristics corre-
spond to the situation at the date of child’s diagnosis. Birth order
and number of siblings were defined by counting all live-births of
the same mother.
Active vital status follow-up is conducted routinely by the GCCR
[22]. We censored at 10 years follow-up as very few disease-
related events occur afterwards but the incidence of competing
risks rises. Further information on the follow-up process of the
GCCR as well as on adjustment characteristics (e.g. maternal
education as indicator of socio-economic status) are published
elsewhere [11,22].
2.2. Statistical analyses
We defined two primary outcomes for these analyses: overall
survival, with death from any cause as the endpoint, and event-free
survival, with the first (if any) relapse (defined as >5%
lymphoblasts in bone marrow), second malignant neoplasm or
death as events. Children were observed for 10 years from the date
of diagnosis until the date of event, last date known to be alive, or
date of 10 years of follow-up, whichever came first.
For graphical illustration we calculated (unadjusted) survival
probabilities stratified by birth order, number of siblings and
parental age, using Kaplan–Meier curves. Statistical significance
(p  0.05) of differences in survival probabilities was assessed by
the log-rank test [23].
Cox proportional hazards models were used to assess the
impact of selected characteristics applying overall (Models I and II)
and event-free survival methods (Models III and IV) [24]. The
multiple regression models were built up in two steps. Initially, we
adjusted for the well–established prognostic factors age at
diagnosis [3] (grouped into <1 year, 1–5 years, 6–9 years, 10–
14 years) and sex [25] (Model I and Model III). Model II and Model
IV were additionally adjusted for the possible mediating effect of
other family variables (adjustment varied between family char-
acteristics). Results were expressed as adjusted hazard ratios (HRs)
with corresponding 95% confidence intervals.
The proportional hazards assumption for the Cox models, tested
using the Schoenfeld residuals test [24], failed for the variable
child’s age at diagnosis in the category ‘‘<1 year’’ (N = 26).
Nevertheless, as the hazard ratios changed only marginally when
excluding the infants from the analyses, results in this manuscript
relate to all subjects combined.
All statistical analyses were performed using Stata 13 [26].
3. Results
As expected from German national cancer registry data [1], out
of the 647 cases, 60% were boys and almost two thirds were 1–5
years of age at diagnosis (Table 1). Among all cohort members, 334
(52%) were firstborns and 159 (25%) were the only child; almost
half of the families of our cohort had two children. With respect to
place of residence, most families were living in urban areas, and
most parents were aged 30 years at diagnosis. Numbers of
missing values were very low for the key variables, ranging
between 0.5% for maternal age and 1.6% for paternal age.
10-year overall survival was 84.7%, based on 98 deaths. Survival
was somewhat better for girls than boys (88% vs. 83%) and age-
wise highest for children aged 1–5 years at diagnosis.
Kaplan–Meier curves suggest differences in overall survival
from ALL by family characteristics (although statistically significant
only for birth order) (Fig. 1). Considerably poorer survival is seen for
children with 3 or more siblings compared to those with fewer
siblings. This dissimilarity appears to emerge about 1.5 years after
diagnosis. Regarding birth order, survival was highest for second
born children (p = 0.048). The relationship of parental age at
diagnosis and long-term survival from ALL appears to be U-shaped,
with poorer survival for children with younger (25 years) or older
parents (maternal age 36 years, paternal age 41 years) but
highest in children of mid-aged parents. This U-shape was
particularly pronounced for the associations seen with father’s age.
Table 2 displays the results from the multivariate analyses on
the impact of family characteristics on overall and event-free
survival. The adjusted findings confirm the overall associations
observed from the unadjusted survival curves, with also similar
patterns found for overall and event-free survival and across
models. The group of second born children had a statistically
significant better survival compared to first or later born children,
with HRs ranging between 0.54 and 0.64 compared to firstborns,
depending on the model. The risk of dying of children with 3 or
more siblings increased with additional adjustment (Models II and
IV), resulting in a non-significant HR of about 1.6 in the fully
adjusted model. Children with one or two siblings showed slightly
better survival than their counterparts from single child families. A
sensitivity analysis mutually adjusting for birth order and number
of siblings pointed towards an even stronger relationship between
number of siblings and ALL survival, with increasing HRs with
increasing number of siblings in a family. HRs for children with 3
and more siblings exceeded 2.4 (overall survival) and 2.7
respectively (event-free survival) in the fully adjusted models.
The non-linear relationship of parental age at diagnosis and
survival persists in the adjusted analyses. Children with a father
aged 41 years or older showed a statistically significant increased
HR of 2.1 (95% CI 1.04; 4.20). Likewise, children with a father aged
25 years or younger at child’s diagnosis had poorer survival (HR
1.65; 95% CI 0.97; 2.81), although not statistically significant. The
relationship was weaker for maternal age and persisted in the fully
adjusted models mainly for young mothers (HR 1.33; 95% CI 0.81;
2.19).
A sensitivity analysis distinguishing between having either a
young mother or a young father and having two young parents
(both 25 years) indicated that particularly the latter was related
to poorer survival. Elevated HRs of up to 1.76 were found for having
both a young mother and a young father.
No relationship between degree of urbanization of place of
residence at diagnosis and survival was observed, although HRs for
living in a rural area were somewhat lower than 1.
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4. Discussion
4.1. Main findings
The role of family circumstances on long-term survival in
childhood acute lymphoblastic leukaemia cases has not been
studied before in Germany. The findings shown here indicate that
family circumstances may affect survival from paediatric ALL,
although most associations were suggestive rather than statisti-
cally significant. Poorer survival was observed for children having
3 or more siblings. Highest survival was seen for second born
children. A non-linear relationship was found for parental age at
diagnosis, with poorer survival for children with younger fathers
and mothers, and most distinct for children with older fathers.
Treatment of ALL lasts over several years, with the maintenance
therapy being very much the responsibility of the family to
administer [3,9]. As soon as the child is discharged from hospital,
parents are responsible to comply with the recommendations for
continuation of a highly demanding therapy, including daily drug
administration and frequent medical outpatient appointments.
Findings from the UK suggest that dissimilarities in ALL survival by
socio-economic status emerged about the time when treatment
management required parental/child’s adherence, i.e. from the
time of oral treatment in the outpatient setting and hypothesized
that this may due to treatment compliance [14]. In our study,
children from families with 4 or more children showed poorer
survival and these dissimilarities emerged about 1.5 years after
diagnosis, a time by which treatment management has usually
moved from hospital to home [3,9]. Smaller families may be able to
devote more time to assisting the child and may be better at coping
with the cancer experience as well as managing the complex
therapy [27,28].
The poorer survival we found for children with young parents
might likewise reflect the ability to manage the complex home-
base maintenance therapy. Similarly, the capacity to cope with the
cancer diagnosis and related circumstances, and may be particu-
larly challenging for young parents [27], with associated effects on
adherence to treatment protocols and outpatient appointments.
As an alternative to reasons related to social interactions, the
lower survival observed in children with fathers aged 41 years or
older might be biological originated. Advanced paternal age has
been associated with a higher risk of germ cell sporadic mutations
[29] and with genetic aberrations in the offspring. Although the
evidence is overall inconsistent, some recent epidemiological
studies with large sample sizes suggested an increased risk of
childhood leukaemia with increasing paternal age at child’s birth
Table 1
Characteristics of childhood acute lymphoblastic leukaemia (ALL) cases diagnosed 1992–1994 in former West Germany by deaths, 10-year survival and person-years under
risk.
All cases (column %) Deaths (row %)a 10-Year survivalb Person-years
Total 647 98 (15.2%) 84.7% 5663
Sex
Boys 389 (60.1%) 66 (17.0%) 82.9% 3330
Girls 258 (39.9%) 32 (12.4%) 87.5% 2333
Age at diagnosis (years)
<1 26 (4.0%) 12 (46.1%) 53.9% 148
1–5 412 (63.7%) 40 (9.7%) 90.2% 3803
6–9 122 (18.9%) 27 (22.1%) 77.5% 1011
10–14 87 (13.5%) 19 (21.8%) 78.1% 701
Birth order
1st born 334 (51.6%) 56 (16.8%) 83.1% 2870
2nd born 207 (32.0%) 21 (10.1%) 89.8% 1910
3rd born and later 101 (15.6%) 19 (18.8%) 81.1% 847
Missing 5 (0.8%) 2 (40.0%) 60.0% 37
Number of siblings
Only child 159 (24.6%) 25 (15.7%) 84.2% 1372
1 sibling 311 (48.1%) 39 (12.5%) 87.4% 2787
2 siblings 123 (19.0%) 20 (16.3%) 83.6% 1076
3 and more siblings 50 (7.7%) 12 (24.0%) 75.7% 401
Missing 4 (0.6%) 2 (50.0%) 50.0% 27
Place of residence at diagnosis
Urban 276 (42.7%) 44 15.9% 83.9% 2377
Mixed 201 (31.1%) 34 16.9% 83.0% 1734
Rural 170 (26.3%) 20 11.8% 88.2% 1552
Mother’s age at diagnosis
25 236 (36.5%) 39 (16.5%) 83.3% 2042
26–30 258 (39.9%) 36 (14.0%) 85.9% 2280
31–35 108 (16.7%) 14 (13.0%) 87.0% 955
36 42 (6.5%) 8 (19.1%) 80.9% 360
Missing 3 (0.5%) 1 (33.3%) 66.7% 27
Father’s age at diagnosis
25 125 (19.3%) 26 (20.8%) 78.9% 1031
26–30 218 (33.7%) 29 (13.3%) 86.5% 1931
31–35 174 (26.9%) 20 (11.5%) 88.5% 1569
36–40 75 (11.6%) 10 (13.3%) 86.7% 676
41 45 (7.0%) 11 (24.4%) 75.6% 363
Missing 10 (1.6%) 2 (20.0%) 80.0% 93
a Proportion of death from all acute lymphoblastic leukaemia cases by covariates.
b Overall survival, with death from any cause or date of 10 years follow-up as endpoint.
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[30–32]. In addition, there is evidence of oligoclonality in a
minority of children with ALL at diagnosis [33,34] and the overall
outcome is dependent upon the clone conferring the worst
prognosis. It might be hypothesized that relapse is due to surviving
clones (or their precursors) present at an undetectable level. These
clones are likely to be exposed to the same environmental factors
which were present prior to initial diagnosis. Therefore, advanced
paternal age might not be only a risk factor for developing ALL but
also a prognostic factor for ALL survival.
Similarly, birth order has been used as proxy for exposures that
may influence the risk of developing ALL, namely for exposure to
infections in early life (perhaps lesser for firstborns) [35] or for
exposure to in utero hormone levels (with the mother’s first
pregnancy endocrinologically differing from later pregnancies
[36], and may therefore likewise be related to the risk of relapse.
The only environmental factor however for which risk of relapse
has been investigated so far is magnetic field exposure, but no
association was seen [37]. It is otherwise difficult to come up with
plausible explanations for the excellent survival found in second
born children; chance may be an option.
Whether children lived in urban or rural areas had no impact on
survival; this is plausible as in Germany a dense network of
specialized paediatric clinics covers the entire country and
treatment is highly standardized [3,9]. Almost all paediatric ALL
cases are treated according to the treatment schemes developed by
the two collaborative study groups ALL-BFM (Berlin–Frankfurt–
Mu¨nster) [3] and COALL (cooperative study group for childhood
acute lymphoblastic leukemia) [9] (today 99.8% (1)).
4.2. Strength and weakness
This is the first study in Germany on this topic, and one of very
few from Europe. Strengths of this study include the nationwide
coverage of cases of former West Germany and the long and
complete follow-up period of 10 years. Multiple characteristics on
family factors were available with almost no missing data.
A limitation of our study is that 18% of the original population-
based case families no information on family characteristics was
available since they did not participate in the former case–control
study, with children of non-participating families having poorer
survival [11]. If participation was related to family size or parental
age, selection bias could affect our results. An inherent limitation is
the sample size with – fortunately for the families – low numbers
of deaths in our cohort, being a follow-up investigation of a
nationwide case control study on the rare disease outcome ALL in
children.
Furthermore, no information on parental marriage and
cohabitation status was available which has been hypothesized
to be associated with treatment adherence [28].
Survival studies are by default historical by the time they are
conducted. As a consequence of the demographic change and the
related decrease of financial resources, the German health care
system went through a series of reforms [10] since the children of
our study were treated. However, financial compensation for
diagnosis and treatment of paediatric cancer is not known to have
been changed by these reforms. Nevertheless, we cannot exclude
that the most recent improvements of treatment may have offset
or flatten the relationship between family characteristics and ALL
survival found here.
4.3. Comparison with previous research
The observed associations between number of siblings, birth
order, and parental age and ALL survival are particularly
interesting in the light of the fact that two previously published
studies from Germany, focussing on other social factors, did not
Fig. 1. Overall survival from childhood acute lymphoblastic leukaemia by family characteristics. Kaplan–Meier curves of overall survival by birth order (Log-rank test of
heterogeneity: x2 = 6.09, p = 0.048), number of siblings (Log-rank test of heterogeneity: x2 = 5.13, p = 0.162), mother’s age at the child’s diagnosis (Log-rank test of
heterogeneity: x2 = 1.38, p = 0.709), and father’s age at the child’s diagnosis (Log-rank test of heterogeneity: x2 = 8.95, p = 0.063).
F. Erdmann et al. / Cancer Epidemiology 39 (2015) 209–215212
find a relationship. Neither family’s socio-economic conditions
[11] as measured by parental education and family income, nor
having a Turkish migration background [38] was reported to be
associated with survival.
Therefore, in Germany, family obligations and family’s social
resources (as measured by number of siblings and parental age in
the present study), appear to be more relevant than the socio-
economic situation whereas for other European countries parental
education, income or occupation did matter [13,14,16–18,20].
However, little is known about the role of family circumstances on
ALL survival, particularly not their interaction with socio-
economic characteristics.
Number of siblings and birth order have been postulated to
be related to the occurrence of childhood ALL [39] but have
rarely been investigated as prognostic factors for ALL, with
inconsistent findings. A large Norwegian study observed for
childhood cancers requiring long-term treatment (including
ALL) that having no siblings was associated with mortality
reductions of approximately 20% [16]. In contrast, in Greece a
reduced risk of death was reported for children with siblings and
a cancer diagnosed in the late 1990s to early 2000s [18],
however, this finding was not confirmed in a recent follow-up
study [17]. To our knowledge paternal age at child’s diagnosis
has not been studied in relation to ALL survival before.
Nevertheless, analyses on mother’s age at child’s birth from
Greece and Norway did not suggest a relationship with ALL
survival [16,17].
With respect to place of residence, findings from Australia
showed that survival was generally poorer for children living in
more isolated parts of the countries [40] and living in more rural
areas was also associated with less favourable prognosis in a recent
multi-national study (including Greece, Bulgaria, Izmir, Antalya
and Moscow) [41]. This contrasts with our results but, given the
high population density and lack of real remote areas in West
Germany, this is not surprising. It should also be kept in mind that
changes of residence after diagnosis could not be taken into
account.
All in all, dissimilarities in welfare systems, including access to
health care and public family support, coverage and distance to
specialized treatment facilities, lifestyle, treatment protocols as
well as methodical differences between studies make an interna-
tional comparison challenging. However, a crucial question is to
what extent the observed differences across studies are real
(reflecting different impact of family conditions due to differences
in health care and social stratification, true overall health inequity)
or to what extent differences can be explained by features of the
studies (including among others differences in study design, data
sources, data collection, cancer type, diagnostic period or adjust-
ment factors).
5. Conclusion
In conclusion, despite of the highly specialized and centralized
treatment and free access for all children to health care services,
Table 2
Cox regression analyses of the association of family characteristics on overall and event-free survival from paediatric acute lymphoblastic leukaemia in Germany, followed-up
for 10 years from date of diagnosis.
Overall survivala Event-free survivale
Model Ib Model IId Model IIIb Model IVd
Hazard
ratio
[95% CI]c Hazard
ratio
[95% CI]d Hazard
ratio
[95% CI]d Hazard
ratio
[95% CI]d
Birth order
1st born 1.0 Reference 1.0 Reference 1.0 Reference 1.0 Reference
2nd born 0.57 [0.34; 0.95] 0.64 [0.37; 1.10] 0.54 [0.36; 0.82] 0.61 [0.39; 0.95]
3rd born and later 1.00 [0.59; 1.69] 1.04 [0.55; 1.95] 0.88 [0.56; 1.37] 1.00 [0.59; 1.71]
Number of siblings
Only child 1.0 Reference 1.0 Reference 1.0 Reference 1.0 Reference
1 sibling 0.71 [0.43; 1.19] 0.86 [0.48; 1.52] 0.84 [0.55; 1.29] 0.98 [0.61; 1.57]
2 siblings 0.81 [0.44; 1.50] 0.83 [0.42; 1.67] 0.85 [0.51; 1.43] 0.95 [0.53; 1.69]
3 and more siblings 1.27 [0.63; 2.57] 1.58 [0.73; 3.44] 1.20 [0.65; 2.23] 1.65 [0.84; 3.25]
Place of residence at diagnosis
Urban 1.0 Reference 1.0 Reference 1.0 Reference 1.0 Reference
Mixed 1.10 [0.69; 1.73] 1.12 [0.69; 1.84] 0.92 [0.62; 1.35] 0.92 [0.61; 1.40]
Rural 0.79 [0.46; 1.36] 0.85 [0.49; 1.49] 0.80 [0.52; 1.23] 0.87 [0.56; 1.35]
Mother’s age at diagnosis
25 1.16 [0.73; 1.83] 1.33 [0.81; 2.19] 1.15 [0.80; 1.66] 1.38 [0.93; 2.06]
26–30 1.0 Reference 1.0 Reference 1.0 Reference 1.0 Reference
31–35 0.84 [0.45; 1.57] 0.82 [0.42; 1.58] 0.70 [0.41; 1.20] 0.71 [0.41; 1.25]
36 1.32 [0.61; 2.84] 1.11 [0.48; 2.55] 0.95 [0.47; 1.91] 0.80 [0.38; 1.72]
Father’s age at diagnosis
25 1.65 [0.97; 2.81] 1.65 [0.93; 2.94] 1.46 [0.94; 2.26] 1.46 [0.91; 2.36]
26–30 1.0 Reference 1.0 Reference 1.0 Reference 1.0 Reference
31–35 0.85 [0.48; 1.50] 0.76 [0.42; 1.40] 0.80 [0.51; 1.26] 0.76 [0.47; 1.22]
36–40 1.00 [0.48; 2.05] 0.91 [0.42; 1.96] 0.86 [0.47; 1.57] 0.80 [0.42; 1.50]
41 2.09 [1.04; 4.20] 1.89 0.89; 4.01] 1.36 [0.72; 2.58] 1.29 [0.66; 2.52]
a Endpoint of overall survival was defined as death from all causes or date of 10 years observation.
b Hazard ratios are adjusted for child’s age at diagnosis and sex.
c Corresponding 95% confidence interval.
d Adjustment factors vary by family characteristic. Birth order: hazard ratios are adjusted for child’s age at diagnosis, sex, maternal education (as SES indicator) and
maternal age at diagnosis. Number of children: hazard ratios are adjusted for child’s age at diagnosis, sex, maternal education (as SES indicator) and maternal age at diagnosis.
Place of residence: hazard ratios are adjusted for child’s age at diagnosis, sex, maternal education (as SES indicator). Mother’s age at diagnosis: hazard ratios are adjusted for
child’s age at diagnosis, sex, maternal education (as SES indicator) and number of children in the family. Father’s age at diagnosis: hazard ratios are adjusted for child’s age at
diagnosis, sex, maternal education (as SES indicator) and number of children in the family.
e Events of event-free survival were defined as relapse, second malignant neoplasm or death from all causes.
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not all children appear to benefit equally from improvements in
ALL survival. Our results indicate that some families may need
extra supportive care during the extensive and demanding
treatment period. Further studies are warranted to confirm our
findings and to identify potential underlying mechanisms,
particularly with regard to differential adherence to therapy and
related interactions of families with paediatric oncologists in
Germany and elsewhere. Moreover, studies on the role of social
and family factors in survival from other types of childhood cancer
are needed.
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Abstract?
BACKGROUND: Today, 22% of all deaths among children in Europe are due to cancer. If 
this proportion is to be reduced, studies are needed not only on the biology and treatment of 
these cancers but also on how social factors affect cure rates. In this Danish nationwide study, 
we investigated associations between certain socioeconomic characteristics and survival after 
childhood cancer.  
METHODS: We identified the parents and siblings of 3797 children with cancer diagnosed in 
1990–2009 before they were 20 years of age; we obtained information on socioeconomic 
variables and vital status at parental individual level through 2012 by linkage to population-
based registries. Hazard ratios (HRs) for dying were estimated in multivariate Cox 
proportional hazard models. 
FINDINGS: Regardless of cancer type, children with cohabiting parents had better survival 
(HR, 0.82; 95% CI, 0·69–0·99) than children of single parents. Children with siblings had 
stepwise worse survival (one sibling: HR, 1·12; 95% CI, 0·95–1·31; two or more siblings: HR, 
1·26; 1·03–1·53) than children without siblings. Children with non-CNS solid tumours had 
significantly better survival (HR, 0·66; 95% CI, 0·44–0·99) when their mothers had higher 
education rather than basic education. 
INTERPRETATION: Having cohabiting parents and no siblings was associated with longer 
survival after any cancer in childhood, and having a mother with higher education was 
associated with longer survival in children with non-CNS tumours. Further studies of how and 
why these indicators of social position influence survival, despite a universal health system, 
are warranted. 
FUNDING: The Danish Cancer Society (grant no.: R81-A5131-13-S7). 
  
 3 
 
Introduction?
All industrialised and most developing countries recognise the special needs of children with 
cancer and offer what each country regards as the best standard of care during all phases of 
the treatment trajectory. It is estimated that more than 90% of the 15 000 children in whom 
cancer is diagnosed annually in the European Union will enter standardised treatment 
programmes, which usually include participation in randomised trials of the effect of new 
treatments. Survival might be affected not only by participation in trials but also by the 
compliance of the treating physician to both standard and experimental protocols, the 
adherence of parents and patients to guidelines for treatment and supportive care, and the 
interactions of these factors.  
Today, 22% of all deaths among children aged 1–14 years in Europe are due to cancer.1 If this 
high proportion of cancer-related deaths is to be reduced, studies must be conducted not only 
on tumour biology and novel treatment approaches but also on how socioeconomic and social 
factors influence cure rates. 
A number of studies have shown an association between socioeconomic position (SEP) and 
survival after cancer in adults, with better survival of cancer patients with higher education or 
high income.2-4 Few studies, however, have addressed the association between socioeconomic 
factors and survival after childhood cancer in high-income countries. Most of the available 
studies included only children with acute lymphoblastic leukaemia (ALL) or haematological 
cancer in general (n = 714–1559), with inconsistent results for a range of SEP indicators, 
some finding differences in survival5–9 and others no differences.10–12 To our knowledge, only 
one study included patients with childhood cancers at all sites (N = 6280); that study showed 
reduced mortality rates from cancers that require lengthy treatment (tumours in the central 
nervous system [CNS], leukaemias, neuroblastomas, and bone tumours) among children 
whose mothers had higher education or who had no siblings.9  
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We investigated the association between SEP and survival after childhood cancer overall and 
separately by diagnostic group in order to determine the extent to which these factors 
influence survival in a large, population-based, nationwide study, with individual-level 
information from Danish public administrative registries for all cases. We defined SEP 
broadly, using parental educational level, income, cohabitation status, and number of siblings 
as measures of knowledge-related assets, material resources, family social support, and family 
obligations, thus covering both SEP and the broader social factors that affect resources in a 
family. 
Material?and?Methods?
Study population 
We identified 3797 children in whom cancer was diagnosed when they were under the age of 
20 years between 1 January 1990 and 31 December 2009 in the Danish Cancer Registry, 
which contains information on all cancers diagnosed since 1943.13 We grouped the cancers 
into 12 diagnostic groups on the basis of the Birch–Marsden classification14 (also called the 
International Classification of Childhood Cancer [ICCC]) and defined three main diagnostic 
groups for our analyses: haematological malignancies (leukaemias and lymphomas; ICCC 
groups 1 and 2), CNS tumours (ICCC group 3), and non-CNS solid tumours (ICCC groups 4–
11).  
 
Identification of families and socioeconomic position 
Since 1968, all residents of Denmark have been assigned a unique 10-digit personal 
identification number by the Danish Civil Registration System, which allows accurate linkage 
among registries.15 The System also holds information on first-degree relatives, and > 99% of 
parents are identifiable for children born in Denmark after 1970.16 Using the children’s 
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personal identification numbers as the key, we identified all parents (n = 7570) and all full 
siblings (n = 3250) and half siblings (n = 953) who were under the age of 19 in the year of 
diagnosis of the cancer. Full siblings have the same mother and father, and half siblings have 
the same mother or father. 
We obtained information on parental socioeconomic factors for the year before diagnosis of 
the child from registries on education and income kept by Statistics Denmark.17–19  
Highest attained level of education was categorised into basic education (7–12 years of basic 
or high school), vocational education (10–12 years), and higher education (? 13 years). 
Individual disposable income after taxation and interest was categorised into quartiles. As the 
father’s income was missing for 9% of cases, the mother’s income was used as the measure of 
material resources. Parental cohabitation status was defined as living with a partner (married 
or cohabiting) or living without a partner (single, widowed, or divorced). Cohabiting in the 
absence of marriage was defined as two people of the opposite sex, over the age of 16 years, 
with a maximum 15 years of age difference, living at the same address with no other adult in 
residence.  
 
Statistics 
Overall survival was our primary outcome. Children were followed-up from the date of 
cancer diagnosis until the date of death from any cause, emigration, or end of follow-up (31 
December 2012), whichever occurred first. For graphical presentation, we calculated 
unadjusted survival probabilities stratified by mother’s education, mother’s income, parental 
cohabitation status, and number of full siblings using Kaplan–Meier curves.  
Cox proportional hazards models were used to estimate the hazard ratio (HR) with 95% 
confidence interval (CI); time since diagnosis was the underlying time scale. We used the 
statistical software R, version 3.0.2.20 To assess the impact of socioeconomic factors on 
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overall survival, we modelled the multivariate analyses in four steps. In the first model, each 
socioeconomic variable was entered alone (crude HR). In the second model, each 
socioeconomic variable was adjusted for well-established prognostic factors: child’s age at 
diagnosis (linear), sex, decade of diagnosis, and site of cancer (in the 12 diagnostic groups). In 
the third model, we further adjusted for the possible mediating effect of parental education, 
income, and cohabitation status; and, in the fourth model, we adjusted further for mother’s 
age at birth (< 20, 20–29, 30–39, ? 40 years) and number of full siblings (none, one, two or 
more). An overall p value for analysis of variance was reported. We performed sub-analyses 
for the three main diagnostic groups (haematological, CNS, and non-CNS solid tumours) and 
a separate analysis for ALL in order to compare our results with those of other studies. We 
conducted separate analyses for non-CNS solid tumours with a favourable prognosis and 
standardised therapy, including early surgery (Wilms tumour), and for non-CNS solid 
tumours that frequently require more complex treatment (bone tumours, liver tumours, 
neuroblastomas, and rhabdomyosarcomas). We repeated all analyses including half siblings. 
Finally, we calculated rate ratios for death in order to estimate absolute excess risk, with 
corresponding 95% CIs. 
Results?
Cancer was diagnosed in 29% of the 3797 children when they were aged 0–4 years and in 
33% when they were 15–19 years. The commonest cancers were CNS tumours, followed by 
leukaemia (Table 1). Almost half the parents had vocational education, and 80% cohabited. 
About 60% of the childhood cancer patients had one or more full siblings. 
 
Survival after childhood cancer 
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The median follow-up time was 9.0 years (range, 0–22 years). There were 841 deaths during 
follow-up, for an overall survival of 78%. Kaplan–Meier curves (Figure 1) indicated better 
survival with increasing level of maternal education, increasing maternal income, fewer full 
siblings, and for children of cohabiting parents. The survival curves appeared to diverge 
within the first year after diagnosis for the association with mother’s education and income 
and after about 2 years for that with cohabitation status and full siblings.  
Having both parents with higher education, a mother with higher income, higher maternal 
age, and cohabiting parents were associated with better survival, as was having no siblings 
(crude HR), although most estimates did not reach statistical significance (Table 2). 
Adjustment for parental education and mother’s income only slightly affected the overall 
results, whereas full adjustment resulted in stronger associations with having parents living 
alone (HR, 0.82; 95% CI, 0.69–0.99) and having two or more full siblings (HR, 1.26; 1.03–
1.53).   
The worse survival of children with the youngest mothers appeared to be mediated partly 
through education, income, cohabitation status, and number of full siblings, the HR 
decreasing from 1·33 to 1·20, whereas adjustment did not change the better survival of 
children with the oldest mothers. Addition of half siblings (both all and by the mother only) to 
the number of full siblings did not change the estimates (data not shown). 
  
Survival by diagnostic group 
Children with non-CNS solid tumours who had higher educated mothers (HRadj 0·66; 95% CI, 
0·44–0·99; Table 3c) survived significantly longer, whereas the statistically non-significant, 
unadjusted better survival of children with haematological cancers whose mothers had higher 
education was not observed in the fully adjusted model (Table 3a), and no association with 
mothers’ educational level was seen in children with CNS tumours (Table 3b).  
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The cohabitation status of the parents was associated with the survival of children with CNS 
tumours and non-significantly so for children with non-CNS solid tumours, whereas the 
number of full siblings was most strongly and statistically significantly associated with the 
survival of children with non-CNS solid tumours, who had a 45% increase in the risk for 
dying if they had one sibling (95% CI, 1·11–1·89) and a 29% increase if they had two or more 
full siblings (95% CI, 0.93–1·79).  
In separate analyses for ALL, the risk estimates were closer to null than those for all cancers. 
Similarly, in separate analyses of subgroups of non-CNS solid tumours that require early 
surgery or more complex treatment, no difference was found from the results for the 
combined group of non-CNS solid tumours (data not shown). 
 
Absolute excess risk 
Five years after diagnosis, the absolute excess risk for death of the full group of childhood 
cancer patients was 6 per 1000 person–years for children of single parents when compared 
with children of cohabiting parents, 6 per 1000 person–years for children with one full sibling 
and 8 per 1000 person–years for children with two or more full siblings when compared with 
children with no full siblings (Table 4). 
 
Discussion?
In this population-based nationwide study with complete follow-up, we found that having 
parents with a higher SEP was associated with better survival of children with cancer. The 
effects of the different indicators of SEP differed, however, by cancer type. For example, the 
beneficial effect of having a mother with higher education and being an only child was 
observed only for children with non-CNS solid tumours, whereas the association with having 
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cohabitating parents was seen mainly for children with CNS tumours, although there were 
indications of association in all groups. 
One explanation of our findings might be delayed diagnosis for some social groups,21 
whereby a more advanced stage of cancer at the time of diagnosis would result in poorer 
survival. Another explanation might be a greater communication barrier between 
socioeconomically disadvantaged families and the health sector. Families depend on 
information and guidance from health personnel, but general health literacy and 
communication and cognitive skills may differ by level of education, resulting in different 
understanding by parents who receive the same information. The problem might be 
exacerbated for children with cancers that require multidisciplinary treatment, like non-CNS 
solid tumours.22–25  
The fact that parental cohabitation status is associated with survival implies that living with a 
partner might facilitate sharing of the prolonged attention and practical work required in 
caring for a child with cancer and also for coping with the associated mental challenges and 
anxiety.9;26–28 Furthermore, cohabitation might enable one parent to reduce his or her working 
hours to be at the hospital. The finding that having siblings is associated with shorter survival 
might reflect similar mechanisms: siblings also require time and attention from parents, which 
could result in less attention to the sick child. The unadjusted survival plots show that 
differences in survival by cohabitation and number of full siblings begin 1–2 years after 
diagnosis, which would correspond well to the time of discharge from hospital.  
Although the impact of SEP on the chances of survival among children with cancer has drawn 
attention, the studies published so far have been limited by patient selection (only certain 
cancer types) or sample size, with limited power. We performed this population-based study 
with complete follow-up of 3797 children with cancer during a diagnostic period from 1990 
to 2009, i.e. when contemporary cancer therapies were used. Some previous studies included 
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only children with leukemia,5-8,11, ALL10 only or lymphomas.12 In our sub-analyses for all 
haematological cancers and for ALL, we found no effect of SEP on survival. These results are 
in line with those of a large study in the USA (subset of children 0-14 year; n = 4158)11, a 
smaller ALL study in Germany (n = 788)10, as well as a Canadian study of lymphomas (n = 
692). 12 In contrast, four smaller European studies (n = 714–1559) found associations between 
various proxies of parental SEP and survival after childhood ALL.5–8 The associations 
between better survival and higher maternal education and being an only child were seen 
mainly for children with non-CNS solid tumours, whereas the association between having 
cohabiting parents and survival was attributable mainly to a protective effect in children with 
CNS tumours and less so in children with non-CNS solid tumours. These findings are partly 
in line with those of a Norwegian study of 6280 children with cancer of all types diagnosed 
between 1974 and 2007, in which the mother’s educational level and the number of siblings 
were associated with survival after cancers with long-term treatment (CNS tumours, 
leukaemias, neuroblastomas, and bone tumours).9 They did not find an association between 
parental marital status and survival, although their definition did not include cohabiting 
unmarried parents, which in our study constituted some 19%.  
The strengths of this study include the population-based approach, almost complete inclusion 
of the study population, and virtually no loss to follow-up. Through the Danish Cancer 
Registry, we included all children with cancer diagnosed in the period 1990–2009 and 
investigated the impact of a range of SEP indicators on survival from various groups of 
cancer. We were able to obtain individual information on SEP for both married and 
cohabiting parents, thus taking into account the joint influence of family and social factors, 
acknowledging that these factors operate together. We included only cases diagnosed and 
treated after 1990, when systematic treatment protocols were introduced in Denmark, thus 
minimising any differences in cancer outcomes due to SEP.  
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A limitation of the study is the size of the cohort, which, however, was unavoidable, in view 
of the population of the country. The confidence intervals reflect this small study population, 
so that several estimates failed to reach statistical significance despite clear patterns of risk by 
social factors. Disposable household income per person would have been a better proxy than 
separate information on income for mothers and fathers, but this information was not 
available. 
The potentially preventable fractions of lives depend on SEP factors that are not--and should 
not be--modifiable, such as the number of siblings. However, the results of our study suggest 
that it should be an achievable goal to optimize the survival of the worse-off subpopulations 
among the childhood cancer cases to the level of those patients who are best-off in terms of 
survival. The absolute number of deaths potentially attributable to these factors is not trivial. 
Further investigations should be conducted into when and how disparities are introduced in 
the trajectory of treatment and recovery of these children.  
In conclusion, despite highly specialised, centralised treatment and free access for all children 
to all health services, not all patients benefit equally from improvements in survival.28 Our 
results indicate that parents with short education, do not cohabit, and who have more children 
might need extra support during the treatment and recovery of their child. Further studies are 
warranted to investigate possible social differences in parent and patient adherence to 
treatment and follow-up and in interactions with physicians and the specific challenges for 
single parents and for the parents of more than one child.  
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Table 1. Characteristics of Danish children with cancer diagnosed in 1990–2009, for all 
childhood cancers combined and for three main diagnostic groups of cancer 
 
 All 
childhood 
cancers 
 
N (%) 
Haematological 
cancers 
 
 
N (%) 
CNS 
tumours 
 
 
N (%) 
Non-CNS 
solid 
tumours 
 
N (%) 
Total 3797 1401 (37) 986 (26) 1353 (36) 
Age at diagnosis (years) 
0–4 
5–9 
 10–14  
 15–19  
 
1118 (29) 
711 (19) 
724 (19) 
1244 (33) 
 
489 (35) 
291 (21) 
251 (18) 
370 (26) 
 
252 (26) 
255 (26) 
224 (23) 
255 (26) 
 
360 (27) 
156 (12) 
237 (18) 
600 (44) 
Sex 
 Female 
 Male 
 
1672 (44) 
2125 (56) 
 
571 (41) 
830 (59) 
 
469 (48) 
517 (52) 
 
602 (44) 
751 (56) 
Decade of diagnosis 
 1990–1999 
 2000–2009 
 
1767 (47) 
2030 (53) 
 
630 (45) 
771 (55) 
 
509 (52) 
477 (48) 
 
621 (46) 
732 (54) 
Cancer type 
 Leukaemia 
 Lymphoma 
Hodgkin 
Non-Hodgkin 
 Central nervous system tumours 
 Sympathetic nervous system tumours 
 Retinoblastomas 
 Renal tumours  
 Hepatic tumours  
 Malignant bone tumours  
 Soft-tissue sarcomas  
 Germ-cell, trophoblastic and other gonadal  
 tumours 
 Carcinomas and other malignant epithelial  
 neoplasms 
 Other and unspecified malignant neoplasms 
 
911 (24) 
 
255 (7) 
235 (6) 
986 (26) 
136 (4) 
52 (1) 
121 (3) 
44 (1) 
184 (5) 
212 (6) 
 
243 (6) 
 
361 (10) 
57 (2) 
 
911 (65) 
 
255 (18) 
235 (17) 
 
 
 
 
 
 
986 (100) 
 
 
 
 
 
 
 
136 (10) 
52 (4) 
121 (9) 
44 (3) 
184 (14) 
212 (16) 
 
243 (18) 
 
361 (27) 
 
Mother’s incomei 
1st quartile (lowest) 
2nd quartile 
3rd quartile 
4th quartile (highest) 
 
950 (25) 
949 (25) 
950 (25) 
948 (25) 
 
346 (25) 
335 (24) 
375 (27) 
345 (25) 
 
242 (25) 
267 (27) 
242 (25) 
235 (24) 
 
355 (26) 
334 (25) 
317 (23) 
347 (26) 
Mother’s education 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
431 (11) 
2193 (58) 
1104 (29) 
69 (2) 
 
149 (11) 
811 (58) 
419 (30) 
22 (2) 
 
111 (11) 
573 (58) 
284 (29) 
18 (2) 
 
164 (12) 
783 (58) 
379 (28) 
27 (2) 
Father’s education 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
517 (14) 
2202 (58) 
940 (25) 
138 (4) 
 
179 (13) 
828 (59) 
346 (25) 
48 (3) 
 
137 (14) 
571 (58) 
247 (25) 
31 (3) 
 
189 (14) 
777 (57) 
331 (24) 
56 (4) 
Cohabitation status 
 Cohabiting 
 Living without a partner 
 
3135 (83) 
662 (17) 
 
1161 (83) 
240 (17) 
 
817 (83) 
169 (17) 
 
1108 (82) 
245 (18) 
Mother’s age at child’s birth (years)     
 14 
 
 < 20 
 20–29 
 30–39 
 ? 40 
108 (3) 
2347 (62) 
1291 (34) 
51 (1) 
32 (2) 
824 (59) 
525 (37) 
20 (1) 
33 (3) 
622 (63) 
319 (32) 
12 (1) 
40 (3) 
869 (64) 
426 (31) 
18 (1) 
Full siblings < 19 years 
 None 
 One 
Two or more 
 
1424 (38) 
1678 (44) 
695 (18) 
 
493 (35) 
654 (47) 
254 (18) 
 
350 (35) 
460 (47) 
176 (18) 
 
555 (41) 
543 (40) 
255 (19) 
Half siblings < 19 years 
 None 
 One 
 Two or more 
 
3224 (85) 
339 (9) 
234 (6) 
 
1192 (85) 
124 (9) 
85 (6) 
 
819 (83) 
107 (11) 
60 (6) 
 
1165 (86) 
103 (8) 
85 (6) 
 
i1st quartile: < 13 315 €, 2nd quartile: 13 315–17 006 €, 3rd quartile: 17 006–22 016 €, 4th quartile: > 22 016 euro 
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Table 2. Associations between parental socioeconomic position and survival from childhood 
cancer  
 
 Overall survival 
Model 1i 
Overall survival 
Model 2ii 
Overall survival 
Model 3iii 
Overall survival 
Model 4iv 
 
 
Deaths 
(n) 
PY at 
risk HR
 95% CI HRadj 95% CI HRadj 95% CI HRadj 95% CI 
Mother’s educationv 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
112 
501 
222 
93 
 
4129 
21892 
10021 
3824 
 
1 
0·86 
0·76 
1·23 
 
– 
0·70–1·05 
0·61–0·96 
0·93–1·62 
 
1 
0·87 
0·80 
1·10 
 
– 
0·71–1·07 
0·64–1·01 
0·84–1·06 
 
1 
0·91  
0·85  
1·06  
 
– 
0·73–1·12 
0·66–1·08 
0·74–1·50 
 
1 
0·93  
0·88  
1·05  
p = 0·68 
–  
0·75–1·15 
0·69–1·13 
0·74–1·49 
Father’s educationv 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
132 
495 
195 
106 
 
4995 
21713 
8775 
4384 
 
1 
0·88 
0·81 
1·21 
 
– 
0·73–1·07 
0·65–1·01 
0·94–1·57 
 
1 
0·87 
0·83 
1·10 
 
– 
0·72–1·05 
0·66–1·03 
0·85–1·42 
 
1 
0·90 
0·89  
1·01  
 
– 
0·74–1·10 
0·70–1·13 
0·73–1·40 
 
1 
0·90  
0·89  
1·05  
p = 0·60 
– 
0·74–1·10 
0·70–1·13 
0·75–1·46 
Mother’s income 
 1st quartile (low) 
 2nd quartile 
 3rd quartile 
 4th quartile (high) 
 
253 
241 
195 
152 
 
11182 
10220 
8344 
6014 
 
1 
0·96 
0·78 
0·63 
 
– 
0·81–1·15 
0·65–0·95 
0·52–0·77 
 
1 
1·01 
0·92 
0·83 
 
– 
0·84–1·20 
0·76–1·13 
0·65–1·04 
 
1 
1·02 
0·94  
0·85  
 
– 
0·85–1·22 
0·76–1·15 
0·67–1·09 
 
1 
1·01  
0·92  
0·84  
p = 0·47 
– 
0·84–1·21 
0·75–1·14 
0·66–1·08 
Mother’s age (years) 
 < 20 
 20–29 
 30–39 
 ? 40 
 
541 
32 
262 
6 
 
1021 
23011 
11255 
473 
 
1·33 
1 
0·89 
0·50 
 
0·93–1·90 
– 
0·77–1·04 
0·22–1·11 
 
1·34 
1 
0·93 
0·50 
 
0·94–1·91 
– 
0·80–1·08 
0·22–1·11 
 
1·22  
1 
0·95  
0·51  
 
0·84–1·75 
– 
0·82–1·11 
0·23–1·13 
 
1·20  
1 
0·97  
0·53  
p = 0·26 
0·83–1·72 
– 
0·83–1·13 
0·24–1·20 
Parents’ cohabitation 
status 
 Single parent 
 Cohabiting 
 
 
164 
677 
 
 
5935 
29826 
 
 
1 
0·86 
 
 
– 
0·72–1·02 
 
 
1 
0·84 
 
 
– 
0·71–1·00 
 
 
1 
0·86  
 
 
– 
0·72–1·02 
 
 
1 
0·82  
p =0·04 
 
– 
0·69–0·99 
Number of full siblings 
< 19 years 
 None  
One 
 Two or more 
 
 
295 
377 
169 
 
 
13699 
15898 
6163 
 
 
1 
1·10 
1·21 
 
 
– 
0·94–1·28 
1·00–1·46 
 
 
1 
1·07  
1·20  
 
 
– 
0·92–1·25 
0·99–1·45 
 
 
1 
1·13  
1·28  
 
 
– 
0·97–1·33 
1·05–1·55 
 
 
1 
1·12  
1·26  
p = 0·07 
 
– 
0·95–1·31 
1·03–1·53 
 
Multivariable Cox regression analyses 
PY, person–years; HR, hazard ratio; CI, confidence interval 
i Crude analysis 
ii Adjusted for child’s age, sex, decade of diagnosis, site of cancer 
iii Adjusted for child’s age, sex, decade of diagnosis, site of cancer, mother’s education, father’s education, mother’s income 
and cohabitation status 
iv Full multivariable model: adjusted for child’s age, sex, decade of diagnosis, site of cancer, mother’s age and SEP variables 
(mother’s education, father’s education, mother’s income, cohabitation status and number of full siblings) 
v Not adjusted for mother’s income 
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Table 3a. Impact of socioeconomic position on overall survival of children with haematological 
malignancies 
 
 
 Crude Full adjustedi 
Deaths 
(n) 
PY at 
risk  HR
 95% CI HRadj 95% CI 
Mother’s educationii 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
31 
163 
75 
35 
 
1497 
8027 
3927 
1330 
 
1 
0·98 
0·87 
1·76 
 
– 
0·67–1·44 
0·58–1·33 
1·09–2·88 
 
1 
1·05 
1·10 
1·00 
p = 0·98 
– 
0·71–1·56 
0·70–1·73 
0·54–1·86 
Father’s educationii 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
34 
170 
57 
43 
 
1775 
8014 
3511 
1482 
 
1 
1·11 
0·85 
2·01 
 
– 
0·77–1·60 
0·56–1·31 
1·28–3·16 
 
1 
1·14 
0·95 
1·94 
p = 0·10 
– 
0·78–1·66 
0·60–1·50 
1·07–3·49 
Mother’s income 
 1st quartile (lowest) 
 2nd quartile 
 3rd quartile 
 4th quartile (highest) 
 
80 
80 
59 
50 
 
4307 
3499 
3280 
2249 
 
1 
1·12 
0·68 
0·65 
 
– 
0·83–1·52 
0·48–0·96 
0·46–0·93 
 
1 
1·17 
0·81 
0·82 
p =0·35 
– 
0·85–1·60 
0·55–1·20 
0·53–1·28 
Mother’s age (years) 
 < 20 
 20–29 
 30–39 
 ? 40 
 
10 
167 
91 
1 
 
299 
8139 
4715 
180 
 
1·59 
1 
0·86 
0·24 
 
0·84–3·01 
– 
0·66–1·11 
0·03–1·70 
 
1·65 
1 
1·03 
0·27 
p = 0·17 
0·86–3·14 
– 
0·78–1·34 
0·04–1·92 
Parents’ cohabitation status 
 Single parent 
 Cohabiting 
 
51 
218 
 
2292 
11042 
 
1 
0·90 
 
– 
0·67–1·22 
 
1 
0·92 
p = 0·65 
– 
0·66–1·29 
Number of full siblings < 19 years 
 None  
 One 
 Two or more 
 
 
95 
123 
51 
 
 
4812 
6332 
2190 
 
 
1 
0·98 
1·08 
 
 
– 
0·75–1·28 
0·77–1·52 
 
 
1 
1·08 
1·18 
p = 0·66 
 
– 
0·81–1·44 
0·83–1·69 
 
PY, person–years; HR, hazard ratio; CI, confidence interval 
i Adjusted for child’s age and sex, decade of diagnosis, type of cancer, mother’s age and SEP variables (parental education, 
income, cohabitation status and number of full siblings) 
ii Not adjusted for mother’s income 
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Table 3b. Impact of socioeconomic position on overall survival of children with CNS tumours 
 
 
  Crude Full adjustedi 
Deaths 
(n) 
PY at 
risk  HR
 95% CI HRadj 95% CI 
Mother’s educationii 
Basic 
Vocational 
Higher 
Unknown 
 
 
29 
156 
74 
23 
 
1110 
5810 
2527 
869 
 
1 
1·04 
1·02 
1·28 
 
– 
0·70–1·55 
0·66–1·56 
0·74–2·21 
 
1 
1·20  
1·17  
1·42  
p = 0·74 
– 
0·79–1·82 
0·73–1·89 
0·73–2·78 
Father’s educationii 
Basic 
Vocational 
Higher 
Unknown 
 
43 
150 
65 
24 
 
1327 
5764 
2214 
1012 
 
1 
0·81 
0·84 
0·93 
 
– 
0·58–1·14 
0·57–1·23 
0·56–1·53 
 
1 
0·82  
0·89  
0·73  
p = 0·65 
– 
0·58–1·17 
0·58–1·36 
0·39–1·36 
Mother’s income 
1st quartile (lowest) 
2nd quartile 
3rd quartile 
4th quartile (highest) 
 
78 
75 
61 
48 
 
2729 
2961 
2154 
1471 
 
1 
0·93 
0·74 
0·70 
 
– 
0·68–1·28 
0·53–1·05 
0·49–0·99 
 
1 
0·92  
0·84  
0·86 
p = 0·74 
– 
0·66–1·28 
0·58–1·22 
0·55–1·34 
Mother’s age, years 
< 20 
20–29 
30–39 
? 40 
 
10 
158 
91 
3 
 
289 
6186 
2763 
77 
 
1·26 
1 
1·18 
1·06 
 
0·67–2·40 
– 
0·91–1·53 
0·34–3·33 
 
1·22  
1 
1·20  
1·03  
p = 0·59 
0·63–2·38 
– 
0·92–1·58 
0·33–3·28 
Parents’ cohabitation status 
Single parent 
Cohabiting 
 
53 
209 
 
1482 
7834 
 
1 
0·79 
 
– 
0·58–1·06 
 
1 
0·70  
p = 0·04 
– 
0·51–0·97 
Number of full siblings < 19 years 
None  
One 
Two or more 
 
 
97 
116 
49 
 
 
3294 
4488 
1533 
 
 
1 
0·90 
1·03 
 
 
– 
0·68–1·17 
0·73–1·45 
 
 
1 
0·89  
1·03  
p = 0·58 
 
– 
0·67–1·18 
0·72–1·48 
 
PY, person–years; HR, hazard ratio; CI, confidence interval 
i Adjusted for child’s age and sex, decade of diagnosis, type of cancer, mother’s age and SEP variables (parental education, 
income, cohabitation status and number of full siblings) 
ii Not adjusted for mother’s income 
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Table 3c. Impact of socioeconomic position on overall survival in children with non-CNS solid 
tumours 
 
   Crude Full adjustedi 
Deaths 
(n) 
PY at 
risk  
HR 95% CI HRadj 95% CI 
Mother’s educationii 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
49 
178 
71 
32 
 
1494 
7874 
3410 
1598 
 
1 
0·70 
0·59 
0·87 
 
– 
0·51–0·96 
0·41–0·85 
0·56–1·36 
 
1 
0·79 
0·66 
0·88 
p = 0·26 
– 
0·56–1·11 
0·44–0·99 
0·48–1·63 
Father’s educationii 
 Basic 
 Vocational 
 Higher 
 Unknown 
 
53 
171 
71 
35 
 
1818 
7771 
2956 
1830 
 
1 
0·78 
0·79 
0·89 
 
– 
0·58–1·07 
0·55–1·13 
0·58–1·37 
 
1 
0·81 
0·97 
0·87 
p = 0·46 
– 
0·59–1·11 
0·65–1·43 
0·45–1·54 
Mother’s income 
 1st quartile (lowest) 
 2nd quartile 
 3rd quartile 
 4th quartile (highest) 
 
94 
82 
73 
51 
 
4114 
3671 
2813 
2179 
 
1 
0·88 
0·94 
0·56 
 
– 
0·65–1·19 
0·69–1·27 
0·40–0·80 
 
1 
0·88 
1·11 
0·81 
p = 0·62 
– 
0·65–1·20 
0·80–1·55 
0·53–1·24 
Mother’s age, years 
 < 20 
 20–29 
 30–39 
 ? 40 
 
11 
209 
78 
2 
 
412 
8473 
3682 
211 
 
1·15 
1 
0·76 
0·41 
 
0·63–2·12 
– 
0·59–0·99 
0·10–1·67 
 
0·87 
1 
0·81 
0·56 
p = 0·39 
0·46–1·65 
– 
0·61–1·07 
0·14–2·28 
Parents’ cohabitation status 
 Single parent 
 Cohabiting 
 
57 
243 
 
2105 
10673 
 
1 
0·90 
 
– 
0·68–1·20 
 
1 
0·80 
p = 0·15 
– 
0·59–1·08 
Number of full siblings < 19 years 
 None  
One 
Two or more 
 
 
100 
134 
66 
 
 
5399 
5003 
2377 
 
 
1 
1·42 
1·47 
 
 
– 
1·09–1·84 
1·08–2·00 
 
 
1 
1·45 
1·29 
p = 0·02 
 
– 
1·11–1·89 
0·93–1·79 
 
PY, person–years; HR, hazard ratio; CI, confidence interval 
i Adjusted for child’s age and sex, decade of diagnosis, type of cancer, mother’s age and SEP variables (parental education, 
income, cohabitation status and number of full siblings) 
ii Not adjusted for mother’s income 
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Table 4. Absolute excess risk for death after 5 years in children with any paediatric cancer, by 
parental cohabitation status and number of full siblings 
 
 Death rate per 1000 person years  
(95% CI) 
Deaths prevented if all children had the 
best rate, per 1000 person–years 
Cohabitation status 
Single parents 
Cohabiting parents 
 
51 (38–67)  
45 (33–60) 
 
6 
Reference 
Number of full siblings 
None 
One 
Two or more 
 
42 (30–57) 
48 (35–64) 
50 (37–66) 
 
Reference 
6 
8 
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Figure 1. Kaplan–Meier plot illustrating the probability of survival stratified by mothers’ 
education (A), income (B), parental cohabitation (C) and number of full siblings (D) 
 
 
Figure 1A 
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Figure 1B 
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Figure 1C 
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Figure 1D 
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Abstract 
Little is known about the role of family characteristics on survival from childhood 
haematological malignancies, which we studied in a nationwide cohort of Danish children. 
All children with haematological malignancies born and diagnosed between 1973 and 
2006 before the age of 20 years (N=1 819) were followed for 10 years. Cox proportional 
hazards models estimating hazard ratios (HR) and 95% confidence intervals (CI) were 
calculated. Increasing birth order and having siblings was associated with worse survival 
from acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML); the 
associations with AML were stronger and statistically significant. HRs of 1.62 (CI 0.85; 
3.09) and of 5.76 (CI 2.01; 16.51) were observed for 4th or later born children with ALL and 
AML, respectively. Children with older parents showed a tendency of inferior ALL survival, 
while for AML young maternal age was related to poorer survival. Based on small 
numbers, NHL survival showed associations with having siblings and with parental age. 
Overall, results for the full cohort were similar to those diagnosed from 1990 onwards. 
Family characteristics may have an impact on survival from haematological malignancies 
in Danish children. Further research should elaborate potential underlying mechanisms, in 
particular adherence to therapy and physicians-parents interaction.   
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Introduction 
Childhood haematological cancers are a heterogeneous group of malignancies, treated 
differently and with dissimilar prognosis (1). Over the past decades, advances in tumour 
biology, risk grouping, and pharmacology have led to substantial improvements in 
treatment of childhood cancers in particular for acute lymphoblastic leukaemia (ALL) and 
non-Hodgkin lymphoma (NHL)(1-3). Diagnostic procedures and treatment protocols are 
nowadays largely standardized within developed countries (3-8). In the Nordic countries 
treatment of childhood cancers has virtually been identical since the early 1990s (3, 5, 6). 
Almost all paediatric haematological malignancy patients are treated according to the 
treatment schemes developed by the collaborative study group NOPHO (Nordic Society of 
Paediatric Haematology and Oncology) (3, 5, 6) with specific treatment protocols 
depending on type, prognostic risk group and stage of cancer.  
 
One of the basic principles of the Danish welfare system is equal rights to social security 
for all citizens, including benefits for families with children as well as tax-funded free 
health care services.(9) Childhood cancer treatment is centralized to four highly 
specialized paediatric oncology centres that offer uniform diagnostics and treatment 
independently of family circumstances or socioeconomic background. Therefore it would 
be expected that there are fairly equal survival rates across social groups and 
independent of family circumstances. However, besides physician’s compliance to the 
treatment protocols, parents’ and child’s adherence to the treatment and supportive care 
as well as the interaction between families and physicians may affect survival. 
 
For adult cancers in Denmark, it is well established that socioeconomic characteristics 
influence survival, with cancer patients with higher education or higher income reaching 
superior survival rates (10). Little is known about the potential role of social conditions and 
family circumstances on childhood cancer survival. Only one ongoing study addressed 
survival differences related to socioeconomic position in Danish children(11). 
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Internationally, only few studies have investigated the relationship between family and 
social conditions and survival from childhood cancer, mainly focussing on leukaemia 
survival and with very diverse findings, even within Europe (12-19). 
 
In this nationwide Danish population-based study, we evaluate for the first time whether 
family circumstances such as birth order, number of siblings, parental age at child’s 
cancer diagnosis and place of residence affect survival from paediatric haematological 
malignancies, in order to investigate whether Danish children irrespective of family 
characteristics benefits equally from the improvements in therapy that have been made 
over the last decades. 
 
Material and Methods 
Denmark has a civil registration system with unique personal identification numbers, 
national population-based administrative registries such as the Danish Cancer Registry or 
the Danish Medical Birth Registry, and legislation that permits and supports registry-based 
research (20). Since 1968, all residents of Denmark have been assigned a civil personal 
registration number (CPR number), which is used in all national registries, enabling 
accurate linkage of information between registries (21). 
 
Study population  
Childhood haematological malignancies were defined as any leukaemia or lymphoma 
diagnosed in patients up to 19 years of age inclusively. Our study population comprised all 
children born and diagnosed with any haematological malignancy in Denmark between 1 
January 1973 and 31 December 2006.1 819 eligible children with haematological 
malignancies were identified for the defined time period in the Danish Cancer Registry. 
 
Haematological malignancies were classified according to the International Classification 
of Childhood Cancer, (ICCC 1st version; i.e., the Birch and Marsden Classification) (22) 
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until 2003 and ICCC 3rd version (23) thereafter) which classifies haematological 
malignancies according to the IDC-O-1 or IDC-O-3 nomenclature into the following 2 main 
diagnostic groups and specific subgroups: I. Leukaemias, myeloproliferative disease and 
myelodysplastic diseases (Leukaemias), and II. Lymphomas and reticuloendothelial 
neoplasms (Lymphomas). 
 
Family characteristics 
Family circumstances were defined by a range of characteristics including birth order, 
number of full and half siblings, parental age at diagnosis as well as place of residence. 
Information on these characteristics for the study subjects was obtained for the date of the 
cancer diagnosis by data linkage to the Danish Medical Birth Register (24) and the Central 
Population Registry (CPR). The unique CPR number includes date of birth and sex and 
allows linkage to first-degree relatives via the Danish Civil Registration System considered 
to be 100% correct (21).  
 
Linkage of the CPR number of the child with the mother and the father enabled, besides 
receiving information on parental age at diagnosis (grouped into ≤ 25, 26-30, 31-35, 36-40, 
41-45, ≥46 years), the identification of full siblings and half siblings (21). Full siblings were 
defined as having the same mother and father, and half siblings as having either the same 
mother or the same father (stillborn children excluded).  
From the birth register we obtained data on birth order (24). Birth order was defined by 
counting all live-births of the same mother (1st born, 2nd born, 3rd born, and 4th born and 
later). Multiple births were assigned the same birth order to multiples and later births 
accounted for the real number of siblings, i.e. for twins the next child would be the 3rd born. 
Information on place of residence at diagnosis was obtained from the Danish Cancer 
Registry and classified by level of municipality. Provincial cities were defined as those 
cities with >10,000 inhabitants; rural areas as rural municipalities with <10,000 inhabitants; 
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and peripheral rural areas as municipalities more than 40 km from a local centre with 
proper employment possibilities and no shared border with a municipality centre (25). 
 
Statistical methods 
We defined overall survival as outcome of our study. Dates of death, disappearance and 
emigration were obtained until 7 October 2013, collected by the Central Population 
Registry, and used as follow-up information (21). Children were observed from the date of 
cancer diagnosis until their death from any cause, emigration, the end of the 10 years 
follow-up or 7 October 2013, whichever came first. We censored at 10 years follow-up as 
very few disease-related events occur afterwards, whereas the incidence of competing 
risks rises. 
 
Cox proportional hazards models were used to assess the impact of family characteristics 
on overall survival with time since diagnosis as underlying time scale. As the proportional 
hazard assumptions did not hold when collapsing all haematological malignancies in one 
group, we analysed the three large subgroups (ALL, AML, NHL) separately, and differing 
results confirmed this choice. Although Hodgkin lymphoma was another sizable group of 
clinical relevance, survival (see below) was very high (> 90%), so that the small number of 
events precluded meaningful survival analyses by subgroups of family circumstances. 
The multiple regression models were built in two steps. Initially, we adjusted for the 
following well-established prognostic factors: child’s age at diagnosis (3, 5, 6) (grouped 
into < 1 year, 1-5, 6-9, and 10-14 years, and 15-19 years), sex (5, 26), as well as 
diagnosis before 1990 versus afterwards (3, 5, 21). In a second set of analyses, additional 
adjustments were made for the possible mediating effects of other family variables (fully 
adjusted models). The specific adjustment variables varied between family characteristics 
(see Figure 1). In additional analyses to investigate whether the observations made in the 
larger cohort of patients diagnosed 1973-2006 held true for the more recent cohort of 
patients, we restricted the study population to cases of ALL and AML diagnosed from 
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1990 onwards as treatment has been particularly standardised since then. Results were 
expressed as adjusted hazard ratios (HRs) with corresponding 95% confidence intervals. 
Trend tests were also performed, using the same categories as for the main analysis. 
 
To investigate when survival differences emerged we calculated unadjusted survival 
probabilities for ALL and AML by birth order, number of full siblings and parental ages at 
diagnosis, using Kaplan-Meier curves and the log-rank test.(27)  
 
Sensitivity analyses were performed to evaluate if (i) adjusting mutually for birth order and 
number of full siblings as well as number of full and half siblings in the respective multiple 
Cox models, and if (ii) distinguishing between having either a young/old mother or a 
young/old father compared to having two young parents (both ≤ 25 years) or having two 
old parents (both ≥ 46 years) modified the associations. 
  
All statistical analyses were performed using Stata 13 (28). 
 
Results 
Of the 1 819 children diagnosed with haematological malignancies between 1973 and 
2006, 59% were boys and 40% occurred in 1 to 4 years old children (Table 1). More than 
half of the cases were diagnosed with ALL (56%), followed by Hodgkin lymphoma 
compromising 13% of all cases, AML (12%) and NHL (9%). Among all cohort members, 
834 (46%) were firstborns and 664 (37%) were second born. 285 (16%) were the only 
child at date of diagnosis. Most families were living in provincial cities (53%). Mothers and 
fathers were most frequently aged 31-35 years at diagnosis. Overall 10-years survival was 
72.1%, based on 504 deaths. Survival was slightly better for girls than boys (72.7% vs. 
71.6%), highest for children aged 1-4 years at diagnosis (76%) and superior for children 
with Hodgkin lymphoma (91%). 
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Family characteristics and survival from acute lymphoblastic leukaemia 
The Cox regression models suggested dissimilarities in ALL survival by some family 
characteristics, although most of the associations did not reach statistical significance in 
either the restricted analysis including children diagnosed with ALL from 1990 onwards 
(Table 2) or in the analysis including all ALL children diagnosed in the full period 1973-
2006 (Figure 1a). Similar results were seen across models (only the fully adjusted models 
are shown in the figures) and for the full and restricted time periods. Poorer survival was 
observed for children born as 3rd child or later compared to those with lower birth order, 
with worst survival for 4th and later born children (non-significant HRs of 1.62; 95% CI 
0.85; 3.09 in the fully adjusted model; Figure1a). A tendency of different survival was also 
noted by number of full or/and half siblings, with best survival for children without any 
siblings (Figure 1a; Table 2). Mutually adjusting for birth order and number of siblings in 
one model abolished the association between number of siblings and survival, but did not 
substantially alter the HRs for the effect of birth order (data not shown). 
 
There was evidence to suggest that children with a mother or father of older age were 
likely to have a poorer survival with elevated HRs close to 1.5 for children with a mother 
aged 46 years or older (Figure 1a;Table 2). The trend test for maternal and paternal age 
reached statistical significance for the diagnostic period since 1990 (maternal age p = 0.04; 
paternal age p = 0.03). Sensitivity analysis distinguishing between having either an older 
mother or an older father and having two older parents (both ≥ 46 years) showed that 
particularly the latter was related to poorer survival (data not shown). 
Visual inspection of survival curves did not clearly indicate a time point from which on 
survival dissimilarities emerged (Figure 2a).  
 
A tendency of poorer survival was observed for children living in peripheral rural areas 
only among the children diagnosed since 1990 (Table 2). 
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Family characteristics and survival from acute myeloid leukaemia 
Associations between birth order, number of full and/or half siblings and AML survival 
were more pronounced than for ALL and often statistically significant. Associations were 
stronger for the diagnostic period 1990 and onwards (Table 2) compared to the full study 
period (Figure 1b). Particular strong dissimilarities in survival were observed for birth order, 
with statistically significant increasing HRs by increasing birth order (p for trend ≤ 0.01), 
resulting in a significant HR of 5.76 (95% CI 2.01; 16.51) for children born 4th or later in the 
fully adjusted model; among children diagnosed since 1990 the HR was even 7.58, 
although the confidence interval was wide (95% CI 1.41; 40.74). Sensitivity analyses, 
mutually adjusting for birth order and number of siblings, showed even higher HRs for the 
association with birth order, while the associations with number of full/ full and half siblings 
were entirely eliminated (data not shown). 
 
A linear relationship of mother’s age at diagnosis, particularly strong for children 
diagnosed since 1990 (p for trend ≤ 0.01) appeared to affect survival from AML, with 
poorer survival among children with a young mother (≤ 25 years; HR 1.62; 95% CI 0.81; 
3.22 for the entire study period; HR 4.47; 95% CI 1.64; 12.20 for children diagnosed since 
1990) and better survival among children with older mothers. The effect of better survival 
among children with older mothers was driven by the good survival of children having both 
an older mother and an older father with a HR of 0.55 in the fully adjusted model (95% CI 
0.17; 1.80) (data not shown). 
 
Family characteristics and survival from non-Hodgkin lymphoma 
Wide confidence intervals reflect the small numbers available for the analyses of NHL 
survival (Figure 1c). Poorer NHL survival was observed for children with full and/or half 
siblings compared to only children. Although estimates for most of the categories were not 
statistically significant, the trend test reached significance (p = 0.02). No clear relationship 
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was found for number of full siblings. Young parental age might be related to poorer 
survival, but numbers were small. 
 
Discussion 
Main findings 
The findings of increasing birth order, numbers of siblings and parental age being 
associated with poorer survival among childhood haematological cancer patients 
emphasize the need to include more than just cancer biology and treatment in survival 
analyses, not least since the impact of these family features might be potentially as strong 
as that of traditional risk factors (3).  
 
International comparison 
Family characteristics such as number of siblings, birth order and parental age have been 
postulated to be related to the occurrence of childhood cancer (29-36), but evidence on 
their role as prognostic factors for leukaemia and in particular lymphoma is sparse and 
with conflicting findings (16-19, 37, 38). In line with our results, a large Norwegian study 
on children with cancer reported that having no siblings was associated with mortality 
reductions of almost 20%.(16) In contrast, a study from Greece on children diagnosed 
with ALL in the late 1990s-early 2000s observed better prognosis for children with 
increasing number of siblings (18). However, this finding was not confirmed in a recent 
follow-up study(17). Likewise and in contrast to our findings for Denmark, no relationship 
between survival from AML and number of siblings was observed there (17).  
To our knowledge, so far no investigation has addressed the possible importance of 
parental age at the child’s cancer diagnosis. Nevertheless, analyses of mother’s age at 
child’s birth from Norway did not indicate a relationship with childhood cancer survival, 
whereas the most recent findings from Greece indicated better survival from AML with 
older maternal age (16, 17), which is basically what we observed for maternal age at 
child’s AML diagnosis. 
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With respect to place of residence, a study from Australia, a country with vast areas of 
very low density population, reported better leukaemia survival for children living in major 
cities compared with those living elsewhere. However, no evidence of geographical 
variation in survival was observed for children with lymphoma (37). Living in rural areas 
was also associated with less favourable prognosis in recent multi-national findings from 
Bulgaria, Turkey and Russia (38). This may likely contrast the small size of Denmark and 
the lack of real remote areas. 
 
However, dissimilarities in welfare systems, including access to health care and public 
family support, coverage and distance to treatment facilities, lifestyle and socio-cultural 
aspects, treatment protocols as well as methodological differences between studies make 
an international comparison challenging. A crucial question is to what extent the observed 
differences across studies are real (reflecting different impact of family characteristic due 
to differences in health care and social stratification, true overall health inequity) or to what 
extent differences can be explained by features of the studies(including differences in data 
sources, data collection, cancer type, and diagnostic period). 
 
National context and comparison  
Our observed associations are particularly interesting in the context of recent findings 
about the role of socioeconomic position and childhood cancer survival in Denmark. 
Whereas parental education and mother’s income did not appear to impact on survival 
from childhood haematological malignancies (11), the demands on families and their 
social resources (as measured by birth order, number of siblings and parental age at 
child’s diagnosis in the present study) appear to be more relevant than the socioeconomic 
situation of a family in Denmark, particularly for survival from AML. 
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The well documented impact of social factors on cancer outcome in adults (10) is 
associated with differences in the time of diagnosis, in the biological characteristics of the 
tumour, in the treatments given or in individual factors, such as lifestyle or the presence of 
comorbidities.(39-41) Nevertheless, dissimilarities in survival from paediatric 
haematological malignancies would be expected to be less likely related to co-morbidities 
and children’s lifestyle, but might include further reasons such as adherence to treatment 
recommendations(42). Treatment of lymphoblastic malignancies (ALL and NHL) lasts over 
several years, and poor adherence to oral maintenance therapy may have negative 
impact on cure rates (43). As soon as the child is discharged from hospital, parents are 
responsible to comply with the recommendations for continuation of a highly demanding 
therapy, including daily drug administration and frequent medical outpatient appointments. 
Accordingly, findings from the UK indicate that ALL survival dissimilarities by 
socioeconomic status emerged about the time when treatment management required 
parental/child’s adherence, i.e. from the time of oral treatment in the outpatient setting and 
hypothesized that this may due to treatment compliance (14). In our study, children with 
siblings as well as children of higher birth order showed indeed poorer survival. However, 
the pattern of diverging survival curves after the beginning of home-administered therapy 
seen in the UK was not reflected in the survival curves for Danish children. Moreover, we 
observed even stronger effects of number of siblings for AML survival, a disease which is 
entirely treated in hospital. Thus, the number of siblings might not only be of relevance for 
the period of the home-administered maintenance therapy for ALL, but for the entire 
treatment period of AML and ALL. Smaller families may be able to devote more time to 
assisting the sick child and may better cope with the complex and demanding therapy in 
general (40). However, the associations seen between number of siblings and leukaemia 
survival, both ALL and AML, were mainly driven by the effect of birth order. Higher birth 
order (34) and more social contacts (44) could, according to the adrenal hypothesis (45) 
suggest that the lymphoblastic malignancies emerged in spite of high glucocorticosteroid 
exposure and thus were more glucocorticosteroid resistance when diagnosed, a feature 
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associated with poor prognosis (46). Nevertheless, this explanation would only apply for 
the observed relationship between birth order and survival from ALL. However, the 
relationship between survival and birth order noticed for children with AML was even 
stronger than for ALL and more pronounced for cases diagnosed in the more recent time 
characterised by a standardised treatment approach (3, 5, 6). Perhaps firstborns might 
receive more attention from their parents than later born children, possibly positively 
affecting abilities to cope with the cancer diagnosis, the demanding therapy and related 
circumstances, but this is speculation. 
 
The poorer survival from AML and NHL reported in this study for children with young 
mothers (for NHL both mothers and fathers) may possibly also reflect the capacity to cope 
with the complex therapy, and may be particularly challenging for young parents (47). This 
might also explain the better survival from AML and NHL among children with older 
mothers. However, as the parental age-survival relationship seems to be reversed for ALL, 
interpretation of these findings remains challenging and unclear at present. 
 
Whether children lived in Copenhagen or in more rural areas appeared not to be of high 
relevance for survival; solely for the very few children living in peripheral rural areas and 
diagnosed with ALL, poorer survival for the most recent diagnostic period since 1990 was 
noticed. This overall lack of residential effects is plausible as four specialized paediatric 
clinics cover the entire country, with relatively short distances to the treating centre from 
most places in Denmark. Further, treatment is highly standardized,(3, 5, 6) irrespective of 
the treating hospital.  
 
Strengths and weaknesses 
Since this study is a nationwide, population- and register-based cohort study with little risk 
of bias, the only weakness is the lack of socioeconomic characteristics such as parental 
education or income as potential confounding factors. Furthermore, no information on 
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parental marriage and cohabitation status was available which has been hypothesized to 
be associated with treatment adherence (42). An inherent limitation is the size of our 
cohort, albeit unavoidable as it reflects the population size of the country. Most of the 
survival estimates failed to reach statistical significance while there were indications of 
possibly strong effects. 
It is noteworthy that this study is the first investigation on this topic in Denmark and one of 
very few from Europe. With the national and register-based approach our study virtually 
covered all cancer cases with a complete follow-up and thus provided a factual reflection 
of the situation in Denmark. 
 
Conclusion 
Despite of the highly specialized treatment of children with cancer and universal 
healthcare coverage in Denmark, not all children appear to benefit equally from 
improvements in survival. Our data further suggest that cancer biology and treatment are 
not the only factors influencing survival. This may in the future call for targeted social 
interventions and psychological support in order to further improve survival rates and 
reduce inequity. However, further studies are warranted to elaborate the relationship and 
underlying mechanism of specific family characteristics and survival, particularly with 
regard to differential adherence to therapy and related interactions of families with 
paediatric oncologists in Denmark and elsewhere. 
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Figure and table legend 
Table 1: Children with haematological malignancies diagnosed between 1973-2006, by 
number of deaths after 10 years of follow-up, 5-year survival and 10-year survival. 
 
Table 2: Analyses of children with acute lymphoblastic leukaemia and acute myeloid 
leukaemia diagnosed from 1990 onwards: Multivariable Cox regression analyses of the 
association of family characteristics on childhood leukaemia survival in Denmark, 
followed-up for 10 years from date of diagnosis. 
 
Figure 1a: Full period multiple Cox regression analyses of the association between family 
characteristics and 10 year overall survival from childhood haematological malignancies in 
Denmark. Fully adjusted hazards ratios with 95% confidence intervals for acute 
lymphoblastic leukaemia (ALL) survival. 
* Adjustment variables vary by family characteristic. Birth order: hazard ratios are adjusted for 
child’s age at diagnosis, sex, place of residence, and maternal age at diagnosis. Number of siblings 
(both full siblings and full and half siblings): hazard ratios are adjusted for child’s age at diagnosis, 
sex, place of residence, and maternal age at diagnosis. Place of residence: hazard ratios are 
adjusted for child’s age at diagnosis, sex, number of full siblings, and mother's age. Mother’s age at 
diagnosis: hazard ratios are adjusted for child’s age at diagnosis, sex, place of residence, and 
number of full siblings. Father’s age at diagnosis: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence, and number of full siblings. 15 cases missed information on 
place of residence, 6 cases missed information on father’s age at diagnosis. 
** Hazard ratio with corresponding 95% confidence interval. 
 
Figure 1b: Full period multiple Cox regression analyses of the association between family 
characteristics and 10 year overall survival from childhood haematological malignancies in 
Denmark. Fully adjusted hazards ratios with 95% confidence intervals for acute myeloid 
leukaemia (AML) survival. If upper bound of the confidence intervals exceeded 7, it was 
trunked in the figure and marked with an arrow. 
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* Adjustment variables vary by family characteristic. Birth order: hazard ratios are adjusted for 
child’s age at diagnosis, sex, place of residence, and maternal age at diagnosis. Number of siblings 
(both full siblings and full and half siblings): hazard ratios are adjusted for child’s age at diagnosis, 
sex, place of residence, and maternal age at diagnosis. Place of residence: hazard ratios are 
adjusted for child’s age at diagnosis, sex, number of full siblings, and mother's age. Mother’s age at 
diagnosis: hazard ratios are adjusted for child’s age at diagnosis, sex, place of residence, and 
number of full siblings. Father’s age at diagnosis: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence, and number of full siblings. 3 cases missed information on place 
of residence, 1 case missed information on father’s age at diagnosis. 
** Hazard ratio with corresponding 95% confidence interval. 
 
Figure 1c: Full period multiple Cox regression analyses of the association between family 
characteristics and 10 year overall survival from childhood haematological malignancies in 
Denmark. Fully adjusted hazards ratios with 95% confidence intervals for Non-Hodgkin’s 
lymphoma (NHL) survival. Confidence intervals which exceed a hazard ratio of 7 are 
trunked in the figure and marked with an arrow. 
* Adjustment variables vary by family characteristic. Birth order: hazard ratios are adjusted for 
child’s age at diagnosis, sex, place of residence, and maternal age at diagnosis. Number of siblings 
(both full siblings and full and half siblings): hazard ratios are adjusted for child’s age at diagnosis, 
sex, place of residence, and maternal age at diagnosis. Place of residence: hazard ratios are 
adjusted for child’s age at diagnosis, sex, number of full siblings, and mother's age. Mother’s age at 
diagnosis: hazard ratios are adjusted for child’s age at diagnosis, sex, place of residence, and 
number of full siblings. Father’s age at diagnosis: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence, and number of full siblings. 3 cases missed information on place 
of residence. 
** Hazard ratio with corresponding 95% confidence interval. 
 
Figure 2a: Overall survival from childhood acute lymphoblastic leukaemia (ALL), by family 
characteristics. Kaplan-Meier curves of overall survival by birth order (Log-rank test of 
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heterogeneity: χ² = 5.79, p = 0.12), number of full siblings (Log-rank test of heterogeneity: 
χ² = 3.92, p = 0.27), mother’s age at the child’s diagnosis (Log-rank test of heterogeneity: 
χ² = 19.02, p = 0.002), and father’s age at the child’s diagnosis (Log-rank test of 
heterogeneity: χ² = 10.37, p = 0.07). 
 
Figure 2b: Overall survival from childhood acute myeloid leukaemia (AML), by family 
characteristics. Kaplan-Meier curves of overall survival by birth order (Log-rank test of 
heterogeneity: χ² = 7.64, p = 0.05), number of full siblings (Log-rank test of heterogeneity: 
χ² = 1.15, p = 0.77), mother’s age at the child’s diagnosis (Log-rank test of heterogeneity: 
χ² = 10.90, p = 0.05), and father’s age at the child’s diagnosis (Log-rank test of 
heterogeneity: χ² = 13.48, p = 0.02). 
Table 1: Children with haematological malignancies diagnosed between 
1973-2006, by number of deaths after 10 years of follow-up, 5-year survival 
and 10-year survival. 
 Cases Deaths (%)a 5-year survival  
10-year 
survival 
Total 1,819 504 (27.7%) 74.5% 72.1% 
     
Sex     
Boys 1,068 (58.7%) 301 (28.2%) 73.9% 71.6% 
Girls 751 (41.3%) 203 (27.0%) 75.4% 72.7% 
     
Age at diagnosis 
(years)     
< 1 93 (5.1%) 65 (69.9%) 31.2% 30.0% 
1 – 4  724 (39.8%) 172 (23.8%) 78.3% 76.1% 
5 – 9  404 (22.2%) 114 (28.2%) 73.3% 71.6% 
10 – 14 283 (15.6%) 68 (24.0%) 80.2% 75.5% 
15 – 19  315 (17.3%) 85 (27.0%) 74.9% 72.8% 
     
Decade of diagnosis     
1973 – 1979  109 (6.0%) 58 (53.2%) 49.5% 46.8% 
1980 – 1989  428 (23.5%) 172 (40.2%) 62.9% 59.8% 
1990 – 1999  708 (38.9%) 177 (25.0%) 77.5% 75.0% 
2000 – 2006  574 (31.6%) 97 (16.9%) 84.2% 82.8% 
     
Decade of birth     
1973 – 1979  481 (26.4%) 194 (40.3%) 63.2% 59.7% 
1980 – 1989  718 (39.5%) 207 (28.8%) 73.8% 71.0% 
1990 – 1999  485 (26.7%) 80 (16.5%) 84.1% 83.4% 
2000 – 2006  135 (7.4%) 23 (17.0%) 83.7% 82.4% 
     
Cancer type b     
Leukaemias 1,294 (71.1%) 388 (30.0%) 72.6% 69.8% 
? ALLc 1,011 (55.6%) 244 (24.1%) 78.7% 75.6% 
? AMLd 213 (11.7%) 110 (51.6%) 49.3% 48.2% 
? otherse 70 (3.9%) 34 (48.6%) 54.3% 51.0% 
Lymphomas 525 (28.9%) 116 (22.1%) 79.2% 77.8% 
? HLf 235 (12.9%) 22 (9.4%) 92.3% 90.5% 
? NHLg 163 (9.0%) 50 (30.7%) 71.2% 69.2% 
? Othersh 127 (7.0%) 44 (34.7%) 65.4% 65.4% 
     
Birth order      
1st born 834 (45.9%) 211 (25.3%) 76.6% 74.5% 
2nd born 664 (36.5%)  189 (28.5%) 74.1% 71.3% 
3rd born 240 (13.2%) 77 (32.1%) 70.4% 67.6% 
4th born and later 81 (4.5%) 27 (33.3%) 67.9% 66.6% 
     
Siblings     
Full siblings     
0 siblings 476 (26.2%) 128 (26.9%) 76.1% 72.9% 
1 sibling 793 (43.6%) 211 (26.6%) 75.3% 73.2% 
2 siblings 358 (19.7%) 108 (30.2%) 72.0% 69.5% 
3 and more siblings 192 (10.6%) 57 (29.7%) 71.9% 70.1% 
     
Full & half siblings     
Only child 285 (15.7%) 75 (26.3%) 75.8% 73.5% 
1 sibling 837 (46.0%) 218 (26.1%) 75.9% 73.8% 
2 siblings 433 (23.8%) 135 (31.2%) 71.8% 68.5% 
3 and more siblings 264 (14.5%) 76 (28.8%) 73.1% 71.0% 
     
Place of residence at 
diagnosisi     
Greater Copenhagen 
area 
540 (30.3%) 140 (25.9%) 
76.3% 73.8% 
Provincial cities 949 (53.2%) 271 (28.6%) 73.3% 71.3% 
Rural areas 225 (12.6%) 70 (31.1%) 70.7% 68.7% 
Peripheral rural areas 71 (4.0%) 17 (23.9%) 83.1% 75.4% 
     
Mother’s age at 
diagnosis (years)     
≤ 25 140 (7.7%) 64 (45.7%) 57.1% 54.2% 
26 – 30  348 (19.1%) 94 (27.0%) 75.9% 72.8% 
31 – 35  491 (27.0%) 129 (26.3%) 76.0% 73.5% 
36 – 40  386 (21.2%) 107 (27.2%) 73.8% 72.1% 
41 – 45  268 (14.7%) 72 (26.9%) 75.4% 72.9% 
≥46 186 (10.2%) 38 (20.4%) 81.2% 79.3% 
     
Father’s age at 
diagnosisj (years)     
≤ 25 51 (2.8%) 20 (39.2%) 60.8% 60.8% 
26 – 30  239 (13.2%) 84 (35.2%) 67.8% 64.7% 
31 – 35  429 (23.7%) 114 (26.6%) 76.2% 73.2% 
36 – 40  413 (22.8%) 109 (26.4%) 75.8% 73.4% 
41 – 45  338 (18.7%) 96 (28.4%) 73.6% 71.3% 
≥46 338 (18.7%) 79 (23.4%) 78.1% 76.4% 
a Number of and proportion of deaths from all childhood haematological malignancy cases, by 
characteristics of cases. 
b Classified by the International Classification of Childhood Cancer, up to 2003 by Birch & Marsden 
(first edition) and from 2003 onwards by third edition (ICCC-3) 
c Acute lymphoblastic leukaemia 
d Acute myeloid leukaemia  
e Chronic myeloid, other specified and unspecified leukaemia 
f Hodgkin lymphoma 
g Non-Hodgkin lymphoma (except Burkitt lymphoma) 
h Burkitt, other specified and unspecified lymphoma 
i Grouped at level of the municipality. Provincial cities are those with >10,000 inhabitants; 
rural areas are rural municipalities with <10,000 inhabitants; peripheral rural areas are 
municipalities more than 40 km from a local centre with proper employment possibilities 
and no shared border with a municipality centre. 
j No information available on father’s age at diagnosis for 11 cases 
  
Table 2: Analyses of children with acute lymphoblastic leukaemia and acute myeloid leukaemia diagnosed 
from1990 onwards: Multivariable Cox regression analyses of the association of family characteristics on 
childhood leukaemia survival in Denmark, followed-up for 10 years from date of diagnosis. 
 Acute lymphoblastic leukaemia Acute myeloid leukaemia 
Family 
characteristic 
Number of 
Cases 
Number of 
deaths HRadj
ab [95% CI]c Number of Cases 
Number of 
deaths HRadj
ab [95% CI]c 
         
Birth order          
1st born 321 54 1.0 [Ref] 66 23 1.0 [Ref] 
2nd born 235 44 1.11 [0.73; 1.68] 59 28 2.84 [1.51; 5.33] 
3rd born 79 19 1.24 [0.71; 2.15] 20 9 3.73 [1.49; 9.34] 
4th born and later 26 6 1.56 [0.63; 3.88] 5 2 7.58 [1.41; 40.74] 
         
Siblings         
Full siblings         
0 siblings 179 26 1.0 [Ref] 33 11 1.0 [Ref] 
1 sibling 290 55 1.18 [0.73; 1.90] 65 30 1.86 [0.86; 4.01] 
2 siblings 113 26 1.25 [0.71; 2.19] 40 16 1.63 [0.68; 3.89] 
3 and more 
siblings 
79 16 1.09 [0.57; 2.07] 12 5 2.65 [0.72; 9.68] 
         
Full & half 
siblings 
        
Only child 105 12 1.0 [Ref] 18 4 1.0 [Ref] 
1 sibling 308 57 1.33 [0.69; 2.54] 66 31 4.55 [1.47; 14.07] 
2 siblings 150 34 1.33 [0.67; 2.67] 49 19 3.30 [1.00; 10.94] 
3 and more 
siblings 
98 20 1.21 [0.57; 2.56] 17 8 6.02 [1.49; 24.24] 
         
Place of 
residence at 
diagnosisd 
  
 
   
 
 
Greater 
Copenhagen area 
205 39 1.0 [Ref] 42 18 1.0 [Ref] 
Provincial cities 335 60 0.93 [0.62; 1.41] 85 34 1.02 [0.53; 1.95] 
Rural areas 87 17 1.04 [0.58; 1.88] 16 6 0.62 [0.23; 1.65] 
Peripheral rural 
areas 
22 6 1.59 [0.67; 3.81] 5 3 1.07 [0.28; 4.16] 
         
Mother’s age at 
diagnosis 
        
≤ 25 33 4 0.78 [0.26; 2.29] 11 7 4.47 [1.64; 12.20] 
26 – 30  129 9 0.46 [0.22; 0.98] 25 12 2.38 [0.98; 5.82] 
31 – 35  217 35 1.0 [Ref] 37 12 1.0 [Ref] 
36 – 40  149 30 1.02 [0.59; 1.74] 35 17 0.96 [0.39; 2.35] 
41 – 45  89 28 1.23 [0.66; 2.29] 22 7 0.38 [0.11; 1.32] 
≥46 44 17 1.50 [0.73; 3.07] 20 7 0.42 [0.12; 1.52] 
         
Father’s age at 
diagnosise 
        
≤ 25 10 0 -- -- 4 1 0.73 [0.09; 5.99] 
26 – 30  66 5 0.65 [0.25; 1.70] 20 9 1.57 [0.58; 4.27] 
31 – 35  189 25 1.0 [Ref] 24 10 1.0 [Ref] 
36 – 40  169 31 1.24 [0.71; 2.18] 35 15 0.91 [0.37; 2.22] 
41 – 45  125 29 1.19 [0.64; 2.23] 29 16 1.49 [0.56; 4.01] 
≥46 96 33 1.75 [0.90; 3.41] 37 11 0.47 [0.15; 1.47] 
a adjusted Hazard ratio. 
b Adjustment variables vary by family characteristic. Birth order: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence and maternal age at diagnosis. Number of siblings (both full siblings and full and 
half siblings): hazard ratios are adjusted for child’s age at diagnosis, sex, place of residence and maternal age at 
diagnosis. Place of residence: hazard ratios are adjusted for child’s age at diagnosis, sex, number of full siblings and 
mother's age. Mother’s age at diagnosis: hazard ratios are adjusted for child’s age at diagnosis, sex, place of 
residence and number of full siblings. Father’s age at diagnosis: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence and number of full siblings. 
c Corresponding 95% confidence intervals. 
d Grouped at level of the municipality. Provincial cities were those with >10,000 inhabitants; rural areas were rural 
municipalities with <10,000 inhabitants; peripheral rural areas were municipalities more than 40 km from a local 
centre with proper employment possibilities and no shared border with a municipality centre. Among ALL patients12 
cases had missing information on place of residence, among AML 2 cases had no information. 
e Among ALL patients 6 cases had no information on father’s age at diagnosis, among AML cases 1 case had no 
information. 
  
?Figure 1a: Full period multiple Cox regression analyses of the association between family 
characteristics and 10 year overall survival from childhood haematological malignancies in Denmark. 
Fully adjusted hazards ratios with 95% confidence intervals for acute lymphoblastic leukaemia (ALL) 
survival. 
* Adjustment variables vary by family characteristic. Birth order: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence, and maternal age at diagnosis. Number of siblings (both full siblings and full 
and half siblings): hazard ratios are adjusted for child’s age at diagnosis, sex, place of residence, and maternal 
age at diagnosis. Place of residence: hazard ratios are adjusted for child’s age at diagnosis, sex, number of full 
siblings, and mother's age. Mother’s age at diagnosis: hazard ratios are adjusted for child’s age at diagnosis, sex, 
place of residence, and number of full siblings. Father’s age at diagnosis: hazard ratios are adjusted for child’s 
age at diagnosis, sex, place of residence, and number of full siblings. 15 cases missed information on place of 
residence, 6 cases missed information on father’s age at diagnosis. 
** Hazard ratio with corresponding 95% confidence interval. 
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?Figure 1b: Full period multiple Cox regression analyses of the association between family 
characteristics and 10 year overall survival from childhood haematological malignancies in Denmark. 
Fully adjusted hazards ratios with 95% confidence intervals for acute myeloid leukaemia (AML) 
survival. If upper bound of the confidence intervals exceeded 7, it was trunked in the figure and marked 
with an arrow. 
 
* Adjustment variables vary by family characteristic. Birth order: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence, and maternal age at diagnosis. Number of siblings (both full siblings and full 
and half siblings): hazard ratios are adjusted for child’s age at diagnosis, sex, place of residence, and maternal 
age at diagnosis. Place of residence: hazard ratios are adjusted for child’s age at diagnosis, sex, number of full 
siblings, and mother's age. Mother’s age at diagnosis: hazard ratios are adjusted for child’s age at diagnosis, sex, 
place of residence, and number of full siblings. Father’s age at diagnosis: hazard ratios are adjusted for child’s 
age at diagnosis, sex, place of residence, and number of full siblings. 3 cases missed information on place of 
residence, 1 case missed information on father’s age at diagnosis. 
 
** Hazard ratio with corresponding 95% confidence interval. 
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 Figure 1c: Full period multiple Cox regression analyses of the association between family characteristics 
and 10 year overall survival from childhood haematological malignancies in Denmark. Fully adjusted 
hazards ratios with 95% confidence intervals for Non-Hodgkin’s lymphoma (NHL) survival. Confidence 
intervals which exceed a hazard ratio of 7 are trunked in the figure and marked with an arrow. 
* Adjustment variables vary by family characteristic. Birth order: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence, and maternal age at diagnosis. Number of siblings (both full siblings and full and 
half siblings): hazard ratios are adjusted for child’s age at diagnosis, sex, place of residence, and maternal age at 
diagnosis. Place of residence: hazard ratios are adjusted for child’s age at diagnosis, sex, number of full siblings, 
and mother's age. Mother’s age at diagnosis: hazard ratios are adjusted for child’s age at diagnosis, sex, place of 
residence, and number of full siblings. Father’s age at diagnosis: hazard ratios are adjusted for child’s age at 
diagnosis, sex, place of residence, and number of full siblings. 3 cases missed information on place of residence. 
 
** Hazard ratio with corresponding 95% confidence interval. 
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ABSTRACT 
Many studies have investigated the possible association between birth order and risk of 
childhood cancer, although the evidence to date has been inconsistent. Birth order has been 
used as a marker for various in utero or childhood exposures and is relatively straightforward 
to assess. Data was obtained on all children born in Denmark between 1973 and 2010, 
involving almost 2.5 million births and about 5,700 newly diagnosed childhood cancers 
before the age of 20 years. Data were analyzed using Poisson regression models. We failed to 
observe associations between birth order and risk of any childhood cancer subtype, including 
acute lymphoblastic leukemia; all rate ratios were close to one. Considering stillbirths and/or 
controlling for birth weight and parental age in the analyses had no effect on the results. We 
observed an association between cancer during infancy and being an only child, explained by 
observing that among firstborn children those who had cancer during infancy had a 1.7-fold 
statistically significant odds of having subsequent siblings compared to those who did not 
have cancer. In conclusion, we did not observe an association between birth order and the 
risk of childhood cancer. 
 
Key words: birth order, childhood cancer, leukemia, risk factors, Denmark 
 
Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia; 
CNS, central nervous system; RR, rate ratio; CI, 95% confidence interval 
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INTRODUCTION 
Little is known about the etiology of the heterogeneous group of childhood cancers, but both 
genetic and environmental factors have been suggested to play a role [1-3]. Many studies 
have investigated the possible association between birth order and risk of childhood cancer, 
although the evidence to date has been inconsistent [1, 4-12]. As birth order is relatively 
straightforward to obtain, either through routine data sources such as birth registries or 
questionnaire-based studies, where it is generally acknowledged to be well reported [13], it 
has often been used as a surrogate marker for in utero and/or childhood exposures. 
Most notably, birth order has been used as a proxy for examining the role of infectious 
exposures early in life and the subsequent development of acute lymphoblastic leukemia 
(ALL), a topic about which there has been much debate, particularly with respect to the 
“delayed infection” hypothesis [14-16]. According to this hypothesis ALL results from an 
abnormal reaction to delayed exposure to common infections [17, 18]. It would then be 
expected that firstborn children would have less contact with infectious agents than children 
with older siblings and as such have an increased risk of ALL. However, given that data from 
medical records suggest that children who develop ALL between the ages of 2-5 years have, 
on average, more infectious illness episodes in the first year of life than those who do not [14, 
19-21] it would also be plausible for children with increasing birth order to be at increased 
risk of ALL.  
With respect to in utero exposures, birth order acts as a surrogate for hormone levels, as a 
mother’s first pregnancy differs endocrinologically from later pregnancies [22] with both 
estrogen and progesterone levels shown to be higher during first pregnancies [23]. Indeed 
epidemiological studies suggest a decreased risk of testicular cancer with increasing birth 
order [24]. There is also a well-established positive relationship between maternal parity and 
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birth weight [25], with high birth weight associated with several different childhood cancer 
types, including ALL [5, 9, 26, 27]. Furthermore, there is recent evidence to suggest that 
maternal immune response may also vary with parity [28] and taken together, these two 
observations may be important for ALL development. One study observed an elevated risk 
with high birth weight in ALL patients who were first rather than later born, which may or 
may not reflect the combination of larger fetal size and later exposure to infectious pathogens 
incurred more frequently in the firstborn child [29]. While birth weight is regarded as a causal 
factor for several childhood cancers, parental age shows inconsistent evidence [1], but both 
factors are related to birth order. 
In addition to causal mechanisms, alternative explanations cannot be ruled out. One may 
speculate that having a child with cancer would impact on family planning, for example by 
not having further children or by delaying having further children. Hence, sampling in case-
control studies might increase the chance for controls to be of higher birth order due to larger 
average numbers of siblings. Lastly, in the case-control studies requiring active participation, 
family size may be related to willingness to participate introducing selection bias into a study, 
as it was observed for other family characteristics [30]. 
The objective of the present study was to investigate the association between birth order and 
childhood cancer in a nationwide birth cohort over a long time period. For this we obtained 
data on all children born in Denmark between 1973 and 2010, involving almost 2.5 million 
births and about 5,700 newly diagnosed childhood cancers before the age of 20 years. 
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MATERIALS AND METHODS 
From the Central Population Register (CPR), we obtained information on all children born in 
Denmark between January, 1, 1973 (start of the Danish Medical Birth Registry, see below) 
and December, 31, 2010. Since 1968, all Danish residents receive a unique CPR number, 
which includes date of birth and sex of the child, and permits accurate record linkage between 
the different national registries in Denmark [31]. The CPR also includes up to date 
information on vital status, migration, and first-degree relatives. Through the mother of the 
index child, all siblings, including their date of birth, were identified in the CPR and all 
stillbirths in the Danish Medical Birth Register; i.e., information used as the basis for 
counting of birth order and pregnancy order. The Danish Medical Birth Register was 
established in 1973 [33] and includes information on parental age at child birth as well as the 
birth weight of the child.  
From the nationwide Danish Cancer Registry established in 1943 [32], we identified all 
children diagnosed with cancer below the age of 20 years within the defined birth cohort. The 
cancers were grouped according to the International Childhood Cancer Classification (ICCC; 
ICCC-1 [Birch Marsden Code; 34] until 2003 and ICCC-3 [35] thereafter). We used the 12 
main groups of ICCC, but combined groups XI and XII with group X as “others (X-XII)” 
because of small numbers and very heterogeneous subtypes. In addition, we subdivided group 
I into acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and other 
leukemias. By using only the main groups of ICCC and subgroups for ALL and AML, the 
potential effect of change in diagnostic classification over time has been minimized. 
Our key exposure variable, birth order, was defined in two ways. First, we defined birth order 
counting all live births of the same mother, in line with the hypothesis that the number of 
older siblings would matter (see above-mentioned delayed infection hypothesis). The group 
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of firstborn children was subdivided into those without siblings (only children) and those 
with further siblings with the same mother, to obtain a surrogate measure of even lesser 
infectious contacts for only children compared to other firstborns, while acknowledging the 
distinction was only to arise in the future. Second, we defined birth order including stillborn 
children of the same mother, in line with the hypotheses that the pregnancy order would 
matter. In both definitions, multiple births were treated by assigning the same birth order to 
multiples and then continuing the counting while accounting for the real number of siblings; 
for example, for a mother having twins and one further child, the twins would both have a 
birth order of one while the last child was counted as the third child.  
When including birth weight and parental age at the child’s birth as other explanatory 
variables to adjust for potential confounding, maternal age was dichotomized at age 35 years, 
paternal age at age 40 years, and birth weight was categorized into three categories of < 
2.5kg, 2.5-4 kg, and >4 kg. Alternatively, we have also modelled paternal and maternal age 
using finer categorizations, specifically by categorizing them into 5 year age groups starting 
with <25 years and ending with >40 years for mothers and >45 years for fathers, respectively. 
Further sensitivity analyses looked separately at children born between 1973 and 1990, and 
born between 1991 and 2010, respectively, as day care patterns and birth rates may have 
changed over time. 
Statistical analyses 
We used Poisson regression models to evaluate associations between birth order and 
childhood cancer, estimating the rate ratios (RRs) and corresponding 95% confidence 
intervals (CIs), with and without controlling for maternal age, paternal age, and birth weight. 
All children were followed up from date of birth until the age of 20 years, date of death, date 
of first cancer diagnosis, or end of study period (October, 31, 2013), whichever occurred first. 
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The firstborn children served as the reference group for the comparisons. Tests for linear 
trend using Poisson regression models were also performed. The main analysis included all 
cancers diagnosed up to 20 years of age, but additional analyses were performed restricting to 
those cases aged 0-14 years at diagnosis for quantitative comparison with previous studies 
using this age range for their definition of childhood cancer. For the main analyses, birth 
order excluded stillbirths and RRs were adjusted for maternal age, paternal age, and birth 
weight. Alternatively using logistic regression models or Cox proportional hazards regression 
models did not change any of the results (data not shown). 
Additional analyses subdividing the group of firstborn children into only children and those 
with further siblings revealed an association restricted to infants (see Results). As the most 
likely explanation is reverse causation, we performed an analysis for the firstborn children by 
modelling the odds of having a subsequent sibling and comparing those who had cancer as 
infants to those who did not. Here we used a logistic regression model that included infant 
cancer status, birth year, parental age and birth weight. All analyses were performed using 
SAS 9.3. 
 
RESULTS 
The birth cohort comprised 2,461,283 children, of which 1,262,979 (51.3%) were boys, born 
between 1973 and 2010 inclusively. Annual numbers of births varied between 52,716 in 1985 
and 73,327 in 1975. Among the total cohort, 1,099,058 children were firstborn (44.7%), of 
which 227,913 (9.3% of total and 20.7% of firstborn) remained only children, with 906,852 
(36.8%) second-born, 336,017 (13.7%) third-born, and 119,356 (4.8%) with a birth order of 
four or higher. When stillbirths were taken into account, there were only slight changes to the 
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birth order proportions: 1,094,468 (44.5%) firstborn, 905,362 (36.8%) second-born, 339,069 
(13.8%) third-born and 122,384 (5.0%) with a birth order of four or higher. 
In the study population accruing a total of 38.6 million person-years of follow up, 5,699 
childhood cancers were observed, with leukemias and CNS tumors each representing 
approximately one quarter of cases. Table 1 shows the expected pattern for cancer subtypes 
with respect to age and sex, with higher proportions of boys being diagnosed with 
lymphomas, and cancers such as retinoblastoma, neuroblastoma, and hepatic tumors 
occurring between the ages 1-4 years, and lymphomas occurring in adolescents (15-19 years). 
Regarding birth order, 45.6% of cancer cases were firstborn, similar to the proportion in the 
overall cohort. 
Table 2 shows the associations between birth order and childhood cancers at ages 0-19 years. 
No significant associations were observed between birth order and any of the cancer subtypes 
when using all firstborn children as the reference group; for the majority of cancer types, rate 
ratios (RRs) were all around one. For acute lymphoblastic leukemia (ALL), all RRs were 
slightly below one. None of the p values for the tests for linear trend were statistically 
significant, including for ALL (p=0.10).  
When the reference group was stratified into firstborn children with and without siblings 
(only children), we observed an inverse association with some reduction in RRs for only 
children, especially for acute myeloid leukemia (AML; RR=0.30; CI 0.13-0.69) and 
neuroblastoma (RR=0.58, CI 0.34-0.99), and tendencies for CNS tumor (RR=0.85; CI 0.69-
1.05), and sarcoma (RR=0.67; CI 0.42-1.07). As these cancers are more likely to be 
diagnosed at a younger age, a separate post-hoc analysis was conducted combining infants 
(up to age 1 year) of all cancers: the respective RR for only children was 0.53 (CI 0.35-0.80); 
reversing the direction of the analysis as the more plausible pathway modeling the odds of 
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having a subsequent sibling (see Methods) showed a 1.7-fold increased odds (CI 1.13-2.62) 
among firstborn infants with cancer, based on 28 infants with cancer without subsequent 
sibling and 193 with subsequent sibling.  
Table 2 also shows the same set of results between birth order and different types of cancers 
among cases aged 0-14 years. Results were similar to the broader age range. None of the p 
values for the tests for linear trend were statistically significant. 
Sensitivity analyses taking into account stillbirths of the same mother in the counting of 
pregnancy order, had no notable effect as RRs only marginally changed compared to the 
main analysis (data not shown). Adjustment for parental age and birth weight had little effect, 
except marginally for all cancers combined and CNS tumors, where non-adjusted RRs were 
slightly lower than one (but statistically non-significant) and varied around one after 
adjustment (data not shown), and also the way how paternal and maternal age were modelled 
(dichotomous or using a finer categorization, see Methods) had no impact. Sensitivity 
analysis by time period (born between 1973 and 1990, and born between 1991 and 2010, 
respectively) did not show any consistent patterns, with small deviations most likely due to 
chance (data not shown). 
 
DISCUSSION 
In this large study which included almost 2.5 million children born over a 37 year period and 
5,699 cases of childhood cancer, we failed to observe associations between birth order and 
risk of any of the childhood cancer subtypes. Considering stillbirths and/or controlling for 
birth weight or parental age in the analyses had no effect on the results. Hence, we didn’t find 
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support for the hypothesis that either the number of older siblings or the pregnancy order 
would matter. 
Our study has a number of strengths over those previously published. Firstly, we adopted a 
nationwide approach with complete follow-up and virtually no missing data and thus provide 
a factual reflection of the situation in Denmark. Furthermore, we had the opportunity to 
incorporate accurate data on stillbirths into our analyses, as well as on some potential 
confounding factors, in particular birth weight and parental age – although neither variable 
impacted the overall results. However, one of the limitations was the lack of socioeconomic 
characteristics, such as parental education or income, given that previous research has shown 
that individual social position was not related with the risk of childhood leukemia in 
Denmark, but children born in low-income municipalities had an increased risk [36].  
For ALL, results from epidemiological studies are not very consistent. In a five-state register-
based study in the US with 4,699 ALL cases diagnosed 1980-2004, odds ratios were non-
significantly lower than one, namely 0.97, 0.96, and 0.94, for children born second, third, or 
fourth or higher, respectively, compared to firstborn children [4]. In a Californian register-
based case-control study of 4,721 ALL cases diagnosed 1988-2008 (overlapping with [4]), 
the observed odds ratio was 0.97 (CI 0.87-1.08) for higher birth order versus first [6]. 
Similarly, a Californian record-based case-control study with 3,402 ALL cases aged 0-5 years 
from 1988-2007 (overlapping with [4, 6]) showed non-significant odds ratios of 1.00, 0.95 
and 0.91 for birth orders second, third and fourth or higher, respectively, compared to 
firstborn children, but indicated some stronger decrease in non-Hispanic whites compared to 
Hispanic whites [7). A pooled analysis from the Childhood Leukemia International 
Consortium (CLIC), using data from 11 questionnaire-based case-control studies from 8 
countries with a total of 7,399 ALL cases diagnosed between 1979-2001, showed a pooled 
odds ratio of 0.94 (CI 0.88-1.00) for later born versus firstborn with no monotonic trend of 
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decrease with increasing birth order, but with substantial heterogeneity across studies (I2 of 
71%) [8]. Individual-study odds ratios ranged from 0.69 (CI 0.55-0.86; France) to 1.44 (CI 
1.15-1.79; Quebec, Canada). A large register-based study combining 1,905 ALL cases from 
Denmark, Iceland, Norway and Sweden diagnosed 1984-1999 however showed a monotonic 
trend with decrease in risk of 0.90 (CI 0.84-0.96) per one unit increase in birth order, 
specifically for B-precursor ALL [5]. This is surprising as there is some overlap of the study 
with the present study in their Danish cases; design features cannot explain the differences 
with both studies using an identical setup of registries and it cannot be explained further by 
the restriction to the subtype, as 86% of ALL were B-precursor ALL in the other study. 
Reasons are therefore either a stronger effect in the other Scandinavian countries or the 
restriction to the earlier time period; however, the differences between the two studies were 
also not marked with clearly overlapping confidence intervals. 
Taken together and including our results for ALL, there is a suggestion of an overall, perhaps, 
10% decrease in risk in children of second or higher birth order compared to firstborn 
children with statistical significance depending on the size of study, but also some 
heterogeneity across studies. This could be due to random variation or because the predictive 
power of birth order, as a surrogate for an unknown exposure, may depend on the source 
population of the study. Overall, this finding for birth order does not appear to lend  strong 
support to the delayed infection hypothesis, but neither does it contradict it andother immune-
system related factors may matter more [15, 18]. In Denmark social contacts through day care 
are very common, and the proportion of 0-6 year old children attending day care increased 
from slightly over 40% in 1980 to 75% in 1999 [37]. Given the UK findings of more frequent 
infections during infancy in children with ALL, it is surprising the estimated rate ratio does 
not point in the other direction [19]. 
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Our lack of observation of an association between any of the solid cancers and birth order 
contrasts with the large US study described above, where reduced risks were restricted to 
birth order of four and higher compared to firstborn children were observed for CNS tumors 
(OR 0.77, CI 0.68-0.89), neuroblastomas (OR 0.68, CI 0.55-0.84), and Wilms tumors (OR 
0.67, CI 0.54-0.84), leading to an overall decreased odds ratio for their combined 17,672 
cancer cases combined of 0.87 (CI 0.81-0.93) [4]. Our respective rate ratio for all cancers 
combined was 1.00, and no association was seen with any of the three diagnostic subgroups. 
For later-born children compared to firstborn children, a recent review of neuroblastoma 
found no clear evidence of an association, although the majority of studies found slightly 
decreased risks [38]. A large registry-based study in the Nordic countries of 3,983 CNS 
tumor cases confirmed our finding of no association with birth order, acknowledging some 
overlap in the Danish cases with our birth cohort [10]. In a similar study in the Nordic 
countries involving 3,298 cases of Wilms tumor, the odds ratio of later born children 
compared to firstborn children was 0.98, again consistent with our findings [11]. Overall, 
there appears to be little evidence of an association between birth order and childhood solid 
tumor risk. The findings in the US study for high birth order needs attention regarding which 
underlying exposure may be reflected in the very high birth order in this setting since that 
might explain the findings being different to the Nordic countries; the US proportion of those 
born fourth or higher was twice as high as in Denmark (approximately 10% [4] compared to 
5%), but we do not know whether this plays any role. 
A recent review suggests some evidence of an increased risk of childhood AML with 
increasing birth order, although the authors suggested this could in part be due to a maternal 
age effect [39]. We did find a slightly increased risk even after adjustment for maternal age, 
although stronger for those born second or third than fourth or higher. 
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An intriguing finding of our study was that there was an inverse association between being an 
only child and AML and neuroblastoma, and to some extent with CNS tumors and sarcomas; 
however with the exception of CNS tumors these observations were based on small numbers. 
A stronger association was observed when combining infants irrespective of type of cancer. 
Approximately 10% of Danish children were only children. This is explained by the finding 
that those who have their firstborn child diagnosed with cancer at a very early age decided 
over-proportionally frequently to later have further children, namely 1.7-fold, which may be 
the most likely reason for seeing this association. As the association was seen only in infants 
when all firstborn children were only children and whether they had siblings was only 
determined in the future, the finding would be difficult to interpret etiologically. 
Nevertheless, it could be worthwhile to check how these families differ in for instance in 
social and family factors and occupational exposures. Chance is another option, although 
both the numbers of affected children and the magnitude of effect are not small and the entire 
Danish childhood population was included in our study. Notably, this finding is contrary to 
the initial expectation that families with a child with cancer may have fewer subsequent 
children; we observed that when the firstborn child has cancer during infancy, it increases the 
probability of having a subsequent child. 
In conclusion, we did not observe an association between birth order and the risk of 
childhood cancer. From the totality of the literature, there may be a weak protective effect for 
ALL, although this is still not clear and there is little insight into any causal mechanisms. 
Among firstborn children, infants with cancer had a higher probability of having subsequent 
siblings than other infants; this observation needs to be confirmed in other studies.  
 
  
14 
 
Acknowledgements 
No specific funding was obtained for this study. Costs for data retrieval were covered by the 
collaboration agreement between the IARC and the Danish Cancer Research Center. 
 
  
15 
 
References 
1. Little J. Epidemiology of childhood cancer. IARC Sci Publ. 149. Lyon: IARC, 1999 
2. Savage S, Schüz J. Environmental Chemicals and Childhood Cancer. In: Nriagu J. 
Encyclopedia of Environmental Healthed.: Elsevier Science & Technology, 2011: 336-47. 
3. Buffler P, Kwan M, Reynolds P, Urayama K. Environmental and Genetic Risk Factors for 
Childhood Leukemia: Appraising the Evidence. Cancer Invest. 2005; 23(1): 60-75. 
4. Von Behren J, Spector LG, Mueller BA, Carozza SE, Chow EJ, Fox EE, Horel S, Johnson 
KJ, McLaughlin C, Puumala SE, Ross JA, Reynolds P. Birth order and risk of childhood 
cancer: a pooled analysis from five US States. Int J Cancer. 2011; 128(11):2709-16. 
5. Hjalgrim LL, Rostgaard K, Hjalgrim H, Westergaard T, Thomassen H, Forestier E, 
Gustafsson G, Kristinsson J, Melbye M, Schmiegelow K. Birth weight and risk for childhood 
leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst. 2004; 96(20):1549-
56. 
6. Oksuzyan S, Crespi CM, Cockburn M, Mezei G, Kheifets L. Birth weight and other 
perinatal characteristics and childhood leukemia in California. Cancer Epidemiol. 2012; 
36(6):e359-65. 
7. Marcotte EL, Ritz B, Cockburn M, Yu F, Heck JE. Exposure to Infections and Risk of 
Leukemia in Young Children. Cancer Epidemiol Biomarkers Prev. 2014 May 3. [Epub ahead 
of print] 
8. Rudant J, Lightfoot T, Urayama KY, Petridou E, Dockerty JD, Magnani C, Milne L, 
Spector LG, Ashton L, Dessypris N, Kang AY, Miller M, Rondelli R, Simpson J, Stiakaki E, 
Orsi L, Roman E, Metayer C, Infante-Rivard C, Clavel J. Childhood acute lymphoblastic 
leukemia and indicators of early immune stimulation: a Childhood Leukemia International 
Consortium (CLIC). Under review 
9. Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer 
with factors related to pregnancy and birth. Int J Epidemiol. 1999; 28(4):631-9. 
10. Schmidt LS, Kamper-Jørgensen M, Schmiegelow K, Johansen C, Lähteenmäki P, Träger 
C, Stokland T, Grell K, Gustafson G, Kogner P, Sehested A, Schüz J. Infectious exposure in 
the first years of life and risk of central nervous system tumours in children: analysis of birth 
order, childcare attendance and seasonality of birth. Br J Cancer. 2010; 102(11):1670-5. 
11. Schüz J, Schmidt LS, Kogner P, Lähteenmäki PM, Pal N, Stokland T, Schmiegelow K. 
Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based 
case-control study. Int J Cancer. 2011; 128(9):2166-73. 
12. Johnson KJ, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, Mueller BA, 
Puumala SE, Reynolds P, Von Behren J, Spector LG. Birth characteristics and childhood 
carcinomas. Br J Cancer. 2011; 105(9):1396-401. 
16 
 
13. Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL. Medical record validation of 
maternally reported birth characteristics and pregnancy-related events: a report from the 
Children's Cancer Group. Am J Epidemiol. 1997; 145(1):58-67. 
14. Crouch S, Lightfoot T, Simpson J, Smith A, Ansell P, Roman E. Infectious illness in 
children subsequently diagnosed with acute lymphoblastic leukemia: modeling the trends 
from birth to diagnosis. Am J Epidemiol. 2012; 176(5):402-8. 
15. Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 2012; 
196(3):59-67. 
16. Greaves MF. Commentary: Birth order and risk of childhood acute lymphoblastic 
leukaemia (ALL). Int J Epidemiol. 2001; 30(6):1438-9. 
17. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. 
Eur J Cancer. 1999; 35(2):173-85. 
18. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat 
Rev Cancer. 2006; 6(3):193-203. 
19. Roman E, Simpson J, Ansell P, Lightfoot T, Smith A. Infectious proxies and childhood 
leukaemia: findings from the United Kingdom Childhood Cancer Study (UKCCS). Blood 
Cells Mol Dis. 2009; 42(2):126-8. 
20. Roman E, Simpson J, Ansell P, Kinsey S, Mitchell CD, McKinney PA, Birch JM, 
Greaves M, Eden T; United Kingdom Childhood Cancer Study Investigators. Childhood 
acute lymphoblastic leukemia and infections in the first year of life: a report from the United 
Kingdom Childhood Cancer Study. Am J Epidemiol. 2007; 165(5):496-504 
21. Simpson J, Smith A, Ansell P, Roman E. Childhood leukaemia and infectious exposure: a 
report from the United Kingdom Childhood Cancer Study (UKCCS). Eur J Cancer. 2007; 
43(16):2396-403. 
22. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE. Higher maternal 
levels of free estradiol in first compared to second pregnancy: early gestational differences. J 
Natl Cancer Inst. 1986; 76(6):1035-9. 
23. Maccoby EE, Doering CH, Jacklin CN, Kraemer H. Concentrations of sex hormones in 
umbilical-cord blood: their relation to sex and birth order of infants. Child Dev. 1979; 
50(3):632-42. 
24. Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA. A systematic 
review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--
experiences of the mother. Int J Epidemiol. 2009; 38(6):1532-42. 
25. Juntunen KS, Läärä EM, Kauppila AJ. Grand grand multiparity and birth weight. Obstet 
Gynecol. 1997; 90:495-9. 
17 
 
26. Harder T, Plagemann A, Harder A. Birth weight and subsequent risk of childhood 
primary brain tumors: a meta-analysis. Am J Epidemiol. 2008; 168(4):366-73. 
27. Harder T, Plagemann A, Harder A. Birth weight and risk of neuroblastoma: a meta-
analysis. Int J Epidemiol. 2010; 39(3):746-56. 
28. Jones M, Jeal H, Harris JM, Smith JD, Rose ML, Taylor AN, Cullinan P. Association of 
maternal anti-HLA class II antibodies with protection from allergy in offspring. Allergy. 
2013; 68(9):1143-9. 
29. Schüz J, Forman MR. Birthweight by gestational age and childhood cancer. Cancer 
Causes Control. 2007; 18(6):655-63. 
30. Schüz J. Non-response bias as a likely cause of the association between young maternal 
age at the time of delivery and the risk of cancer in the offspring. Paediatr Perinat Epidemiol. 
2003; 17(1):106-12. 
31. Thygesen LC, Daasnes C, Thaulow I, Bronnum-Hansen H. Introduction to Danish 
(nationwide) registers on health and social issues: structure, access, legislation, and archiving. 
Scand J Public Health 2011; 39(7 Suppl):12-16. 
32. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39(7 Suppl):42-
45. 
33. Nguyen-Nielsen M, Svensson E, Vogel I, Ehrenstein V, Sunde L. Existing data sources 
for clinical epidemiology: Danish registries for studies of medical genetic diseases. Clin 
Epidemiol. 2013; 5:249-62. 
34. Birch JM, Marsden HB. A classification scheme for childhood cancer. Int J Cancer. 1987; 
40(5):620-4. 
35. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of 
Childhood Cancer, third edition. Cancer. 2005; 103(7):1457-67. 
36. Raaschou-Nielsen O, Obel J, Dalton S, Tjønneland A, Hansen J. Socioeconomic status 
and risk of childhood leukaemia in Denmark. Scand J Public Health. 2004; 32(4):279-86. 
37. Petersen AN (editor). Børns levevilkår [Childrens living conditions]. Statistics Denmark 
2002; Statistics Denmark Printing, Copenhagen; ISBN 87-501-1286-4 
38. Heck JE, Ritz B, Hung RJ, Hashibe M, Boffetta P. The epidemiology of neuroblastoma: a 
review. Paediatr Perinat Epidemiol. 2009; 23(2):125-43. 
39. Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid 
leukemia. Pediatr Blood Cancer. 2013; 60(5):728-33. 
 
 
18
 
 Ta
bl
e 
1.
 D
em
og
ra
ph
ic
 c
ha
ra
ct
er
is
tic
s o
f c
hi
ld
ho
od
 c
an
ce
r c
as
es
 a
t a
ge
s 0
-1
9 
ye
ar
s o
bs
er
ve
d 
in
 a
 c
oh
or
t o
f a
ll 
liv
e-
bo
rn
 c
hi
ld
re
n 
bo
rn
 in
 
D
en
m
ar
k 
be
tw
ee
n 
19
73
 a
nd
 2
01
0,
 fo
llo
w
ed
 u
p 
un
til
 3
1/
10
/2
01
3,
 b
y 
se
x,
 a
ge
 g
ro
up
 a
t d
ia
gn
os
is
, a
nd
 b
irt
h 
or
de
r, 
an
d 
by
 c
an
ce
r t
yp
e.
 
 
A
ll 
ca
nc
er
s 
(I
-X
II)
 
Le
uk
em
ia
s 
(I
) 
A
LL
a 
(I
a)
 
A
M
Lb
 
(I
b)
 
Ly
m
ph
om
as
 
(I
I)
 
C
N
S 
Tu
m
or
s 
(I
II)
 
N
eu
ro
bl
as
to
m
as
 
(I
V
) 
 
N
 
%
 
N
 
%
 
N
 
%
 
N
 
%
 
N
 
%
 
N
 
%
 
N
 
%
 
To
ta
l 
 
56
99
 
10
0.
0 
14
64
 
10
0.
0 
11
37
 
10
0.
0 
24
5 
10
0.
0 
64
8 
10
0.
0 
14
69
 
10
0.
0 
30
3 
10
0.
0 
Se
x 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
B
oy
s 
31
50
 
55
.3
 
81
7 
55
.8
 
65
6 
57
.7
 
11
7 
47
.8
 
42
2 
65
.1
 
77
1 
52
.5
 
16
8 
55
.4
 
   
G
irl
s 
 
25
49
 
44
.7
 
64
7 
44
.2
 
48
1 
42
.3
 
12
8 
52
.2
 
22
6 
34
.9
 
69
8 
47
.5
 
13
5 
44
.6
 
A
ge
 a
t 
di
ag
no
si
s 
(y
ea
rs
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
< 
1 
50
2 
8.
8 
89
 
6.
1 
30
 
2.
6 
40
 
16
.3
 
12
 
1.
9 
11
2 
7.
6 
99
 
32
.7
 
   
1-
4 
17
34
 
30
.4
 
73
5 
50
.2
 
61
8 
54
.4
 
90
 
36
.7
 
71
 
11
.0
 
36
5 
24
.9
 
14
7 
48
.5
 
   
5-
9 
11
67
 
20
.5
 
33
0 
22
.5
 
28
5 
25
.1
 
34
 
13
.9
 
13
7 
21
.1
 
41
7 
28
.4
 
35
 
11
.5
 
   
10
-1
4 
95
6 
16
.8
 
17
3 
11
.8
 
13
0 
11
.4
 
34
 
13
.9
 
16
4 
25
.3
 
30
0 
20
.4
 
16
 
5.
3 
   
15
-1
9 
 
13
40
 
23
.5
 
13
7 
9.
4 
74
 
6.
5 
47
 
19
.2
 
26
4 
40
.7
 
27
5 
18
.7
 
6 
2.
0 
B
irt
h 
or
de
r 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
1s
t   
25
95
 
45
.6
 
65
8 
44
.9
 
52
3 
46
.0
 
96
 
39
.1
 
30
4 
46
.9
 
68
3 
46
.5
 
13
4 
44
.2
 
   
2n
d   
20
90
 
36
.7
 
54
4 
37
.2
 
41
2 
36
.2
 
10
1 
41
.2
 
22
5 
34
.7
 
53
3 
36
.3
 
11
2 
37
.0
 
   
3r
d   
75
0 
13
.2
 
20
0 
13
.7
 
15
3 
13
.5
 
37
 
15
.2
 
82
 
12
.7
 
18
5 
12
.6
 
47
 
15
.5
 
   
4t
h  o
r h
ig
he
r 
26
4 
4.
6 
62
 
4.
2 
49
 
4.
3 
11
 
4.
5 
37
 
5.
7 
68
 
4.
6 
10
 
3.
3 
(c
on
tin
ue
d)
 
 
19
 
  
R
et
in
ob
la
st
om
as
 
(V
) 
R
en
al
 tu
m
or
s 
(V
I)
 
H
ep
at
ic
 tu
m
or
s 
(V
II)
 
B
on
e 
Tu
m
or
s 
(V
II
I)
 
Sa
rc
om
as
 
(I
X
) 
O
th
er
s 
(X
-X
II)
 
 
 
N
 
%
 
N
 
%
 
N
 
%
 
N
 
%
 
N
 
%
 
N
 
%
 
 
 
To
ta
l (
N
) 
 
14
0 
10
0.
0 
25
0 
10
0.
0 
67
 
10
0.
0 
23
3 
10
0.
0 
32
5 
10
0.
0 
80
0 
10
0.
0 
 
 
Se
x 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
B
oy
s 
79
 
56
.4
 
11
8 
47
.2
 
38
 
56
.7
 
12
3 
52
.8
 
19
2 
59
.1
 
42
2 
52
.8
 
 
 
   
G
irl
s 
 
61
 
43
.6
 
13
2 
52
.8
 
29
 
43
.3
 
11
0 
47
.2
 
13
3 
40
.9
 
37
8 
47
.3
 
 
 
A
ge
 a
t 
di
ag
no
si
s 
(y
ea
rs
) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
< 
1 
63
 
45
.0
 
35
 
14
.0
 
17
 
25
.4
 
1 
0.
4 
33
 
10
.2
 
41
 
5.
1 
 
 
   
1-
4 
71
 
50
.7
 
14
6 
58
.4
 
27
 
40
.3
 
13
 
5.
6 
93
 
28
.6
 
66
 
8.
3 
 
 
   
5-
9 
6 
4.
3 
50
 
20
.0
 
7 
10
.4
 
64
 
27
.5
 
65
 
20
.0
 
56
 
7.
0 
 
 
   
10
-1
4 
0 
0.
0 
12
 
4.
8 
6 
9.
0 
87
 
37
.3
 
56
 
17
.2
 
14
2 
17
.7
 
 
 
   
15
-1
9 
 
0 
0.
0 
7 
2.
8 
10
 
14
.9
 
68
 
29
.2
 
78
 
24
.0
 
49
5 
61
.9
 
 
 
B
irt
h 
or
de
r 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
1s
t   
61
 
43
.6
 
11
0 
44
.0
 
28
 
41
.8
 
10
9 
46
.7
 
14
7 
45
.3
 
36
1 
45
.1
 
 
 
   
2n
d   
50
 
35
.7
 
96
 
38
.4
 
26
 
38
.8
 
78
 
33
.5
 
12
1 
37
.2
 
30
5 
38
.1
 
 
 
   
3r
d   
20
 
14
.3
 
32
 
12
.8
 
7 
10
.4
 
34
 
14
.6
 
43
 
13
.2
 
10
0 
12
.5
 
 
 
   
4t
h  o
r h
ig
he
r 
9 
6.
4 
12
 
4.
8 
6 
9.
0 
12
 
5.
2 
14
 
4.
3 
34
 
4.
3 
 
 
a  A
LL
= 
ac
ut
e 
ly
m
ph
ob
la
st
ic
  l
eu
ke
m
ia
, b
 A
M
L 
= 
ac
ut
e 
m
ye
lo
id
 le
uk
em
ia
 
  
 
20
 
 Ta
bl
e 
2.
 A
dj
us
te
da
 a
ss
oc
ia
tio
ns
 b
et
w
ee
n 
bi
rth
 o
rd
er
 a
nd
 c
hi
ld
ho
od
 c
an
ce
rs
 a
t a
ge
s 0
-1
9 
an
d 
in
 a
 su
b-
co
ho
rt 
of
 th
os
e 
di
ag
no
se
d 
at
 a
ge
s 0
-1
4 
ye
ar
s, 
by
 c
an
ce
r t
yp
e,
 in
 a
 c
oh
or
t o
f a
ll 
ch
ild
re
n 
liv
e-
bo
rn
 in
 D
en
m
ar
k 
be
tw
ee
n 
19
73
 a
nd
 2
01
0 
, f
ol
lo
w
ed
 u
p 
un
til
 3
1/
10
/2
01
3.
  
A
ge
s 0
-1
9 
ye
ar
s  
A
ll 
ca
nc
er
s 
(I
-X
II)
 
Le
uk
em
ia
s 
(I
) 
A
LL
b 
(I
a)
 
A
M
Lc
 
(I
b)
 
Ly
m
ph
om
as
 
(I
I)
 
C
N
S 
Tu
m
or
s 
(I
II)
 
N
eu
ro
bl
as
to
m
as
 
(I
V
) 
 
R
R
c  
C
I 
R
R
d  
C
I 
R
R
  
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
B
irt
h 
or
de
r 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
1s
t  
1.
00
 
(r
ef
.) 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
   
2n
d   
0.
97
 
0.
92
-1
.0
3 
0.
98
 
0.
88
-1
.1
1 
0.
93
 
0.
82
-1
.0
6 
1.
30
 
0.
97
-1
.7
3 
0.
91
 
0.
76
-1
.0
7 
0.
96
 
0.
86
-1
.0
8 
0.
97
 
0.
75
-1
.2
5 
   
3r
d   
0.
95
 
0.
87
-1
.0
3 
0.
97
 
0.
82
-1
.1
4 
0.
91
 
0.
75
-1
.0
9 
1.
35
 
0.
91
-2
.0
0 
0.
89
 
0.
69
-1
.1
5 
0.
91
 
0.
77
-1
.0
8 
1.
10
 
0.
78
-1
.5
5 
   
4t
h  o
r h
ig
he
r 
0.
96
 
0.
84
-1
.1
0 
0.
81
 
0.
61
-1
.0
7 
0.
80
 
0.
58
-1
.0
9 
1.
00
 
0.
49
-2
.0
2 
1.
20
 
0.
83
-1
.7
3 
1.
02
 
0.
78
-1
.3
3 
0.
72
 
0.
37
-1
.4
0 
p 
fo
r t
re
nd
d  
 
0.
20
 
 
0.
25
 
 
0.
10
 
 
0.
21
 
 
0.
81
 
 
0.
48
 
 
0.
78
 
A
ge
s 0
-1
9 
ye
ar
s 
R
et
in
ob
la
st
om
as
 
(V
) 
R
en
al
 tu
m
or
s 
(V
I)
 
H
ep
at
ic
 tu
m
or
s 
(V
II)
 
B
on
e 
Tu
m
or
s 
(V
II
I)
 
Sa
rc
om
as
 
(I
X
) 
O
th
er
s 
(X
-X
II)
 
 
 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
 
 
B
irt
h 
or
de
r 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
1s
t  
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
 
 
   
2n
d   
0.
96
 
0.
65
-1
.4
0 
1.
05
 
0.
79
-1
.3
9 
1.
05
 
0.
61
-1
.8
2 
0.
87
 
0.
65
-1
.1
6 
0.
99
 
0.
78
-1
.2
6 
1.
03
 
0.
88
-1
.2
0 
 
 
   
3r
d   
1.
04
 
0.
61
-1
.7
6 
1.
01
 
0.
68
-1
.5
2 
0.
72
 
0.
31
-1
.7
0 
1.
05
 
0.
71
-1
.5
6 
0.
97
 
0.
69
-1
.3
8 
0.
91
 
0.
72
-1
.1
5 
 
 
   
4t
h  o
r h
ig
he
r 
1.
48
 
0.
71
-3
.0
8 
1.
18
 
0.
63
-2
.1
9 
1.
02
 
0.
33
-3
.1
1 
1.
12
 
0.
60
-2
.0
8 
0.
79
 
0.
43
-1
.4
5 
0.
91
 
0.
63
-1
.3
2 
 
 
p 
fo
r t
re
nd
d  
 
0.
52
 
 
0.
69
 
 
0.
72
 
 
0.
90
 
 
0.
59
 
 
0.
51
 
 
 
(t
ab
le
 to
 b
e 
co
nt
in
ue
d)
 
 
21
 
 A
ge
s 0
-1
4 
ye
ar
s 
A
ll 
ca
nc
er
s 
(I
-X
II)
 
Le
uk
em
ia
s 
(I
) 
A
LL
a 
(I
a)
 
A
M
Lb
 
(I
b)
 
Ly
m
ph
om
as
 
(I
I)
 
C
N
S 
Tu
m
or
s 
(I
II)
 
N
eu
ro
bl
as
to
m
as
 
(I
V
) 
 
R
R
c  
C
Id  
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
B
irt
h 
or
de
r 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
1s
t  
1.
00
 
(r
ef
.) 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
   
2n
d   
0.
96
 
0.
89
-1
.0
2 
0.
99
 
0.
88
-1
.1
2 
0.
93
 
0.
81
-1
.0
7 
1.
38
 
0.
99
-1
.8
9 
0.
88
 
0.
70
-1
.1
0 
0.
91
 
0.
80
-1
.0
3 
0.
98
 
0.
76
-1
.2
7 
   
3r
d   
0.
93
 
0.
84
-1
.0
2 
0.
99
 
0.
84
-1
.1
8 
0.
91
 
0.
75
-1
.1
0 
1.
54
 
1.
01
-2
.3
5 
0.
70
 
0.
49
-0
.9
9 
0.
86
 
0.
71
-1
.0
4 
1.
14
 
0.
80
-1
.6
1 
   
4t
h  o
r h
ig
he
r 
0.
96
 
0.
83
-1
.1
2 
0.
82
 
0.
61
-1
.1
0 
0.
82
 
0.
60
-1
.1
3 
0.
84
 
0.
36
-1
.9
7 
0.
99
 
0.
61
-1
.6
3 
0.
94
 
0.
70
-1
.2
7 
0.
75
 
0.
39
-1
.4
5 
p 
fo
r t
re
nd
d  
 
0.
13
 
 
0.
41
 
 
0.
14
 
 
0.
17
 
 
0.
14
 
 
0.
13
 
 
0.
94
 
A
ge
s 0
-1
4 
ye
ar
s 
R
et
in
ob
la
st
om
as
 
(V
) 
R
en
al
 tu
m
or
s 
(V
I)
 
H
ep
at
ic
 tu
m
or
s 
(V
II)
 
B
on
e 
Tu
m
or
s 
(V
II
I)
 
Sa
rc
om
as
 
(I
X
) 
O
th
er
s 
(X
-X
II)
 
 
 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
R
R
 
C
I 
 
 
B
irt
h 
or
de
r 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
1s
t  
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
1.
00
 
- 
 
 
   
2n
d   
0.
96
 
0.
66
-1
.4
1 
1.
06
 
0.
79
-1
.4
1 
1.
15
 
0.
64
-2
.0
9 
0.
90
 
0.
63
-1
.2
6 
0.
98
 
0.
74
-1
.3
0 
0.
96
 
0.
74
-1
.2
4 
 
 
   
3r
d   
1.
05
 
0.
62
-1
.7
7 
1.
06
 
0.
71
-1
.5
9 
0.
80
 
0.
32
-2
.0
3 
0.
95
 
0.
59
-1
.5
5 
0.
91
 
0.
61
-1
.3
7 
0.
89
 
0.
61
-1
.2
9 
 
 
   
4t
h  o
r h
ig
he
r 
1.
50
 
0.
72
-3
.1
2 
1.
25
 
0.
67
-2
.3
2 
1.
40
 
0.
45
-4
.3
6 
1.
29
 
0.
65
-2
.5
7 
0.
93
 
0.
49
-1
.7
6 
1.
16
 
0.
69
-1
.9
6 
 
 
p 
fo
r t
re
nd
d  
 
0.
50
 
 
0.
52
 
 
0.
85
 
 
0.
87
 
 
0.
67
 
 
0.
93
 
 
 
a 
A
dj
us
te
d 
fo
r p
ar
en
ta
l a
ge
 a
nd
 b
irt
h 
w
ei
gh
t, 
b  A
LL
= 
ac
ut
e 
ly
m
ph
ob
la
st
ic
 le
uk
em
ia
, c
 A
M
L 
= 
ac
ut
e 
m
ye
lo
id
 le
uk
em
ia
, d
 R
R
=r
at
e 
ra
tio
, e
 C
I=
95
%
 
co
nf
id
en
ce
 in
te
rv
al
, d
 p
 v
al
ue
 fo
r t
es
t f
or
 li
ne
ar
 tr
en
d 
w
ith
 in
cr
ea
si
ng
 b
irt
h 
or
de
r 
 
XVI 
 
Acknowledgements 
I would like to thank all those who supported me over the last years and months and 
contributed towards the completion of this doctoral dissertation. 
Firstly, I express my gratitude to my supervisors Professor Joachim Schüz and Professor Hajo 
Zeeb for their guidance, advice and support. I also like to particularly thank my colleagues 
Fiona and Sara for their support and advice on the dissertation. 
Secondly, I would like to thank the entire Section of Environment and Radiation at IARC. 
Since I arrived at IARC many people helped me to orient myself in my work at IARC and in 
Lyon.  
My special thanks to Ann, Anya, Carolina, Caroline, Charlotte, Eleonora, Fiona, Helen, Lucian, 
Melina, Rachel D, Rachel H, Rémi, Sara and Simon who are not only colleagues but have 
become friends. Thank you for your constant support in both my work (including proof 
reading my thesis) and life outside work. Thanks for all the fun times we have had and also 
your emotional support.  
Furthermore, I would also like to thank my friends and family (and in particular Daniela) for 
their support, sympathy and steady friendship over the last years irrespective of the 
geographical distance between us most of the time.  
And last but not least would like to take the opportunity to thank all my international co-
authors and other colleagues I worked with over the years. Thank you for sharing your 
expertise, giving advice and contributing to my work. But especially I like to thank you for 
wonderful collaborations, the hospitality and kindness and giving me insight into your 
culture. 
  
XVII 
 
Versicherung der eigenständigen 
Verfassung 
Hiermit versichere ich, dass ich die vorliegende Dissertation selbständig verfasst und keine 
weiteren als die angegebenen Quellen und Hilfsmittel verwendet habe. Alle Stellen, die ich 
wörtlich oder sinngemäß aus anderen Werken entnommen habe, sind unter Angabe der 
Quellen als solche kenntlich gemacht.  
Diese Arbeit hat in gleicher oder ähnlicher Form noch keiner anderen Prüfungsbehörde 
vorgelegen. 
 
 
Lyon, 19. März 2015   
Ort und Datum 
 
Friederike Erdmann   
Unterschrift 
 
 
